EFSA (European Food Safety Authority) and ECDC (European Centre for Disease Prevention and Control), 2014. The European Union Summary Report on Trends and Sources of Zoonoses, Zoonotic Agents and Food-borne Outbreaks in 2012 by 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners 
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
• You may not further distribute the material or use it for any profit-making activity or commercial gain 
• You may freely distribute the URL identifying the publication in the public portal  
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
   
 
Downloaded from orbit.dtu.dk on: Nov 08, 2017
EFSA (European Food Safety Authority) and ECDC (European Centre for Disease
Prevention and Control), 2014. The European Union Summary Report on Trends and
Sources of Zoonoses, Zoonotic Agents and Food-borne Outbreaks in 2012
Korsgaard, Helle Bisgaard; Helwigh, Birgitte; Sørensen, Anna Irene Vedel; Skiby, Jeffrey Edward; Borck
Høg, Birgitte; EFSA Journal
Publication date:
2014
Document Version
Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
EFSA Journal (2014). EFSA (European Food Safety Authority) and ECDC (European Centre for Disease
Prevention and Control), 2014. The European Union Summary Report on Trends and Sources of Zoonoses,
Zoonotic Agents and Food-borne Outbreaks in 2012. Parma, Italy: Europen Food Safety Authority.  (The EFSA
Journal; No. 3547, Vol. 12(2)).
  
EFSA Journal 2014;12(2):3547 
 
Suggested citation: EFSA (European Food Safety Authority) and ECDC (European Centre for Disease Prevention and 
Control), 2014. The European Union Summary Report on Trends and Sources of Zoonoses, Zoonotic Agents and Food-borne 
Outbreaks in 2012. EFSA Journal 2014;12(2):3547, 312 pp. doi:10.2903/j.efsa.2014.3547  
Available online: www.efsa.europa.eu/efsajournal 
© European Food Safety Authority, 2014 
SCIENTIFIC REPORT OF EFSA AND ECDC 
The European Union Summary Report on Trends and Sources of Zoonoses, 
Zoonotic Agents and Food-borne Outbreaks in 2012
1
 
European Food Safety Authority
2, 3 
European Centre for Disease Prevention and Control
2, 3 
European Food Safety Authority (EFSA), Parma, Italy 
European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden 
This scientific output, published on 17 July 2014, replaces the earlier version published on 19 February 2014*. 
ABSTRACT 
The European Food Safety Authority and the European Centre for Disease Prevention and Control analysed 
information submitted by 27 European Union Member States on the occurrence of zoonoses and food-borne 
outbreaks in 2012. Campylobacteriosis was the most commonly reported zoonosis, with 214,268 confirmed 
human cases. The occurrence of Campylobacter continued to be high in broiler meat at EU level. The decreasing 
trend in confirmed salmonellosis cases in humans continued with a total of 91,034 cases reported in 2012. Most 
Member States met their Salmonella reduction targets for poultry. In foodstuffs, Salmonella was most often 
detected in meat and products thereof. The number of confirmed human listeriosis cases increased to 1,642. 
Listeria was seldom detected above the legal safety limit from ready-to-eat foods. A total of 5,671 confirmed 
verocytotoxigenic Escherichia coli (VTEC) infections were reported. VTEC was also reported from food and 
animals. The number of human tuberculosis cases due to Mycobacterium bovis was 125 cases, and 328 cases of 
brucellosis in humans were reported. The prevalence of bovine tuberculosis in cattle increased, and the 
prevalence of brucellosis in cattle, sheep or goats decreased. Trichinella caused 301 human cases and was 
mainly detected in wildlife. One domestically acquired human case and one imported human case of rabies were 
reported. The number of rabies cases in animals increased compared with 2011. A total of 643 confirmed human 
cases of Q fever were reported. Almost all reporting Member States found Coxiella burnetii (Q fever) positive 
cattle, sheep or goats. A total of 232 cases of West Nile fever in humans were reported. Nine Member States 
reported West Nile virus findings in solipeds. Most of the 5,363 reported food-borne outbreaks were caused by 
Salmonella, bacterial toxins, viruses and Campylobacter, and the main food sources were eggs, mixed foods and 
fish and fishery products. 
© European Food Safety Authority, European Centre for Disease Prevention and Control, 2014 
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About EFSA 
The European Food Safety Authority (EFSA), located in Parma, Italy, was established and funded by the 
European Union (EU) as an independent agency in 2002 following a series of food scares that prompted the 
European public to voice concerns about food safety and the ability of regulatory authorities to protect 
consumers. EFSA provides objective scientific advice on all matters, in close collaboration with national 
authorities and in open consultation with its stakeholders, with a direct or indirect impact on food and feed 
safety, including animal health and welfare and plant protection. EFSA is also consulted on nutrition in 
relation to EU legislation. EFSA’s work falls into two areas: risk assessment and risk communication. In 
particular, EFSA’s risk assessments provide risk managers (EU institutions with political accountability, i.e. 
the European Commission, the European Parliament and the Council) with a sound scientific basis for 
defining policy-driven legislative or regulatory measures required to ensure a high level of consumer 
protection with regard to food and feed safety. EFSA communicates to the public in an open and transparent 
way on all matters within its remit. Collection and analysis of scientific data, identification of emerging risks 
and scientific support to the Commission, particularly in the case of a food crisis, are also part of EFSA’s 
mandate, as laid down in the founding Regulation (EC) No 178/2002
4
 of 28 January 2002. 
About ECDC 
The European Centre for Disease Prevention and Control (ECDC), an EU agency based in Stockholm, 
Sweden, was established in 2005. The objective of ECDC is to strengthen Europe’s defences against 
infectious diseases. According to Article 3 of the founding Regulation (EC) No 851/2004
5
 of 21 April 2004, 
ECDC’s mission is to identify, assess and communicate current and emerging threats to human health 
posed by infectious diseases. In order to achieve this mission, ECDC works in partnership with national 
public health bodies across Europe to strengthen and develop EU-wide disease surveillance and early 
warning systems. By working with experts throughout Europe, ECDC pools Europe’s knowledge on health so 
as to develop authoritative scientific opinions about the risks posed by current and emerging infectious 
diseases. 
About the report 
EFSA is responsible for examining the data on zoonoses, antimicrobial resistance and food-borne outbreaks 
submitted by Member States in accordance with Directive 2003/99/EC
6
 and for preparing the EU Summary 
Report from the results. Data from 2012 in this EU Summary Report were produced in collaboration with 
ECDC which provided the information on, and analyses of, zoonoses cases in humans.  
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Summary 
Zoonoses are infections and diseases that are naturally transmissible, directly or indirectly, for example via 
contaminated foodstuffs, between animals and humans. The severity of these diseases in humans varies 
from subclinical infection or mild symptoms to life-threatening conditions. In order to prevent zoonoses from 
occurring, it is important to identify which animals and foodstuffs are the main sources of infection. For this 
purpose information aimed at protecting human health is collected and analysed from all European Union 
Member States. 
In 2012, 27 Member States submitted information on the occurrence of zoonoses, zoonotic agents and 
food-borne outbreaks to the European Commission and the European Food Safety Authority. Furthermore, 
information on cases of zoonoses reported in humans was provided by the European Centre for Disease 
Prevention and Control. In addition, three European countries that were not European Union Member States 
provided information. The European Food Safety Authority and the European Centre for Disease Prevention 
and Control jointly analysed the data, the results of which are published in this annual European Union 
Summary Report, which covers 15 zoonoses and food-borne outbreaks.  
In 2012, the notification rate and confirmed number of cases of human campylobacteriosis in the 
European Union decreased compared with 2011. Human campylobacteriosis, however, continued to be the 
most commonly reported zoonosis with 214,268 confirmed cases. The number of confirmed cases of 
campylobacteriosis in the European Union has followed a significant increasing trend in the last five years 
(2008-2012), along with a clear seasonal trend. The proportion of Campylobacter-positive food and animal 
samples remained mainly at levels similar to previous years, with the occurrence of Campylobacter 
continuing to be high in broiler meat. 
The number of salmonellosis cases in humans decreased by 4.7 % compared with 2011. A statistically 
significant decreasing trend in the European Union was observed over the period 2008-2012. In total, 
91,034 confirmed human cases were reported in 2012. It is assumed that the observed reduction in 
salmonellosis cases is mainly a result of the successful Salmonella control programmes in poultry 
populations. Most Member States met their Salmonella reduction targets for poultry, and Salmonella is 
declining in these animal populations. In foodstuffs, Salmonella was most often detected in fresh broiler 
meat. The food categories with the highest proportion of products not complying with the European Union 
Salmonella criteria were minced meat and meat preparations, meat products, as well as live bivalve 
molluscs.  
The number of listeriosis cases in humans increased slightly compared with 2011, and 1,642 confirmed 
human cases were reported in 2012. A statistically significant increasing trend in the European Union was 
observed over the period 2008-2012, though only slowly increasing, along with a seasonal pattern. As in 
previous years, a high fatality rate (17.8 %) was reported among the cases. A total of 198 deaths due to 
listeriosis were reported by 18 Member States in 2012, which was the highest number of fatal cases reported 
since 2006. Listeria monocytogenes was seldom detected above the legal safety limit from ready-to-eat 
foods at point of retail. Samples exceeding this limit were most often found in fishery products. 
A total of 5,671 confirmed verocytotoxigenic Escherichia coli infections were reported in 2012, which was a 
decrease of 40 % compared with 2011. Of those cases in which the serogroup was known, most were 
caused by serogroup O157, followed by O26 and O91. There was an increasing European Union trend of 
confirmed human verocytotoxigenic Escherichia coli infections in 2008–2012. Even without the 2011 data the 
European Union trend for verocytotoxigenic Escherichia coli infections during 2008–2010 was significantly 
increasing. Human pathogenic verocytotoxigenic Escherichia coli strains were detected by the reporting 
Member States from fresh bovine meat occasionally and at low levels. The human pathogenic 
verocytotoxigenic Escherichia coli serogroups isolated from the bovine meat and cattle samples included 
VTEC O157, O26, O91, O103 and O145. 
The number of confirmed human tuberculosis cases due to Mycobacterium bovis in the European Union in 
2012 was 125. This was a decrease compared with 2011, with a few Member States accounting for the 
majority of the reported cases. The reported prevalence of bovine tuberculosis in cattle increased slightly at 
European Union level, but remained at a very low level. This slight increase was, however, due to one 
Member State that reported an increase in prevalence of bovine tuberculosis for the fourth consecutive year.  
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The number of confirmed brucellosis cases in humans was 328 at European Union level, which was almost 
the same as in 2011. The number of brucellosis-positive cattle, and sheep and goat herds continued to 
decrease, although marginally compared with 2011. 
Trichinella caused 301 confirmed human cases in the European Union. Although the number of cases was 
slightly higher in 2012 than in 2011, human trichinellosis cases remained at a low level in the 
European Union compared with 2009 and previous years. In 2012, the prevalence of Trichinella in pigs was 
similar to that observed in 2011. The parasite was more prevalent in wildlife than in farmed animals. 
However, seven out of the nine strong-evidence outbreaks reported were due to consumption of pig meat. 
Toxoplasma was reported by the Member States from pigs, sheep, goats, hunted wild boar and hunted deer, 
in 2011 and 2012. In addition, positive findings were detected in cats (the natural hosts), cattle and dogs as 
well as several other animal species, indicating the wide distribution of the parasite among different animal 
and wildlife species.  
One domestically acquired human case and one imported human case of rabies were reported in the 
European Union in 2012. The general decreasing trend in the total number of rabies cases in animals 
observed in previous years was reversed in 2012, as there was an increase in the rabies cases reported in 
animals. In the European Union, the number of cases reported in farm animals and foxes increased. 
In 2012, a total of 643 confirmed cases of Q fever in humans were reported in the European Union. There 
was an overall 15.3 % decrease in the number of reported confirmed cases compared with 2011 (759 
cases). All 22 reporting Member States, except one, found animals positive for Coxiella burnetii, the 
causative agent of Q fever, which demonstrates that the pathogen is widely distributed in the European 
Union. Positive findings were detected in cattle, sheep as well as goats. 
A total of 232 cases of West Nile fever in humans were reported in the European Union. There was an 
overall 75.8 % increase in the number of reported cases compared with 2011 (132 cases), but a 33.5 % 
decrease compared with 2010 (349 cases). 2012 was the first year in which Member States were specifically 
invited to report data on West Nile virus in animals. Most data were from solipeds, notably horses, and less 
information was received from birds and other animal species. Test-positive solipeds were reported by 
Southern European countries but few test-positive horses were also reported by Central and Western 
European Member States. 
A total of 5,363 food-borne outbreaks were reported in the European Union, resulting in 55,453 human 
cases, 5,118 hospitalisations and 41 deaths. Most of the reported outbreaks were caused by Salmonella, 
bacterial toxins, viruses and Campylobacter. The most important food sources of the outbreaks were eggs 
and egg products, followed by mixed food and fish and fish products. Overall, 16 waterborne outbreaks were 
reported in 2012, caused by calicivirus, verocytotoxigenic E. coli, Cryptosporidium parvum and rotavirus. 
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1. INTRODUCTION 
The European Union (EU) system for the monitoring and collection of information on zoonoses is based on 
the Zoonoses Directive 2003/99/EC, which obliges EU Member States (MSs) to collect relevant and, where 
applicable, comparable data on zoonoses, zoonotic agents, antimicrobial resistance and food-borne 
outbreaks. In addition, MSs are required to assess trends and sources of these agents as well as outbreaks 
in their territory, submitting an annual report to the European Commission (EC) covering the data collected. 
The European Food Safety Authority (EFSA) is assigned the tasks of examining these data and publishing 
the EU Summary Report.  
Decision 2119/98/EC
7
 on setting up a network for the epidemiological surveillance and control of 
communicable diseases in the EU, as complemented by Decision 2000/96/EC
8
 on the diseases to be 
progressively covered by the network, established the basis for data collection on human diseases from 
MSs. The Decisions anticipated that data from the networks would be used in the EU Summary Report.  
Since 2005, the European Centre for Disease Prevention and Control (ECDC) has provided data on zoonotic 
infections in humans, as well as their analyses, for the EU Summary Report. Starting in 2007, data on 
human cases have been reported from The European Surveillance System (TESSy), maintained by ECDC.  
This EU Summary Report 2012 on zoonoses, zoonotic agents and food-borne outbreaks was prepared by 
EFSA in collaboration with ECDC. MSs, other reporting countries, the EC, members of EFSA’s Scientific 
Panels on Biological Hazards (BIOHAZ) and Animal Health and Welfare (AHAW) and the relevant EU 
Reference Laboratories (EURLs) were consulted while preparing the report. 
The efforts made by MSs, the reporting non-MSs and the EC in the reporting of zoonoses data and in the 
preparation of this report are gratefully acknowledged.  
The data on antimicrobial resistance in zoonotic agents in 2012 are published in a separate EU Summary 
Report. 
In 2012, data were collected on a mandatory basis for the following eight zoonotic agents in animals, food 
and feed: Salmonella, Campylobacter, Listeria monocytogenes (L. monocytogenes), verocytotoxigenic 
Escherichia coli (VTEC), Mycobacterium bovis (M. bovis), Brucella, Trichinella and Echinococcus. Data on 
human cases were reported via TESSy by the 27 MSs and 2 European Economic Area (EEA)/European 
Free Trade Association (EFTA) countries (Iceland and Norway) for all diseases. Switzerland reported human 
cases directly to EFSA. Moreover, mandatory reported data included antimicrobial resistance in Salmonella 
and Campylobacter isolates from animals and food, food-borne outbreaks and susceptible animal 
populations. In addition, based on the epidemiological situations in MSs, data were reported on the following 
agents and zoonoses: Yersinia, Toxoplasma, rabies virus, Coxiella burnetii (Q fever), West Nile virus (WNV), 
Anisakis, Cysticerci, Francisella and Sarcocystis. Data on Staphylococcus and antimicrobial resistance in 
indicator E. coli and enterococci isolates were also submitted. Furthermore, MSs provided data on certain 
other microbiological contaminants in foodstuffs - histamine, staphylococcal enterotoxins and 
Enterobacter sakazakii (Cronobacter spp.) - for which food safety criteria are set down in EU legislation. 
All 27 MSs submitted national zoonoses reports concerning the year 2012. In addition, zoonoses reports 
were submitted by three non-MSs (Iceland, Norway and Switzerland).  
The 2012 EU Summary Report on zoonoses and food-borne outbreak is a restricted report focusing on the 
most relevant annual information on zoonoses and food-borne outbreaks. If substantial changes compared 
with the previous year were observed, they have been reported.  
The current report includes a general summary and main findings (Level 1), and EU assessments of the 
specific zoonoses and items (Level 2). Level 3 of the report consists of an overview of all data submitted by 
MSs in table format (Level 3 Tables) and is available only online 
(http://www.efsa.europa.eu/en/efsajournal/pub/3547.htm). 
                                                 
7
 Decision No 2119/98/EC of the European Parliament and of the Council of 24 September 1998 setting up a network for the 
epidemiological surveillance and control of communicable diseases in the Community. OJ L 268, 3.10.98, p. 1-6. 
8
 Commission Decision 2000/96/EC of 22 December 1999 on the communicable diseases to be progressively covered by the 
Community network under Decision No 2119/98/EC of the European Parliament and of the Council. OJ L 28, 3.2.2000, p. 50–53. 
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Monitoring and surveillance schemes for most zoonotic agents covered in this report are not harmonised 
among MSs, and findings presented in this report must, therefore, be interpreted with care. The data 
presented may not have necessarily been derived from sampling plans that were statistically designed, and, 
thus, findings may not accurately represent the national situation regarding zoonoses. Regarding data on 
human infections, please note that the numbers presented in this report may differ from national zoonoses 
reports due to differences in case definitions used at EU and national level or because of different dates of 
data submission and extraction. Results are generally not directly comparable among MSs and sometimes 
not even between different years in one country. 
The national zoonoses reports submitted in accordance with Directive 2003/99/EC are published on the 
EFSA website together with the EU Summary Report. 
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2. MAIN FINDINGS 
2.1. Main conclusions of the European Union Summary Report in 2012 
 In 2012, the notification rate and the reported confirmed number of cases of human 
campylobacteriosis in the European Union decreased compared with 2011. Despite this, the number 
of confirmed campylobacteriosis cases in humans shows an increasing trend over the past five years 
in the EU, and campylobacteriosis remains the most frequently reported zoonotic disease in 
humans. Overall, about a quarter of the tested fresh broiler meat samples were reported as 
Campylobacter positive, although there were large differences between the MSs.  
 The number of notified salmonellosis cases in humans in the EU decreased, and this decline is a 
continuation of the significant declining trend observed during the past five years. It is assumed that 
the observed reduction in salmonellosis cases is mainly a result of the successful Salmonella control 
programmes in poultry populations. Most MSs met their Salmonella reduction targets for poultry in 
2012, and Salmonella is declining in these animal populations. Salmonella in foodstuffs was mainly 
detected in meat and products thereof.  
 The reported number of confirmed human cases of listeriosis in the EU increased compared with 
2011 and there was a statistically increasing trend over the past five years, though only slowly 
increasing. The highest proportions of food samples exceeding the legal safety limit, at retail, set for 
Listeria monocytogenes (L. monocytogenes) in 2012 were observed in ready-to-eat (RTE) fishery 
products and RTE products of meat origin. 
 The number of confirmed verocytotoxigenic Escherichia coli (VTEC) infections reported in the EU in 
2012 decreased markedly compared with 2011 when a large outbreak of STEC/VTEC occurred in 
several MSs but primarily affecting Germany. However, the EU trend for VTEC infections during 
2008–2010 was significantly increasing even without the 2011 data and the case numbers also 
increased in 2012 compared with 2010. Human-pathogenic VTEC strains were detected by the 
reporting MSs from fresh bovine meat occasionally and at low levels. 
 In 2012, the reported total number of confirmed human tuberculosis cases due to 
Mycobacterium bovis in the EU decreased for the second consecutive year. The reported prevalence 
of bovine tuberculosis in cattle increased slightly at the EU level. However, this was mainly due to 
one MS. 
 The annual number of human brucellosis cases reported in the EU has decreased over the past five 
years. Concomitantly, the prevalence of both bovine and small ruminant brucellosis has continued to 
decrease within the EU. 
 The five-year trend of trichinellosis in the EU was greatly influenced by a number of small and large 
outbreaks reported, particularly in the first two years of the period. All pigs reported as Trichinella 
positive in 2012 were from non-controlled housing conditions. The proportion of positive farmed wild 
boar was higher than the prevalence in pigs. One horse was found positive for Trichinella.  
 Toxoplasma was reported by the MSs from pigs, sheep, goats, hunted wild boar and hunted deer, in 
2011 and 2012. In addition, positive findings were made from cats (the natural hosts), cattle and 
dogs as well as several other animal species, indicating the wide distribution of the parasite among 
different animal and wildlife species. 
 Two human rabies cases, one domestically acquired and another one related to travel outside the 
EU were reported in 2012. The number of animals reported rabies-positive in 2012 increased 
compared with 2011. Six Central and Western European MSs reported rabies positive bats.  
 In 2012, the reported number of human Q fever cases decreased compared with 2011. In animals all 
22 reporting MSs except one found the causative agent (Coxiella burnetii) in cattle, goats or sheep.  
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 There was an increase in the numbers of total cases of West Nile fever reported in humans in the 
EU compared with 2011 but the case numbers still remained below those reported in 2010. West 
Nile virus (WNV) test-positive solipeds were reported by Southern European countries but few test-
positive horses were also reported by Central and Western European MSs. Two Southern MSs 
reported positive WNV findings in birds. 
 Salmonella remained the most frequently reported cause of food-borne outbreaks in EU, with a slight 
increase in the numbers of outbreaks compared with 2011. The second most important causative 
agent group was bacterial toxins, followed by viruses and Campylobacter. The main food vehicles in 
the reported food-borne outbreaks were eggs and egg products, mixed food and fish and fish 
products. In terms of the number of people affected, however, the largest outbreak in 2012 was due 
to norovirus in frozen strawberries. 
 
2.2. Zoonoses and item-specific summaries 
The public health importance of a zoonosis is not only dependent on its incidence in the human population. 
The severity of the disease, case fatality, post-infection (chronic) complications and possibilities for 
prevention are also key factors determining the importance of the disease. For instance, despite the 
relatively low number of cases caused by Listeria and Lyssavirus (rabies), compared with the number of 
human campylobacteriosis and salmonellosis cases (Figure SU1), these infections are considered important 
because of the severity of the associated illness and the higher case-fatality rate (Table SU1). The case-
fatality rates should, however, be interpreted with caution as the final fate of surviving cases is often 
unknown beyond the initial sampling and, regarding fatal cases, it can be difficult to ascertain that the 
disease was the primary cause of death. 
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Figure SU1.   Reported notification rates of zoonoses in confirmed human cases
1,2
 in the EU, 2012 
 
Note: Total number of confirmed cases is indicated in parenthesis at the end each bar. 
1. For West Nile fever the total number of cases is indicated. 
2. Due to the restricted nature of the present report, the 2012 human notification  rates for yersiniosis and echinococcosis were not 
produced but will be available in the ‘Annual Epidemiological Report 2014 - Reporting on 2012 surveillance data and 2013 
epidemic intelligence data, ECDC 2014’ (in preparation). The 2011 rates for these diseases were reported in ‘The European 
Union Summary Report on Trends and Sources of Zoonoses, Zoonotic Agents and Food-borne Outbreaks in 2011. EFSA 
Journal 2013;11(4):3129’. 
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Table SU1. Reported hospitalisation and case-fatality rates due to zoonoses in confirmed human cases in the EU, 2012 
Disease 
Number of 
confirmed
1
 
human cases 
Hospitalisation Deaths 
Confirmed 
cases 
covered
1,2
 (%) 
Number of 
reporting 
MSs
3
 
Reported 
hospitalised 
cases 
Hospitalisation 
rate (%) 
Confirmed 
cases 
covered
1,2
 (%) 
Number of 
reporting 
MSs
3
 
Reported 
deaths 
Case-
fatality 
rate (%) 
Campylobacteriosis 214,268 9.7 12 9,946 47.7 52.0 14 31 0.03 
Salmonellosis 91,034 10.1 10 4,134 45.1 48.9 14 61 0.14 
VTEC infections 5,671 37.5 13 777 36.5 58.7 18 12 0.36 
Listeriosis 1,642 41.5 14 624 91.6 67.7 18 198 17.8 
Q fever 643 NA NA NA NA 56.1 12 1 0.28 
Brucellosis 328 51.2 6 131 78.0 32.9 7 1 0.93 
Trichinellosis 301 73.1 5 177 80.5 72.4 7 0 0 
West Nile fever 232 13.8 3 28 84.4 85.3 6 22 11.1 
Rabies 2 100 2 2 100 100 2 2 100 
Note: NA: not applicable as the information is not collected for this disease. 
1. Except for West Nile fever, for which the total number of cases was included. 
2. The proportion (%) of confirmed cases for which the information on hospitalisation or death was available.  
3. Not all countries observed cases of all diseases. 
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Campylobacter 
Humans 
Campylobacteriosis has been the most frequently reported zoonotic disease in humans in the EU since 
2005. In 2012, 214,268 confirmed cases of campylobacteriosis were reported, which was a decrease of 
4.3 % compared with 2011. The EU notification rate was 55.49 per 100,000 population in 2012. There was a 
clear seasonal trend in confirmed campylobacteriosis cases reported in the EU in 2008–2012 and a 
significant increasing EU trend. Considering the high number of human campylobacteriosis cases, the 
severity in terms of reported fatalities was low (0.03 %) (Table SU1). 
Foodstuffs 
Overall, 23.6 % of the samples (single or batch) of fresh broiler meat were found to be positive for 
Campylobacter in the reporting MSs, which was less than in 2011, when 31.3 % of the samples were 
positive. However, the reporting MSs in 2011 and 2012 were not exactly the same ones, which make the 
data non-comparable. In addition, for the MSs reporting data for both years, there were increases, decreases 
and comparable prevalence in the reported proportions of positive samples compared with 2011.  
Animals 
In two of the five MSs reporting flock-based data for broilers, the reported prevalence was very high (63.4 %) 
to extremely high (83.6 %). The occurrence of Campylobacter varied widely among the three MSs reporting 
slaughter batch-based data, with prevalence ranging from 1.6 % to 62.1 %. One MS, Germany, also 
reporting animal-based data, found 9.2 % of broilers positive out of 672 units tested at the farm.  
Salmonella 
Humans 
In 2012, a total of 91,034 confirmed cases of human salmonellosis were reported in the EU. This represents 
a decrease of 4.7 % compared with 2011 and a decrease of 43,546 cases (32 %) compared with the case 
numbers reported in 2008. The EU notification rate for confirmed cases was 22.2 cases per 
100,000 population. The EU case-fatality rate was 0.14 % as 61 deaths due to non-typhoidal salmonellosis 
were reported in the EU in 2012 (Table SU1). As in previous years, S. Enteritidis and S. Typhimurium were 
the most frequently reported serovars (41.3 % and 22.1 %, respectively, of all known reported serovars in 
human cases). As a result of the harmonised reporting and also several large outbreaks, monophasic 
S. Typhimurium 1,4,[5],12:i:- was the third most commonly reported serovar in the EU (7.2 %). The fourth 
most common serovar in humans was Salmonella Infantis (S. Infantis), of which the numbers of reported 
isolates have been increasing over the last five years. 
It is assumed that the observed reduction in salmonellosis cases in humans is mainly the result of successful 
Salmonella control programmes in fowl (Gallus gallus) populations that are in place in EU MSs and that have 
particularly resulted in a lower occurrence of Salmonella in eggs, though other control measures might also 
have contributed to the reduction.  
Foodstuffs 
Information on Salmonella was reported from a wide range of foodstuff categories in 2012, but the majority of 
data were from various types of meat and products thereof. The highest proportions of Salmonella-positive 
single samples were reported for fresh broiler meat at an average level of 5.5 %. In fresh turkey, pig and 
bovine meat, the percentage of tested single samples found positive for Salmonella in the group of reporting 
MSs were, respectively, 5.5 %, 0.7 % and 0.2 %. 
Salmonella was found in a very low proportion of table eggs, at levels of 0.1 % (single samples) or <0.1 % 
(batch samples). Salmonella was also detected in other foods, including vegetables, but also in samples 
originating from both fruit and vegetables, in spices and herbs, in egg products and in live bivalve molluscs. 
Non-compliance with the EU Salmonella criteria was most often observed in food categories of meat origin. 
Minced meat and meat preparations from poultry intended to be eaten cooked had the highest level of non-
compliance (8.7 % of single samples and 5.7 % of batches). A high proportion of non-compliance was also 
reported for minced meat and meat preparations from animal species other than poultry intended to be eaten 
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cooked (2.0 % of single samples and 0.9 % of batch samples) and meat products from poultry meat intended 
to be eaten cooked (2.9 % of single samples). In 12 batch samples, 8.3 % of mechanically separated meat 
was found to be contaminated with Salmonella. Of relevance are the Salmonella findings in RTE foods, such 
as minced meat and meat preparations intended to be eaten raw. 0.2 % of single samples and 0.5 % of 
batch samples were found positive. Non-compliance was also observed in live bivalve molluscs and live 
echinoderms, tunicates and gastropods, where 1.8 % of batches were non-compliant. All samples of egg 
products and RTE sprouted seeds were compliant with the criteria in 2012.  
Animals 
In 2012, 19 MSs met the Salmonella reduction target of ≤1 % set for breeding flocks of Gallus gallus (fowl), 
which covers five target serovars (S. Enteritidis, S. Typhimurium, S. Hadar, S. Infantis, S. Virchow). Overall, 
0.4 % of breeding flocks of Gallus gallus in the EU were positive for the target serovars during the production 
period, which was less than in 2011 (0.6 %). In 2012, 0.2 % of the adult breeding flocks tested under the 
mandatory Salmonella control programmes was positive for S. Enteritidis. Altogether 2.0 % of the breeding 
flocks of Gallus gallus in the EU were positive for Salmonella spp. (1.9 % in 2011). 
In the case of flocks of laying hens, 24 MSs (compared with 22 MSs in 2011) met their relative Salmonella 
reduction targets, which cover S. Enteritidis and S. Typhimurium. The EU prevalence was reduced for the 
two target serovars from 1.5 % in 2011 to 1.3 % in 2012. Overall, during the production period, 3.2 % (4.2 % 
in 2011) of laying hen flocks in the EU were positive for Salmonella spp.  
2012 was the fourth year for implementing the EU reduction target of ≤1 % prevalence for S. Enteritidis and 
S. Typhimurium in broiler flocks. As in 2011, 24 MSs met this target in 2012. The EU prevalence for the 
target serovars was 0.3 %, as in 2011. The prevalence of Salmonella spp. was also further reduced from 
3.2 % in 2011 to 3.1 % in 2012.  
2012 was the third year of MSs implementing the Salmonella reduction targets for turkey flocks (≤1 % for 
S. Enteritidis and S. Typhimurium). All but 1 of the 14 MSs which reported data on turkey breeding flocks 
met the target, with an overall prevalence of 0.5 % for the two target serovars (0.2 % in 2011). A further 
21 MSs met the target for fattening turkey flocks before slaughter, with only 1 MS not meeting the target. At 
the EU level 0.4 % of the fattening turkey flocks were infected with the two target serovars (0.5 % in 2011, 
two MSs with target-positive flocks). In total, 4.6 % and 14.5 % of turkey breeding and fattening flocks, 
respectively, were positive for Salmonella spp. in 2012 (3.5 % and 10.1 % in 2011). 
All these results indicate that MSs continued to invest in Salmonella control and that this work is yielding 
further improvements in results. 
Salmonella findings were also reported in other animal species, including ducks, geese, pigs, cattle, sheep 
and goats.  
Feedingstuffs 
Salmonella was detected most often in feed materials from fish meal, up to levels of 4.5 %. Some findings 
were also detected in feed materials derived from land animal origin, cereals and oil seeds. Salmonella was 
reported in compound feedingstuffs for cattle, pigs and poultry with the proportion of positive samples 
ranging between 0.2 % (batch level) and 2.1 % (single samples) at the EU level.  
Listeria 
Humans 
The number of reported listeriosis cases in humans in the EU in 2012 increased by 10.5 % compared with 
2011. The overall EU notification rate was 0.41 cases per 100,000 population. The highest notification rates 
of listeriosis, in 2012, were reported in children below one and persons aged 65 years and above. A total of 
198 deaths due to listeriosis were reported by 18 MSs in 2012, which was the highest number of fatal cases 
reported since 2006. The EU case-fatality rate was 17.8 % among the confirmed cases for which this 
information was reported (67.7 % of all confirmed cases). The number of listeriosis cases reported in the EU 
in the last five years has fluctuated somewhat over time, but overall in the period 2008-2012, a slowly 
increasing trend was observed. 
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Foodstuffs 
MSs provided information on numerous investigations of L. monocytogenes in different categories of RTE 
food in 2012. In the case of RTE products at point of retail, very low proportions of samples were generally 
found to be non-compliant with the EU criterion of ≤100 cfu/g. The highest reported levels of non-compliance 
at retail were observed in RTE fishery products (0.5 % of single samples and 0.7 % of batch samples), 
followed by RTE products of meat origin (0.4 % of single samples). Concerning samples taken at processing, 
the highest level of non-compliance in single food samples was observed in RTE fishery products (8.0 %), 
followed by unspecified cheeses (3.4 %). Unspecified cheeses was also the food category with the highest 
reported level of non-compliance at processing in batch samples (7.2 %). 
Animals 
In 2012, L. monocytogenes was detected by several MSs in various animal species, including cattle, fowl, 
sheep, goats and horses. As in previous years the highest proportions of positive findings were reported 
from goats and sheep, especially from Germany, where 13.3 % of the tested goat herds and 14.5 % of the 
tested sheep herds were positive for this ubiquitous environmental organism. 
Verocytotoxigenic E. coli 
Humans 
In 2012, a total of 5,671 confirmed human VTEC cases were reported by 22 MSs. This represents a 
decrease of 40 % compared with 2011 (N = 9,487) when a large outbreak of STEC/VTEC O104:H4 occurred 
in the EU, primarily in Germany. The overall EU notification rate of VTEC was 1.15 cases per 
100,000 population in 2012. An increase in the reported number of confirmed VTEC infections was observed 
in the EU in the past five years. This trend also remained when the 2011 outbreak data were omitted. As in 
previous years, the most commonly identified VTEC serogroup was O157 followed by O26 and O91. The 
case fatality rate for human VTEC infections in 2012 was 0.36 % compared with 0.75 % in 2011, with 
12 deaths reported (Table SU1). 
Foodstuffs and animals 
Human pathogenic VTEC strains were detected by the reporting MSs from fresh bovine meat occasionally 
and at low levels. The human pathogenic VTEC serogroups isolated from bovine meat and cattle samples 
included VTEC O157, O26, O91, O103 and O145.  
Tuberculosis due to Mycobacterium bovis 
Humans 
Tuberculosis due to M. bovis is a rare infection in humans in the EU. In 2012, the total number of confirmed 
human tuberculosis cases due to M. bovis was 125, representing a decrease of 15.5 % compared with 2011. 
This was the second consecutive year for which a decrease in the confirmed human case numbers in the EU 
was observed. 
Animals 
In 2012, two provinces in one MS as well as a superior administrative unit in another MS were declared 
officially bovine tuberculosis free (Officially Tuberculosis Free, OTF). As in 2011, 15 MSs were OTF as well 
as 3 non-MSs. Additionally, Scotland (in the United Kingdom), the superior administrative unit of Algarve in 
Portugal as well as 6 regions and 15 provinces in Italy were OTF in 2012. Seven OTF MSs reported infected 
cattle herds in 2012. Eight non-OTF MSs reported positive or infected herds. In most of these non-OTF MSs, 
the prevalence of bovine tuberculosis remained at a level comparable with 2011 or decreased, except in the 
United Kingdom, which reported an increase in the overall proportion of existing herds positive from 9.06 % 
to 10.4 %. M. bovis was also detected in over 10 animal species other than cattle, including wildlife. 
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Brucella 
Humans 
In 2012, a total of 328 confirmed cases of human brucellosis were reported in the EU, representing a 
decrease of 2.4 % compared with the 336 confirmed cases in 2011. An overall decrease in the reported 
number of confirmed brucellosis cases was also noted in the EU in the past five years. As in previous years, 
the highest numbers were reported by non-Officially Brucellosis-Free (non-OBF)/non-Officially 
Brucella melitensis (B. melitensis)-Free (non-ObmF) MSs. Significant decreasing trends by country were also 
observed in two MSs, Italy and Spain, which is in accordance with the findings in the animal population in 
these countries. Almost four out of five of the human brucellosis cases (for which hospitalisation information 
was available) had been hospitalised but only one fatal case was reported in 2012 (Table SU1). 
Foodstuffs 
In 2012 Brucella was reported in milk samples at processing plant, by two MSs. 
Animals 
In 2012, 16 MSs were OBF and 19 MSs were ObmF for sheep and goats. In addition, some regions and 
provinces in Italy, Spain and Portugal as well as England, Scotland, Wales and the Isle of Man, in the United 
Kingdom, were OBF. Furthermore, a number of departments in France and some regions and provinces in 
Italy, Portugal and Spain were ObmF.  
At the EU level, the prevalence of bovine brucellosis in cattle herds has been decreasing, and in 2012, only 
0.05 % of the existing cattle herds were infected with or positive for Brucella. In the EU non-OBF MSs, the 
percentage of existing infected/positive herds decreased between 2005 and 2007, then stabilised until 2011, 
after which a decrease continued in 2012. In 2012, bovine brucellosis was rare also in the non-OBF MSs 
(0.09 %). The prevalence of brucellosis in sheep and goat herds decreased more substantially both at the 
EU level and in the non-ObmF MSs, with a statistically significant decreasing trend in EU co-financed non-
ObmF MSs since 2004. In 2012, the proportion of existing infected/positive sheep and goat herds infected 
with B. melitensis in the EU was 0.14 %.  
Trichinella 
Humans 
In 2012, confirmed cases of trichinellosis increased by 12.3 %, with 301 cases reported, compared with 
268 cases in 2011. The EU notification rate was 0.06 cases per 100,000 population and the highest 
notification rates in 2012 were reported in Latvia, Lithuania, Romania and Bulgaria. These four countries 
accounted for 82.4 % of all confirmed cases reported in 2012. No increasing or decreasing EU trend could 
be observed for the period 2010-2012. No deaths due to trichinellosis were reported in 2012 from the seven 
MSs that provided information (Table SU1). 
Animals 
All MSs and three non-MSs provided data on Trichinella in animals. Trichinella was very rarely detected in 
2012 from pigs in the EU, and all the positive findings reported by MSs were from pigs from non-controlled 
housing conditions. Eight MSs provided data on samplings of farmed wild boar and the proportion of positive 
farmed wild boar was higher than the prevalence in pigs. Eighteen MSs and three non-MSs reported data on 
solipeds, and one (0.0005 %) was found positive for Trichinella, in 2012. Trichinella is often reported in 
wildlife species by some Eastern and Northern European MSs, where the parasite is circulating in wildlife 
populations. 
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Toxoplasma 
Animals 
Fifteen MSs reported data on Toxoplasma for the years 2011 or 2012. Positive findings were detected in 
pigs, cattle, sheep, goats, dogs, cats, water buffaloes and some wildlife animal species.  
Rabies  
Humans 
In 2012, Romania reported one domestically acquired case in a five-year-old girl. The girl had been bitten by 
a stray dog in a village in Eastern Romania and she died in February 2012. In addition, in May 2012, one 
travel-associated case of rabies was reported in the EU, from the United Kingdom. The patient was a 
woman, resident in United Kingdom, who visited her country of origin, India, where she was bitten by a dog 
(Table SU1).  
Animals 
In 2012, 712 animals other than bats tested positive for either classical rabies virus or unspecified Lyssavirus 
in eight MSs and one non-MS (Norway). The number of cases reported in 2012 increased compared with 
2011, when 512 cases where detected in animals other than bats. In addition, six Central and Western 
European MSs reported rabies cases from bats.  
Q-fever 
Humans 
In 2012, a total of 643 confirmed human cases of Q fever were reported in the EU, representing a 15.3 % 
decrease compared with 2011 (759). One death due to Q fever was reported in Germany in 2012 (Table 
SU1).  
Animals 
All but one of the 22 reporting MSs found Coxiella burnetii (Q fever)-positive animals in their cattle, sheep or 
goat populations in 2011 or 2012. Positive pigs and wild boar were also reported.  
West Nile virus 
Humans 
In 2012, a total of 232 total cases of West Nile fever in humans were reported in the EU. The EU case-
fatality rate was 11.1 % among the 198 cases for which this information was reported.  
Animals 
Nine of 11 Southern, Central and Western European MSs reporting 2012 data on horses and donkeys, found 
animals that tested positive for WNV. Two from four MSs in Southern Europe and reporting 2012 data on 
domestic and wild birds, found animals that tested positive for WNV.  
Other zoonoses and zoonotic agents 
A few MSs reported data on Anisakis, Cysticercus, Sarcocystis or Francisella tularensis in food or animals 
for the years 2011 or 2012.  
Food-borne outbreaks 
A total of 5,363 food-borne outbreaks, including waterborne outbreaks, were reported in the EU. Overall, 
55,453 human cases, 5,118 hospitalisations and 41 deaths were recorded. The evidence supporting the link 
between human cases and food vehicles was strong in 763 outbreaks.  
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The largest number of reported food-borne outbreaks was caused by Salmonella (28.6 % of all outbreaks), 
followed by bacterial toxins (14.5 %), viruses (14.1 %) and Campylobacter (9.3 %). For 27.6 % of the 
outbreaks the causative agent was unknown. The numbers of reported outbreaks caused by viruses, 
Salmonella and bacterial toxins increased compared with the previous year. The most important food 
vehicles in the 763 strong evidence outbreaks were eggs and egg products (in 22.0 % of outbreaks), mixed 
foods (15.6 %) and fish and fish products (9.2 %).  
In 2012, 16 strong-evidence waterborne outbreaks were reported in the EU, and the main causative agents 
were VTEC and calicivirus. Cryptosporidium parvum and rotavirus were also the causative agent in one 
outbreak each.  
The largest food-borne outbreak in terms of human cases, in 2012, was a norovirus outbreak, in which 
10,950 people were affected. 
The revised food-borne outbreak reporting specifications were implemented for the third time in 2012. 
Approximately one-third of the outbreaks, supported by strong evidence, in 2012 were supported only by the 
new evidence categories (descriptive epidemiological evidence and detection of the causative agent in the 
food chain). The number of outbreaks, supported by strong evidence, increased compared with 2011 (763 in 
2012 compared with 701 in 2011) as well as the proportion of these outbreaks out of the total number of 
outbreaks reported (14.2 % in 2012 compared with 12.4 % in 2011). This indicates that the MSs had 
implemented the revised reporting specifications and that these specifications had an impact on the reporting 
of outbreaks.  
Figure SU2.   Distribution of food-borne outbreaks per causative agent in the EU, 2012 
 
Note:  Bacterial toxins include toxins produced by Bacillus, Clostridium and Staphylococcus. Food-borne viruses include calicivirus, 
hepatitis A virus, flavivirus, rotavirus and other unspecified viruses. Other causative agents include mushroom toxins, marine 
biotoxins, histamine, mycotoxins, atropine and other unspecified agents. Parasites include primarily Trichinella, but also 
Cryptosporidium, Giardia, Anisakis and other unspecified parasites. Other bacterial agents include Listeria, Brucella, Shigella, 
Vibrio and Francisella. Pathogenic Escherichia coli includes also verotoxigenic Escherichia coli. 
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3.  INFORMATION ON SPECIFIC ZOONOSES AND ZOONOTIC AGENTS 
3.1. Salmonella 
The genus Salmonella is divided into two species: Salmonella enterica (S. enterica) and S. bongori. 
S. enterica is further divided into six subspecies, and most zoonotic Salmonella belong to the subspecies 
enterica. This subspecies can be further divided into serovars, which are often named according to the place 
of first isolation. In the following text, a genus name followed by serovar is used, for example 
S. Typhimurium. More than 2,600 serovars of zoonotic Salmonella exist although a limited number are 
associated with most human infections and the prevalence of different serovars may change over time.  
Human salmonellosis is usually characterised by acute onset of fever, abdominal pain, nausea, and 
sometimes vomiting, after an incubation period of 12–36 hours. Symptoms are often mild, and most 
infections are self-limiting, lasting a few days. However, in some patients, the infection may be more serious 
and the associated dehydration can be life-threatening. When Salmonella causes systemic infections, such 
as septicaemia, effective antimicrobials are essential for treatment. Salmonellosis has also been associated 
with long-term and sometimes chronic sequelae, e.g. reactive arthritis. Mortality is usually low, and less than 
1 % of reported Salmonella cases have been fatal.  
The common reservoir of Salmonella is the intestinal tract of a wide range of domestic and wild animals, 
which may result in a variety of foodstuffs, of both animal and plant origin, becoming contaminated with 
faecal organisms either directly or indirectly. Transmission often occurs when organisms are introduced into 
food preparation areas and are allowed to multiply in food, e.g. due to inadequate storage temperatures, 
inadequate cooking or cross-contamination of RTE food. The organism may also be transmitted through 
direct contact with infected animals or humans or faecally contaminated environments. Infected food 
handlers may also act as a source of contamination for foodstuffs. 
Contaminated foodstuffs serving as a source for Salmonella infection for humans include table eggs closely 
followed by pig meat, whereas the risks associated with broiler and turkey meat are similar and 
approximately two-fold lower
9
. In the EU, S. Enteritidis and S. Typhimurium are the serovars most frequently 
associated with human illness. Human S. Enteritidis cases are most commonly associated with the 
consumption of contaminated eggs and poultry meat, while S. Typhimurium cases are mostly associated 
with the consumption of contaminated pig meat or bovine meat. 
In animals, sub-clinical infections are common. The organism may easily spread between animals in a herd 
or flock without detection and animals may become intermittent or persistent carriers. Infected cattle, sheep 
and horses may succumb to fever, diarrhoea and abortion. Also within calf herds, Salmonella may cause 
outbreaks of diarrhoea and septicaemia with high mortality. Clinical signs are less common in pigs and goats 
and poultry usually show no obvious signs of infection with zoonotic serovars.  
Table SA1 presents the countries reporting data for 2012. 
  
                                                        
9
 EFSA Panel on Biological Hazards (BIOHAZ), 2012. Scientific Opinion on an estimation of the public health impact of setting a new 
target for the reduction of Salmonella in turkeys. EFSA Journal 2012;10(4):2616, 89 pp.  doi:10.2903/j.efsa.2012.2616 
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Table SA1. Overview of countries reporting data for Salmonella, 2012 
Data 
Total number of  
reporting MSs  
Countries 
Human 27 
All MSs 
Non-MSs: CH, IS, NO 
Food 26 
All MSs except MT      
Non-MSs: CH, IS, NO 
Animal 27 
All MSs  
Non-MSs: CH, IS, NO 
Feed 23 
All MSs except BG, CY, MT, UK  
Non-MSs: CH, NO 
Serovars  
(food and animals) 
22 
All MSs except BE, FR, LT, LU, MT 
Non-MSs: IS, NO 
Note: The overview table includes all data reported by MSs and non-MSs.  
3.1.1. Salmonellosis in humans 
Salmonellosis continued to decrease in 2012. A total of 92,916 salmonellosis cases were reported by the 
27 EU MSs (though only provisional data were reported from Italy), with 91,034 confirmed cases (EU 
notification rate 22.2 cases per 100,000 population) (Table SA2). This represented a 4.7 % decrease in 
confirmed cases compared with 2011. The highest notification rates, in 2012, were reported by the Czech 
Republic and Slovakia (≥85 cases per 100,000), while the lowest rates were reported by Portugal, Greece 
and Romania (≤4 per 100,000). The proportion of domestic cases versus travel-associated cases varied 
markedly between countries, with the highest proportion of travel-related cases, >70 %, in the Nordic 
countries, Finland, Sweden and Norway (Figure SA1).  
There was a clear seasonal trend in confirmed salmonellosis cases reported in the EU in 2008–2012, with 
most cases reported during summer months. The significant decreasing EU trend observed for several years 
continued in 2012 (p < 0.001 with linear regression) (Figure SA2). Significant decreasing trends, by country, 
were observed in 15 MSs and two non-MS: Austria, Belgium, Cyprus, Denmark, Estonia, Finland, Germany, 
Greece, Iceland, Ireland, Lithuania, Norway, Portugal, Slovakia, Slovenia, Sweden and the United Kingdom. 
Significant increasing trends were observed in France and the Netherlands. The increasing trend in the 
Netherlands could be explained by a very large outbreak of S. Thompson in 2012, in which smoked salmon 
was the suggested vehicle
10
.  
Ten MSs provided information on hospitalisation for some or all of their cases. On average, 45.1 % of the 
confirmed salmonellosis cases were hospitalised; hospitalisation status was, however, provided for only 
10.1 % of all confirmed cases. The highest hospitalisation rates were reported in Greece, Romania, Cyprus 
and Portugal (73–91 % of cases hospitalised). Three of these countries also reported the lowest notification 
rates of salmonellosis, which indicates that the surveillance systems in these countries primarily capture the 
more severe cases.  
Fourteen MSs provided data on the outcome of their cases and, of these, eight MSs reported a total of 
61 fatal cases. This gives an EU case-fatality rate of 0.14 % among the 44,532 confirmed cases for which 
this information was reported (48.9 % of all confirmed cases). 
  
                                                        
10 
Friesema IH, de Jong AE, Fitz James IA, Heck ME, van den Kerkhof JH, Notermans DW, van Pelt W  and Hofhuis A, 2012. 
Outbreak of Salmonella Thompson in the Netherlands since July 2012. Euro Surveillance, 17(43): pii=20303. Available online: 
http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20303  
EU summary report on zoonoses, zoonotic agents and 
food-borne outbreaks 2012 
 
EFSA Journal 2014;12(2):3547 22 
Table SA2. Reported cases of human salmonellosis in 2008–2012 and notification rate for confirmed 
cases in the EU, 2012 
Country 
2012 2011 2010 2009 2008 
Report 
type
1
 
Cases 
Confirmed 
cases 
Confirmed 
cases/ 
100,000 
Confirmed cases 
Austria C  1,778 1,773 21.0 1,432 2,179 2,775 2,312 
Belgium
2
 C  3,101 3,101 – 3,177 3,169 3,113 3,831 
Bulgaria A  839 839 11.5 924 1,154 1,247 1,516 
Cyprus C  90 90 10.4 110 136 134 169 
Czech Republic C  10,397 10,245 97.5 8,499 8,209 10,480 10,707 
Denmark C  1,207 1,207 21.6 1,170 1,608 2,130 3,669 
Estonia C  287 249 18.6 375 381 261 647 
Finland C  2,204 2,204 40.8 2,108 2,437 2,338 3,126 
France C  8,705 8,705 13.3 8,685 7,184 7,153 7,186 
Germany C  20,848 20,493 25.1 23,982 24,833 31,395 42,885 
Greece C  404 404 3.6 471 297 403 792 
Hungary C  5,867 5,462 55.8 6,169 5,953 5,873 6,637 
Ireland C  315 309 6.7 311 349 335 447 
Italy
3
 C  1,453 1,453 – 3,344 4,752 5,715 6,662 
Latvia C  556 547 26.8 995 877 795 1,229 
Lithuania C  1,762 1,762 58.6 2,294 1,962 2,063 3,308 
Luxembourg C  136 136 25.9 125 211 162 153 
Malta C  88 88 21.1 129 160 125 161 
Netherlands
4
 C  2,198 2,198 20.5 1,284 1,447 1,204 1,627 
Poland A  8,444 7,952 20.6 8,400 9,257 8,529 9,149 
Portugal C  190 185 1.8 174 205 220 332 
Romania C  775 698 3.3 989 1,285 1,105 624 
Slovakia C  4,965 4,627 85.6 3,897 4,942 4,182 6,849 
Slovenia C  392 392 19.1 400 363 616 1,033 
Spain
5
 C  4,181 4,181 36.2 3,786 4,420 4,304 3,833 
Sweden C  2,922 2,922 30.8 2,887 3,612 3,054 4,185 
United Kingdom C  8,812 8,812 14.3 9,455 9,670 10,479 11,511 
EU Total   92,916 91,034 22.2 95,572 101,052 110,190 134,580 
Iceland C  38 38 11.9 45 34 35 134 
Liechtenstein – – – – – – – 2 
Norway C  1,371 1,371 27.5 1,290 1,370 1,235 1,941 
Switzerland
6
 C  1,241 1,241 16.1 1,302 1,177 1,302 2,028 
1. A: aggregated data report; C: case-based report; –: no report. 
2. Sentinel surveillance; no information on estimated coverage. Thus, the notification rate cannot be estimated.  
3. Provisional data for 2012. Thus, the notification rate can not be estimated.  
4 Sentinel system; notification rates calculated with an estimated population coverage of 64 %.  
5. Notification rates calculated with estimated population coverage of 25 %. 
6. Switzerland provided data directly to EFSA.  
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Figure SA1.  Notification rates and origin of infection in human salmonellosis in the EU/EFTA, 2012 
 
Note: The map shows the distribution of human cases shaded according to incidence rate per 100,000 based on quartile 
classification method (EUROSTAT population data 2012). 
Figure SA2.  Trend in reported confirmed cases of human salmonellosis in the EU, 2008–2012 
 
Source: 24 MSs: Austria, Belgium, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, 
Latvia, Lithuania, Luxembourg, Malta, Netherlands, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, and United 
Kingdom. Bulgaria and Poland are excluded as they reported only monthly data. Italy is excluded as its 2012 data were not 
representative. 
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Information on Salmonella serovars from cases of human infection was available from 25 MSs (Bulgaria and 
Poland reported no case-based serovar data) and two non-MSs. As in previous years, the two most 
commonly reported Salmonella serovars in 2012 were S. Enteritidis and S. Typhimurium, representing 
41.3 % and 22.1 %, respectively, of all reported serovars in human confirmed cases (N = 82,409) (Figure 
SA3 and Table SA3). The decrease in S. Enteritidis continued with 2,103 fewer cases (5.8 %) reported in the 
EU in 2012 than in 2011. Cases of S. Typhimurium decreased in 2012 compared with 2011 but, if added 
together with the monophasic S. Typhimurium, there was an increase of 2.8 %. The case numbers reported 
for monophasic S. Typhimurium 1,4,[5],12:i:- continued to increase in 2012  (reported by 11 MSs compared 
with 10 in 2011) and with  higher number of cases was reported in 2012 than in 2011 in all but one MS. (The 
reporting of this variant was harmonised in 2010, when a separate serovar code was introduced in TESSy).  
 
Salmonella Infantis, the fourth most common serovar, continued to increase in 2012, by 14.5 % (from 2.1 to 
2.5 %). A major increase was observed in S. Stanley due to a multi-country outbreak, affecting at least seven 
MSs, and being linked to the turkey production chain
11
. New on the top 10 serovar list were S. Thompson 
with 1,100 cases and S. Panama with 706 cases (Table SA3). The majority of S. Thompson cases were 
reported by the Netherlands and were linked to an outbreak with smoked salmon as the suggested vehicle
12
. 
The increase in S. Panama cases primarily occurred in one German federal state where an outbreak was 
reported (Christina Frank, Robert Koch Institute, personal communication, September 2013), and one Italian 
region (Ida Luzzi, Istituto Superiore di Sanità, personal communication, September 2013). The German 
outbreak involved a total of 334 cases and the highest incidence was in the age group of one- to three- year- 
olds, with 56 cases per 100,000 population (Sabine Schroeder, Thuringia State health office, personal 
communication, September 2013). The outbreak investigation concluded that consumption of raw pork 
products, such as seasoned minced pork and shortly ripened raw sausages, was the likely source of the 
outbreak.  
Figure SA3.  Distribution of the 10 most common Salmonella serovars in humans in the EU, 2012  
(N = 82,409) 
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  ECDC-EFSA, 2012. Multi-country outbreak of Salmonella Stanley infections. Joint ECDC/EFSA rapid risk assessment. Update 20 
September 2012. Available online: http://www.ecdc.europa.eu/en/publications/publications/20120921_rra_stanley_salmonella.pdf  
12
 Friesema IH, de Jong AE, Fitz James IA, Heck ME, van den Kerkhof JH, Notermans DW, van Pelt W and Hofhuis A, 2012. Outbreak 
of Salmonella Thompson in the Netherlands since July 2012. Euro Surveillance, 17(43):pii=20303. Available online: 
http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20303  
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Table SA3. Distribution of reported confirmed cases of human salmonellosis by serovar (10 most 
frequent serovars) in the EU/EEA, 2011–2012 
2012 2011 
Serotype N % Serotype N % 
S. Enteritidis 34,019 41.3 S. Enteritidis 36,122 44.6 
S. Typhimurium 18,248 22.1 S. Typhimurium 19,785 24.4 
S. Typhimurium, monophasic 1,4,[5],12:i:- 5,932 7.2 S. Typhimurium, monophasic 1,4,[5],12:i:- 3,739 4.6 
S. Infantis 2,021 2.5 S. Infantis 1,765 2.2 
S. Stanley 1,128 1.4 S. Newport 813 1.0 
S. Thompson 1,100 1.3 S. Derby 712 0.9 
S. Newport 777 0.9 S. Kentucky 583 0.7 
S. Derby 735 0.9 S. Poona 559 0.7 
S. Panama 706 0.9 S. Stanley 526 0.6 
S. Kentucky 651 0.8 S. Virchow 497 0.6 
Other 17,092 20.7 Other 15,941 19.7 
Total 82,409 100 Total 81,042 100 
Source: 25 MSs and two non-MSs: Austria, Belgium, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, 
Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Portugal, Romania, Slovakia, 
Slovenia, Spain, Sweden, and United Kingdom.  
 
3.1.2. Salmonella in food 
Twenty-six MSs and three non-MSs provided data on Salmonella in various foodstuffs. Most MSs reported 
data on Salmonella in food of animal origin, primarily broiler meat, pig meat and bovine meat (Table SA4).  
In the following sections, only results based on 25 or more units tested are presented, with the exception of 
the section on compliance with microbiological criteria, where investigations with fewer than 25 units have 
also been included. Results from industry own-check programmes and Hazard Analysis and Critical Control 
Point (HACCP) sampling, as well as specified suspect sampling, selective sampling and outbreak or clinical 
investigations, have also been excluded owing to difficulties with the interpretation of data. These data are, 
however, presented in the Level 3 Tables.  
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Table SA4. Overview of countries reporting data for Salmonella in food, 2011–2012 
Data 
Total number of  
reporting MSs  
Countries 
Broiler meat 
2012 - 25 
All MSs except MT, UK 
Non-MSs: CH, IS 
2011 - 25 
All MSs except MT, SI 
Non-MSs: CH, IS 
Turkey meat 
2012 - 21 
All MSs except DK, ES, FR, MT, SI, UK 
Non-MSs: CH, IS 
2011 - 20 
All MSs except DK, ES, FR, LT, MT, SI, UK 
Non-MSs: CH, IS 
Eggs and egg products 
2012 - 19 All MSs except DK, FI, FR, LU, MT, SE, SI, UK 
2011 - 20 All MSs except DK, FI, FR, LU, MT, SE, SI, UK 
Pig meat 
2012 - 23 
All MSs except  MT,SE, SI, UK 
Non-MSs: IS, NO 
2011 - 25 
All MSs except MT,UK 
Non-MSs: IS, NO 
Bovine meat 
2012 - 24 
All MSs except MT, SE, UK 
Non-MSs: CH, NO 
2011 - 25 
All MSs except MT, UK 
Non-MSs: CH, NO 
Milk and dairy products 
2012 - 20 
All MSs except BG, DK, FI, LU, MT, SI, UK 
Non MS: CH 
2011 - 20 All MSs except DK, FI, FR, LT, LU, MT, UK 
Fruit and vegetables 
2012 - 21 All MSs except CY, FI, FR, GR, LU, MT 
2011 - 20 All MSs except CY, FI, FR, GR, LU, MT 
Fish and other fishery 
products
1
  
2012 - 21 
All MSs except DK, FI, FR, GR, LU, MT, UK 
Non-MSs: CH, NO 
2011 - 20 
All MSs except DK, FI, FR, LT, LU, MT, UK  
Non-MSs: CH, NO 
Note: The overview table includes all data reported by MSs.  
1. This category includes fish, fishery products, crustaceans, live bivalve molluscs, molluscan shellfish and surimi.  
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Compliance with microbiological criteria 
The Salmonella criteria laid down by Regulation (EC) No 2073/2005
13
 have been in force since 1 January 
2006. The criteria were modified by Regulation (EC) No 1441/2007
14
, which came into force in December 
2007. The Regulations prescribe rules for sampling and testing, and set limits for the presence of Salmonella 
in specific food categories and in samples from food processing. The food safety criteria for Salmonella 
apply to products placed on the market within their shelf life. According to these criteria, Salmonella must be 
absent in the food categories listed in Table SA5. Absence is defined by testing five or 30 samples of 25 g 
per batch depending on the food category. In official controls, often only single samples are taken to verify 
compliance with the criteria. 
An evaluation of compliance with the Salmonella criteria at EU level is presented in Table SA5. The 
evaluation includes only investigations where the sampling unit (single samples or batches) and sampling 
stage at retail level has been reported for the relevant food types. Results are highly influenced by the MSs 
reporting and the sample sizes in their investigations, both of which vary between the years. 
In 2012, as in 2011 and in previous years, the highest levels of non-compliance with Salmonella criteria 
generally occurred in foods of meat origin which are intended to be cooked before consumption 
(Figure SA4). Minced meat and meat preparations from poultry intended to be eaten cooked had the highest 
level of non-compliance (category 1.5; 8.7 % of single samples and 5.7 % of batches). The level of non-
compliance among the 15 MSs which reported data varied markedly, ranging from 0 to 48.5 %.  
For minced meat and meat preparations, from animal species other than poultry intended to be eaten 
cooked, non-compliance was also reported (category 1.6, 2.0 % of single samples and 0.9 % of batches 
positive for Salmonella). Except for a very high level of non-compliance in one investigation of 22 single 
samples (54.5 %), the level of non-compliance among the 17 MSs that reported data ranged from 0 to 6.1 %.  
A high proportion of non-compliance was also reported for meat products from poultry meat intended to be 
eaten cooked (category 1.9, 2.9 % of single samples with none of the batches being positive); however, only 
three of the 10 MSs that reported data reported positive samples.  
The occurrence of Salmonella in foods of meat origin intended to be eaten raw is of particular relevance 
because of the risk such foods pose to human health. There were only a few positive findings of minced 
meat, meat preparations and meat products intended to be eaten raw (food categories 1.4 and 1.8). Most of 
the reported data, on minced meat and meat preparations to be eaten raw, originated from three MSs, 
whereas most of the single samples of meat preparations intended to be eaten raw (including all the positive 
samples) originated from one MS. 
Non-compliance was also observed in live bivalve molluscs and live echinoderms, tunicates and gastropods 
(category 1.17), where 1.8 % of batches were not compliant. 
In addition, very low proportions of single samples not complying with Salmonella criteria were observed in 
other ready-to-eat (RTE) products. All non-compliant samples of cheeses, butter and cream made from raw 
or low heat-treated milk (category 1.11, 0.6 %) originated from a small investigation where the three tested 
samples were all positive. Single samples of pre-cut fruit and vegetables were also found to be non-
compliant (category 1.19, 0.4 %), where the few positive samples originated from three of the six included 
MSs. 
As in previous years, all samples/batches of dried infant formulae and dried dietary foods for medical 
purposes were found to be compliant with the Salmonella criteria. 
In 2012, a high proportion of non-compliance was reported for fresh poultry meat. This is a new category 
1.28 (Table SA5) and came into force in December 2011 (Regulation (EC) No 1086/2011)
15
. Of the single 
                                                        
13 
Commission Regulation (EC) No 2073/2005 of 15 November 2005 on microbiological criteria for foodstuffs. OJ L 338, 22.12.2005, 
p. 1–26. 
14
 Commission Regulation (EC) No 1441/2007 of 5 December 2007 amending Regulation (EC) No 2073/2005 on microbiological 
criteria for foodstuffs. OJ L 322, 7.12.2007, p. 12–29.  
15
 Commission Regulation (EU) No 1086/2011 of 27 October 2011 amending Annex II to Regulation (EC) No 2160/2003 of the 
European Parliament and of the Council and Annex I to Commission Regulation (EC) No 2073/2005 as regards salmonella in fresh 
poultry meat. OJ L 281, 28.10.2011, p. 7–11.  
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samples, 0.5 % were positive, whereas 0.7 % of the batches were positive. Six MSs, out of the 15 MSs 
which submitted data, reported positive samples.  
Table SA5. Compliance with the food safety Salmonella criteria laid down by EU Regulation 
2073/2005 and 1441/2007, 2012 
Food categories1 
Total single samples Total batches 
Sample 
weight N 
% non-
compliant 
Sample 
weight N 
% non-
compliant 
1.4 
Minced meat and meat 
preparations intended to be eaten 
raw 
25 g 619 0.2 25 g 390 0.5 
1.5 
Minced meat and meat 
preparations from poultry intended 
to be eaten cooked 
25 g or 
not 
stated 
2,246 8.7 25 g 689 5.7 
1.6 
Minced meat and meat 
preparations from other species 
than poultry intended to be eaten 
cooked 
10 g or 
25 g 5,479 2.0 
10 g or 
14 g or 
25 g or 
not 
stated 
874 0.9 
1.7 Mechanically separated meat 25 g 3 0 10 g or 25 g 12 8.3 
1.8 Meat products intended to be eaten raw 
10 g or 
25 g 324 1.5 25 g 32 0 
1.9 Meat products from poultry meat intended to be eaten cooked 25 g 413 2.9 
25 g or 
200 g 370 0 
1.10 Gelatine and collagen 25 g 91 0 25 g 94 0 
1.11 Cheeses, butter and cream made from raw or low heat-treated milk 25 g 462 0.6 25 g  1,506 0 
1.12 Milk and whey powder 25 g 136 0 25 g  43 0 
1.13 Ice cream 25 g or 50 g 8,571 <0.1 25 g 307 0 
1.14 Egg products 25 g or 120 g 476 0 25 g 22 0 
1.15 RTE foods containing raw eggs 25 g 25 0 25 g 43 0 
1.16 Cooked crustaceans and molluscan shellfish 25 g 72 0 25 g  385 0 
1.17 
Live bivalve molluscs and live 
echinoderms, tunicates and 
gastropods 
25 g 6 0 25 g  340 1.8 
1.18 Sprouted seeds (RTE) 25 g 61 0 25 g or 250 g 60 0 
1.19 Pre-cut fruit and vegetables (RTE) 25 g 1,797 0.4 
25 g or 
250 g or 
not 
stated 
1,217 0 
1.20 Unpasteurised fruit and vegetable juices (RTE) 25 g 13 0 
25 g or 
25 ml or 
not 
stated 
366 0 
1.22-1.23 
Dried infant formulae, dried dietary 
foods for medical purposes2 and 
dried follow-on formulae 
25 g 788 0 25 g 262 0 
1.28 Fresh poultry meat3 25 g 2,384 0.5 25 g 682 0.7 
Note: Includes investigations where the sampling unit (single samples or batches) and sampling stage at retail (also catering, hospitals 
and care homes) has been specified for the relevant food types. Includes investigations with sample size <25.  
 RTE: ready-to-eat products.  
1. Numbers before food categories refer to Annex 1, chapter 1 of Regulation (EC) No 1441/2007. See this Regulation for full 
description of food categories. 
2. Intended for infants below six months of age. 
3. Salmonella criterion for S. Enteritidis and S. Typhimurium (including monophasic S. Typhimurium strains with the antigenic 
formula 1,4,[5],12:i:-, in fresh poultry meat (including fresh meat from breeding flocks of Gallus gallus, laying hens, broilers and 
breeding and fattening flocks of turkeys). 
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Figure SA4.  Proportion of units not complying with the EU Salmonella criteria, 2011–2012 
 
Note: Includes investigations where the sampling unit (single samples or batches) and sampling stage at retail (also catering, hospitals and care homes) has been specified for the relevant food types. 
Includes investigations with sample size <25. The 8.3 % of non-compliance in mechanically separated meat is based on only 12 tested batches.  
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Broiler meat and products thereof 
In 2012, 24 MSs and 1 non-MS, reported data on Salmonella in fresh broiler meat from investigations with 25 
or more samples. The findings of Salmonella in these investigations, conducted at different points in the 
production chain, are presented in Table SA6.  
Salmonella was detected in most of the 65 reported investigations, with only five MSs (Denmark, Finland, 
Ireland, Italy and Portugal) and one non-MS (Iceland) reporting no Salmonella findings. Overall, 51,093 fresh 
broiler meat units (single or batch) were tested, within the EU, and 4.1 % of these were positive. Compared 
with 2011, when the results of 25,611 samples were reported, the number of tested units almost doubled. 
Thus, comparing the EU totals for 2012 with the results of previous years should be done very cautiously.  
Trends in the occurrence of Salmonella in broiler meat from 2004 to 2012 are presented in Figures SA5 and 
SA6 for MSs that have reported at least six years of data, either single samples (13 MSs) or batches (five 
MSs). When exploring data by logistic regression analysis, combining single sample data from all sampling 
levels from the 13 MSs reporting from 2004 to 2012, no significant trend was observed in the MS-group 
weighted prevalence of positive samples (Figure SA7).  
At the slaughterhouse level, the proportions of positive samples ranged from 0 to 22.7 %, with no positive 
samples in five MSs. Most of the tested samples were neck skin samples.  
At the processing or cutting plant, the proportion of positive samples ranged from 0 to 25.2 %, with the 
highest proportions found in the two MSs also reporting the highest prevalences at the slaughterhouse level. 
In most MSs, the sample material for testing at processing was meat samples or unspecified material, but in 
Poland neck skin samples and carcases were tested. At retail, more than 10 % Salmonella-positive samples 
were detected in Hungary (29.3 %), and in imported meat on the Austrian market (12.7 %). Belgium, Estonia, 
Hungary, Latvia, Romania and Spain sampled fresh broiler meat at all three levels in the production chain. In 
some cases results in all three steps were comparable, but sometimes relatively large variations were 
observed.  
Nine MSs reported results of investigations of ready-to-eat (RTE) broiler meat products, comprising more 
than 25 tested units. The results are presented in Table SA7. Of the 2,673 units tested in 2012, none were 
found to be Salmonella positive. In 2011, when a larger amount of units were tested (4,702), the overall 
prevalence was very low (0.1 % or one positive sample in each of three different investigations). 
For further information see Level 3 Tables. 
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Table SA6. Salmonella in fresh broiler meat at slaughter, processing/cutting level and retail, 2012 
Country Description 
Sample  
unit 
Sample 
weight 
2012 
N N pos % pos 
At slaughterhouse           
Belgium Neck skin Single 1 g 270 3 1.1 
Bulgaria Meat Batch 25 g 770 42 5.5 
Cyprus 
Meat Single 25 g 80 5 6.3 
Neck skin Single 25 g 300 68 22.7 
Czech Republic Neck skin Batch 25 g 665 72 10.8 
Denmark Neck skin Batch 300 g 368 0 0 
Estonia Neck skin Batch 25 g 48 0 0 
Finland Neck skin Batch 15x10 g 195 0 0 
Greece   Single 25 g 56 11 19.6 
Hungary Neck skin Batch 25 g 166 25 15.1 
Ireland Neck skin Single 25 g 182 0 0 
Latvia Neck skin Single 25 g 100 0 0 
Lithuania Neck skin Batch - 180 4 2.2 
Poland 
Meat Batch 25 g 205 0 0 
Neck skin Batch 25 g 7,924 265 3.3 
Meat Single 25 g 922 13 1.4 
Neck skin Single 25 g 2,584 179 6.9 
Romania 
Meat Batch 25 g 181 0 0 
Neck skin Batch 25 g 1,039 36 3.5 
Spain Meat Single 25 g 203 30 14.8 
Sweden Neck skin Batch - 4,124 1 <0.1 
Iceland Neck skin Batch 25 g 868 2 0.2 
At processing or cutting plant           
Belgium Meat, at processing plant Single 25 g 590 22 3.7 
Bulgaria Meat, at processing plant Batch 25 g 384 7 1.8 
Cyprus Meat, at processing plant Single 25 g 170 40 23.5 
Czech Republic Meat, at processing plant Batch 25 g 110 8 7.3 
Estonia Meat, at cutting plant Batch 25 g 48 0 0 
Germany Meat, at processing plant Single 25 g 88 3 3.4 
Greece At processing plant Single 25 g 31 3 9.7 
Hungary Meat, at processing plant Single 25 g 218 55 25.2 
Italy At processing plant Single 25 g 36 0 0 
Latvia At processing plant Single 25 g 35 7 20.0 
Poland 
Meat, at processing plant Batch 25/125 g 7,922 207 2.6 
Neck skin, at processing plant Batch 25 g 834 7 0.8 
Carcase swabs, at processing 
plant 
Single 1000 g 1,229 17 1.4 
Meat, at processing plant Single 25 g 5,568 164 2.9 
Neck skin, at processing plant Single 25/200 g 1,030 4 0.4 
Meat, at cutting plant Batch 25 g 105 14 13.3 
Neck skin, at cutting plant Batch 25 g 50 11 22.0 
Meat, at cutting plant Single 25 g 271 15 5.5 
Table continued overleaf.  
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Table SA6 (continued). Salmonella in fresh broiler meat at slaughter, processing/cutting level and 
retail, 2012 
Country Description 
Sample  
unit 
Sample 
weight 
2012 
N N pos % pos 
Portugal Meat, at processing plant Single 25 g 50 0 0 
Romania Meat, at processing plant Batch 25 g 79 3 3.8 
Slovenia At processing plant Batch 25 g 100 13 13.0 
Spain Meat, at processing plant Single 25 g 74 9 12.2 
Sweden Meat, at cutting plant Batch - 792 0 0 
At retail             
Austria 
Food sample, domestic 
production 
Single 25 g 56 2 3.6 
Food sample, imported Single 25 g 79 10 12.7 
Belgium   Batch 25 g 406 20 4.9 
Estonia 
Meat, European Union Single 25 g 142 2 1.4 
Meat Single 25 g 75 0 0 
Germany Meat Single 25 g 553 16 2.9 
Hungary Meat Single 25 g 328 96 29.3 
Latvia   Single 25 g 180 16 8.9 
Netherlands   Single 25 g 564 37 6.6 
Portugal Meat Batch 25 g 100 0 0 
Romania Meat Batch 25 g 46 1 2.2 
Slovakia Meat Batch 25 g 42 4 9.5 
Spain Meat Single 25 g 89 2 2.2 
Iceland 
Neck skin, neck skin of whole 
chicken 
Single 25 g 117 0 0 
Skinned loins Single 90 ml 117 0 0 
Wings with skin Single 90 ml 117 0 0 
Sampling level not stated           
Poland 
Meat Batch 25 g 2,879 176 6.1 
Neck skin Batch 25 g 60 18 30.0 
Meat Single 25 g 3,785 325 8.6 
Neck skin Single 25 g 1,333 25 1.9 
  Total     51,093 2,113 4.1 
EU Total Single     21,271 1,179 5.5 
  Batch     29,822 934 3.1 
Note: Only investigations covering 25 or more samples are included. 
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Figure SA5.  Salmonella in fresh broiler meat (single samples), prevalence and 95 % confidence 
interval in 13 Member States, 2004–2012 
 
Figure SA6.  Salmonella in fresh broiler meat (batches), prevalence and 95 % confidence interval in 
five Member States, 2004–2012 
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Figure SA7.  Weighted prevalence
1
 and 95 % confidence interval
2
 of Salmonella-positive broiler meat 
samples
3
, overall for 13 Member States
4
, 2004–2012 
 
1. The MS group prevalence is estimated using weights. The MS specific weight is the ratio between the slaughter broiler 
population size and the number of tested samples per MS per year. Slaughtered numbers of broilers were reported by MSs in the 
framework of the 2008 baseline survey in broiler flocks and broiler carcases, and supplemented with EUROSTAT data from 
2008. Batch-based data excluded. 
2. Vertical bars indicate the exact binomial 95 % confidence interval. 
3. Combined data (samples taken at slaughter, at processing/cutting plant or at retail) have been used to calculate the percentage 
of Salmonella-positive fresh broiler meat samples. Batch based data excluded. 
4. Include only MSs that reported data for at least six years: Austria, Belgium, Finland, Germany, Greece, Hungary, Ireland, Italy, 
Luxembourg, Netherlands, Portugal, Slovenia and Spain. 
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Table SA7. Salmonella in ready-to-eat broiler meat product samples, 2011–2012 
Country Description 
Sample  
unit 
Sample      
weight 
2012 2011 
N N pos % pos N N pos % pos 
At processing                   
Belgium Broiler meat products - cooked, ready-to-eat
1
 Batch 25/200 g 45 0 0 45 0 0 
Bulgaria Broiler meat products - cooked, ready-to-eat Batch 25 g 667 0 0 1,640 0 0 
Czech Republic Broiler meat products - cooked, ready-to-eat Batch 25 g 175 0 0 176 0 0 
Germany 
Broiler meat products - cooked, ready-to-eat, domestic 
production 
Single 25 g 25 0 0 29 0 0 
Greece Broiler meat products - cooked, ready-to-eat Single 25 g - - - 125 1 0.8 
Hungary Broiler meat products - cooked, ready-to-eat Single 25 g 85 0 0 172 0 0 
Ireland 
Broiler meat products Single 25 g - - - 80 0 0 
Broiler meat products - cooked, ready-to-eat Single 25 g - - - 112 0 0 
Poland 
Broiler meat products - cooked, ready-to-eat Batch 25 g 55 0 0 - - - 
Broiler meat products - cooked, ready-to-eat Single 25 g 103 0 0 888 0 0 
Broiler meat products - cooked, ready-to-eat Single 500 g 186 0 0 - - - 
Spain Broiler meat products - cooked, ready-to-eat Single 25 g - - - 39 0 0 
At retail                   
Belgium Broiler meat products - cooked, ready-to-eat Batch 25 g 47 0 0 - - - 
Bulgaria Broiler meat products - cooked, ready-to-eat Batch 25 g - - - 155 0 0 
Estonia Broiler meat products - cooked, ready-to-eat Single 25 g - - - 41 0 0 
Germany 
Broiler meat products - cooked, ready-to-eat, domestic 
production 
Single 25 g 225 0 0 153 0 0 
Hungary Broiler meat products - cooked, ready-to-eat Single 25 g 132 0 0 96 0 0 
Ireland 
Broiler meat products - cooked, ready-to-eat, domestic 
production 
Single 25 g 58 0 0 - - - 
Broiler meat products - cooked, ready-to-eat, imported Single 25 g 111 0 0 - - - 
Broiler meat products Single 25 g - - - 59 0 0 
Broiler meat products - cooked, ready-to-eat Single 25 g - - - 512 0 0 
Table continued overleaf. 
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Table SA7 (continued). Salmonella in ready-to-eat broiler meat product samples, 2011–2012 
Country Description 
Sample  
unit 
Sample      
weight 
2012 2011 
N N pos % pos N N pos % pos 
Latvia Broiler meat products - cooked, ready-to-eat Single 25 g 125 0 0 130 0 0 
Slovakia Broiler meat products - cooked, ready-to-eat Batch 25 g - - - 37 0 0 
Spain 
Broiler meat products - raw and intended to be eaten 
raw 
Single 25 g 42 0 0 - - - 
Broiler meat products - cooked, ready-to-eat Single 25 g - - - 95 1 1.1 
United Kingdom Broiler meat products - cooked, ready-to-eat Single 25 g - - - 75 1 1.3 
Sampling level not stated                 
Ireland Broiler meat products, imported Single 25 g 82 0 0 - - - 
Poland Broiler meat products - cooked, ready-to-eat Single 25 g 510 0 0 - - - 
Sweden Broiler meat products Single - - - - 43 0 0 
Total (2012: 9 MSs, 
2011: 13 MSs) 
Total     2,673 0 0 4,702 3 <0.1 
Single     1,684 0 0 2,649 3 0.1 
Batch     989 0 0 2,053 0 0 
Note: Only investigations covering 25 or more samples are included. 
1.  Sample weight was 25 g in 2012 and 200 g in 2011. 
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Turkey meat and products thereof 
Eleven MSs reported test results for Salmonella in fresh turkey meat; the results of investigations including 
more than 25 units are presented in Table SA8. In total, 6,412 samples were tested (50 % batch samples 
and 50 % single samples) with overall 4.4 % of the units testing positive. These overall results were 
comparable with the 2011 reported data. 
At slaughterhouse, three MSs and one non-MS (Finland, Lithuania, Sweden and Iceland) found no positive 
samples, while in the remaining four MSs, the proportion of positive samples ranged from 9.3 % to 13.1 %. 
At processing or cutting plant level, Poland conducted several investigations comprising a very high number 
of samples (in total 2,354 batches and 707 single samples), in which the proportions of Salmonella positive 
samples ranged from 1.0 % to 8.1 %. At retail, no positive samples were found in the Netherlands and 
Portugal. In the four other MSs reporting results from single samples at the retail level, the proportions of 
positive samples ranged from 2.2 % to 12.7 %.  
Four MSs reported results from sampling turkey meat products. In total, 737 samples were tested, none of 
which was found to be positive. In 2011 Salmonella was detected in 0.6 % of samples (four samples in total 
obtained in three different MSs), see Table SA9. 
For further information see Level 3 Tables. 
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Table SA8. Salmonella in fresh turkey meat, 2011–2012 
Country Description 
Sample  
unit 
Sample 
weight 
2012 2011 
N 
N 
pos 
% 
pos 
N 
N 
pos 
% 
pos 
At slaughterhouse                 
Czech Republic Neck skin Batch 25 g 270 25 9.3 350 10 2.9 
Finland Neck skin Batch 
10 x 
15 g 
65 0 0 - - - 
Germany 
Neck skin, domestic 
production 
Slaughter 
batch 
25 g 352 46 13.1 - - - 
Hungary Neck skin Single 25 g 192 22 11.5 286 43 15.0 
Lithuania Neck skin Batch - 31 0 0 - - - 
Poland 
Neck skin Batch 25 g 55 7 12.7 - - - 
Neck skin Single 25 g 420 46 11.0 1,295 83 6.4 
Sweden Neck skin Single - 450 0 0 1,046 0 0 
Iceland Neck skin Batch 25 g 67 0 0 63 0 0 
At processing or cutting plant                 
Bulgaria At processing plant Batch 25 g - - - 70 0 0 
Finland At cutting plant Single 25 g - - - 298 0 0 
Hungary 
Meat, at processing 
plant 
Single 25 g 281 13 4.6 296 38 12.8 
Italy 
Domestic 
production, at 
processing plant 
Single 25 g - - - 116 16 13.8 
Poland 
Meat, at processing 
plant 
Batch 25 g 1,633 17 1.0 - - - 
Neck skin, at 
processing plant 
Batch 25 g 640 8 1.3 - - - 
Meat, at processing 
plant 
Single 25 g 472 38 8.1 453 14 3.1 
Neck skin, at 
processing plant 
Single 200 g 235 3 1.3 - - - 
Meat, at cutting 
plant 
Batch 25 g 81 0 0 - - - 
Sweden 
Meat, at cutting 
plant 
Batch - 48 0 0 - - - 
At retail                   
Austria 
Food sample, 
domestic production 
Single 25 g 62 7 11.3 33 3 9.1 
Estonia 
Food sample, 
European Union 
Single 25 g 45 1 2.2 - - - 
Germany 
Meat, domestic 
production 
Single 25 g 751 25 3.3 - - - 
Hungary Meat Single 25 g 102 13 12.7 34 3 8.8 
Netherlands Food sample Single 25 g 71 0 0 123 1 0.8 
Portugal Food sample Batch 25 g 25 0 0 - - - 
Sampling level not stated                
Poland Meat Single 25 g 131 10 7.6 - - - 
Total  
(2012: 11 MSs,  
2011: 9 MSs) 
Total     6,412 281 4.4 4,400 211 4.8 
Single     3,212 178 5.5 3,980 201 5.1 
Batch     3,200 103 3.2 420 10 2.4 
Note: Only investigations covering 25 or more samples are included. 
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Table SA9. Salmonella in ready-to-eat turkey meat product samples, 2011–2012 
Country Description 
Sample  
unit 
Sample      
weight 
2012 2011 
N N pos % pos N N pos % pos 
At processing                 
Hungary 
Turkey meat products - cooked, ready-
to-eat 
Single 25 g 92 0 0 196 1 0.5 
Ireland 
Turkey meat products - cooked, ready-
to-eat 
Single 25 g - - - 53 0 0 
Poland 
Turkey meat products - cooked, ready-
to-eat 
Batch 25 g 129 0 0 - - - 
At retail                   
Germany 
Turkey meat products - cooked, ready-
to-eat, domestic production 
Single 25 g 105 0 0 126 1 0.8 
Hungary 
Turkey meat products - cooked, ready-
to-eat 
Single 25 g 220 0 0 110 0 0 
Ireland 
Turkey meat products - cooked, ready-
to-eat 
Single 25 g - - - 75 0 0 
Netherlands 
Turkey meat products - cooked, ready-
to-eat 
Single 25 g - - - 34 2 5.9 
Portugal 
Turkey meat products - cooked, ready-
to-eat 
Batch 25 g 105 0 0 - - - 
Sampling level not stated                 
Italy 
Meat from turkey - meat products, 
domestic production 
Single 25 g - - - 31 0 0 
Poland 
Turkey meat products - cooked, ready-
to-eat 
Single 25 g 86 0 0 - - - 
Total (2012: 4 MSs, 
2011: 5 MSs) 
Total     737 0 0 625 4 0.6 
Single     503 0 0 625 4 0.6 
Batch     234 0 0 0 0 0 
Note: Only investigations covering 25 or more samples are included. 
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Eggs and egg products 
According to EU legislation, starting from 1 January 2009, eggs shall not be used for direct human 
consumption as table eggs unless they originate from a commercial flock of laying hens subject to a national 
Salmonella control programme. Eggs originating from flocks with unknown Salmonella status, that are 
suspected of being infected or known to be infected with S. Enteritidis or S. Typhimurium, or which were 
identified as the source of infection in a specific human food-borne outbreak, may be placed on the market 
only if treated in a manner that guarantees the elimination of all Salmonella serovars of public health 
significance and marked in a way that easily distinguishes them from table eggs before being placed on the 
market (Regulation (EC) No 1237/2007)
16
. These provisions, together with the mandatory Salmonella control 
programmes in flocks of laying hens, implementing a final annual Salmonella reduction target for laying hen 
flocks (Regulation (EC) No 517/2011)
17
, are believed to have contributed to the reduction in Salmonella 
contaminated laying hens in the EU. 
In 2012, 16 MSs reported data from investigations in table eggs with 25 or more samples. The findings are 
presented in Table SA10. In total 0.1 % of the 18,843 tested units were found to be Salmonella positive, with 
detection of at least one positive unit in 11 of the 29 listed investigations. The proportion of positive units 
ranged from 0 to 7.0 %. The highest proportion of positive samples was found in a relatively small 
investigation (43 single samples) of Italian eggs tested during processing. As in 2011, approximately 60 % of 
the investigations were carried out on single samples and 0.1 % of the 11,523 units tested were found to be 
Salmonella positive. Of the 7,320 batches, 0.1 % tested positive. The majority of the tested eggs were 
sampled at retail, where Germany and the Netherlands carried out some large investigations including 
6,464 single samples and 3,734 batches, respectively. Germany also tested a large number of samples 
obtained at the processing plant level (1,645 samples in total), including separate investigations of shell, 
white and yolk, where no samples tested positive. Only Poland tested table eggs at the farm level and found 
one positive sample in an investigation of 378 batches, and no positive samples when testing 112 single 
samples. 
It should be noted that what constituted a batch or single sample varied in terms of weight (25–500 g) and 
content among the MSs. This may have an impact on the results from the investigations and should be kept 
in mind when comparing the results.  
For further information see Level 3 Tables. 
  
                                                        
16
 Commission Regulation (EC) No 1237/2007 of 23 October 2007 amending Regulation (EC) No 2160/2003 of the European 
Parliament and of the Council and Decision 2006/696/EC as regards the placing on the market of eggs from Salmonella infected 
flocks of laying hens. OJ L 280, 24.10.2007, p 5–9. 
17
  Commission Regulation (EU) No 517/2011 of 25 May 2011 implementing Regulation (EC) No 2160/2003 of the European 
Parliament and of the Council as regards a Union target for the reduction of the prevalence of certain Salmonella serotypes in laying 
hens of Gallus gallus and amending Regulation (EC) No 2160/2003 and Commission Regulation (EU) No 200/2010. OJ L 138, 
26.5.2011, p. 45–51.  
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Table SA10. Salmonella in table egg samples, 2012  
Country Description 
Sample  
unit 
Sample 
weight 
2012 
N N pos % pos 
At farm             
Poland 
  Batch 25 g 378 1 0.3 
  Single 25 g 112 0 0 
At packing center/processing plant            
Bulgaria At packing centre Batch - 2,372 1 <0.1 
Germany 
Shell, at processing plant, 
domestic production 
Single 25 g 223 0 0 
White, at processing plant, 
domestic production 
Single 25 g 27 0 0 
Yolk, at processing plant, 
domestic production 
Single 25 g 223 0 0 
At processing plant, domestic 
production 
Single 25 g 1,645 0 0 
Italy 
At processing, domestic 
production 
Single 25 g 43 3 7.0 
Poland 
At packing centre Batch 25 g 204 1 0.5 
At packing centre Single 25 g 44 0 0 
At processing Single 500 g 139 0 0 
Portugal At packing centre Batch - 30 0 0 
Romania At packing centre Batch 25 g 318 0 0 
Spain At packing centre Single 25 g 240 5 2.1 
At retail             
Austria Domestic production Single 300 g 51 0 0 
Belgium   Batch 25 g 118 0 0 
Bulgaria   Batch - 57 0 0 
Germany 
Eggs - table eggs - shell, domestic 
production 
Single 25 g 605 0 0 
Eggs - table eggs - white, 
domestic production 
Single 25 g 64 0 0 
Eggs - table eggs - yolk, domestic 
production 
Single 25 g 641 0 0 
Eggs - table eggs, domestic 
production 
Single 25 g 6,464 5 <0.1 
Hungary   Single 10 eggs 655 0 0 
Latvia   Single 25 g 90 1 1.1 
Lithuania Eggs - table eggs - whole Batch - 38 0 0 
Netherlands   Batch 25 g 3,734 2 <0.1 
Romania   Batch 25 g 39 1 2.6 
Slovakia 
  Batch 25 g 32 0 0 
  Single 25 g 257 8 3.1 
Spain   Single 25 g 265 17 6.4 
Total (16 MSs) 
Total     18,843 28 0.1 
Single     11,523 17 0.1 
Batch     7,320 6 <0.1 
Note: Only investigations covering 25 or more samples are included. 
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Pig meat and products thereof 
Most of the national monitoring programmes for Salmonella in pig meat and products thereof are based on 
sampling at the slaughterhouse and/or processing or cutting plants. At the slaughterhouse, sampling is often 
carried out by means of swabbing an area of the carcase, varying from 300 cm
2
 (Iceland and Poland) to 
1,400 cm
2
 (Estonia, Finland and Sweden).  
In 2012, 19 MSs and 2 non-MSs reported data on Salmonella in fresh pig meat from investigations with 25 or 
more samples. The occurrence of Salmonella in these food samples at different levels in the production line 
is presented in Table SA11. In total, 85,000 units were tested in the EU, of which 0.7 % tested positive. As 
for fresh broiler meat, there was a substantial increase in the number of samples compared with 2011 
(52,868 samples, of which 0.7 % were found to be Salmonella positive). No Salmonella was detected in 18 of 
the 46 investigations and the overall proportion of positive samples in the investigations ranged from 0 to 
17.5 %. The highest proportion of positive samples was found at processing plants in Portugal in a relatively 
small investigation of 40 single samples. In total, 51,933 single samples were tested, of which 0.7 % were 
found to be positive. The proportion of positive samples in the 33,067 tested batch samples was 0.6 %. 
At slaughterhouse some very large investigations were carried out by the Czech Republic, Finland, Poland 
and Sweden, yielding 0 or <1 % positive results. The highest levels of positive samples at slaughterhouse 
were found in Belgium (10.8 %) and Spain (7.8 %). At the processing level, Poland reported the largest 
investigation comprising 10,503 batch samples, of which 1.1 % tested positive for Salmonella. A relatively 
large proportion of samples were found to be positive in a Portuguese investigation (17.5 %) based on a 
smaller number of samples (40 single samples). At the retail level, the proportion of Salmonella-positive 
samples in the investigations were generally low, ranging from 0 to 2.1 %. 
Sixteen MSs reported results from investigations of RTE minced meat, meat preparations and meat products 
from pig meat which included more than 25 samples (Table SA12). The proportion of positive samples 
ranged from 0 to 9.4 %. Overall, 0.6 % of the 22,517 units tested positive for Salmonella; 12,096 of the 
tested units (54 %) were single samples, of which 0.4 % tested positive. Among the 10,421 batch samples, 
Salmonella was detetcted in 0.8 % of samples. Only Poland reported results from testing minced meat that 
was meant to be eaten raw; Salmonella was not detected in any of the 29 tested single samples. Overall, the 
highest prevalence (9.4 %) was found in a smaller investigation (85 single samples) of meat preparations 
intended to be eaten raw in Poland. In cooked RTE meat preparations or meat products, the highest 
proportion of positive samples was found in Portugal (3.3 % positive samples in each of two investigations at 
processing and at retail levels). Four MSs (Belgium, Cyprus, Germany and Hungary) reported results for 
fermented sausages, which in all four countries were tested at both processing and retail levels. Belgium and 
Cyprus found no positive samples, whereas in Germany and Hungary the proportion of positive samples 
ranged from 0.2 % to 1.7 %.  
For further information see Level 3 Tables. 
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Table SA11. Salmonella in fresh pig meat, at slaughter, cutting/processing level and retail, 2012 
Country Description 
Sample  
unit 
Sample 
weight 
2012 
N N pos % pos 
At slaughterhouse            
Belgium Carcase swabs Single 600 cm
2
 535 58 10.8 
Bulgaria Carcase swabs Batch 400 cm
2
 1,122 5 0.4 
Czech Republic Carcase swabs Batch 400 cm
2
 5,941 43 0.7 
Denmark
1
 Carcase swabs Single 400 cm
2
 18,655 136 1.2 
Estonia Carcase swabs Single 1,400 cm
2
 600 16 2.7 
Finland Carcase swabs Single 1,400 cm
2
 6,412 0 0 
Hungary Carcase swabs Batch 400 cm
2
 268 0 0 
Latvia Carcase swabs Single - 750 5 0.7 
Lithuania Meat Batch - 178 3 1.7 
Poland 
Carcase swabs Batch 300/400 cm
2
 9,100 17 0.2 
Meat Batch 25 g 495 0 0 
Carcase swabs Single 300/400 cm
2
 7,951 18 0.2 
Portugal Carcase swabs Single - 431 9 2.1 
Romania 
Carcase swabs Batch - 447 1 0.2 
Meat Batch 25 g 161 0 0 
Spain Meat Single 25 g 206 16 7.8 
Sweden  Carcase swabs Single 1,400 cm
2
 5,317 0 0 
Iceland Carcase swabs Batch 300 cm
2
 2,172 7 0.3 
Norway Carcase swabs Single - 3,066 0 0 
At processing or cutting plant          
Belgium Meat, at processing plant Single 25 g 151 4 2.6 
Bulgaria 
Carcase swabs, at 
processing plant 
Batch 25 g 191 0 0 
Cyprus 
Food sample, at 
processing plant 
Single 10 g 305 0 0 
Estonia 
Meat, at processing plant Single 25 g 32 0 0 
Meat, at cutting plant Single 25 g 248 0 0 
Finland Meat, at cutting plant Single 25 g 1,464 0 0 
Germany Meat Single 25 g 736 37 5.0 
Hungary Meat, at processing plant Single 25 g 249 2 0.8 
Italy 
At processing plant, 
domestic production 
Single 25 g 35 1 2.9 
Food sample, at 
processing plant, 
domestic production 
Single 25 g 41 2 4.9 
Poland 
Meat Batch 10/25 g 10,503 114 1.1 
Meat Single 25 g 775 12 1.5 
Carcase swabs, at cutting 
plant 
Single 400 cm
2
 497 0 0 
Meat, at cutting plant Single 25 g 74 0 0 
Portugal Meat, at processing plant Single 25 g 40 7 17.5 
Romania Meat, at processing plant Batch 25 g 172 3 1.7 
Table continued overleaf. 
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Table SA11 (continued). Salmonella in fresh pig meat, at slaughter, cutting/processing level and 
retail, 2012 
Country Description 
Sample  
unit 
Sample 
weight 
2012 
N N pos % pos 
At retail           0 
Bulgaria Meat Single 10 g 90 1 1.1 
France Meat Single 25 g 334 7 2.1 
Germany Meat Single 25 g 1,875 29 1.5 
Hungary Meat Batch 25 g 146 2 1.4 
Italy 
Food sample, domestic 
production 
Single 25 g 27 0 0 
Netherlands Food sample Single 25 g 967 14 1.4 
Romania Meat Batch 25 g 112 0 0 
Sampling level not stated      
Poland 
Carcase swabs Batch 25 g/400 cm
2
 1,676 0 0 
Meat Batch 10/25 g 2,555 0 0 
Carcase swabs Single 
400 cm
2
/ 
unspecified 
3,031 14 0.5 
Meat Single 10/25 g 105 0 0 
Total (19 MSs) 
Total     85,000 576 0.7 
Single     51,933 388 0.7 
Batch     33,067 188 0.6 
Note: Only investigations covering 25 or more samples are included. 
1. Most of the Danish samples were pooled samples, and a single-carcase prevalence was calculated. Both the loss of sensitivity 
and the probability of more than one sample being positive in each pool were taken into consideration. A conversion factor was 
determined on the basis of comparative studies. Therefore, the adjusted prevalence is 1.2 %. 
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Table SA12. Salmonella in ready-to-eat minced meat, meat preparations and meat products from pig meat, 2011–2012 
Country Description 
Sample  
unit 
Sample      
weight 
2012 2011 
N N pos % pos N N pos % pos 
At processing                 
Belgium 
Pig meat products - fermented sausages Batch 25 g 41 0 0 - - - 
Pig meat products - raw ham Batch 25 g 42 0 0 - - - 
Pig meat products - cooked, ready-to-eat Batch 200 g - - - 41 0 0 
Bulgaria 
Pig meat preparation - intended to be eaten raw Batch 25 g 170 0 0 380 0 0 
Pig meat products - cooked, ready-to-eat Batch 25 g 941 0 0 3,019 0 0 
Cyprus 
Pig meat products - cooked, ready-to-eat Single 25 g 275 0 0 275 0 0 
Pig meat products - fermented sausages Single 25 g 125 0 0 125 0 0 
Czech Republic 
Pig meat products - cooked, ready-to-eat Batch 25 g 159 0 0 350 0 0 
Pig minced meat - intended to be eaten raw Batch 25 g - - - 140 0 0 
Estonia Pig meat products - cooked, ready-to-eat Single 25 g 86 0 0 123 0 0 
Germany 
Pig meat products - cooked, ready-to-eat, domestic 
production 
Single 25 g 73 0 0 54 0 0 
Pig meat products - fermented sausages, domestic 
production 
Single 25 g 233 4 1.7 214 2 0.9 
Greece Pig meat products - cooked, ready-to-eat Single 25 g 85 0 0 65 5 7.7 
Hungary 
Pig meat products - cooked, ready-to-eat Single 25 g 101 0 0 190 0 0 
Pig meat products - fermented sausages Single 25 g 529 2 0.4 538 8 1.5 
Pig meat products - raw ham Single 25 g 174 1 0.6 174 1 0.6 
Ireland 
Pig meat products Single 25 g - - - 109 2 1.8 
Pig meat products - cooked, ready-to-eat Single 25 g - - - 188 0 0 
Italy Pig meat products, domestic production Single 25 g 766 9 3.8 984 1 0.1 
Poland 
Pig meat preparation - intended to be eaten raw Batch 25 g 1,669 2 0.1 - - - 
Pig meat preparation - intended to be eaten raw Single 10/25 g 695 9 1.4 - - - 
Pig meat products - cooked, ready-to-eat Batch 25/325 g 1,675 11 0.7 - - - 
Pig meat products - cooked, ready-to-eat Single 10/25/500 g 4,245 1 0.4 - - - 
Pig meat products - raw and intended to be eaten raw Batch 25 g 240 5 2.1 - - - 
Pig minced meat - intended to be eaten raw Single 200 g 29 0 0 - - - 
Table continued overleaf. 
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Table SA12 (continued). Salmonella in ready-to-eat minced meat, meat preparations and meat products from pig meat, 2011–2012 
Country Description 
Sample  
unit 
Sample      
weight 
2012 2011 
N N pos % pos N N pos % pos 
Portugal 
Pig meat products - cooked, ready-to-eat Batch 10/25 g 105 1 2.5 - - - 
Pig meat products - cooked, ready-to-eat Single 25 g 60 2 3.3 105 5 4.8 
Romania Pig meat products - cooked, ready-to-eat Batch 25 g 153 2 1.3 109 0 0 
Slovakia 
Pig meat products - cooked, ready-to-eat Batch 25 g 79 0 0 - - - 
Pig meat products - unspecified, ready-to-eat Batch 25 g - - - 37 0 0 
Spain 
Pig meat products - raw and intended to be eaten raw Single 25 g/unspecified 357 6 2.0 - - - 
Pig meat products, at cutting plant Single - - - - 74 2 2.7 
At retail                   
Austria Pig meat products - cooked, ready-to-eat Single 10 g 83 0 0 - - - 
Belgium 
Pig meat products - fermented sausages Batch 25 g 38 0 0 - - - 
Pig meat products - raw ham Batch 25 g 46 0 0 - - - 
Pig meat products - cooked, ready-to-eat Batch 200 g - - - 38 0 0 
Bulgaria 
Pig meat products - cooked, ready-to-eat Batch 25 g 215 0 0 225 0 0 
Pig meat products - cooked, ready-to-eat Single 10 g 40 0 0 - - - 
Pig meat preparation - intended to be eaten raw Batch 25 g - - - 205 0 0 
Cyprus Pig meat products - fermented sausages Single - 35 0 0 35 0 0 
Czech Republic 
Pig meat preparation - intended to be eaten raw Batch 25 g 27 0 0 41 0 0 
Pig meat products - cooked, ready-to-eat Batch 25 g 74 0 0 83 0 0 
Germany 
Pig meat products - cooked, ready-to-eat, domestic 
production 
Single 25 g 422 0 0 591 1 0.2 
Pig meat products - fermented sausages, domestic 
production 
Single 25 g 619 5 0.8 658 3 0.5 
Hungary 
Pig meat products - cooked, ready-to-eat Single 25 g 128 1 0.8 100 0 0 
Pig meat products - fermented sausages Single 25 g 571 1 0.2 197 1 0.5 
Pig meat products - raw ham Single 25 g 132 0 0 51 0 0 
Ireland Pig meat products - cooked, ready-to-eat Single 25 g - - - 402 0 0 
Italy Pig meat products, domestic production Single 25 g 217 0 0 1,249 10 0.8 
Latvia Pig meat products - cooked, ready-to-eat Single 25 g 55 0 0 - - - 
Luxembourg Pig meat products - cooked, ready-to-eat Single 25 g - - - 140 0 0 
Table continued overleaf.  
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Table SA12 (continued). Salmonella in ready-to-eat minced meat, meat preparations and meat products from pig meat, 2011–2012 
Country Description 
Sample  
unit 
Sample      
weight 
2012 2011 
N N pos % pos N N pos % pos 
Netherlands Pig meat products - cooked, ready-to-eat Single 25 g - - - 591 3 0.5 
Portugal 
Pig meat products - cooked, ready-to-eat Batch 25 g 430 14 3.3 - - - 
Pig meat products - unspecified, ready-to-eat Batch 25 g - - - 360 7 1.9 
Romania Pig meat products - cooked, ready-to-eat Batch 25 g - - - 169 1 0.6 
Slovakia 
Pig meat products - cooked, ready-to-eat Batch 25 g 47 0 0 - - - 
Pig meat products - cooked, ready-to-eat Single 25 g 65 1 1.5 - - - 
Spain Pig meat products - raw and intended to be eaten raw Single 25 g 158 3 1.9 - - - 
Sampling level not stated   
Austria 
Pig meat products - cooked, ready-to-eat, domestic 
production 
Single 10 g - - - 508 2 0.4 
Italy Pig meat products, domestic production Single 25 g - - - 2,116 43 2.0 
Poland 
Pig meat preparation - intended to be eaten raw Batch 25 g 1,400 50 3.6 - - - 
Pig meat preparation - intended to be eaten raw Single 25 g 85 8 9.4 - - - 
Pig meat products - cooked, ready-to-eat Batch 25 g 2,870 0 0 - - - 
Pig meat products - cooked, ready-to-eat Single 25 g 1,653 0 0 - - - 
Sweden Pig meat products Single - - - - 38 0 0 
Total  
(2012: 16 MSs, 
2011: 18 MSs) 
Total     22,517 138 0.6 15,091 97 0.6 
Single     12,096 53 0.4 9,894 89 0.9 
Batch     10,421 85 0.8 5,197 8 0.2 
Note: Only investigations covering 25 or more samples are included. 
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Bovine meat and products thereof 
Seventeen MSs and one non-MS reported results from testing of fresh bovine meat based on more than 
25 samples. The overall proportion of positive samples of the 47,279 samples of bovine meat tested, in EU 
MSs, was 0.2 % (Table SA13). This number was similar to the number of samples from fresh broiler meat 
and pig meat and the number of tested samples increased considerably compared with 2011 
(25,497 samples), but the overall proportion of positive samples remained at a comparable level (0.2 % in 
2012 and 0.3 % in 2011).  
In 21 of the 37 reported investigations Salmonella was not detected. The highest proportion of positive 
samples was found at the slaughterhouse level in Spain, where 11.6 % of 189 single samples tested positive 
in 2012, compared with 8.0 % of 112 samples in 2011. In Portugal, Salmonella was detected in 2.0 % of 
450 single samples obtained at slaughter, and in Hungary, 1.0 % and 1.1 % of single samples tested 
Salmonella positive at the processing and retail levels, respectively. In the remaining 11 investigations with 
positive results, Salmonella was found in less than 1 % of the tested units. 
Nine MSs reported results of Salmonella testing of RTE minced meat, meat preparations and meat products 
from bovine meat based on more than 25 samples. In the tested 2,244 samples, Salmonella was detected in 
0.6 % of the samples (Table SA14). In 13 of 17 investigations Salmonella was not detected in any samples. 
A relatively high occurrence of Salmonella (20.0 %) was found in a small investigation (25 single samples) of 
fermented sausages in Cyprus, whereas the proportion of Salmonella-positive units in the three other 
investigations with Salmonella findings ranged from 0.8 % to 3.7 %.  
For further information see Level 3 Tables. 
  
EU summary report on zoonoses, zoonotic agents and 
food-borne outbreaks 2012 
 
EFSA Journal 2014;12(2):3547  49 
Table SA13. Salmonella in fresh bovine meat, at slaughter, cutting/processing level and retail, 2011–
2012 
Country Description 
Sample 
unit 
Sample 
weight 
2012 2011 
N N pos % pos N N pos % pos 
At slaughterhouse                 
Belgium 
Carcase 
swabs 
Batch 1600 cm
2
 - - - 649 3 0.5 
Bulgaria 
Carcase 
swabs 
Batch 400 cm
2
 366 0 0 - - - 
Meat 
Slaughter 
batch 
25 g - - - 415 0 0 
Czech Republic 
Carcase 
swabs
1
 
Batch 100/400 cm
2
 4,699 10 0.2 4,644 20 0.4 
Denmark 
Carcase 
swabs
2
 
Single 400 cm
2
 5,315 9 0.3 7,635 22 0.3 
Estonia 
Carcase 
swabs 
Single 1400 cm
2
 207 0 0 250 0 0 
Finland 
Carcase 
swabs 
Single 1400 cm
2
 3,058 0 0 3,151 0 0 
Hungary 
Carcase 
swabs 
Batch 400 cm
2
 259 1 0.4 - - - 
Carcase 
swabs 
Single - - - - 168 0 0 
Lithuania Meat Batch - 78 0 0 - - - 
Poland 
Carcase 
swabs 
Batch 400 cm
2
 3,885 5 0.1 - - - 
Meat Batch 25 g 335 0 0 - - - 
Carcase 
swabs 
Single 400 cm
2
 3,996 3 <0.1 - - - 
Portugal 
Carcase 
swabs 
Single - 450 9 2.0 - - - 
Romania 
Carcase 
swabs 
Batch 
100 cm
2
/ 
unspecified 
277 0 0 226 2 0.9 
Meat Batch 25 g 48 0 0 46 0 0 
Slovakia Meat Batch 25 g - - - 73 0 0 
Spain Meat Single 25 g 189 22 11.6 112 9 8.0 
Sweden 
Carcase 
swabs 
Single 1400 cm
2
 3,375 0 0 3,432 1 <0.1 
Norway 
Carcase 
swabs 
Single - 2,857 0 0 1,799 0 0 
At processing or cutting plant                 
Bulgaria 
Carcase 
swabs, at 
processing 
plant 
Batch 25 g 25 0 0 - - - 
Meat 
Slaughter 
batch 
25 g - - - 415 0 0 
Cyprus 
At 
processing 
plant 
Single 10 g 60 0 0 60 0 0 
Estonia 
Meat, at 
processing 
plant 
Single 25 g - - - 38 0 0 
Meat, at 
cutting plant 
Single 25 g 138 0 0 122 0 0 
Finland 
Meat, at 
cutting plant 
Single 25 g 2,110 0 0 1,872 1 <0.1 
Hungary 
Meat, at 
processing 
plant 
Single 25 g 103 1 1.0 150 3 2.0 
Table continued overleaf.  
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Table SA13 (continued). Salmonella in fresh bovine meat, at slaughter, cutting/processing level and 
retail, 2011–2012 
Country Description 
Sample 
unit 
Sample 
weight 
2012 2011 
N N pos % pos N N pos % pos 
Ireland 
Meat, at 
processing plant 
Single 25 g - - - 71 0 0 
Italy 
At processing 
plant, domestic 
production 
Single 25 g 61 0 0 81 0 0 
Poland 
Meat, at 
processing plant 
Batch 25 g 9,709 6 <0.1 - - - 
Carcase swabs, 
at processing 
plant 
Single 400 cm
2
 53 0 0 - - - 
Meat, at 
processing plant 
Single 10/25 g 939 0 0 - - - 
Carcase swabs, 
at cutting plant 
Single 400 cm
2
 99 0 0 - - - 
Meat, at cutting 
plant 
Single 10/25/125 g 1,800 2 0.1 - - - 
Portugal 
Meat, at 
processing plant 
Single 25 g 30 0 0 48 0 0 
Romania 
Meat, at cutting 
plant 
Batch 25 g - - - 28 0 0 
At retail                   
Bulgaria Meat Batch 25 g - - - 28 0 0 
France Meat Single 25 g 247 2 0.8 - - - 
Germany 
Meat, domestic 
production 
Single 25 g 747 2 0.3 524 0 0 
Greece   Single 25 g - - - 35 0 0 
Hungary Meat Single 25 g 177 2 1.1 63 0 0 
Italy 
Domestic 
production 
Single 25 g 26 0 0 84 0 0 
Netherlands   Single 25 g 649 6 0.9 756 1 0.1 
Portugal   Single 25 g - - - 75 2 2.7 
Spain Meat Single 25 g 40 0 0 114 1 0.9 
Sampling level not stated                 
Poland 
Meat Batch 10/25 g 2,600 15 0.6 - - - 
Carcase 
swabs 
Single 400 cm
2
 1,089 1 <0.1 327 0 0 
Meat Single 10 g 40 0 0 - - - 
Sweden Meat Single - - - - 29 0 0 
Total  
(2012: 17 MSs, 
2011: 19 MSs) 
Total     47,279 96 0.2 25,497 66 0.3 
Single     24,998 59 0.2 19,197 40 0.2 
Batch     22,281 37 0.2 6,300 26 0.4 
Note: Only investigations covering 25 or more samples are included. 
1. Sample weight was 400 cm
2 
in 2012 and 100 cm
2
 in 2011. 
2. In 2012, most of the Danish samples were pooled samples, and a single-carcase prevalence was calculated. Both the loss of 
sensitivity and the probability of more than one sample being positive in each pool were taken into consideration. A conversion 
factor was determined on the basis of comparative studies. Therefore, the adjusted prevalence is 0.3 %.  
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Table SA14. Salmonella in ready-to-eat minced meat, meat preparations and meat products from bovine meat, 2011–2012 
Country Description 
Sample  
unit 
Sample      
weight 
2012 2011 
N N pos % pos N N pos % pos 
At processing                 
Belgium Bovine meat preparation - intended to be eaten raw Batch 200 g - - - 26 0 0 
Bulgaria 
Bovine meat products - cooked, ready-to-eat
1
 Batch 
25 g/ 
unspecified 
136 0 0 25 0 0 
Bovine minced meat - intended to be eaten raw Batch 25 g 410 0 0 165 0 0 
Cyprus Bovine meat products - fermented sausages Single 25 g 25 5 20.0 25 5 20.0 
Ireland 
Bovine meat products Single 25 g - - - 152 0 0 
Bovine meat products - cooked, ready-to-eat Single 25 g - - - 132 0 0 
Luxembourg Bovine minced meat - intended to be eaten raw Single 25 g 35 0 0 43 0 0 
Poland 
Bovine meat products - cooked, ready-to-eat Batch 25 g 153 5 3.3 - - - 
Bovine meat products - cooked, ready-to-eat Single 25 g 93 0 0 - - - 
Bovine minced meat - intended to be eaten raw Batch 25 g 241 2 0.8 - - - 
Bovine minced meat - intended to be eaten raw Single 25 g 229 0 0 - - - 
At retail           0       
Belgium 
Bovine meat preparation - intended to be eaten raw
2
 Batch 25/100 g 284 0 0 49 0 0 
Bovine minced meat - intended to be eaten raw
3
 Batch 25/150 g 44 0 0 43 0 0 
Germany 
Bovine meat products - cooked, ready-to-eat, domestic 
production 
Single 25 g 31 0 0 50 0 0 
Bovine meat products - fermented sausages, domestic 
production 
Single 25 g 36 0 0 29 0 0 
Hungary Bovine meat products - cooked, ready-to-eat Single 25 g 37 0 0 - - - 
Ireland Bovine meat products - cooked, ready-to-eat Single 25 g - - - 192 0 0 
Luxembourg Bovine minced meat - intended to be eaten raw Single 25 g 235 0 0 106 0 0 
Netherlands 
Bovine meat products - cooked, ready-to-eat Single 25 g - - - 38 1 2.6 
Bovine minced meat - intended to be eaten raw Single 25 g 78 0 0 - - - 
Spain Bovine meat products - raw and intended to be eaten raw Single 25 g 27 1 3.7 - - - 
Table continued overleaf. 
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Table SA14 (continued). Salmonella in ready-to-eat minced meat, meat preparations and meat products from bovine meat, 2011–2012 
Country Description 
Sample  
unit 
Sample      
weight 
2012 2011 
N N pos % pos N N pos % pos 
Sampling level not stated                 
Italy Bovine meat preparation - intended to be eaten raw Single 25 g - - - 220 27 12.3 
Poland Bovine meat products - cooked, ready-to-eat Batch 25 g 150 0 0 - - - 
Total  
(2012: 9 MSs, 
2011: 8 MSs) 
Total     2,244 13 0.6 1,295 33 2.5 
Single     826 6 0.7 987 33 3.3 
Batch     1,418 7 0 308 0 0 
Note: Only investigations covering 25 or more samples are included. 
1. Sample weight was unspecified in 2012 and 25 g in 2011. 
2. Sample weight was 25 g in 2012 and 100 g in 2011. 
3. Sample weight was 25 g in 2012 and 150 g in 2011. 
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Salmonella in other foodstuffs 
Twenty-one MSs reported results of investigations in other foodstuffs (Table SA15). The largest group of 
samples were from vegetables, where Salmonella was detected in nine of the 20 reported investigations. 
The highest prevalence of positive samples was found in a small Danish investigation of leafy greens 
originating within the EU, where Salmonella was detected in three of 33 samples (9.1 %). In the remaining 
eight investigations, where one or more samples were found to be Salmonella positive, the proportion of 
positive samples ranged from <0.1 % to 1.2 %. Salmonella was not detected in any of the 11 reported 
investigations of fruit; however, in two of the six investigations of samples originating from both fruits and 
vegetables, Salmonella was detected in 1.7 % and 0.3 % of the tested units, respectively.  
In the four reported investigations of sprouted seed, Salmonella was found in one of the tested samples, and 
in none of the 44 samples of dried seed (one investigation).  
In eight of the 18 reported investigations of Salmonella in spices and herbs, one or more samples were found 
to be Salmonella positive. The highest proportions of positive samples were found in a Danish investigation 
of imported fresh herbs and spices (9.4 % of 60 batches) and in a Dutch investigation of dried herbs and 
spices (10.5 % of 277 batches).  
Salmonella was not detected in any of the relatively few tested nuts and nut products (two investigations in 
two different MSs).  
Salmonella was isolated from one or more samples in four of the 13 investigations of egg products. In Spain, 
Salmonella was found in 5.5 % of the 55 unspecified samples of egg products, but also in 5.5 % of the 
91 tested samples of RTE egg products. Salmonella was also detected in one of 27 samples of dried egg 
products in Hungary and in 1.6 % of batches of egg products tested at the processing plant level in Poland.  
In the six MSs reporting test results for Salmonella in live bivalve molluscs, the proportion of positive samples 
ranged from 0 to 3.0 %. 
For further information see Level 3 Tables. 
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Table SA15. Salmonella in other foodstuffs, 2011–2012 
Country Description 
Sample  
unit 
Sample      
weight 
2012 2011 
N N pos % pos N N pos % pos 
Fruit                 
Belgium 
At processing plant Batch 200 g - - - 45 0 0 
Whole, at retail
1
 Batch 15/100 g 160 0 0 46 0 0 
Bulgaria 
Pre-cut, ready-to-eat, at 
retail
2
  
Batch 250/25 g 181 0 0 30 0 0 
Denmark Whole, at retail, imported Batch 5x100 g  92 0 0 - - - 
France Pre-cut, ready-to-eat, at retail Single 25 g - - - 1,240 0 0 
Italy At retail, domestic production Single 25 g 39 0 0 35 0 0 
Netherlands Pre-cut, ready-to-eat, at retail Single 25 g 132 0 0 - - - 
Poland Fresh fruits Single 25 g 26 0 0 - - - 
Portugal Pre-cut, ready-to-eat, at retail Batch 25 g 100 0 0 - - - 
Romania 
Pre-cut, ready-to-eat, at 
catering 
Batch 25 g 38 0 0 165 0 0 
Pre-cut, ready-to-eat, at retail Batch 25 g 65 0 0 85 0 0 
Pre-cut, ready-to-eat, at 
processing plant 
Batch 25 g - - - 68 0 0 
United Kingdom 
Products, dried, at retail, non 
EU 
Single 25 g 175 0 0 - - - 
Pre-cut, ready-to-eat, at retail Single 25 g 306 0 0 - - - 
Vegetables                   
Belgium At retail
3
 Batch 25/150 g 359 0 0 443 2 0.5 
Bulgaria 
Pre-cut, ready-to-eat, at 
retail
4
 
Batch Unspecified/25 g 592 0 0 41 0 0 
Czech Republic Pre-cut, ready-to-eat, at retail Batch 25 g - - - 33 0 0 
Denmark 
Leaves, at retail, European 
Union 
Batch 500 g  33 3 9.1 - - - 
Non-pre-cut, at retail, 
European Union 
Batch 500 g  86 0 0 - - - 
Non-pre-cut, at retail, non EU Batch 500 g  64 0 0 - - - 
Germany 
At processing plant, domestic 
production 
Single 25 g 153 1 0.7 150 0 0 
At retail, domestic production Single 25 g 1,159 1 <0.1 1,076 6 0.6 
Table continued overleaf. 
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Table SA15 (continued). Salmonella in other foodstuffs, 2011–2012 
Country Description 
Sample  
unit 
Sample      
weight 
2012 2011 
N N pos % pos N N pos % pos 
Hungary 
Pre-cut, ready-to-eat, at 
catering 
Single 25 g 85 1 1.2 - - - 
Pre-cut, ready-to-eat, at retail Single 25 g 133 1 0.8 92 0 0 
Italy 
At retail, domestic production Single 25 g 224 1 0.4 737 0 0 
At catering, domestic 
production 
Batch 25 g - - - 87 0 0 
At processing plant, domestic 
production 
Single 25 g - - - 224 0 0 
Unspecified, domestic 
production 
Single 25 g - - - 50 0 0 
Lithuania Pre-cut, ready-to-eat, at retail Batch - 46 0 0 - - - 
Netherlands Pre-cut, ready-to-eat, at retail Single 25 g 666 4 0.6 - - - 
Poland Fresh vegetables Single 25 g 437 1 0.2 - - - 
Portugal Pre-cut, ready-to-eat, at retail Single 25 g - - - 80 0 0 
Romania 
Pre-cut, ready-to-eat, at 
catering 
Batch 25 g 50 0 0 - - - 
Pre-cut, ready-to-eat, at retail Batch 25 g 96 0 0 - - - 
Non-pre-cut, at processing 
plant 
Single 25 g 26 0 0 - - - 
Pre-cut, ready-to-eat, at 
processing plant 
Single 25 g - - - 47 0 0 
Pre-cut, ready-to-eat, at 
catering 
Single 25 g 136 0 0 - - - 
Pre-cut, ready-to-eat, at retail Batch 25 g - - - 53 0 0 
Pre-cut, ready-to-eat, at retail Single 25 g 184 1 0.5 43 0 0 
Pre-cut, ready-to-eat, at retail, 
European Union 
Single 25 g 95 0 0 28 0 0 
Unspecified Single 25 g - - - 202 0 0 
Unspecified Single - 51 0 0 106 0 0 
Table continued overleaf.  
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Table SA15 (continued). Salmonella in other foodstuffs, 2011–2012 
Country Description 
Sample  
unit 
Sample      
weight 
2012 2011 
N N pos % pos N N pos % pos 
Fruits and vegetables                 
Austria 
Domestic production, at retail Single 25 g 35 0 0 - - - 
Imported, at border control Single 25 g 32 0 0 - - - 
Imported, at retail Single 25 g 35 0 0 - - - 
Belgium 
Pre-cut, at retail
5
 Batch 25/200 g 60 1 1.7 60 0 0 
Pre-cut, at processing plant Batch 200 g - - - 31 0 0 
Denmark Non EU, non-pre-cut, at retail Batch 500 g - - - 217 1 0.5 
Ireland 
At retail Single 25 g - - - 502 0 0 
Pre-cut, ready-to-eat, at retail Single 25 g - - - 186 0 0 
Products, at retail Single 25 g - - - 415 0 0 
Italy 
Domestic production, 
products, unspecified 
Single 25 g - - - 30 0 0 
Poland Products, at processing plant Single 25 g 108 0 0 - - - 
Slovenia 
Imported, products, 
unspecified 
Single 25 g - - - 30 0 0 
Spain Pre-cut, ready-to-eat Single - 614 2 0.3 - - - 
Seed, dried                   
United Kingdom At retail, non EU Single 25 g 44 0 0 - - - 
Seed, sprouted                   
Czech Republic 
Ready-to-eat, at processing 
plant 
Batch 25 g 35 0 0 - - - 
Non-ready-to-eat, at 
processing plant 
Batch 25 g - - - 39 0 0 
Finland At retail Single 25 g - - - 60 0 0 
Germany 
At processing plant, domestic 
production 
Single 25 g 35 0 0 - - - 
At retail, domestic production Single 25 g 206 1 0.5 166 0 0 
Hungary Ready-to-eat, at retail Single 25 g 56 0 0 52 0 0 
Table continued overleaf.  
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Table SA15 (continued). Salmonella in other foodstuffs, 2011–2012 
Country Description 
Sample  
unit 
Sample      
weight 
2012 2011 
N N pos % pos N N pos % pos 
Spices and herbs                   
Austria 
At retail, domestic production Single 25 g 43 0 0 96 0 0 
At retail, imported Single 25 g 35 1 2.9 36 0 0 
Belgium 
Dried, at processing plant Batch 100 g - - - 59 2 3.4 
Dried, at retail
6
 Batch 25/100 g 59 0 0 59 0 0 
Fresh, at retail Batch 25 g 88 0 0 - - - 
Denmark 
Fresh Batch 500 g  26 0 0 - - - 
Fresh, imported Batch 500 g  60 3 9.4 - - - 
Fresh, at retail, non EU Batch 500 g - - - 69 4 5.8 
Finland Fresh, at retail Single 25 g - - - 84 0 0 
Germany 
At processing plant, domestic 
production 
Single 25 g 160 1 0.6 128 0 0 
At retail, domestic production Single 25 g 661 3 0.5 499 0 0 
Hungary 
Dried, at retail Single 25 g 222 0 0 - - - 
Dried Single 25 g - - - 127 1 0.8 
Ireland At retail Single 25 g - - - 164 1 0.6 
Italy At retail, domestic production Single 25 g 34 0 0 25 2 8.0 
Netherlands 
Dried Batch 25 g 277 29 10.5 - - - 
Fresh Batch 25 g 31 2 6.5 - - - 
Poland Unspecified Single 25 g 224 2 0.9 - - - 
Romania At processing plant Batch 25 g 77 0 0 - - - 
Slovakia 
At retail Batch 25 g 27 0 0 26 0 0 
Dried, at processing plant Single 25 g 25 0 0 - - - 
Dried, at retail Batch 25 g 40 0 0 - - - 
Dried, at retail Single 25 g - - - 30 0 0 
Slovenia Dried, at retail Single 25 g - - - 40 0 0 
United Kingdom Dried, at retail, non EU Single 100 g 31 1 3.2 - - - 
Table continued overleaf.  
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Table SA15 (continued). Salmonella in other foodstuffs, 2011–2012 
Country Description 
Sample  
unit 
Sample      
weight 
2012 2011 
N N pos % pos N N pos % pos 
Nuts and nut products                 
Hungary Dried, unspecified Single 25 g 85 0 0 - - - 
United Kingdom Dried, at retail, non EU Single 100 g 63 0 0 - - - 
Egg products                   
Austria 
Non-ready-to-eat, at retail, 
domestic production 
Single 25 g 39 0 0 - - - 
Non-ready-to-eat, at retail, 
imported 
Single 25 g 27 0 0 - - - 
Belgium At processing plant
7
 Batch 25/500 g 114 0 0 111 0 0 
Bulgaria At processing plant
4
 Batch Unspecified/25 g 800 0 0 640 0 0 
Germany 
At processing plant, domestic 
production 
Single 25 g 45 0 0 45 0 0 
At retail, domestic production Single 25 g 179 0 0 226 0 0 
Hungary 
At processing plant Single 25 g 72 0 0 - - - 
Dried, unspecified Single 25 g 27 1 3.7 29 0 0 
Liquid, at processing plant Single 25 ml - - - 48 0 0 
Liquid, unspecified Single 25 ml 66 0 0 - - - 
Ireland Ready-to-eat, at retail Single 25 g - - - 143 0 0 
Italy 
At processing plant, domestic 
production 
Single 25 g - - - 35 0 0 
At retail, domestic production Single 25 g - - - 130 0 0 
Unspecified Single 25 g - - - 56 0 0 
Poland 
At processing plant Batch 25 g 125 2 1.6 - - - 
At processing plant Single 25 g 52 0 0 827 1 0.1 
Spain 
Unspecified Single 25 g 55 3 5.5 101 0 0 
Ready-to-eat Single 25 g 91 5 5.5 - - - 
Table continued overleaf. 
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Table SA15 (continued). Salmonella in other foodstuffs, 2011–2012 
Country Description 
Sample  
unit 
Sample      
weight 
2012 2011 
N N pos % pos N N pos % pos 
Live bivalve molluscs                 
Belgium Unspecified, at retail Batch 25 g 92 1 1.1 87 2 2.3 
Bulgaria Unspecified, at retail, non EU Batch 25 g 83 0 0 105 0 0 
Greece 
Unspecified, at processing 
plant 
Single 25 g 953 6 0.6 - - - 
Unspecified, at retail Single 25 g - - - 45 0 0 
Netherlands 
Mussels, at retail Single 25 g - - - 52 2 3.8 
Oysters, at retail Single 25 g - - - 75 1 1.3 
Portugal 
At retail Batch 25 g 165 5 3.0 60 0 0 
Unspecified, at processing 
plant 
Batch/single
8
 25 g 33 1 3.0 100 0 0 
Spain Unspecified, at retail Single 25 g 306 5 1.6 647 9 1.4 
Total (2012: 21 MSs, 2011: 20 MSs)   12,841 89 0.7 11,998 34 0.3 
Note: Only investigations covering 25 or more samples are included. 
1. Sample weight was 15 g in 2012 and 100 g in 2011.  
2. Sample weight was 250 g in 2012 and 25 g in 2011.  
3. Sample weight was 25 g in 2012 and 150 g in 2011.  
4. Sample weight was unspecified in 2012 and 25 g in 2011.  
5. Sample weight was 25 g in 2012 and 200 g in 2011.  
6. Sample weight was 25 g in 2012 and 100 g in 2011.  
7. Sample weight was 25 g in 2012 and 500 g in 2011.  
8. Sample unit was 'batch' in 2012 and 'single' in 2011. 
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3.1.3. Salmonella in animals 
EU MSs have compulsory or voluntary Salmonella control or monitoring programmes in place for a number 
of farm animal species. An overview of the countries which reported data on Salmonella in animals for 2012 
is presented in Table SA16. In the following chapter, data tables on breeders of Gallus gallus, laying hens, 
broilers, breeding turkeys and fattening turkeys also include results from investigations with sample sizes 
below 25; for other animal species, only results based on 25 or more units tested are presented. Results 
from industry own-control programmes, HACCP sampling, suspect sampling, selective sampling and clinical 
investigations have been excluded owing to difficulties in interpreting the data. These data are, however, 
presented in the Level 3 Tables. 
Table SA16. Overview of countries reporting data for Salmonella in animals, 2011–2012 
Data 
Total number of  
reporting MSs  
Countries 
Gallus gallus (no further 
sampling level) 
2012 - 1 
MS: IT 
Non-MS: NO 
2011 - 3 
MSs: IT, PT, RO 
Non-MS: NO 
Breeders of Gallus gallus 
2012 - 25 
All MSs except LU, MT 
Non-MSs: CH, IS, NO 
2011 - 25 
All MSs except LU, MT 
Non-MSs: CH, IS, NO 
Laying hens 
2012 - 27 
All MSs  
Non-MSs: CH, IS, NO 
2011 - 27 
All MSs  
Non-MSs: CH, IS, NO 
Broilers 
2012 - 27 
All MSs  
Non-MSs: CH, IS, NO 
2011 - 27 
All MSs  
Non-MSs: CH, IS, NO 
Turkeys 
2012 - 24 
All MSs except LU, LV, MT 
Non-MSs: CH, IS, NO 
2011 - 25 
All MSs except LU, MT 
Non-MSs: CH, IS, NO 
Ducks 
2012 - 10 
MSs: BE, DE, DK, HU, IT, LV, PL, SE, SK, UK  
Non-MSs: IS, NO 
2011 - 11 
MSs: BE, CY, DE, DK, IT, LV, PL, PT, SE, SK, UK 
Non-MSs: IS, NO 
Geese 
2012 - 6 
MSs: DE, HU, IT, PL, SE, SK 
Non-MS: NO 
2011 - 6 
MSs: DE, IT, LV, PL, SE, SK  
Non-MS: NO 
Other poultry
1
  
2012 - 15 
All MSs except AT, BG, CY, CZ, FI, LT, LU, MT, NL,SE, SI, 
UK 
Non MS: NO 
2011 - 14 
MSs: BE, BG, CY, DK, EE, ES, IE, IT, LV, PL, PT, RO, SK, 
UK   
Table continued overleaf.  
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Table SA16 (continued). Overview of countries reporting data for Salmonella in animals, 2011–2012 
Data 
Total number of  
reporting MSs  
Countries 
Pigs 
2012 - 17 
All MSs except AT, CY, CZ, DK, FR, LT, LU, MT, PT, SI     
Non-MSs: CH, IS, NO 
2011 - 18 
All MSs except AT, BE, CY, CZ, FR, LT, LU, MT, SI  
Non-MSs: CH, IS, NO 
Cattle 
2012 - 17 
All MSs except AT, BE, CY, CZ, DK, FR, LT, MT, RO, SI 
Non-MSs: CH, NO 
2011 - 18 
All MSs except AT, BE, CZ, DK, FR, LT, MT, RO, SI     
Non-MSs: CH, NO 
Sheep and goats 
2012 - 16 
All MSs except AT, BE, CY, CZ, DK, FI, FR, LT, MT, PL, SI     
Non-MSs: CH, NO 
2011 - 13 
MSs: BG, DE, EE, GR, IE, IT, LV, NL, PT, RO, SE, SK, UK  
Non-MSs: CH, NO 
Other animal species 
2012 - 15 
MSs: except AT, BE, BG, CY, CZ, ES, FI, FR, LU, MT, PT, 
SI 
Non-MSs: CH, NO 
2011 - 18 
All MSs except AT, BE, CZ, FI, FR, HU, LU, MT, SI       
Non-MSs: CH, NO 
Note: The overview table includes all data reported by MSs and non-MSs.  
1. This category includes doves, guinea fowl, partridges, peafowl, pheasants, pigeons, quails, other poultry and poultry unspecified. 
To protect human health against Salmonella infections transmissible between animals and humans, EU 
Regulation (EC) No 2160/2003
18
 obliges MSs to set up national control programmes for Salmonella serovars 
in poultry and pigs deemed to be of particular importance for public health. The animal populations which are 
currently targeted include breeding flocks, laying hens, broilers of Gallus gallus and breeding and fattening 
turkeys. The national control programmes are established to achieve EU reduction targets to decrease the 
Salmonella prevalence in those animal populations at the primary production level.  
Poultry production lines involve a breeding pyramid so that genetic improvement, which mainly takes place 
through selection at the top of the production pyramid, can be rapidly distributed among commercial poultry 
populations. The top of the pyramid comprises elite flocks, great grandparent flocks and grandparent flocks, 
with parent flocks in the middle, and production flocks at the bottom of the pyramid. Hereafter in this report, 
elite flocks, great grandparent flocks, grandparent flocks and parent flocks are generically referred to as 
breeding flocks.  
In poultry, Salmonella may be transmitted both horizontally and vertically. The relevance of Salmonella 
infection in breeding flocks is mainly related to the potential for vertical transmission to production flocks, and 
the impact of the vertical route of transmission is amplified by the pyramidal structure of the egg and broiler 
production sectors, contamination of hatcheries and trade in grandparent, parent and commercial stock and 
hatching eggs.  
The national control programmes may vary to some extent between MSs owing to their different 
circumstances, while aiming to achieve the same goal. National control programmes have to be approved by 
the EC. The results of the programmes have to be reported to the EC and EFSA as part of the annual 
zoonoses report. 
 
Breeding flocks of Gallus gallus  
The year 2012 was the sixth year in which MSs were obliged to implement Salmonella control programmes 
in breeding flocks of Gallus gallus in accordance with Regulation (EC) No 2160/2003 and Regulation (EC) 
                                                        
18
 Regulation (EC) No 2160/2003 of the European Parliament and of the Council and Regulation of 17 November 2003 on the control 
of salmonella and other specified food-borne zoonotic agents. OJ L 325, 12.12.2003, p. 1–15. 
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No 200/2010
19
. The control programmes for breeding flocks aim to meet a reduction target of 1 % or less of 
positive flocks for the following serovars: S. Enteritidis, S. Typhimurium, S. Infantis, S. Virchow and S. Hadar, 
including monophasic S. Typhimurium. The target was set for all commercial-scale adult breeding flocks, 
during the production period, comprising at least 250 birds. However, MSs with fewer than 100 breeding 
flocks would attain the target if only one adult breeding flock remained positive. 
The minimum requirements for Salmonella detection in breeding flocks, laid down in Regulation (EC) No 
2160/2003, include sampling three times during the rearing period and every two to three weeks during the 
production (laying) period. Test results have to be reported, as well as any relevant additional information, on 
a yearly basis to the EC and EFSA as part of the annual report on trends and sources of zoonoses and 
zoonotic agents. A flock is reported positive if one or more of the samples have been found positive.  
In 2012, control programmes approved by the Commission were implemented in all MSs. In total, 25 MSs 
and three non-MSs reported 2012 data within the framework of the programme. This is because two MSs, 
Luxembourg and Malta, do not have breeding flocks of Gallus gallus. 
The total Salmonella prevalence data for Gallus gallus breeding flocks during the production period in 2012 
are presented in Table SA17. 
The trends in prevalence of the five target serovars (S. Enteritidis, S. Typhimurium, S. Infantis, S. Virchow 
and S. Hadar), at EU level and at MS level, are shown in Figures SA8 and SA9, respectively. The prevalence 
of the five target serovars and the target for Gallus gallus breeding flocks during the production period for 
MSs and non-MSs in 2012 are shown in Figure SA10. The geographical distribution of prevalence by MS is 
presented in Figure SA11. 
Overall during 2012, Salmonella was found in 2.0 % of breeding flocks in the EU at some stage during the 
production period, compared with 1.9 % in 2011. The prevalence of the five targeted Salmonella serovars in 
adult breeding flocks tested under the mandatory Salmonella control programmes was 0.4 % in 2012. This 
was a further decrease compared with 2011 (0.6 %) and 2010 (0.7 %) at the EU level (Table SA17 and 
Figure SA8).  
In total, 19 MSs and 3 non-MSs met the target of 1 % set for 2012. The MSs that failed to meet the target 
were Austria, Cyprus, the Czech Republic, Greece, Hungary and Poland, with the highest flock prevalence of 
8.6 % reported by Cyprus (Figure SA10). Of these MSs, Cyprus, Hungary and Poland also did not meet the 
target in 2011. A total of 11 MSs and two non-MSs reported no positive flocks for the target serovars. 
Figure SA9 presents the trends in prevalence of the five target serovars for the 24 MSs and two non-MSs 
which reported data for all six years. The results show that 11 MSs and one non-MSs maintained a 
prevalence below the 1 % threshold in the last four to five years. Of these, four MSs (Estonia, Finland, Latvia 
and Lithuania), plus Norway, did not report any positive results in all six years. Poland never met the target 
until 2012. Besides fluctuations around the 1 % prevalence threshold in previous reporting years, compared 
with 2011, six MSs reported an increase and seven MSs a decrease. The remaining 12 MSs reported an 
unchanged zero or very low (0.1 % to 1 %) prevalence. 
The most commonly reported target serovar in breeding flocks of Gallus gallus in 2012 was S. Enteritidis 
(0.2 %), which was the most common serovar in most MSs and reported by 11 MSs. The next most 
commonly reported target serovar was S. Infantis (0.095 %), reported by six MSs. Also S. Typhimurium was 
reported in breeding flocks by six MSs (0.045 %). Monophasic S. Typhimurium, which is counted as a target 
serovar, was reported in 2012 in three breeding flocks of Gallus gallus, one in France and two in Cyprus. A 
total of 15 MSs reported findings of Salmonella serovars other than the five target ones, generally at low 
levels. Cyprus and Italy reported the highest prevalence (10.3 % and 16.4 %, respectively) of flocks testing 
positive for serovars other than the targeted ones, and in 12 MSs, the prevalence of non-targeted serovars 
was higher than that of the target serovars (Table SA17).  
                                                        
19
 Commission Regulation (EC) No 200/2010 of 10 March 2010 implementing Regulation (EC) No 2160/2003 of the European 
Parliament and of the Council as regards a Union target for the reduction of the prevalence of Salmonella serotypes in adult 
breeding flocks of Gallus gallus. OJ L 61, 11.3.2010, p. 1–9. 
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Table SA17. Salmonella in breeding flocks of Gallus gallus during the production period (all types of 
breeding flocks, flock-based data) in countries running control programmes in accordance with 
Regulation (EC) No 2160/2003, 2012 
Country N 
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Austria 128 3.9 1.6 1.6 0 0 0 0 2.3 
Belgium 557 2.5 0.2 0.2 0 0 0 0 2.3 
Bulgaria 127 1.6 0.8 0 0.8 0 0 0 0.8 
Cyprus 58 19.0 8.6 3.4 0 1.7 0 0 10.3 
Czech Republic 642 3.6 1.2 1.1 0 0.2 0 0 2.3 
Denmark 196 0 0 0 0 0 0 0 0 
Estonia 19 0 0 0 0 0 0 0 0 
Finland 165 0 0 0 0 0 0 0 0 
France
2
 2,338 - 0.1 0 <0.1 0 0 0 - 
Germany 682 2.6 0.3 0.1 0.1 0 0 0 2.3 
Greece 256 5.1 1.2 0.4 0.4 0 0 0.4 4.3 
Hungary 671 4.2 1.3 0.3 0 1.0 0 0 2.8 
Ireland 326 0 0 0 0 0 0 0 0 
Italy 1,111 16.3 0.5 <0.1 0 0.4 0 0 16.4 
Latvia 30 0 0 0 0 0 0 0 0 
Lithuania 71 0 0 0 0 0 0 0 0 
Netherlands 1,108 0.8 0.7 0.7 0 0 0 0 <0.1 
Poland 1,519 2.5 2.0 1.6 0 0.3 <0.1 0.1 0.5 
Portugal 531 2.1 0 0 0 0 0 0 2.1 
Romania 8,652 0.4 <0.1 0 <0.1 <0.1 0 0 0.3 
Slovakia 151 0 0 0 0 0 0 0 0 
Slovenia 144 0 0 0 0 0 0 0 0 
Spain 1,635 2.9 0.1 <0.1 <0.1 0 0 0 2.8 
Sweden 143 0 0 0 0 0 0 0 0 
United Kingdom 1,473 0.8 0 0 0 0 0 0 0.8 
EU Total 22,733 2.0 0.4 0.2 <0.1 <0.1 <0.1 <0.1 1.7 
Iceland 35 0 0 0 0 0 0 0 0 
Norway 156 0 0 0 0 0 0 0 0 
Switzerland 47 2.1 2.1 2.1 0 0 0 0 0 
Note: Luxembourg and Malta do not have breeding flocks of Gallus gallus. 
 Data presented include sample size <25. 
1. S. Enteritidis, S. Typhimurium including monophasic S. Typhimurium, S. Infantis, S. Virchow, S. Hadar. 
2. France did not provide data on non-target serovars. 
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Figure SA8.  Prevalence of S. Enteritidis, S. Typhimurium, S. Infantis, S. Virchow and S. Hadar-
positive breeding flocks of Gallus gallus during production in the EU
1
, 2007–2012 
 
1. No data from Luxembourg and Malta as they have no breeding flocks of Gallus gallus.  
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Figure SA9.  Prevalence of S. Enteritidis, S. Typhimurium, S. Infantis, S. Virchow and S. Hadar-
positive breeding flocks of Gallus gallus during the production period in 24 Member States, Norway 
and Switzerland
1
, 2007–2012 
 
Note: The dashed line indicates the EU Salmonella targets of 1 %.  
1. No data from Luxembourg and Malta as they have no breeding flocks of Gallus gallus. Cyprus is not included because fewer than 
100 adult breeding flocks were tested for some years (before 2011) and one positive flock was reported leading to a proportion of 
positives higher than 1 %. Based on Regulation (EC) No 1003/2005 (Art. 1, point 1), Cyprus met the EU target for these years. In 
2011 and 2012, Cyprus tested five flocks positive out of, respectively, 50 and 58 flocks, and consequently did not meet the target. 
Iceland was not included because data were reported only from 2011 onwards. Switzerland tested fewer than 100 adult breeding 
flocks and reported one positive flock leading to a proportion of positives higher than 1 %. Based on Regulation (EC) No 
1003/2005 (Art. 1, point 1), Switzerland met the EU target. 
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Figure SA10.  Prevalence of S. Enteritidis, S. Typhimurium, S. Infantis, S. Virchow and S. Hadar-
positive breeding flocks of Gallus gallus during the production period and target for Member States
1
, 
Iceland, Norway and Switzerland, 2012 
 
Note:  Nineteen MSs and three non-MSs met the target in 2012, indicated with a '+'. 
1. No data from Luxembourg and Malta as they have no breeding flocks of Gallus gallus. Switzerland tested less than 100 adult 
breeding flocks and reported one positive flock leading to a proportion of positives higher than 1 %. Based on the Regulation 
(EC) No 1003/2005 (Art. 1, point 1), Switzerland met the EU target.  
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Figure SA11.  Prevalence of the five target serovars (S. Enteritidis, S. Typhimurium, S. Infantis, 
S. Virchow and S. Hadar)-positive breeding flocks of Gallus gallus during the production period
1
, 
2012 
 
1. No breeding flocks of Gallus gallus in Luxembourg, Malta, French Guiana, Guadeloupe, Martinique and Reunion. These MSs are 
indicated by ‘No data (MS)’. 
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Laying hen flocks 
From 2008, MSs have implemented Salmonella control programmes for S. Enteritidis and S. Typhimurium in 
laying hen flocks of Gallus gallus providing eggs intended for human consumption in accordance with 
Regulation (EC) No 2160/2003. The control programmes consist of measures for prevention, detection and 
control of Salmonella at all relevant stages of the primary production of eggs, in order to reduce the 
prevalence of Salmonella and the risk to public health.  
In 2011, a final annual Salmonella reduction target for laying hen flocks of Gallus gallus came into force. This 
target was an extension of the transitional target implemented in the period 2008–2010. The EU definitive 
target for laying hens is defined in Regulation (EC) No 517/2011 as an annual minimum percentage of 
reduction in the number of adult laying hen flocks (i.e. in the production period) remaining positive for 
S. Enteritidis and/or S. Typhimurium by the end of the previous year. The annual targets are proportionate, 
depending on the prevalence in the preceding year, but the final EU target is defined as a maximum 
percentage of flocks remaining positive at 2 %. However, MSs with fewer than 50 flocks of adult laying hens 
would attain the target if only one adult flock remained positive.  
Minimum sampling requirements laid down in Regulation (EC) No 2160/2003 include sampling flocks twice 
during the rearing period (day-old chicks and at the end of the rearing period before moving to the laying 
unit), as well as sampling every 15th week during the production period, starting at a flock-age between 
22 and 26 weeks. Test results have to be reported, as well as any relevant additional information, on a yearly 
basis to the EC and EFSA as part of the annual report on trends in and sources of zoonoses and 
zoonotic agents. A flock is reported as positive if one or more samples are positive during the production 
period. However, only flocks testing positive for S. Typhimurium and/or S. Enteritidis during the production 
period are taken into consideration when assessing whether MSs meet the target. Any reporting of 
monophasic S. Typhimurium is included within the S. Typhimurium total and as such is counted as a target 
serovar.  
Regulation (EC) No 517/2011 setting the definitive target for laying hens has simplified the reporting of 
results of Salmonella testing programmes in adult laying hens; the reporting should include the results from 
all samples taken under the testing programme by both food business operators and competent authorities. 
As flocks may test positive at different stages and ages of their lifespan, positive flocks must be counted and 
reported only once during the production period (flock level prevalence), irrespective of the number of 
sampling and testing operations. 
In 2012, all MSs had control programmes approved by the EC. In total, 27 MSs and three non-MSs reported 
data within the framework of the laying hen flock programme for 2012. The prevalence of Salmonella spp. 
and of the two serovars (S. Enteritidis and S. Typhimurium) targeted in the control programmes for laying 
hen flocks during the production period are presented in Table SA18. The trends in prevalence of the two 
target serovars, at EU level and at MS level, are shown in Figures SA12 and SA13, respectively. The 
prevalence of S. Enteritidis and S. Typhimurium and the target for production flocks of laying hens, for MSs 
and non-MSs, in 2012, are shown in Figure SA14. The geographical distribution of prevalence by MS is 
presented in Figure SA15. 
Overall, 24 MSs and 3 non-MSs met their 2012 reduction targets. Three MSs did not achieve the reduction in 
Salmonella prevalence (Belgium, Cyprus and Luxembourg). The prevalence of the two target serovars in 
laying hen flocks tested under the mandatory control programmes was 1.3 % (Table SA18). The most 
common of the target serovars in laying hen flocks was S. Enteritidis (1.0 % compared with 0.3 % 
S. Typhimurium), which was the most common serovar in all MSs reporting positive findings for the target 
serovars, except for Finland, France and Italy, where S. Typhimurium was the most common serovar. 
Finland detected only S. Typhimurium in three flocks and no other serovars were isolated. 
Eleven MSs and three non-MSs reported no flocks positive with S. Enteritidis and/or S. Typhimurium or very 
low prevalence, whereas Cyprus and Malta reported the highest prevalence (13.7 % and 6.1 %, respectively) 
(Table SA18). Monophasic S. Typhimurium was detected only in Denmark (one flock), France (three flocks), 
Italy (five flocks) and Spain (one flock).  
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The reported EU level prevalence of adult laying hen flocks positive with S. Enteritidis and/or S. Typhimurium 
decreased further to 1.3 % from 1.5 % in 2011 (Figure SA12). This indicates that progress is still being made 
in combating these Salmonella serovars. At MS level the prevalence declined in 17 MSs compared with 2011 
while seven MSs reported a slight increase in their prevalence from 2011 to 2012 and Cyprus reported a 
more substantial increase (Figure SA13). 
In 2012, the EU level prevalence of adult laying hen flocks positive with Salmonella spp. was 3.2 %, 
compared with 4.2 % in 2011. Estonia, Ireland and Lithuania were the only MSs reporting no positive flocks, 
and Latvia and Sweden detected only serovars other than the two target ones. Eighteen MSs reported flocks 
positive for serovars other than the two target ones at very low to high levels, and in 11 of them, the 
prevalence of these serovars was higher than the prevalence of the target serovars. Iceland, Norway and 
Switzerland reported no Salmonella spp.-positive flocks.  
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Table SA18. Salmonella in laying hen flocks of Gallus gallus during the production period (flock-
based data) in countries running control programmes, 2012 
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Austria 2,740 2.0 2.2 0.7 0.5 0.3 1.4 
Belgium 764 2.0 4.7 2.2 2.0 0.3 2.1 
Bulgaria 252 2.0 6.0 1.6 1.6 0 4.4 
Cyprus 51 5.2 39.2 13.7 7.8 5.9 25.5 
Czech Republic 392 2.4 2.0 1.5 1.5 0 0.5 
Denmark 359 2.0 0.8 0.6 0.3 0 0.3 
Estonia 38 7.7 0 0 0 0 0 
Finland 704 2.0 0.4 0.4 0 0.4 0 
France 4,026 2.0 1.4 1.4 0.6 0.8 0 
Germany 5,474 2.0 1.6 1.0 0.8 0.2 0.6 
Greece 454 2.0 5.7 1.1 0.9 0.2 4.6 
Hungary 1,134 2.7 5.3 1.6 1.6 0 3.7 
Ireland 186 2.0 0 0 0 0 0 
Italy 2,772 2.0 7.1 1.7 0.1 1.4 5.7 
Latvia 50 2.0 6.0 0 0 0 6.0 
Lithuania 24 2.0 0 0 0 0 0 
Luxembourg 222 2.0 4.5 3.6 3.6 0 0.9 
Malta 66 7.9 50.0 6.1 6.1 0 - 
Netherlands 2,346 2.0 1.5 1.5 1.3 0.2 0 
Poland 2,358 3.3 4.3 2.8 2.7 0.2 0 
Portugal 364 2.0 6.3 1.1 1.1 0 5.8 
Romania 5,808 2.0 2.4 1.2 1.1 <0.1 1.2 
Slovakia 387 2.0 1.8 1.8 1.8 0 0 
Slovenia 161 2.0 1.2 0.6 0.6 0 0.6 
Spain 1,943 2.5 11.8 2.2 1.9 0.3 9.6 
Sweden 626 2.0 0.3 0 0 0 0.3 
United Kingdom 4,042 2.0 0.8 <0.1 <0.1 <0.1 0.8 
EU Total 37,743  3.2 1.3 1.0 0.3 1.7 
Iceland 19 - 0 0 0 0 0 
Norway 738 2.0 0 0 0 0 0 
Switzerland 756 2.0 0 0 0 0 0 
Note: Target (production period) is calculated from the prevalence reported in 2011. 
 Data presented include sample size <25. 
1. S. Typhimurium includes monophasic S. Typhimurium. 
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Figure SA12.  Prevalence of S. Enteritidis and/or S. Typhimurium-positive laying hen flocks of 
Gallus gallus during the production period in the EU, 2008–2012 
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Figure SA13.  Prevalence of S. Enteritidis and/or S. Typhimurium-positive laying hen flocks of 
Gallus gallus during the production period in Member States, Norway and Switzerland
1
, 2008–2012 
 
1. Iceland was not included because data were reported only from 2011 onwards. 
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Figure SA14.  Prevalence of S. Enteritidis and/or S. Typhimurium-positive laying hen flocks of 
Gallus gallus during the production period and targets for Member States, Iceland, Norway and 
Switzerland, 2012 
 
Note: MSs are ordered alphabetically. Twenty-four MSs and three non-MSs met the 2012 targets, indicated with a '+'. 
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Figure SA15.  Prevalence of the two target serovars (S. Enteritidis and/or S. Typhimurium)-positive 
laying hen flocks of Gallus gallus during the production period, 2012 
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Broiler flocks 
Since 2009 MSs have been obliged to implement national control programmes for Salmonella in broiler 
flocks in accordance with Regulation (EC) No 2160/2003. The Regulation requires that effective measures 
are taken to prevent, detect and control Salmonella at all relevant stages of production, processing and 
distribution, particularly in primary production, in order to reduce Salmonella prevalence and the risk to public 
health. 
In 2012 a final annual Salmonella reduction target for broiler flocks came into force. This target was an 
extension of the transitional target implemented in the period 2009–2011. The EU definitive target for broiler 
flocks is defined in Regulation (EC) No 200/2012
20
 as a maximum percentage of broiler flocks remaining 
positive for the target serovars S. Enteritidis and/or S. Typhimurium (including monophasic S. Typhimurium) 
of 1 % or less. Minimum detection requirements in broiler flocks laid down in the Regulation include the 
sampling of flocks within the three weeks before the birds are moved to the slaughterhouse, taking at least 
two pairs of boot/sock swabs per flock. Test results have to be reported as Food Chain Information to 
slaughterhouses and to EFSA and EC, along with any relevant additional information, on a yearly basis as 
part of the annual report on trends in and sources of zoonoses and zoonotic agents. Positive flocks have to 
be counted and reported once only (flock level prevalence), irrespective of the number of sampling and 
testing operations.  
In 2012 all MSs had control programmes approved by the EC. Twenty-seven MSs and three non-MSs 
reported data on broiler flocks before slaughter. The prevalence of Salmonella spp. and of the two serovars 
(S. Enteritidis and S. Typhimurium) targeted in the national control programmes for broilers are presented in 
Table SA19. The trends in prevalence of the two target serovars, at EU level and at MS level, are shown in 
Figures SA16 and SA17, respectively. The prevalence of S. Enteritidis and S. Typhimurium and the target for 
broiler flocks for MSs and non-MSs, in 2012, are shown in Figure SA18. The geographical distribution of 
prevalence by MS is presented in Figure SA19. 
In 2012, as in 2011, 24 MSs and 3 non-MSs met the target of 1 % or less of broiler flocks positive for 
S. Enteritidis and/or S. Typhimurium (Figure SA18). Three MSs (the Czech Republic, Luxembourg and 
Slovakia) did not achieve the 2012 Salmonella reduction target. Overall in 2012, the MSs reported 0.3 % of 
positive flocks for the two target serovars (Table SA19). Nine MSs and three non-MS reported no findings for 
the two target serovars, while 18 MSs reported prevalence of the two serovars ranging from <0.1 % to 4.6 %. 
Monophasic S. Typhimurium was detected in Belgium, France, Italy, Spain and the United Kingdom in three 
flocks, 27 flocks, one flock, three flocks and one flock, respectively.  
The reported prevalence of S. Enteritidis and S. Typhimurium in the EU was the same as in 2011, after a 
decline from 0.7 % in 2009 to 0.4 % in 2010 and to 0.3 % in 2011 (Figure SA16). A decreasing trend in the 
reported prevalence has been observed in 10 MSs (Figure SA17) compared with 2011, whereas prevalence 
slightly increased in six MSs. The remaining 11 MSs reported an unchanged zero or very low (0.1 % to 1 %) 
prevalence. 
In 2012, the EU level prevalence of broiler flocks positive with Salmonella spp. was 3.1 %, compared with 
3.2 % in 2011. Estonia, Finland, Latvia and Lithuania were the only MSs reporting no positive flocks, and 
Bulgaria, Cyprus, Greece, Ireland and Slovenia reported only serovars other than the two target ones. 
Nineteen MSs reported positive findings for serovars other than S. Enteritidis and S. Typhimurium with a 
prevalence that ranged from 0 % to 43.8 % and this was, in most cases, higher than the prevalence of the 
target serovars.  
  
                                                        
20
  Commission Regulation (EC) No 200/2012 of 8 March 2012 concerning a Union target for the reduction of Salmonella enteritidis 
and Salmonella typhimurium in flocks of broilers, as provided for in Regulation (EC) No 2160/2003 of the European Parliament and 
of the Council. OJ L 71, 9.3.2012, p. 31–36.  
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Table SA19. Salmonella in broiler flocks of Gallus gallus before slaughter (flock-based data) in 
countries running control programmes, 2012 
Country N 
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Austria 3,510 3.2 0.7 0.6 <0.1 2.6 
Belgium 8,739 3.4 0.6 0.2 0.4 2.9 
Bulgaria 220 2.3 0 0 0 2.3 
Cyprus 16 43.8 0 0 0 43.8 
Czech Republic 5,145 6.8 4.6 4.6 0 2.2 
Denmark 3,342 0.8 0.2 0 0.2 0.6 
Estonia 504 0 0 0 0 0 
Finland 3,200 0 0 0 0 0 
France
2
 64,563 0.5 0.5 0.1 0.4 0 
Germany 15,393 2.6 0.1 <0.1 <0.1 2.5 
Greece 6,485 0.3 0 0 0 0.4 
Hungary 7,433 20.5 0.4 0.2 0.2 20.2 
Ireland 54 3.7 0 0 0 3.7 
Italy 18,721 11.0 <0.1 0 <0.1 11.0 
Latvia 563 0 0 0 0 0 
Lithuania 180 0 0 0 0 0 
Luxembourg 132 3.8 2.3 2.3 0 1.5 
Malta 581 24.3 0.3 0.2 0.2 - 
Netherlands 13,928 7.7 0.3 <0.1 0.2 7.5 
Poland 31,182 0.4 0.3 0.3 0 0.2 
Portugal 10,929 1.2 0.2 0.2 0 1.0 
Romania 13,315 5.9 <0.1 <0.1 <0.1 5.8 
Slovakia 2,297 1.1 1.1 1.1 0 0 
Slovenia 2,202 2.2 0 0 0 2.2 
Spain 29,548 2.2 <0.1 <0.1 <0.1 2.2 
Sweden 2,977 <0.1 <0.1 0 <0.1 0 
United Kingdom 37,946 1.8 <0.1 0 <0.1 1.8 
EU Total 283,105 3.1 0.3 0.2 0.1 2.8 
Iceland 657 1.5 0 0 0 1.5 
Norway 4,720 0 0 0 0 0 
Switzerland 504 1.0 0 0 0 1.0 
Note: Data presented include sample size <25. 
1. S. Typhimurium includes monophasic S. Typhimurium. 
2. French 2012 data for broiler flocks include also data for turkey fattening flocks.  
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Figure SA16.  Prevalence of S. Enteritidis and/or S. Typhimurium-positive broiler flocks of 
Gallus gallus during the production period in the EU, 2009–2012 
 
Figure SA17.  Prevalence of S. Enteritidis and/or S. Typhimurium-positive broiler flocks of 
Gallus gallus before slaughter in Member States, Norway and Switzerland
1
, 2009–2012 
 
Note: The dashed line indicates the EU Salmonella target of 1 %. 
1. Iceland was not included because data were reported only from 2011 onwards. 
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Figure SA18.  Prevalence of S. Enteritidis and/or S. Typhimurium-positive broiler flocks of 
Gallus gallus before slaughter and target for Member States, Iceland, Norway and Switzerland, 2012 
 
Note: In 2012, 24 MSs and 3 non-MSs met the target, indicated with a '+'. 
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Figure SA19.  Prevalence of the two target serovars (S. Enteritidis and/or S. Typhimurium)-positive 
broiler flocks of Gallus gallus before slaughter, 2012 
 
Breeding and fattening turkeys 
The mandatory national control programme for Salmonella in breeding and fattening turkeys came into effect 
on 1 January 2010 and has been implemented to comply with Regulation (EC) No 2160/2003 and 
Regulations (EC) No 584/2008
21
 and 213/2009
22
. All flocks of 250 or more breeding turkeys and 500 or more 
fattening turkeys are to be included in the national control programme unless exempt in Regulation (EC) No 
2160/2003 under Article 1.3, that is, birds produced for private domestic consumption, or where there is a 
direct supply of small quantities of products to the final consumer or to local retail establishments directly 
supplying the primary products to the final consumer. A target for the reduction of S. Enteritidis and/or 
S. Typhimurium in turkey flocks is set by Regulation (EC) No 584/2008, according to which no more than 
1 % of adult breeding turkey flocks and fattening turkey flocks are to remain positive for S. Enteritidis and/or 
S. Typhimurium by 31 December 2012. For MSs with fewer than 100 flocks of adult breeding or fattening 
turkeys, the EU target is that no more than one flock of adult breeding or fattening turkeys may remain 
positive by 31 December 2012.  
For breeding turkeys, samples for the detection of Salmonella should be taken by the operator from rearing 
turkey breeding flocks at one day of age, at four weeks of age and two weeks before moving to the laying 
phase or laying unit. In adult breeding flocks, samples shall be taken at least every three weeks during the 
laying period at the holding or at the hatchery. The samples in adult breeding flocks shall be taken in 
                                                        
21 
Commission Regulation (EC) No 584/2008 of 20 June 2008 implementing Regulation (EC) No 2160/2003 of the European 
Parliament and of the Council as regards a Community target for the reduction of the prevalence of Salmonella enteritidis and 
Salmonella typhimurium in turkeys. OJ L 162, 21.6.2008, p. 3–8. 
22
 Commission Regulation (EC) No 213/2009 of 18 March 2009 amending Regulation (EC) No 2160/2003 of the European Parliament 
and of the Council and Regulation (EC) No 1003/2005 as regards the control and testing of Salmonella in breeding flocks of 
Gallus gallus and turkeys. OJ L 73, 19.3.2009, p. 5–11. 
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accordance with the provisions laid down in point 2.2.2 of the Annex to Regulation (EC) No 1003/2005
23
. 
Official control samples are required to be taken from all flocks on 10 % of holdings with at least 250 adult 
breeding turkeys between 30 and 45 weeks of age but including in any case all holdings in which 
S. Enteritidis and/or S. Typhimurium were detected during the previous 12 months and all holdings with elite, 
great grandparent and grandparent breeding turkeys; this sampling may also take place at the hatchery. 
For fattening turkeys, samples must be taken by the operator within the three weeks before the birds are 
moved to the slaughterhouse. The results remain valid for up to six weeks after sampling. The samples in 
fattening turkey flocks shall be taken in accordance with the provisions laid down in point 2 of the Annex to 
Regulation (EC) No 584/2008. In addition, each year up to 2013, official control samples are to be taken from 
all flocks on 10 % of holdings with at least 500 fattening turkeys.  
Any reporting of monophasic S. Typhimurium was included within the S. Typhimurium total and was counted 
as a target serovar. The prevalence of Salmonella spp. and of the two serovars targeted in the control 
programmes are presented in Tables SA20 and SA21 for breeding and fattening flocks, respectively. The 
trends in prevalence of the two target serovars, at EU level and at MS level, for breeding and fattening 
turkeys are respectively shown in Figures SA20, SA21, SA24 and SA25. The prevalence of S. Enteritidis and 
S. Typhimurium and the target for flocks of breeding and of fattening turkeys, for MSs and non-MSs, in 2012, 
are shown in Figures SA22 and SA26, respectively. The geographical distribution of prevalence by MS is 
presented for flocks of breeding turkeys in Figure SA23 and for flocks of fattening turkeys in Figure SA27. All 
results are presented at flock level. A flock was reported as positive if one or more samples were positive for 
S. Typhimurium and/or S. Enteritidis.  
Fourteen MSs and two non-MSs reported data from Salmonella testing in adult turkey breeding flocks in 
2012 (Table SA20), which was similar to that reported in 2011. Data show that 88.1 % of the 2,076 turkey 
breeding flocks at EU level were reported by France, Germany, Hungary, Italy and the United Kingdom, 
whereas few flocks were reported by the other countries. In total, 13 MSs and two non-MS met the target 
prevalence of S. Enteritidis and/or S. Typhimurium set for adult turkey breeding flocks in 2012, whereas 
Poland did not meet this target (Figures SA21 and SA22), compared with 2011 when all 14 reporting MSs 
and two non-MS met their 2011 target. With the exception of France and Poland, countries did not detect the 
two target serovars. Compared with 2011, an increase was observed for France (0.3 % in 2011 to 0.5 % in 
2012) and Poland (0 % in 2011 to 6.1 % in 2012), and mostly S. Typhimurium was isolated by these two 
MSs in 2012. Monophasic S. Typhimurium was detected in two flocks in France. In Hungary the prevalence 
decreased from 0.8 % in 2011 to 0 % in 2012 (Figure SA21). Overall, the EU level prevalence for the target 
serovars was 0.5 % (Figure SA20), which is slightly higher than in 2011 (0.2 %). 
Six MSs reported Salmonella spp. in their turkey breeding flocks and the overall EU prevalence of 
Salmonella was 4.6 %, which was at a higher level than in 2011 (3.5 %). Hungary, Italy, Spain and the 
United Kingdom reported only serovars other than the two targeted ones.  
In addition, 22 MSs and 3 non-MSs provided data from turkey fattening flocks before slaughter 
(Table SA21) and findings were similar to those reported in 2011. In 2012, 21 MSs and three non-MSs met 
their 2012 reduction targets set for fattening turkeys (Figures SA25 and SA26), which was similar to that 
reported in 2011. Spain did not meet the target in 2012, but reported a relatively low prevalence (1.5 %). Ten 
MSs reported S. Enteritidis and/or S. Typhimurium infection; the overall prevalence at EU level was 0.4 %, 
which is comparable to the prevalence in 2011 (0.5 %) (Figure SA24). 
Compared with 2011, a decreasing trend in the reported target prevalence was observed in seven MSs 
(Figure SA25), whereas prevalence slightly increased in four MSs. The remaining 12 MSs reported an 
unchanged zero or very low (0.1 % to 1 %) prevalence. Monophasic S. Typhimurium was detected in 
12 flocks in Italy and in one flock in the United Kingdom. 
 
                                                        
23
  Commission Regulation (EC) No 1003/2005 of 30 June 2005 implementing Regulation (EC) No 2160/2003 as regards a Community 
target for the reduction of the prevalence of certain salmonella serotypes in breeding flocks of Gallus gallus and amending 
Regulation (EC) No 2160/2003. OJ L 170, 1.7.2005, p. 12–17. 
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In 2012, the EU level prevalence of turkey fattening flocks positive with Salmonella spp. was 14.5 %, which is 
an increase compared with 2011, when prevalence was 10.1 %. In 2012, Bulgaria, Denmark, Greece, Latvia, 
Lithuania, Romania, Slovakia and Sweden were the only MSs reporting no positive flocks. Belgium, Cyprus, 
Ireland, the Netherlands and Slovenia, reported only serovars other than the targeted ones, as did 
Switzerland. In addition, nine MSs reported serovars other than the targeted ones with a prevalence higher 
than the prevalence reported for the target serovars. 
Table SA20. Salmonella in breeding flocks of turkeys (adults, flock-based data) in countries running 
control programmes, 2012 
Country N 
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Bulgaria 2 0 0 0 0 0 
Czech Republic 18 0 0 0 0 0 
Finland 8 0 0 0 0 0 
France 912 0.5 0.5 0.1 0.4 0 
Germany 196 0 0 0 0 0 
Greece 5 0 0 0 0 0 
Hungary 124 12.9 0 0 0 12.9 
Ireland 6 0 0 0 0 0 
Italy 323 18.9 0 0 0 18.9 
Poland 99 6.1 6.1 1.0 5.1 0 
Slovakia 49 0 0 0 0 0 
Spain 57 5.3 0 0 0 5.3 
Sweden 4 0 0 0 0 0 
United Kingdom 273 1.8 0 0 0 1.8 
EU Total (14 MSs) 2,076 4.6 0.5 <0.1 0.4 4.1 
Iceland 2 0 0 0 0 0 
Norway 13 0 0 0 0 0 
Note: Data presented include sample size <25. 
1. S. Typhimurium includes monophasic S. Typhimurium. 
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Figure SA20.  Prevalence of S. Enteritidis and/or S. Typhimurium-positive breeding flocks of turkeys 
during the production period, in the EU, 2010–2012 
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Figure SA21.  Prevalence of S. Enteritidis and/or S. Typhimurium-positive breeding flocks of turkeys 
during the production period in 14 Member States, Iceland and Norway, 2010–2012 
 
Note: The dashed line indicates the EU Salmonella target of 1 %. 
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Figure SA22.  Prevalence of S. Enteritidis and/or S. Typhimurium-positive breeding flocks of turkeys 
during the production period and target for Member States, Iceland and Norway, 2012 
 
Note: In 2012, 13 MSs and 2 non-MSs met the target, indicated with a '+'.  
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Figure SA23.  Prevalence of the two target serovars (S. Enteritidis and/or S. Typhimurium)-positive 
breeding flocks of turkeys during the production period, 2012 
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Table SA21. Salmonella in fattening flocks of turkeys before slaughter (flock-based data) in countries 
running control programmes, 2012 
Country N 
% positive 
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Austria 375 9.6 0.5 0.3 0.3 9.1 
Belgium 163 0.6 0 0 0 0.6 
Bulgaria 1 0 0 0 0 0 
Cyprus 11 9.1 0 0 0 9.1 
Czech Republic 266 7.5 0.4 0.4 0 7.1 
Denmark 23 0 0 0 0 0 
Finland 342 0.3 0.3 0 0.3 0 
France
2
 - - - - - - 
Germany 3,643 1.3 0.5 0 0.5 0.9 
Greece 46 0 0 0 0 0 
Hungary 3,189 44.2 0.3 0.2 <0.1 43.9 
Ireland 19 15.8 0 0 0 15.8 
Italy 5,369 23.0 0.3 0 0.3 23.7 
Lithuania 24 0 0 0 0 0 
Netherlands 241 4.1 0 0 0 4.1 
Poland 5,230 2.5 0.3 <0.1 0.2 2.2 
Portugal 833 1.0 0.1 0.1 0 0.8 
Romania 403 - 0 0 0 0 
Slovakia 8 0 0 0 0 0 
Slovenia 129 3.1 0 0 0 3.1 
Spain 2,117 15.4 1.5 <0.1 1.5 13.8 
Sweden 139 0 0 0 0 0 
United Kingdom 3,558 15.6 <0.1 0 <0.1 15.5 
EU Total 26,129 14.5 0.4 <0.1 0.3 14.3 
Iceland 28 0 0 0 0 0 
Norway 216 0 0 0 0 0 
Switzerland 27 3.7 0 0 0 3.7 
Note: Data presented include sample size <25. 
1. S. Typhimurium includes monophasic S. Typhimurium. 
2. French 2012 data for turkey fattening flocks are included in the broiler flocks data (Table SA19). 
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Figure SA24.  Prevalence of S. Enteritidis and/or S. Typhimurium-positive fattening flocks of turkeys, 
in the EU, 2010–2012 
 
Figure SA25.  Prevalence of S. Enteritidis and/or S. Typhimurium-positive fattening flocks of turkeys 
in 24 Member States, Iceland, Norway and Switzerland, 2009–2012 
 
  
0
0.5
1
1.5
2
1 2 3
E
U
  f
lo
c
k
s
 p
re
v
a
le
n
c
e
 
Year
EU summary report on zoonoses, zoonotic agents and 
food-borne outbreaks 2012 
 
EFSA Journal 2014;12(2):3547  88 
Figure SA26.  Prevalence of S. Enteritidis and/or S. Typhimurium-positive fattening flocks of turkeys 
and target for Member States, Iceland, Norway and Switzerland, 2012 
 
Note: In 2012, 21 MSs and 3 non-MSs met the target, indicated with a '+'.  
1. French 2012 data for turkey fattening flocks are included in the broiler flocks data (Table SA19). 
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Figure SA27.  Prevalence of the two target serovars (S. Enteritidis and/or S. Typhimurium)-positive 
fattening flocks of turkeys, 2012 
 
Ducks and geese 
In 2011 and 2012, three MSs reported Salmonella monitoring data in duck flocks (Table SA22) from 
investigations with at least 25 samples. Poland submitted information from a large number of investigations. 
Owing to differences in sampled types of flocks (breeding or meat production flocks), sampling strategy and 
sample type, prevalences are not comparable across MSs. Iceland and Norway did not detect any 
Salmonella in duck flocks. 
In 2012, three MSs reported Salmonella monitoring data in geese flocks (Table SA22) from investigations 
with at least 25 samples, two of which (Germany and Poland) also submitted such data in 2011. Poland 
submitted large numbers of investigations. Owing to differences in sampled types of flocks (breeding or meat 
production flocks), sampling strategy and sample type, prevalences are not comparable across MSs.  
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Table SA22. Salmonella in flocks of ducks and geese (flock-based data), 2011–2012 
Country Description 
2012 
Description 
2011 
N 
% positive 
N 
% positive 
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Ducks               
Denmark 
Meat production flocks (rearing 
period) sampled at farm, 
environmental samples (boot swabs), 
control and eradication programmes, 
official sampling and objective 
sampling 
96 49.0 3.1 
Meat production flocks (rearing 
period) sampled at farm, 
environmental samples (boot swabs), 
control and eradication programmes, 
official sampling and objective 
sampling 
95 57.9 1.1 
Germany 
At farm, domestic production, animal 
samples, official sampling 
46 6.5 2.2 
At farm, domestic production, animal 
samples, surveillance, official 
sampling 
57 3.5 0 
Poland 
Meat production flocks sampled at 
farm, animal samples (caecum), 
industry sampling 
1,006 2.5 1.5 
Breeding flocks sampled at farm, 
environmental samples, surveillance, 
industry sampling 
768 6.0 2.5 
Meat production flocks, environmental 
samples, industry sampling 
352 9.7 5.7 
Breeding flocks, environmental 
samples (boot swabs), official and 
industry sampling, objective sampling 
29 20.7 6.9 
Total ducks (3 MSs in 2012) 1,148 7.3 2.7   949 11.5 2.3 
Iceland - - - - 
Meat production flocks, animal 
samples (faeces), industry sampling, 
census 
26 0 0 
Norway 
Meat production flocks sampled at 
farm, domestic production, animal 
samples (faeces) control and 
eradication programmes, official and 
industry sampling, census 
68 0 0 
Meat production flocks, environmental 
samples (boot swabs and dust), 
official and industry sampling, census 
67 0 0 
Table continued overleaf  
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Table SA22 (continued). Salmonella in flocks of ducks and geese (flock-based data), 2011–2012 
Country Description 
2012 
Description 
2011 
N 
% positive 
N 
% positive 
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Geese               
Germany 
At farm, domestic production, animal 
samples, official sampling 
55 5.5 3.6 
At farm, domestic production, animal 
samples, surveillance, official 
sampling 
51 0 0 
Poland 
Breeding flocks sampled at farm, 
animal samples (caecum), industry 
sampling, convenience sampling 
2,143 4.9 3.7 
Breeding flocks sampled at farm, 
environmental samples, surveillance, 
industry sampling 
1,231 7.8 5.4 
Meat production flocks, animal 
samples (caecum), industry sampling 
74 12.2 8.1 
Meat production flocks, 
environmental samples, official and 
industry sampling, objective sampling 
309 4.5 2.9 
Sweden 
Meat production flocks sampled 
before slaughter at farm, domestic 
production, environmental samples 
(boot swabs), control and eradication 
programmes, official and industry 
sampling, census 
25 4.0 4.0 - - - - 
Total geese (3 MSs in 2012) 2,297 5.2 3.8   1,591 6.9 4.7 
Note: Only investigations covering 25 or more samples are included. 
1. S. Typhimurium includes monophasic S. Typhimurium. 
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Pigs 
Data on the prevalence of Salmonella from the bacteriological monitoring of pigs from investigations with at 
least 25 samples were reported by 10 MSs and one non-MS in 2011, and by seven MSs and one non-MS in 
2012 (Table SA26). The number of reported tested animals was much larger for the year 2012, and this was, 
in major part, due to the reporting by Germany and by the Netherlands. Consequently, overall animal level 
Salmonella prevalence data are unlikely to be comparable between the reporting 2011 (1.2 %) and 2012 
(5.5 %) data. At the herd or batch level, the overall Salmonella prevalence was 15.2 % in 2011 and 17.5 % in 
2012. 
Investigations were reported from both breeding and fattening pigs (or unspecified) and from the sampling 
stages; at farm, at the slaughterhouse or unspecified. Sample types reported were faeces, lymph nodes or 
were unspecified. 
Data on the prevalence of Salmonella at farm level ranged at the herd level from 0.2 % to 28.8 % in 2011 
and from 0 % to 33.1 % in 2012. At animal level the ranges were from 4.9 % to 100 % in 2011 and from 
1.4 % to 36.4 % in 2012. At slaughter, data on the batch prevalence of Salmonella were 35.5 % in 2011 and 
29.4 % in 2012. At animal level the ranges were from <0.1 % to 25.0 % in 2011 and from <0.1 % to 9.7 % in 
2012. 
Finland, Sweden and Norway reported no positive findings or very low numbers of positive results. 
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Table SA23. Salmonella in pigs from bacteriological monitoring programmes, 2011–2012 
Country Description 
Sampling 
stage 
2012 2011 
N % positive N % positive 
Bulgaria 
Herd (fattening), batch, 
lymph nodes 
Farm - - 170 11.2 
Estonia 
Herd (unspecified), faeces Farm 66 19.7 53 17.0 
Animal (fattening), lymph 
nodes 
Slaughter 144 9.7 145 3.4 
Finland 
Herd (breeding), faeces Farm 68 0 540 0.2 
Herd (unspecified), faeces Farm 90 0 - - 
Animal (breeding), lymph 
nodes 
Slaughter 3,168 <0.1 3,106 <0.1 
Animal (fattening), lymph 
nodes 
Slaughter 3,257 <0.1 3,179 0.1 
Germany 
Herd (breeding) Farm 49 24.5 73 28.8 
Animal (breeding) Farm 375 34.4 - - 
Herd (fattening) Farm 329 26.7 1,601 14.4 
Animal (fattening) Farm 3,517 9.2 - - 
Herd (unspecified) Farm 1,711 14.4 996 19.4 
Animal (unspecified) Farm 21,183 7.7 - - 
Hungary Animal (unspecified) Unspecified - - 45 100 
Italy 
Animal (unspecified) Farm 187 36.4 82 4.9 
Animal (unspecified) Slaughter - - 40 25.0 
Netherlands 
Herd (unspecified), faeces Farm 148 33.1 - - 
Animal (unspecified) Farm 2,943 1.4 - - 
Portugal 
Animal (breeding) Farm - - 32 37.5 
Animal (fattening) Farm - - 209 8.1 
Animal (unspecified) Unspecified - - 35 2.9 
Romania Animal (unspecified) Farm - - 41 100 
Spain 
Slaughter batch (fattening), 
faeces (2012), lymph nodes 
(2011) 
Slaughter 163 29.4 231 35.5 
Sweden 
Animal (breeding), lymph 
nodes 
Slaughter 2,231 <0.1 2,313 0.2 
Animal (fattening), lymph 
nodes 
Slaughter 3,070 <0.1 3,379 <0.1 
Total  
(7 MSs in 2012) 
Total   42,699 6.3 16,270 4.3 
Animal   40,075 5.5 12,606 1.2 
Batch/Herd/holding   2,624 17.5 3,664 15.2 
Norway 
Herd (breeding), faeces Farm 94 0 98 0 
Animal, lymph nodes Slaughter 3,059 <0.1 2,305 <0.1 
Animals, lymph nodes Slaughter 3,066 0 2,212 0 
Note: Only investigations covering 25 or more samples are included. 
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Cattle 
Data on the prevalence of Salmonella from the bacteriological monitoring of cattle from investigations with at 
least 25 samples were reported by seven MSs and one non-MS in 2011, and by eight MSs and one non-MS 
in 2012 (Table SA24). The numbers of reported tested animals and herds were much larger for the year 
2012 and this was, in major part, due to the reporting by Germany. Consequently, overall Salmonella 
prevalence data are not comparable between the reporting 2011 (2.3 % for animals and 7.1 % for herd or 
batch level) and 2012 (2.3 % for animals and 3.8 % for herd or batch level) data.  
Investigations were reported from breeding animals, from dairy cows or calves, or unspecified, and were 
from at farm or at the slaughterhouse. Used sample types were faeces, lymph nodes, organ or tissue 
samples, carcase swabs, or were unspecified. 
Data on the prevalence of Salmonella at farm level ranged, at the herd level, from 0.8 % to 16.4 % in 2011 
and from 0 % to 15.0 % in 2012. At animal level the ranges were from 0 % to 4.7 % in 2011 and from 0 % to 
4.0 % in 2012. At slaughter, data on the batch prevalence of Salmonella were 5.4 % in 2011 and 6.2 % in 
2012. At animal level the ranges were from <0.1 % to 2.2 % in 2011 and from <0.1 % to 0.9 % in 2012. 
Bulgaria, Finland, Sweden, and Norway reported no positive findings or very low numbers of positive results. 
  
EU summary report on zoonoses, zoonotic agents and 
food-borne outbreaks 2012 
 
EFSA Journal 2014;12(2):3547  95 
Table SA24. Salmonella in cattle from bacteriological monitoring programmes, 2011–2012 
Country Description Sampling stage 
2012 2011 
N 
% 
positive 
N 
% 
positive 
Bulgaria 
Animal (adult cattle over 
two years), faeces 
Farm 53 0 - - 
Estonia Herd, faeces Farm 162 3.7 181 4.4 
Finland 
Herd (breeding bulls), 
faeces 
Farm 131 0 132 0.8 
Animal (unspecified), 
lymph nodes 
Slaughter 3,154 <0.1 3,126 <0.1 
Germany 
Animal (calves under 1 
year) 
Farm 8,663 1.9 - - 
Herd (calves under 1 year) Farm 877 4.8 777 5.5 
Animal (dairy cows) Farm 14,749 4.0 - - 
Herd (dairy cows) Farm 180 15.0 171 16.4 
Animal Farm 103,270 2.2 - - 
Herd Farm 5,693 2.8 1,456 7.2 
Italy 
Herd (dairy cows and 
heifers) 
Farm 294 14.3 - - 
Animal Farm 107 0 1,151 2.2 
Animal Slaughter 651 0.9 833 2.2 
Netherlands 
Animal (adult cattle over 2 
years), organ/tissue 
Farm 2,851 3.1 6,033 4.7 
Animal, faeces Farm 1,662 4.0 - - 
Holding (calves under 1 
year), faeces 
Farm - - 175 14.3 
Spain 
Slaughter batch (young 
cattle, 1-2 years), faeces 
Slaughter 146 6.2 239 5.4 
Sweden Animal, lymph nodes Slaughter 3,364 0.2 3,372 0.1 
Total 
Total   146,007 2.4 17,646 3.2 
Animal   138,524 2.3 14,515 2.3 
Batch/Herd/holding   7,483 3.8 3,131 7.1 
Norway 
Animal, carcase swabs Slaughter 2,857 0 1,799 0 
Animal, lymph nodes Slaughter 2,849 <0.1 2,246 0.4 
Note: Only investigations covering 25 or more samples are included. 
   
Other animal species 
Salmonella was also detected in other animals (21 MSs and 1 non-MS). 
For further information on reported data, refer to the Level 3 Tables. 
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3.1.4. Salmonella in feedingstuffs 
Data on Salmonella in feedingstuffs collected by MSs are generated from different targeted surveillance 
programmes as well as from unbiased reporting of random sampling of domestic and imported feedingstuffs. 
The presentation of single sample and batch-based data from the different monitoring systems has therefore 
been summarised and includes both domestic and imported feedingstuffs. Owing to differences in monitoring 
and reporting strategies, data are not necessarily comparable between MSs or reporting years. There are 
also very large differences in the number of samples tested among MSs, which can limit comparisons 
between investigations. 
An overview of the countries which reported data on Salmonella in feed for 2012 is presented in Table SA1. 
In the following sections, only results based on 25 or more units tested are presented. Results from industry 
own-check programmes and sampling, as well as specified suspect sampling or selective sampling have 
also been excluded owing to difficulties with the interpretation of data. These data are, however, presented in 
the Level 3 Tables. 
Table SA25 presents the EU proportion of Salmonella-positive samples in animal- and vegetable-derived 
feed material reported by MSs in 2012. The numbers of reported tested sampling units were much smaller 
for the year 2012 than in 2011. Consequently, overall Salmonella contamination data are not comparable 
between the reporting in 2011 and 2012. In feed material from fish meal, Salmonella was detected in 3.8 % 
of batches tested (1.5 % in 2011). More single samples were tested in 2012 than in 2011, and 4.5 % were 
contaminated with Salmonella. In feed material derived from land animals, results have been described 
according to origin. The highest level of Salmonella contamination in 2012 (2.2 %) was reported in meat and 
bone meal, while in 2011 this was in feed other than meat and bone meal or dairy products. The lowest 
contamination (0.3 % in batches) was detected in feed other than meat and bone meal or dairy products. In 
meat and bone meal Salmonella contamination is to be considered only an indicator, and it does not pose 
any risk to animals because meat and bone meal is still prohibited for feeding food-producing animals, 
although it is used in pet foods. In cereals and oil seeds and products thereof, overall reported Salmonella 
contamination percentages were low to very low, as in 2011.  
In compound feedingstuffs, the finished feed for animals, the proportion of Salmonella-positive findings in 
2012 ranged among the reporting MSs from no positive findings to 2.9 % in cattle feed when single samples 
were tested, and from no positive findings to 6.5 % in MSs sampling cattle feed at batch level. In compound 
pig feed Salmonella findings ranged from no positive findings to 2.3 % in single samples, and from 0.3 % 
positive findings to 4.0 % at batch level. In poultry compound feed data were reported only from sampling of 
batches and the proportion Salmonella-contaminated batches varied from 0.1 % to 4.4 % (Table SA26). 
As in the previous years, the Netherlands reported large numbers of units tested at batch level for all three 
categories of compound feedingstuffs and reported very low proportions of Salmonella contamination. 
Among the reporting MSs, Spain accounted for the highest proportion of Salmonella-contaminated 
compound feedingstuffs (for cattle; 6.5 %), at the batch level. Poland reported the highest contamination of 
pig feed (4.0 % batches) and Belgium the highest contamination of poultry feed batches; 4.4 %. It should be 
highlighted that the reported proportions of positive samples might not always be representative of 
feedingstuffs on the national markets, as some reports might reflect intensive sampling of high-risk products.  
For more information on reported data, refer to the Level 3 Tables. 
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Table SA25. Salmonella in animal and vegetable derived feed material, 2012 
EU Totals 
2012 
Sample unit  N % pos 
Fish meal   Batch  523 3.8 
    Single  648 4.5 
Feed material of land animal origin Meat and bone meal Batch  1,184 1.9 
   Single  186 2.2 
  Dairy product  Batch  384 0 
   Single  - - 
  Other Batch  308 0.3 
   Single  841 1.8 
Cereals   Batch  1,039 0.6 
    Single  2,233 0.2 
Oil seeds and products   Batch  1,949 1.5 
    Single  4,195 3.1 
Note: Only investigations covering 25 or more samples are included. 
  
Table SA26. Salmonella in compound feedingstuffs, 2012  
Feedingstuff 
2012 
Sample unit N % pos 
Cattle feed       
Germany   Single 345 2.0 
Ireland   Single 70 0 
Netherlands   Batch 1,111 0.2 
Poland 
  Batch 137 0 
  Single 128 0.8 
Spain   Batch 46 6.5 
Total cattle feed (5 MSs) 
Single 543 1.5 
Batch 1,294 0.4 
Pig feed      
Belgium   Batch 89 1.1 
France   Single 86 2.3 
Germany   Single 646 0.9 
Hungary   Batch 175 0.6 
Ireland   Single 25 0 
Netherlands   Batch 2,080 0.3 
Poland 
  Batch 502 0.4 
  Batch 25 4.0 
Romania   Batch 67 3.0 
Total pig feed (9 MSs) 
Single 757 1.1 
Batch 2,938 0.4 
Poultry feed      
Belgium   Batch 90 4.4 
Hungary   Batch 52 3.8 
Netherlands   Batch 4,361 0.1 
Poland   Batch 558 0.2 
Total poultry feed (4 MSs) Batch 5,061 0.2 
Note: Only investigations covering 25 or more samples are included. 
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3.1.5. Discussion 
Salmonellosis in humans continued to decrease in 2012. Significant decreasing five-year trends were 
observed in 15 MSs and two non-MSs as well as in the EU as a whole, representing a decrease of 
43,546 cases (32 %) in 2012 when compared with the case numbers reported in 2008. Salmonellosis is 
nonetheless the second most common zoonosis in humans in the EU, with 1,531 foodborne outbreaks 
reported in 2012 involving 12,000 affected persons. The EU case-fatality rate was 0.14 % and 61 deaths due 
to non-typhoidal salmonellosis were reported in the EU in 2012. 
The salmonellosis notification rates for human cases of infection vary between the Member States, reflecting 
differences in, for example, disease prevalence in the domestic animal population, the proportion of travel-
associated cases and the quality and coverage of the surveillance system. One example of the latter is that 
countries reporting the lowest notification rate for salmonellosis had the highest proportion of hospitalisation, 
which may indicate that the surveillance systems in these countries is focusing on diagnosis of the most 
severe cases.  
No trend analysis for separate Salmonella serovars was included in this year’s report but the trends 
observed in 2007–2011 continued in 2012. Reported human case numbers of S. Enteritidis decreased, but 
monophasic S. Typhimurium 1,4,[5],12:i:- increased (possibly a reporting bias) as did S. Infantis. A multi-
country outbreak of S. Stanley, affecting several MSs and linked to the turkey production chain, resulted in 
this serovar becoming the fifth most commonly reported in 2012. Large outbreaks in individual countries 
were also reflected in the top 10 serovar list, e.g. S. Thompson in the Netherlands.  
The continuing decrease in the numbers of salmonellosis cases in humans is likely to be mainly related to 
the successful Salmonella control programmes in fowl (Gallus gallus) populations that are in place in EU 
MSs and that have particularly resulted in a lower occurrence of Salmonella in eggs, though other control 
measures might also have contributed to the reduction. The majority of MSs met their Salmonella reduction 
targets for breeding flocks, laying hens and broilers of Gallus gallus and for turkey flocks in 2012. The EU 
level prevalence of the target serovars, including S. Enteritidis, was further reduced in breeding flocks and 
laying hens of Gallus gallus and for turkey fattening flocks to respectively 0.4 %, 1.3 % and 0.4 %. In broiler 
flocks the EU level prevalence remained at 0.3 % whereas in turkey breeding flocks the overall prevalence 
for the two target serovars in the two MSs with positive flocks was 0.5 %. All these results indicate that MSs 
continued to invest in Salmonella control and this work is yielding further positive results. It is noteworthy 
that, compared with 2011, the 2012 EU level prevalence of flocks positive with Salmonella spp. decreased in 
laying hens, remained almost the same in breeding hens and broilers, but increased in breeding turkeys and 
fattening turkeys. In this context, the multi-country S. Stanley outbreak, which was highly likely due to 
contamination of the turkey production chain, serves as a reminder of the importance of acting upon any 
Salmonella serovar contamination in the food chain and monitoring to detect the emergence of new serovars 
or strains
24
. 
Reports on food-borne outbreaks caused by Salmonella within the EU have shown a reduction of 19 % from 
2008 to 2012, but slightly increased since 2011. Important sources of food-borne Salmonella outbreaks in 
2012 were eggs and egg products, cheese, and mixed foods.  
As in 2011, monophasic S. Typhimurium was in third place in the top 10 list of the most commonly reported 
serovars in human cases in 2012. The BIOHAZ Panel concluded in its opinion
25
 that monophasic 
S. Typhimurium appears to be of increasing importance in many MSs and has caused a substantial number 
of infections in both humans and animals bred for food. However, the agreed reporting guidelines since 2010 
for more accurate identification of these strains may have partly contributed to the increased reports in 2011 
and in 2012 in some MSs. 
As regards findings in food, Salmonella was most often detected in fresh broiler and turkey meat. It was less 
often detected in pig or bovine meat and rarely in table eggs. The highest levels of non-compliance with 
Salmonella criteria generally occurred in foods of meat origin. Otherwise no major developments in 
occurrence were observed compared with previous years. 
                                                        
24
 European Food Safety Authority (EFSA) and European Centre for Disease Prevention and Control (ECDC), 2012. Multi-country 
outbreak of Salmonella Stanley infections Update. EFSA Journal 2012;10(9):2893, 16 pp. doi:10.2903/j.efsa.2012.2893 
25
  EFSA Panel on Biological Hazards (BIOHAZ), 2010. Scientific Opinion on monitoring and assessment of the public health risk of  
‘Salmonella Typhimurium-like’ strains. EFSA Journal 2010;8(10):1826, 48 pp. doi:10.2903/j.efsa.2010.1826 
EU summary report on zoonoses, zoonotic agents and 
food-borne outbreaks 2012 
 
EFSA Journal 2014;12(2):3547  99 
3.  INFORMATION ON SPECIFIC ZOONOSES AND ZOONOTIC AGENTS 
3.2. Campylobacter 
Campylobacteriosis in humans is caused mainly by thermotolerant Campylobacter spp. The infective dose of 
these bacteria is generally low. The species most commonly associated with human infection are 
Campylobacter jejuni (C. jejuni) followed by C. coli, and C. lari, but other Campylobacter species, including 
the non-thermophilic C. fetus, are also known to occasionally cause human infection. 
The average incubation periods in humans range from two to five days. Patients may experience mild to 
severe symptoms, with common clinical symptoms including watery, sometimes bloody diarrhoea, abdominal 
pain, fever, headache and nausea. Usually infections are self-limiting and last only a few days. Extra-
intestinal infections or post-infection complications such as reactive arthritis and neurological disorders can 
also occur. C. jejuni has become the most commonly recognised antecedent cause of Guillain–Barré 
syndrome, a polio-like form of paralysis that can result in respiratory failure and severe neurological 
dysfunction and even death. 
Thermotolerant Campylobacter spp. are widespread in nature. The principal reservoirs are the alimentary 
tract of wild and domesticated birds and mammals. These bacteria are prevalent in food-producing animals 
such as poultry, cattle, pigs and sheep, in pets, including cats and dogs, in wild birds and in environmental 
water sources. Animals rarely succumb to disease caused by these organisms. However, C. jejuni is known 
to cause abortions in sheep. Lately, a highly virulent clone that causes outbreaks of ovine abortions has 
emerged in the United States and its zoonotic potential has recently been suggested
26
. 
Campylobacter can readily contaminate various foodstuffs, including meat, raw milk and dairy products, and, 
less frequently, fish and fishery products, mussels and fresh vegetables. Among sporadic human cases, 
contact with live poultry, consumption of poultry meat, drinking water from untreated water sources, and 
contact with pets and other animals have been identified as the major sources of infections. Cross-
contamination during food preparation has also been described as an important transmission route. Raw milk 
and contaminated drinking water have been implicated in both small and large outbreaks.  
Table CA1 presents the countries reporting data for 2012. Only the information reported on 
campylobacteriosis in humans and on Campylobacter in fresh broiler meat and in broilers is included in this 
report.  
Table CA1.  Overview of countries reporting data for Campylobacter, 2012 
Data 
Total number of  
 reporting MSs 
Countries 
Human 27 
All MSs  
Non-MSs: CH, IS, NO 
Food 21 
All MSs except CY, FI, GR, LT, LV, MT 
Non-MSs: CH, IS 
Animal 20 
All MSs except BE, BG, CY, CZ, FR, LT, MT 
Non-MSs: CH, IS, NO 
Note: The overview table contains all data reported by MSs and non-MSs. 
  
                                                          
26  
Sahin O, Fitzgerald C, Stroika S, Zhao S, Sippy RJ, Kwan P, Plummer PJ, Han J, Yaeger MJ and Zhang Q, 2012. Molecular 
evidence for zoonotic transmission of an emergent, highly pathogenic Campylobacter jejuni clone in the United States. Journal of 
Clinical Microbiology, 50(3), 680-687. 
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3.2.1. Campylobacteriosis in humans 
In 2012, Campylobacter continued to be the most commonly reported gastrointestinal bacterial pathogen in 
humans, in the EU, since 2005. The number of reported confirmed cases of human campylobacteriosis in the 
EU, in 2012, was 214,268, which was a decrease of 4.3 % compared with 2011. The EU notification rate was 
55.49 per 100,000 population in 2012 (Table CA2).  
The highest country-specific notification rates were observed in the Czech Republic (174 cases per 
100,000), and Slovakia, Luxembourg and the United Kingdom (106-117 per 100,000 population), while the 
lowest rates were reported in Bulgaria, Latvia, Italy, Poland and Romania (<2 per 100,000). The proportion of 
domestic cases versus travel-associated varied markedly between countries, with the highest proportion of 
domestic cases (≥92 %) reported in the Czech Republic, Estonia, Germany, Hungary, Latvia, Malta, the 
Netherlands, Poland, Slovakia and Spain. The highest proportions of travel-associated cases were reported 
in the Nordic countries Finland, Iceland, Sweden and Norway (≥46 % of the cases) (Figure CA1).  
There was a clear seasonal trend in confirmed campylobacteriosis cases, reported in the EU, in 2008-2012 
and a significant increasing EU trend (p = 0.001 with linear regression) (Figure CA2). Significant increasing 
trends in campylobacteriosis from 2008 to 2012 were observed in 15 MSs: Austria, Belgium, Denmark, 
Estonia, France, Hungary, Ireland, Italy, Lithuania, Luxemburg, Malta, the Netherlands, Poland, Slovakia and 
the United Kingdom.  
Twelve MSs provided information on hospitalisation for some or all of their cases, which was three MSs more 
than those reporting in 2011. Despite this, information on hospitalisation covered only 9.7 % of all confirmed 
campylobacteriosis cases in 2012. The reason for this is that many MSs have surveillance systems for 
campylobacteriosis which are based on laboratory notifications where information on hospitalisation is not 
usually available. Of the cases where the information was provided, on average 47.7 % of cases were 
hospitalised. The highest hospitalisation rates (74-87 % of cases hospitalised) were reported in Cyprus, 
Latvia, Lithuania, Romania and the United Kingdom. Three of these countries also reported among the 
lowest notification rates of campylobacteriosis, which indicates that the surveillance systems in these 
countries primarily capture the more severe cases. The United Kingdom provided information on 
hospitalisation for only 7.5 % of its cases and the data may, therefore, be biased.  
In 2012, 31 deaths due to campylobacteriosis were reported by 14 MSs, with the United Kingdom accounting 
for 20 of these. This results in an EU case-fatality rate of 0.03 % among the 111,464 confirmed cases for 
which this information was provided (52.0 % of all reported cases). 
Species information was provided for 46.3 % of confirmed cases reported in the EU, Iceland and Norway. Of 
these 81.1 % were reported to be C. jejuni, 6.2 % C. coli, 0.2 % C. lari, 0.06 % C. upsaliensis, 0.01 % 
C. fetus. ‘Other’ Campylobacter species accounted for 12.4 % but the large majority of those cases were 
reported at the national level as ‘C. jejuni/C. coli not differentiated’.  
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Table CA2.  Reported cases of human campylobacteriosis in 2008–2012 and notification rates for 
confirmed cases in the EU, 2012 
Country 
2012 2011 2010 2009 2008 
Report 
Type
1
 
Cases 
Confirmed 
Cases 
Confirmed 
cases/ 
100,000 
Confirmed cases 
Austria
 
 C 4,992 4,710 55.79 5,129 4,404 4,502 4,280 
Belgium
2
 C 6,607 6,607 ‒ 7,716 6,047 5,697 5,111 
Bulgaria A 97 97 1.32 73 6 26 19 
Cyprus C 68 68 7.89 62 55 37 23 
Czech Republic C 18,412 18,287 174.08 18,743 21,075 20,259 20,067 
Denmark C 3,720 3,720 66.66 4,060 4,037 3,353 3,470 
Estonia C 268 268 20.01 214 197 170 154 
Finland C 4,251 4,251 78.70 4,267 3,944 4,050 4,453 
France
3 
C 5,079 5,079 38.89 5,538 4,324 3,956 3,424 
Germany C 62,880 62,504 76.54 70,812 65,110 62,787 64,731 
Greece
4
 ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ 
Hungary C 6,384 6,367 65.10 6,121 7,180 6,579 5,516 
Ireland C 2,392 2,391 52.17 2,433 1,660 1,810 1,752 
Italy C 774 774 1.27 468 457 531 265 
Latvia C 8 8 0.39 7 1 0 0 
Lithuania C 917 917 30.49 1,124 1,095 812 762 
Luxembourg C 581 581 110.70 704 600 523 439 
Malta C 220 214 51.26 220 204 132 77 
Netherlands
5
 C 4,248 4,248 48.83 4,408 4,322 3,782 3,341 
Poland C 431 431 1.12 354 367 359 270 
Portugal
4
 ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ 
Romania C 92 92 0.43 149 175 254 2 
Slovakia C 5,844 5,704 105.55 4,565 4,476 3,813 3,064 
Slovenia C 983 983 47.83 998 1,022 952 898 
Spain
6
 C 5,488 5,488 47.53 5,469 6,340 5,106 5,160 
Sweden C 7,901 7,901 83.32 8,214 8,001 7,178 7,692 
United Kingdom C 72,578 72,578 117.43 72,150 70,298 65,043 55,609 
EU Total 
 
215,215 214,268 55.49 223,998 215,397 201,711 190,579 
Iceland C 60 60 18.77 123 55 74 98 
Liechtenstein ‒ ‒ ‒ ‒ ‒ ‒ ‒ 2 
Norway C 2,933 2,933 58.83 3,005 2,682 2,848 2,875 
Switzerland
7
 C 8,432 8,432 105.49 7,963 6,611 7,803 7,559 
1. A: aggregated data report; C: case-based report; –: no report. 
2. Sentinel surveillance; no information on estimated coverage. Thus, the notification rate cannot be estimated. 
3.  Sentinel surveillance; notification rates calculated on estimated coverage of 20 %. 
4. No surveillance system. 
5. Sentinel surveillance; notification rates calculated on estimated coverage of 52 %. 
6. Sentinel surveillance; notification rates calculated on estimated coverage of 25 %. 
7. Switzerland provided data directly to EFSA. 
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Figure CA1.  Notification rates and origin of infection in human campylobacteriosis in the EU/EFTA
1
, 
2012 
 
Note: The map shows the distribution of human cases shaded according to incidence rate per 100,000 based on quartile 
classification method (EUROSTAT population data 2012). 
Figure CA2.  Trend in reported confirmed cases of human campylobacteriosis in the EU, 2008-2012 
 
Source: Data for EU trend 24 MSs: Austria, Belgium, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Hungary, 
Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Romania, Slovakia, Slovenia, Spain, Sweden, and 
United Kingdom. Bulgaria is excluded because only monthly data were reported and Greece and Portugal do not have 
surveillance systems for this disease.  
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3.2.2. Campylobacter in food 
Twenty-one MSs and two non-MSs reported data on Campylobacter in food in 2012 (Table CA1). The 
number of samples, within the food categories tested, ranged from a few to more than a thousand. Most of 
the MSs reported data on food of animal origin, primarily poultry meat, which is considered to be one of the 
major vehicles of Campylobacter infections in humans. In the following sections, only results based on 25 or 
more units tested are presented. Moreover, results from industry own control programmes and HACCP 
sampling, as well as specified suspect sampling, selective sampling and outbreak investigations, have also 
been excluded owing to difficulties in the interpretation of the data. These data are presented in the Level 
3 Tables. 
It is important to note that results from different countries are not directly comparable owing to between-
country variation in the sampling and testing methods used. Also, it should be taken into consideration that 
the proportion of positive samples observed could have been influenced by the sampling season because in 
many countries Campylobacter infections are known to be more prevalent during the summer than during the 
winter. 
Fresh broiler meat 
Broiler meat is considered to be the main food-borne source of human campylobacteriosis. In 2012, 15 MSs 
reported data on fresh broiler meat from investigations with 25 or more samples. The occurrence of 
Campylobacter in fresh broiler meat sampled at slaughter, processing and retail, in 2012, is presented in 
Table CA3. 
Overall, 23.6 % of the samples (single or batch) were found to be positive for Campylobacter in the reporting 
MSs, which was less than in 2011, when 31.3 % of the samples were positive. However, the reporting MSs 
in 2011 and 2012 were not exactly the same ones, which makes the figures non-comparable. In addition, for 
the MSs reporting data for both the years, there were increases, decreases, and no changes in the reported 
proportions of positive samples compared with 2011.  
As in previous years, the proportions of Campylobacter-positive broiler meat samples (single or batch), at 
any sampling level, varied widely among MSs, with the prevalence ranging from 0 % to 80.6 %.  
At the slaughterhouse, six MSs reported testing of single carcases, with the proportion of positive samples 
ranging from 10.0 % to 54.4 %. Two MSs reported testing of batches of carcases at slaughter, with the 
proportion of positive batches ranging from 12.5 % to 60.0 %. 
In the seven MSs reporting data on the testing of single samples at processing level, the prevalence of 
Campylobacter-positive samples ranged from 1.0 % to 69.7 %. Only Poland reported data on batches at 
processing, with 28.6 % of batches positive.  
At retail, nine MSs reported data on testing of single broiler samples, with the proportion of Campylobacter-
positive broiler samples ranging from 0 % to 80.6 %. Belgium and Romania tested batches at retail, with a 
prevalence of 11.5 % and 32.2 %, respectively. 
Data from seven MSs (Belgium, Denmark, Germany, Hungary, the Netherlands, Poland and Spain) reporting 
investigations at the same sampling unit in at least two sampling stages showed that samples tested at 
processing level and/or retail were less contaminated than samples tested earlier in the food chain. The 
Netherlands and Spain were the exceptions, with almost the same proportion of the positives at processing 
level and retail (around 38 %) and at slaughterhouse and retail (around 50 %). 
Other food 
Refer to the Level 3 Tables for detailed information on the data reported and on the occurrence of 
Campylobacter in the different food categories.  
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Table CA3.  Campylobacter in fresh broiler meat, 2012 
Country Description 
Sample  
unit 
Sample 
weight 
2012 
N N pos % pos 
At slaughterhouse           
Belgium Carcase, neck skin Single 1 g 440 44 10.0 
Bulgaria Carcase Single - 98 18 18.4 
Czech Republic Carcase, caecum, monitoring Batch  25 g 125 75 60.0 
Denmark
1
 Fresh chilled meat, monitoring Single  10 g/15 g 865 185 21.4 
Estonia Carcase, neck skin, monitoring Batch  25 g 48 6 12.5 
Hungary Carcase, meat Single  25 g 70 32 45.7 
Poland Carcase, carcase swab Single  - 401 218 54.4 
Spain Carcase, meat Single  25 g 72 39 54.2 
At processing plant or cutting plant           
Belgium Fresh meat Single 1 g 714 16 2.2 
Germany Fresh meat Single 25 g 62 18 29.0 
Hungary Fresh meat Single 25 g 140 42 30.0 
Netherlands Fresh meat Single 160 g 411 160 38.9 
Poland 
Fresh meat, surveillance Batch  25 g 56 16 28.6 
Fresh meat Single  500 g 521 5 1.0 
Portugal Fresh meat Single 25 g 50 16 32.0 
Slovenia Fresh meat Single 20 g 66 46 69.7 
Spain Fresh meat Single  25 g 29 4 13.8 
At retail             
Austria Fresh meat, imported, surveillance Single 25 g 29 1 3.4 
Belgium Fresh meat Batch 1 g 383 44 11.5 
Czech Republic Fresh meat Single  25 g 30 0 0 
Denmark
2
 
Fresh chilled meat, monitoring 
Single  10 g/15 g 
521 59 11.3 
Fresh frozen meat, monitoring 216 9 4.2 
Estonia Fresh meat, national survey Single  25 g 217 29 13.4 
Germany Fresh meat Single 25 g 627 146 23.3 
Hungary Fresh meat Single  25 g 276 104 37.7 
Luxembourg Fresh meat Single  10 g 93 75 80.6 
Netherlands Fresh meat Single  25 g 563 216 38.4 
Romania 
Fresh meat, monitoring EFSA 
specifications 
Batch  25 g 466 150 32.2 
Spain Fresh meat Single 25 g 74 37 50.0 
Total (15 MSs)       7,663 1,810 23.6 
Iceland 
At retail, wings with skin, national 
survey 
Batch  - 117 0 0 
At retail, skinned loins, survey Single - 117 0 0 
At retail, neck skin of whole chicken, 
chilled, national survey 
Single  25 g 117 0 0 
Note: Data presented include only investigations with sample sizes ≥25. Only data specified as fresh or carcase are included.  
1. Denmark: sampled at two major slaughterhouses representing >98 % of the total production. The data exclude samples from 
smaller slaughterhouses, in 2012 (49 of 179 samples were positive). 
2. Denmark: data from 2012 are not comparable with previous years as the method of analysis used has been changed.  
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3.2.3. Campylobacter in animals 
In 2012, 20 MSs and 3 non-MSs reported data on Campylobacter in animals (Table CA1), primarily in broiler 
flocks, but also in pigs, cattle, goats, sheep and pets. In this section, only results based on 25 or more units 
tested are presented. Moreover, results from industry own control programmes and HACCP sampling, as 
well as results from clinical investigations, specified suspect sampling, selective sampling and outbreak 
investigations, have also been excluded owing to difficulties in the interpretation of the data. These data are, 
however, presented in the Level 3 Tables. 
It should be noted that results are not directly comparable between countries and, sometimes, within 
countries and between years, owing to differences in sampling and testing schemes, as well as the impact of 
the season of sampling. 
Broilers  
In 2012, eight MSs and three non-MSs provided information on the occurrence of Campylobacter in broiler 
flocks, slaughter batches or individual animals based on a sample size ≥25 (Table CA4). In two of the five 
MSs reporting flock-based data, the reported prevalence was very high (63.4 %) to extremely high (83.6 %). 
The occurrence of Campylobacter varied widely among the three MSs reporting slaughter batch-based data, 
with prevalence ranging from 1.6 % to 62.1 %. One MS, Germany, also reporting animal-based data, found 
9.2 % of broilers positive out of 672 units tested.  
As in 2011, Denmark, Sweden, and Norway reported the highest numbers of broiler flocks tested, while 
Finland reported the highest number of slaughter batch-based data. These four countries have a 
Campylobacter control or monitoring programme in place. All reported a low to moderate prevalence.  
Finland provided information on different sampling periods with different sampling strategies and reported a 
higher Campylobacter prevalence in slaughter animal batches sampled during June–October (5.3 %) than in 
those sampled during January–May and November–December (1.6 %).  
Other animals 
For detailed information on the occurrence of Campylobacter in the different animal species refer to the Level 
3 Tables.  
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Table CA4.  Campylobacter in broilers, 2012 
Country Description 
2012 
N N pos % pos 
Animal-based data       
Germany At farm, official sampling 672 62 9.2 
Flock-based data         
Denmark At farm, boot swabs, monitoring, industry sampling 3,376 392 11.6 
Germany At farm, official sampling 43 0 0 
Hungary At slaughterhouse, monitoring 165 138 83.6 
Slovenia 
At slaughterhouse, neck skin, monitoring, official 
sampling 
30 23 76.7 
At slaughterhouse, faeces, monitoring, official sampling 41 26 63.4 
Sweden At slaughterhouse, monitoring, official sampling 2,346 217 9.2 
Iceland At farm, faeces, monitoring, industry sampling 645 28 4.3 
Norway
1
 At farm, faeces, surveillance 2,417 106 4.4 
Switzerland
2
 
At slaughterhouse, cloacal swab, monitoring, official 
sampling 
546 190 34.8 
Slaughter batch-based data       
Austria 
At slaughterhouse, caecum, monitoring - active, official 
sampling 
312 146 46.8 
Finland 
At slaughterhouse, caecum, control and eradication 
programmes, industry sampling
3
 
1,534 82 5.3 
At slaughterhouse, caecum, control and eradication 
programmes, industry sampling
4
 
321 5 1.6 
Spain At slaughterhouse, faeces, monitoring 153 95 62.1 
Iceland 
At slaughterhouse, caecum, monitoring, official and 
industry sampling 
589 26 4.4 
Note: Data include only investigations with sample sizes ≥25.  
1. In Norway, sampling was performed between 1 May and 31 October. 
2. In Switzerland, data originated from the antimicrobial resistance monitoring. 
3. In Finland, census sampling of all slaughter batches was performed between June and October. 
4. In Finland, random sampling (expected prevalence 1 %, accuracy 1 %, confidence level 95 %) was performed between January 
and May and between November and December. 
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3.2.4. Discussion 
Campylobacteriosis continued to be the most commonly reported zoonosis in humans, in the EU, since 
2005. In 2012, the number of notified cases of Campylobacter infection in the EU decreased by 4.3 % 
compared with 2011, to about the same level as in 2010. The number of human campylobacteriosis cases 
has shown a statistically significant increasing trend in the last five years (2008–2012). The reasons for this 
increasing trend are not completely understood at present. Owing to the characteristics of this multi-host 
pathogen and its prevalence in the environment, where climate factors may play an important role, it is 
difficult to understand all aspects of its epidemiology and the possible reasons for the increase in human 
cases.  
Considering the high number of campylobacteriosis cases, the severity in terms of fatalities reported was low 
(0.03 %). The proportion of hospitalised cases was, on the other hand, larger than expected taking into 
account the fact that the symptoms are often relatively mild. An explanation for this could be that in some 
countries, the surveillance is focused on the diagnosis of severe cases. In addition, the country with the most 
campylobacteriosis cases only reported hospitalisation status for a fraction of its cases and of these, the 
majority were hospitalised. This fraction most likely represents cases reported from the hospital surveillance, 
while for cases reported from other sources, e.g. laboratories, information on hospitalisation status is often 
missing. Both these situations result in an overestimation of the proportion of hospitalised cases.  
In 2012, overall, about a quarter of the fresh broiler meat samples were reported as Campylobacter positive, 
although there were large differences between the MSs.  
The importance of broiler meat as a source of human Campylobacter infections was illustrated by the 
reported food-borne outbreak data from 2012. Approximately half (11 out of 25) of the Campylobacter 
outbreaks, in which information on the implicated food vehicle was provided, were linked to broiler meat. In 
addition, Switzerland reported two outbreaks, with strong evidence, associated with broiler meat and one 
fatal case was reported in one of them. In five of the outbreaks the implicated food vehicle was milk and, out 
of these, three outbreaks were attributed to raw milk, indicating the importance of risks related to consuming 
unpasteurised milk. The risk of campylobacteriosis and other diseases associated with the consumption of 
raw milk has been well documented
27,28,29
. 
In reporting countries the prevalence of campylobacteriosis in broilers remained mainly at levels similar to 
previous years.  
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3. INFORMATION ON SPECIFIC ZOONOSES AND ZOONOTIC AGENTS 
3.3. Listeria 
The bacterial genus Listeria currently comprises 10 species, but human cases of listeriosis are almost 
exclusively caused by the species Listeria monocytogenes (L. monocytogenes). Listeria species are 
ubiquitous organisms that are widely distributed in the environment, especially in plant matter and soil. The 
principal reservoirs of Listeria are soil, forage and water. Other reservoirs include infected domestic and wild 
animals. The main route of transmission, to both humans and animals, is through consumption of 
contaminated food or feed. The bacterium can be found in raw foods and in processed foods which are 
contaminated after processing. Infection can also rarely be transmitted directly from infected animals to 
humans. Cooking at temperatures higher than 65 °C destroys Listeria, but the bacteria are able to multiply at 
temperatures as low as +2/+4 °C, which makes presence of Listeria in ready-to-eat (RTE) foods, with a 
relatively long shelf-life, of particular concern. 
In humans, severe illness mainly occurs in developing fetuses, newborn infants, the elderly and those with 
weakened immune systems. Symptoms vary, ranging from mild flu-like symptoms and diarrhoea, to life- 
threatening infections characterised by septicaemia and meningoencephalitis. In pregnant women, the 
infection can spread to the fetus, leading to severe illness at birth or death in the uterus, resulting in abortion. 
Illness is often severe with high hospitalisation and mortality rates. Human infections are rare yet important, 
given the associated high mortality rate. These organisms are among the most important causes of death 
from food-borne infections in industrialised countries. 
Clinical symptoms of listeriosis in domestic animals (especially sheep and goats) include encephalitis, 
abortion, mastitis or septicaemia.  
Table LI1 presents the countries reporting data for 2011 and 2012. 
Table LI1.  Overview of countries reporting L. monocytogenes data, 2011-2012 
Data 
Total number of  
 reporting MSs 
Countries 
Human  
2012 - 26 
All MSs except PT 
Non-MSs: CH, IS, NO 
2011 - 26 
All MSs except PT 
Non-MSs: CH, IS, NO 
Food  
2012 - 25 
All MSs except FI, MT 
Non-MSs: CH, NO 
2011 - 25 
All MSs except FI, MT 
Non-MSs: CH, NO 
Animal 
2012 - 14 
All MSs except AT, BE, BG, CY,CZ, DK, FR, LT, LU, MT, 
PT, RO, SI 
Non-MSs: CH, NO 
2011 - 13 
MSs: DE, EE, ES, FI, GR, IE, IT, LV, NL, PL, PT, SK, UK 
Non-MSs: CH, NO 
Note: The overview table contains all data reported by MSs and non-MSs. 
3.3.1. Listeriosis in humans 
In 2012, 26 MSs reported 1,642 confirmed human cases of listeriosis (Table LI2), a 10.5 % increase 
compared with 2011. The EU notification rate was 0.41 cases per 100,000 population with the highest 
MS-specific notification rates observed in Finland, Spain and Denmark (1.13, 0.93 and 0.90 cases per 
100,000 population, respectively). The lowest notification rate was reported in Romania (0.05 cases per 
100,000 population). The vast majority of cases were reported to be domestically acquired (Figure LI1). 
A seasonal pattern was observed in the listeriosis cases reported in the EU in the period 2008-2012 (Figure 
LI2). There was a statistically increasing trend (p = 0.001 with linear regression) over this period, though only 
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slowly increasing. Statistically increasing trends were also observed in Finland, Germany, the Netherlands 
and Poland. No country-specific decreasing trends were observed and, for several countries, too few cases 
were reported for a trend analysis to be possible. 
Table LI2.  Reported cases of human listeriosis in 2008-2012, and notification rate for confirmed 
cases in the EU, 2012 
Country 
2012 2011 2010 2009 2008 
Report 
Type
1
 
Cases 
Confirmed 
Cases 
Confirmed 
cases/ 
100,000 
Confirmed cases 
Austria C 36 36 0.43 26 34 46 31 
Belgium C 83 83 0.75 70 40 58 64 
Bulgaria A 10 10 0.14 4 4 5 5 
Cyprus C 1 1 0.12 2 1 0 0 
Czech Republic C 32 32 0.30 35 26 32 37 
Denmark C 50 50 0.90 49 62 97 51 
Estonia C 3 3 0.22 3 5 3 8 
Finland C 62 61 1.13 43 71 34 40 
France C 348 348 0.53 282 312 328 276 
Germany C 427 412 0.50 330 377 394 306 
Greece C 11 11 0.10 10 10 4 1 
Hungary C 13 13 0.13 11 20 16 19 
Ireland C 11 11 0.24 7 10 10 13 
Italy
2
 C 36 36 ‒ 100 137 109 118 
Latvia C 6 6 0.29 7 7 4 5 
Lithuania C 8 8 0.27 6 5 5 7 
Luxembourg C 2 2 0.38 2 0 3 1 
Malta C 1 1 0.24 2 1 0 0 
Netherlands C 73 73 0.44 87 72 44 45 
Poland C 54 54 0.14 62 59 32 33 
Portugal
3
 ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ 
Romania C 11 11 0.05 1 6 6 0 
Slovakia C 11 11 0.20 31 5 10 8 
Slovenia C 7 7 0.34 5 11 6 3 
Spain
4
 C 107 107 0.93 91 129 121 88 
Sweden C 72 72 0.76 56 63 73 60 
United Kingdom C 183 183 0.30 164 176 235 206 
EU Total 
 
1,658 1,642 0.41 1,486 1,643 1,675 1,425 
Iceland C 4 4 1.25 2 1 0 0 
Liechtenstein 
 
‒ ‒ ‒ ‒ ‒ ‒ 0 
Norway C 30 30 0.60 21 22 31 34 
Switzerland
5
 C 39 39 0.50 47 67 41 43 
1. A: aggregated data reported; C: case-based data reported; –: no report;  
2. Data provisional for 2012 as several regions have not yet reported their cases. Thus, the notification rate cannot be estimated. 
3. No surveillance system exists.  
4. Sentinel surveillance; notification rates calculated on estimated coverage of 25 %. 
5. Switzerland provided data directly to EFSA. 
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Figure LI1.  Notification rates and origin of infection in human listeriosis in the EU/EFTA, 2012 
 
Note: The map shows the distribution of human cases shaded according to incidence rate per 100,000 based on quartile 
classification method (EUROSTAT population data 2012). 
Figure LI2.  Trend in reported confirmed cases of human listeriosis in the EU, 2008-2012 
 
Source: 24 MSs: Austria, Belgium, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, 
Ireland, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Poland, Romania, Slovakia, Slovenia, Spain, Sweden, and the 
United Kingdom. Bulgaria is excluded as only monthly data was reported and Italy is excluded because the 2012 data 
reported are not representative. Portugal has no surveillance system for listeriosis.  
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In 2012, the highest notification rates of listeriosis were reported in persons aged below one and those aged 
65 years and above (Figure LI3). In the latter group, the rates increased by age. In those aged below one 
year, 79 % of the cases were reported as related to transmission during pregnancy (information provided for 
24 out of 67 cases). Major differences in notification rates were also observed in terms of gender. Female 
cases dominated in the age groups 15-24 and 25-44 years and 71.3 % of these cases were related to 
pregnancy (information provided for 55.4 % of cases). Higher incidence rates were observed in male cases 
compared to female cases in all age groups above 45 years. In these age groups, the male-to-female rate 
ratio increased by age and in the oldest age group, 85 years or above, the male-to-female rate ratio was 
1.7 (male notification rate 3.61 per 100,000 population vs. 2.07 for females). 
Figure LI3.  Notification rates of human listeriosis by age and gender in the EU, 2012 
 
Fourteen MSs provided information on hospitalisation for all or the majority of their cases (which represented 
41.5 % of all confirmed cases reported in the EU) in 2012. On average, 91.6 % of the cases were 
hospitalised and, in eight MSs, this proportion was 100 %. This is the highest proportion of hospitalised 
cases of all zoonoses under EU surveillance and reflects the focus of EU surveillance on severe, systemic 
infections. In order to assess the clinical manifestation of the disease, the variable specimen type was 
introduced to EU level surveillance as a surrogate to the clinical manifestation. For cases where this 
information was provided (41.7 %), 70.8 % of positive specimens were from blood, 21.2 % from 
cerebrospinal fluid and 8.0 % from another normally sterile site. 
A total of 198 deaths due to listeriosis were reported by 18 MSs in 2012, which was the highest number of 
fatal cases reported since 2006. Fifteen MSs reported one or more fatal cases with France reporting the 
highest number, 63 cases. The EU case fatality rate was 17.8 % among the 1,112 confirmed cases for which 
this information was reported (67.7 % of all confirmed cases).  
Seven MSs and Norway provided information on conventional serotypes of L. monocytogenes (accounting 
for 17.4 % of all confirmed cases). The most common serotypes in 2012 were 1/2a (46.8 %) and 4b 
(41.7 %), followed by 1/2b (8.5 %), 1/2c (2.7 %) and 3a (0.3 %). As some countries have changed to 
molecular-based techniques for serotyping, PCR serogrouping was introduced in TESSy in 2012 data 
collection. Three MSs provided data on this variable (accounting for 30.7 % of all confirmed cases). The 
most common PCR serogroup was IVb (53.1 %, corresponding to conventional serotype 4b, 4d, and 4e), 
followed by IIa (30.7 %, corresponding to conventional serotype 1/2a and 3a), IIb (12.1 %, corresponding to 
conventional serotype 1/2b, 3b and 7) and IIc (4.2 %, corresponding to conventional serotype 1/2c and 3c).  
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3.3.2. Listeria in food  
EU legislation (Regulation (EC) No 2073/2005) lays down food safety criteria for L. monocytogenes in RTE 
foods. This regulation came into force in January 2006, and the criteria are described below. Data reported 
reflect the obligations on MSs under the Regulation and the investigations have, therefore, focused on 
testing RTE foods for compliance within these limits. 
In the following sections, only results based on investigations of 25 or more units tested are presented, with 
the exception of the section on compliance with microbiological criteria, where investigations with fewer than 
25 units have also been included. Results from industry own control programmes, HACCP sampling and EU 
baseline surveys, as well as specified suspect sampling, selective sampling and outbreak or clinical 
investigations, have also been excluded owing to difficulties with the interpretation of such data. These data 
are, however, presented in the Level 3 Tables.  
In 2012, 25 MSs and 2 non-MSs reported data on Listeria in food. These data cover a substantial number of 
food samples and food categories. The data presented in this section focus on RTE foods, in which 
L. monocytogenes was detected either by qualitative (absence or presence, using detection methods) and/or 
by quantitative investigations (determination of L. monocytogenes counts (colony forming units/gram (cfu/g)) 
using enumeration methods). 
Compliance with microbiological criteria 
In total, 24 MSs reported data which were included in the evaluation for compliance with microbiological 
criteria (Table LI3 and Figure LI4). 
A wide range of different foodstuffs can be contaminated with L. monocytogenes. For a healthy human 
population, foods in which the levels do not exceed 100 cfu/g are considered to pose a negligible risk. 
Therefore, the EU microbiological criterion for L. monocytogenes is set as ≤100 cfu/g for RTE products on 
the market. 
The reported results of L. monocytogenes testing in RTE food samples were evaluated according to the 
Listeria criteria indicated in EU legislation applying certain assumptions where appropriate.  
Regulation (EC) No 2073/2005 covers primarily RTE food products, and requires the following: 
 In RTE products intended for infants and for special medical purposes L. monocytogenes must not 
be present in 25 g. 
 L. monocytogenes must not be present in levels exceeding 100 cfu/g during the shelf-life of other 
RTE products. 
 In RTE foods that are able to support the growth of the bacterium, L. monocytogenes may not be 
present in 25 g at the time of leaving the production plant; however, if the producer can demonstrate, 
to the satisfaction of the competent authority, that the product will not exceed the limit of 100 cfu/g 
throughout its shelf-life, this criterion does not apply. 
 In the case of RTE foods that are able to support the growth of L. monocytogenes, the 
microbiological criterion to be applied depends on the stage in the food chain and whether the 
producer has demonstrated that L. monocytogenes will not multiply to levels exceeding 100 cfu/g 
throughout the shelf-life. 
For many of the reported data, it was not evident whether or not the RTE food tested was able to support the 
growth of L. monocytogenes. This information is difficult to collect as the ability of a product to support 
growth of L. monocytogenes depends on various factors, such as the pH, water activity and composition of 
the specific product, which can vary even within the same food category. Also, information from studies, 
carried out by the producers, on the growth capacity of L. monocytogenes in individual products was not 
available. Furthermore, in some cases, the stage in the production chain from which samples were collected 
could not be established. 
  
DRAFT 
FOR 
CONSULTA TION 
EU summary report on zoonoses, zoonotic agents and 
food-borne outbreaks 2012 
 
EFSA Journal 2014;12(2):3547  113 
For the reasons described above, the following assumptions were applied for the evaluation: 
 For samples reported to be taken at processing, a criterion of absence in 25 g was applied for single 
samples. Samples from hard cheeses and fermented sausages are an exception, as these 
categories are assumed to be unable to support the growth of L. monocytogenes. For these samples 
the limit ≤100 cfu/g was applied at processing; 
 For all investigations for which the sampling stage was not reported, it was assumed that samples 
were collected from products placed on the market, and the criterion ≤100 cfu/g was applied. 
 For food intended for infants and special medical purposes the criterion, ‘absence in 25 g’, was 
applied throughout the food chain. 
 Samples collected at farm level are reported separately but compliance is evaluated with the criteria 
stated for the processing plant level. 
 Unspecified cheeses were reported separately but compliance was evaluated with criteria applied for 
soft and semi-soft cheeses. 
The results from qualitative examinations using the detection method have been used to analyse the 
compliance with the criterion of absence in 25 g, and the results from quantitative analyses using the 
enumeration method have been used to analyse compliance with the criterion ≤100 cfu/g. All data submitted 
by MSs and other reporting countries are presented in the Level 3 Tables. 
The percentage of single samples or batches not complying with the L. monocytogenes criteria in 2012 is 
shown in Table LI3. For RTE products on the market, very low percentages (<1 %) were generally found not 
to comply with the criterion of ≤100 cfu/g. However, higher levels of non-compliance were reported in 
samples of RTE products at the processing stage, ranging from 0 to 8.0 %. 
As in previous years all samples of RTE food intended for infants and for medical purposes were compliant 
with the L. monocytogenes criterion. 
At retail, as well as at processing plant, the levels of non-compliance for different RTE food categories were 
comparable between 2011 and 2012 (Figure LI4). However, it must be noted that these results are highly 
influenced by variability in MSs reporting and the sample sizes in their investigations. 
RTE products at processing and farm level 
The highest level of non-compliance in single food samples at processing was observed in RTE fishery 
products (8.0 %), while the percentage of non-compliance for RTE fishery products at the batch level was 
1.0 %. The level of non-compliance among RTE fishery products varied markedly among the 12 MSs which 
provided data, ranging from 0 to 25.0 % (single samples and batches), and more than half of the tested units 
originated from one MS.  
Investigations of soft cheeses, semi-soft cheeses and hard cheeses were reported by 15 MSs, and more 
than 99 % of the single samples and batches collected at processing were in compliance with the 
L. monocytogenes criteria. The highest level of non-compliance among cheeses tested at processing was 
found in the category ‘unspecified cheeses’ (3.4 % of single samples and 7.2 % of batches). This category 
covered investigations in which the information on the type of cheese (soft, semi-soft or hard) was not 
provided. Almost all of the reported single samples were from one MS and most of the reported batches 
came from two MSs. 
In RTE milk samples, collected at processing, the level of non-compliance was very low in single samples, 
and none of the tested batches of RTE milk was found to be positive. In RTE milk samples collected at the 
farm, slightly higher but still low levels of non-compliance were observed (1.9 % of single samples and 4.4 % 
of batches). The samples collected at farms originated from five MSs and were mainly from raw cow milk 
intended for direct human consumption. Approximately 40 % of all reported single samples, including the few 
positive samples, were from one MS. 
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The proportion of non-compliance in other dairy products at processing was 0.5 % for single samples, 
whereas none of the tested batches was positive. Investigations from nine MSs were included but all positive 
samples originated from one MS. 
Among samples from RTE products of meat origin, other than fermented sausages, low levels of non-
compliance were observed at processing (2.5 % of single samples and 1.5 % of batches). The level of non-
compliance varied markedly among the 14 MSs reporting data, ranging from 0 to 36.1 % of single samples 
and from 0 to 20.0 % of batches. Most of the tested units originated from one MS, and most of the positive 
samples originated from RTE products of cooked pig meat. In the case of fermented sausages, less than 
0.1 % of the single samples were found not to meet the L. monocytogenes criterion at processing 
(≤100 cfu/g).  
Some non-compliance was also detected in the food category ‘other RTE products’ (2.6 % of single samples 
and 0.4 % of batches). Most of the positive samples were from ‘prepared dishes’ or ‘spices and herbs’. 
RTE products at retail level 
At retail, the levels of non-compliance are generally lower than those observed at processing plant. However, 
it should be noted that different thresholds are applied depending on the stage of sampling, i.e. samples 
tested at retail may contain up to 100 cfu/g and still be in compliance with the L. monocytogenes criterion. 
At retail, as was the case for samples obtained at processing plant, the highest reported levels of non-
compliance were observed in RTE fishery products (0.5 % of single samples and 0.7 % of batch samples). 
Investigations from 18 MSs were reported. The majority of the reported batches and single samples 
originated from one MS.  
In the two categories of RTE products of meat origin, 0.4 % of single samples did not comply with the 
L. monocytogenes criterion. Investigations from 20 MSs were included and the few non-compliant samples 
were primarily from fermented sausages, cooked meat products and minced meat intended to be eaten raw. 
All reported batches of cheeses complied with the L. monocytogenes criterion at retail, and very few single 
samples were non-compliant (investigations from 20 MSs in total). In RTE dairy products, other than milk and 
cheeses, as well as the category ‘other RTE products’, none or very few samples were in non-compliance 
with the L. monocytogenes criteria. 
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Figure LI4.  Proportion of single samples at processing and retail non-compliance with EU 
L. monocytogenes criteria, 2011-2012 
 
Note: RTE: ready-to-eat products.  
 Includes investigations where the sampling unit (single samples or batches) and sampling stage at retail (also catering, hospitals 
and care homes) has been specified for the relevant food types.  
Please note that these results are highly influenced by the MSs reporting and the sample sizes in their investigations, both of 
which vary between the years. Includes also investigations with sample size <25.  
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Table LI3.  Compliance with the L. monocytogenes criteria laid down by Regulation (EC)  
No 2073/2005 in food categories in EU, 2012 
Food category
1
 
Sampling 
unit 
Absence in 25 g ≤100 cfu/g 
Units tested 
% non 
compliant 
Units tested 
% non 
compliant 
RTE food intended for infants and for medical purposes       
Processing plant 
Batch 80 0     
Single 20 0     
Retail 
Batch 599 0     
Single 760 0     
RTE products of meat origin other than fermented sausage       
Processing plant 
Batch 34,947 1.5     
Single 12,216 2.5     
Retail 
Batch     5,724 <0.1 
Single     7,224 0.4 
RTE products of meat origin, fermented sausage       
Processing plant 
Batch     27 0 
Single     1,283 <0.1 
Retail 
Batch     59 0 
Single     2,772 0.4 
Milk, RTE 
 
        
At farm 
Batch 104 1.9     
Single 275 4.4     
Processing plant 
Batch 1,440 0     
Single 769 1.0     
Retail 
Batch     176 0 
Single     416 0 
Soft and semi-soft cheeses, RTE 
 
        
At farm 
Batch 45 0     
Single 166 0     
Processing plant 
Batch 5,192 0.4     
Single 3,354 0.3     
Retail 
Batch     1,080 0 
Single     2,171 0.3 
Hard cheeses, RTE 
 
        
At farm Single     132 0.8 
Processing plant 
Batch     7,862 <0.1 
Single     1,894 0.2 
Retail 
Batch     871 0 
Single     2,058 <0.1 
Unspecified cheeses, RTE 
 
        
At farm 
Batch 20 5.0     
Single 13 0     
Processing plant 
Batch 376 7.2     
Single 1,365 3.4     
Retail 
Batch     355 0 
Single     1,037 <0.1 
Table continued overleaf.  
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Table LI3 (continued). Compliance with the L. monocytogenes criteria laid down by Regulation (EC) 
No 2073/2005 in food categories in EU, 2012 
Food category
1
 
Sampling 
unit 
Absence in 25 g ≤100 cfu/g 
Units tested 
% non 
compliant 
Units tested 
% non 
compliant 
Other Dairy products, RTE 
 
        
At farm Batch 262 1.1     
Processing plant 
Batch 4,197 0     
Single 2,901 0.5     
Retail 
Batch     680 0 
Single     4,173 0.1 
Fishery products, RTE 
 
        
At border control Single 9 0     
Processing plant 
Batch 1,143 1.0     
Single 2,569 8.0     
Retail 
Batch     11,525 0.7 
Single     3,026 0.5 
Other RTE products  
 
        
At border control Batch 7 0     
Processing plant 
Batch 1,995 0.4     
Single 604 2.6     
Retail 
Batch     2,131 <0.1 
Single     14,985 <0.1 
Note: RTE: ready-to-eat products.  
 Investigations with sample size <25 are included.    
 Data reported as HACCP or own control, suspect sampling, selective sampling and outbreak or clinical investigations are 
excluded.  
1. Retail includes data with unspecified sampling stage. 
 
 
RTE meat products, meat preparations and minced meat  
In 2012, data from investigations of L. monocytogenes in RTE meat products, including 25 units or more, 
were reported from 17 MSs. Data,categorised according to the origin of the meat, are presented in Tables 
LI4, LI5, LI6 and LI7.  
Poultry meat 
In 2012, nine MSs reported test results for L. monocytogenes in RTE products of broiler meat (Table LI4), 
and four MSs reported on RTE products of turkey meat (Table LI5). In 2012, 2,224 samples of broiler meat 
were tested using the detection method, and Listeria was detected in 1.0 % of the tested units. In three of the 
qualitative investigations, L. monocytogenes was not detected. In the remaining six investigations, the 
proportion of L. monocytogenes-contaminated units ranged from 0.7 % to 4.8 %.  
Using the enumeration method, L. monocytogenes was not detected in four out of the seven reported 
investigations. In the two quantitative investigations in which L. monocytogenes was detected at levels above 
100 cfu/g (both conducted at processing plants in Poland), the percentage of results with L. monocytogenes 
counts above 100 cfu/g was 0.3 % for the tested batches and 2.2 % for the tested single samples. 
In 2012, 365 samples of RTE products of turkey meat were tested using the detection method, and Listeria 
was detected in 0.5 % of the tested units. L. monocytogenes was detected in only one of the three qualitative 
investigations, and in one of the three quantitative investigations. It should be noted that L. monocytogenes 
was not found in any samples from RTE turkey meat products in 2011. 
Bovine meat 
Test results for RTE bovine meat products were reported by eight MSs in 2012 and are summarised in Table 
LI6. The number of reported tested units increased considerably compared with 2011.   
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In total, L. monocytogenes was found by the detection method in 4.3 % of the units tested and levels above 
100 cfu/g were observed in 0.2 % of the units tested by the enumeration method. The highest qualitative 
occurrence of L. monocytogenes at processing was detected in single samples of fermented sausages from 
a small investigation (25 samples) conducted in Cyprus (20.0 %). However, fermented sausages are 
assumed not to support growth of L. monocytogenes during their shelf-life, and only concentrations 
exceeding 100 cfu/g are considered to pose a risk to public health. In 2012, L. monocytogenes, at levels 
above 100 cfu/g was reported only in a few single samples of minced meat intended to be eaten raw tested 
at retail in Luxembourg. 
Pig meat 
Data on RTE pig meat products were provided by 17 MSs (Table LI7). Just over 33,000 units were tested 
using the detection method, among which L. monocytogenes was detected in 3.2 %. Among the 19,007 units 
tested using the enumeration method, L. monocytogenes was found at levels above 100 cfu/g in 0.3 % of the 
tested units.  
Among the qualitative investigations of RTE pig meat products, the proportion of L. monocytogenes positive 
units ranged from 0 to 40.0 % at processing and from 0 to 26.3 % at retail. In 2012 Poland reported a very 
high number of tested units, including investigations at processing where L. monocytogenes was found in 
levels between the detection limit of the enumeration method and 100 cfu/g at very high levels (51.4 % of 
9,774 batches and 89.7 % of 68 single samples). 
A summary of the proportions of units positive for L. monocytogenes in RTE products of meat origin is 
presented in Figure LI5. Using detection methods, L. monocytogenes was most commonly detected in RTE 
products from bovine meat. For samples tested using enumeration methods, the occurrence in pig meat 
products was higher than the other meat types, followed by broiler meat products. However, because a very 
large proportion of the reported samples of RTE products of broiler meat and pig meat all came from one 
MS, and many of these were found to be contaminated with L. monocytogenes at levels between the 
detection limit and 100 cfu/g, these results cannot be considered representative for the EU and any 
comparisons with previous years should be done cautiously.  
For further information on reported data, refer to the Level 3 Tables. 
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Table LI4.  L. monocytogenes in ready-to-eat broiler meat products, 2011-2012 
Country 
Sampling 
unit 
2012 2011 
Presence in 
25 g 
Enumeration 
Presence in 
25 g 
Enumeration 
N 
% 
Pos 
N 
% ≤100 
cfu/g 
% >100 
cfu/g 
N 
% 
Pos 
N 
% ≤100 
cfu/g 
% >100 
cfu/g 
At processing plant                     
Belgium  Batch
1
 74 1.4 96 0 0 - - - - - 
Czech Republic Batch 155 1.3 - - - 377 0.3 57 0 0 
Hungary Single
2
 - - - - - 43 2.3 - - - 
Ireland Single - - - - - 84 0 - - - 
Poland 
Batch
3
 1,016 0.9 389 45.8 0.3 - - - - - 
Single
4,5
 676 0.7 139 0.7 2.2 222 0 455 1.1 0 
At retail 
 
                    
Bulgaria Batch 35 2.9 - - - - - - - - 
Czech Republic Batch 95 0 - - - - - - - - 
Estonia Single - - 30 0 0 - - 39 0 0 
France Single - - - - - 164 3.7 164 0.6 0.6 
Hungary 
Single 65 0 - - - - - - - - 
Single
1
 - - - - - 109 0 35 0 0 
Ireland 
Single 83 4.8 518 0.4 0 - - - - - 
Single
5
 - - - - - 128 0.8 488 0.2 - 
Romania Batch
6
 - - 41 0 0 282 0 - - - 
Slovakia Batch
6
 - - - - - - - 26 0 0 
Spain Single - - 56 0 0 - - - - - 
United Kingdom Single - - - - - 70 0 70 0 0 
Sampling level not specified                   
Poland Single 25 0 - - - - - - - - 
Spain Single - - - - - - - 31 3.2 0 
Total  
(2012: 9 MSs, 2011: 10 MSs) 
2,224 1.0 1269 14.3 0.3 1,479 0.6 1,365 0.6 <0.1 
Note: Data are presented only for sample size ≥25.    
 Sample weight is 25 g, unless otherwise stated.    
1. Sample weight: 1 g.    
2. Sample weight: 10 or 20 g.    
3. Sample weight: 1, 10 or 25 g.    
4. In 2012: sample weight: 1, 25 or 500 g.     
5. Sample weight is most usually 25 g but occasionally there are other sample weights recorded.     
6. Sample weight: 10 g.   
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Table LI5.  L. monocytogenes in ready-to-eat turkey meat products, 2011-2012 
Country 
Sampling 
unit 
2012 2011 
Presence  
in 25 g 
Enumeration 
Presence 
in 25 g 
Enumeration 
N % Pos N 
% ≤100 
cfu/g 
% >100 
cfu/g 
N 
% 
Pos 
N 
% ≤100 
cfu/g 
% >100 
cfu/g 
At processing plant                     
Hungary Single 45 0 - - - - - - - - 
Ireland Single
1
 - - - - - 52 0 - - - 
Poland
 
 Single
2
 - - - - - 35 0 35 0 0 
At retail 
 
                  0 
Hungary Single 105 0 45 0 0 - - - - - 
Ireland Single
1
 - - 68 1.47 0 - - 73 0 - 
Portugal Batch - - 95 0 0 - - - - - 
Sampling level not specified                    
Poland Single
3
 215 0.9 - - - - - - - - 
Total  
(2012: 4 MSs, 2011: 2 MSs) 
365 0.5 208 0.5 0 87 0 108 0 0 
Note: Data are only presented for sample size ≥25. 
 Sample weight is 25 g, unless otherwise stated. 
1. Sample weight is most usually 25 g but occasionally there are other sample weights recorded. 
2. Sample weight: 10 g or 25 g. 
3. Sample weight: 500 g. 
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Table LI6.  L. monocytogenes in ready-to-eat bovine meat products, 2011-2012 
Country Description 
Sampling 
unit 
2012 2011 
Presence in 
25 g 
Enumeration 
Presence in 
25 g 
Enumeration 
N 
% 
Pos 
N 
% ≤100 
cfu/g 
% >100 
cfu/g 
N 
% 
Pos 
N 
% ≤100 
cfu/g 
% >100 
cfu/g 
At processing plant 
   
  
    
  
Bulgaria 
Meat products, 
cooked, ready-
to-eat 
Batch 180 0 - - - - - - - - 
Cyprus 
Meat products, 
fermented 
sausages 
Single 25 20.0 - - - 25 20.0 - - - 
Ireland 
Meat products, 
cooked, ready-
to-eat 
Single
1
 - - - - - 109 0.9 - - - 
Luxembourg 
Minced meat, 
intended to be 
eaten raw 
Single 35 2.9 35 0 0 39 10.3 39 0 0 
Poland 
Meat products, 
cooked, ready-
to-eat 
Batch
2
 130 4.6 - - - - - - - - 
At retail                         
Czech Republic 
Meat products, 
cooked, ready-
to-eat 
Batch 697 0 186 0 0 - - - - - 
Germany 
Meat products, 
fermented 
sausages 
Single 28 10.7 - - - - - - -   
Meat products, 
cooked, ready-
to-eat 
Single - - - - - 28 3.6 48 0 0 
Hungary 
Meat products, 
cooked, ready-
to-eat 
Single
3
 - - - - - 28 0 - - - 
Ireland 
Meat products, 
cooked, ready-
to-eat 
Single
1
 30 0 161 0.6 0 48 0 188 0 0 
Luxembourg 
Minced Meat, 
intended to be 
eaten raw 
Single 235 19.1 235 1.7 0.4 106 26.4 106 2.8 0 
Netherlands 
Meat products, 
cooked, ready-
to-eat 
Single - - - - - - - 33 3.0 0 
Romania 
Meat products, 
cooked, ready-
to-eat 
Batch - - - - - 26 0 - - - 
Spain 
Meat products, 
cooked, ready-
to-eat 
Single 28 0 - - - - - - - - 
Sampling level not specified                        
Spain 
Meat products, 
unspecified, 
ready-to-eat 
Single - - - - - 31 0 - - - 
Total (2012: 8 MSs, 2011: 8 MSs) 1,388 4.3 617 0.8 0.2 440 8.9 414 1.0 0 
Note: Data are presented only for sample size ≥25. 
 Sample weight is 25 g, unless otherwise stated. 
1. In 2011: sample weight is most usually 25 g but occasionally there are other sample weights recorded.  
2. Sample weights: 1 g or 25 g. 
3. In 2011: sample weight: 10 or 25 g. 
 
 
DRAFT 
FOR 
CONSULTA TION 
EU summary report on zoonoses, zoonotic agents and 
food-borne outbreaks 2012 
 
EFSA Journal 2014;12(2):3547  122 
Table LI7.  L. monocytogenes in ready-to-eat pig meat products, 2011-2012 
Country Description 
Sampling 
unit 
2012 2011 
Presence in 25 g Enumeration Presence in 25 g Enumeration 
N % Pos N 
% ≤ 100 
cfu/g 
% > 100 
cfu/g 
N % Pos N 
% ≤ 100 
cfu/g 
% >100 
cfu/g 
At processing plant  
 
                    
Belgium 
Meat products, raw ham Batch
1
 83 1.2 33 3.0 - - - - - - 
Meat products, cooked, ready-to-eat Batch
2
 - - - - - 51 7.8 58 5.2 0 
Bulgaria Meat products, cooked, ready-to-eat Batch 2,373 0 - - - - - - - - 
Cyprus 
Meat products, cooked, ready-to-eat Single 275 0 - - - 275 0 - - - 
Meat products, fermented sausages Single 125 24.0 - - - 125 24.0 - - - 
Czech Republic Meat products, cooked, ready-to-eat Batch 1,622 2.3 489 0 1.0 2,994 0.8 754 0 0.5 
Estonia Meat products, cooked, ready-to-eat Single 76 1.3 - - - 110 8.2 - - - 
Germany 
Meat products, cooked, ready-to-eat Single 241 3.7 192 0.5 0 145 1.4 85 0 0 
Meat products, fermented sausages Single 238 10.9 168 9.5 0 157 14.6 118 5.1 0.8 
Greece Meat products, cooked, ready-to-eat Single 79 38.0 - - - - - - - - 
Hungary 
Meat products, raw ham Single 122 4.1 - - - - - - - - 
Meat products, fermented sausages Single 185 6.5 132 1.5 0 - - - - - 
Meat products, cooked, ready-to-eat Single
3
 - - - - - 72 0 - - - 
Ireland Meat products, cooked, ready-to-eat Single
4
 - - - - - 153 0.7 - - - 
Italy Meat products Single 1,085 2.3 110 0.9 1.8 1,114 1.8 124 0 0 
Luxembourg Meat products, cooked, ready-to-eat Single 35 0 35 0 0 78 2.6 78 0 0 
Poland  
Meat products, cooked, ready-to-eat Batch
5
 15,702 2.5 9,774 51.4 0.1 - - - - - 
Meat products, cooked, ready-to-eat Batch
6
 195 25.1 - - - - - - - - 
Meat products, raw and intended to be 
eaten raw 
Batch
7
 - - 90 5.6 0 - - - - - 
Meat preparation, intended to be eaten 
raw 
Single 50 40.0 68 89.7 10.3 - - - - - 
Meat products, cooked, ready-to-eat Single
8,9
 5,979 3.1 4,234 2.7 0.5 7,792 4.3 7,513 0.5 <0.1 
Portugal 
Meat products, unspecified, ready-to-eat Single 65 20.0 65 20.0 0           
Meat products, cooked, ready-to-eat Single - - - - - 105 11.4 105 1.9 1.9 
Slovakia Meat products, cooked, ready-to-eat Batch 105 0 - - - 56 0 - - - 
Table continued overleaf. 
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Table LI7 (continued). L. monocytogenes in ready-to-eat pig meat products, 2011-2012 
Country Description 
Sampling 
unit 
2012 2011 
Presence in 25 g Enumeration Presence in 25 g Enumeration 
N % Pos N 
% ≤ 100 
cfu/g 
% > 100 
cfu/g 
N % Pos N 
% ≤ 100 
cfu/g 
% >100 
cfu/g 
At retail   
 
                    
Austria Meat products, cooked, ready-to-eat Single
10
 145 8.3 145 1.4 0 - - - - - 
Belgium 
Meat products, raw ham Batch
1
 - - 114 0 0 - - - - - 
Meat products, cooked, ready-to-eat Batch
11
 - - - - - - - 93 4.3 0 
Bulgaria Meat products, cooked, ready-to-eat Batch 135 3.7 - - - 60 0 - - - 
Cyprus 
Meat products, unspecified, ready-to-eat, 
traditional sausages 
Single 35 0 - - - 35 0 - - - 
Czech Republic 
Meat products, fermented sausages Batch - - 31 0 0 - - - - - 
Meat products, cooked, ready-to-eat Batch 1,628 0 497 0 0 - - 96 0 0 
Estonia Meat products, cooked, ready-to-eat Single - - - - - - - 34 0 0 
France Meat products, cooked, ready-to-eat Single - - - - - 4,475 1.4 4,475 0.2 0.2 
Germany 
Meat products, cooked, ready-to-eat Single 531 4.9 517 0.6 0.2 531 2.4 354 7.3 0.3 
Meat products, fermented sausages Single 413 12.1 513 1.4 0 393 9.2 273 1.8 0.4 
Greece Meat products, cooked, ready-to-eat Single - - - - - 34 0 - - - 
Hungary 
Meat products, cooked, ready-to-eat Single 59 3.4 - - - - - - - - 
Meat products, fermented sausages Single 255 0.8 144 0 0 - - - - - 
Meat products, raw ham Single 65 4.6 34 5.9 0 - - - - - 
Meat products, cooked, ready-to-eat Single
3
 - - - - - 154 1.3 60 3.3 1.7 
Ireland Meat products, cooked, ready-to-eat Single
4,12
 65 0 378 0 0 227 3.5 329 - - 
Italy Meat products Single 212 2.8 42 2.4 0 779 1.7 491 0.8 0 
Luxembourg Meat products, cooked, ready-to-eat Single 194 6.7 194 0 0 68 2.9 68 0 0 
Netherlands Meat products, cooked, ready-to-eat Single - - - - - 216 8.3 382 0 0.3 
Portugal 
Meat products, cooked, ready-to-eat Batch 34 8.8 373 1.6 0.3 - - - - - 
Meat products, unspecified, ready-to-eat Batch - - - - - - - 570 0 0 
Meat products, cooked, ready-to-eat Single 95 26.3 - - - 54 7.4 29 10.3 3.4 
Romania Meat products, cooked, ready-to-eat Batch
13
 - - 60 0 0 175 0 - - - 
Slovakia 
Meat products, cooked, ready-to-eat Batch
14
 - - 79 0 0 - - 58 0 0 
Meat products, fermented sausages Batch
14
 - - 28 0 0 - - - - - 
Spain Meat products, cooked, ready-to-eat Single 645 11.8 468 5.3 1.5 - - - - - 
Table continued overleaf.  
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Table LI7 (continued). L. monocytogenes in ready-to-eat pig meat products, 2011-2012 
Country Description 
Sampling 
unit 
2012 2011 
Presence in 25 g Enumeration Presence in 25 g Enumeration 
N % Pos N 
% ≤ 100 
cfu/g 
% > 100 
cfu/g 
N % Pos N 
% ≤ 100 
cfu/g 
% >100 
cfu/g 
Sampling level not specified 
 
                    
Austria   Meat products, cooked, ready-to-eat Single
10
 - - - - - 787 5.3 787 0 0 
Spain Meat products, unspecified, ready-to-eat Single
15
 - - - - - 756 7.9 403 3.7 2.2 
Sweden Meat products Single
16
 - - - - - 57 1.8 - - - 
Total (2012: 17 MSs, 2011: 19 MSs) 33,146 3.2 19,007 27.8 0.3 22,028 3.3 17,337 0.6 0.2 
Note:  Data are presented only for sample size ≥25. 
 In France, at retail in 2011, the enumeration analysis was carried out on samples positive with the detection method only. Of the 64 samples that were positive by detection method, seven were also 
positive by the enumeration method with a count of less than or equal to 100 cfu/g and nine were positive with a count higher than 100 cfu/g of L. monocytogenes. 
 In Austria, for samples at retail in 2012, the enumeration analysis was carried out only on 18 samples (which included the 12 samples that were positive with the detection method), two of which were 
positive with a count of less than or equal to 100 cfu/g of L. monocytogenes. 
 Sample weight is 25 g, unless otherwise stated. 
1. Sample weight: 1 g, 2011: sample weight >200 g. 
2. Sample weight: >200 g. 
3. Sample weight: 10 or 25 g. 
4. Sample weight is most usually 25 g but occasionally there are other sample weights recorded.     
5. Sample weight: 1, 10, 20, 25 or 125 g. 
6. Raw-smoked products.   
7. Sample weight: 1 g.      
8. Sample weight: 1, 10, 20, 25 or 500 g. 
9. Sample weight: 10, 25, 75, 125 g.       
10. Sample weight: detection in 25 g, enumeration in 1 g.       
11. Sample weight: 200 g.       
12. Sample weight is most usually 25 g but occasionally there are other sample weights recorded for 2012, cooked ham products are also included.  
13. In 2012 samples - sample weight: 10 g.       
14. Sample weight: 10 g.       
15. Sample weight: 25 g or unspecified. 
16. Sample weight: not reported. 
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Figure LI5.  Proportion of L. monocytogenes-positive units in ready-to-eat meat categories in the EU, 
2012
1
 
 
Note: Test results obtained by detection and enumeration methods are presented separately.  
 RTE broiler meat includes data from Belgium, Bulgaria, Czech Republic, Estonia, Hungary, Ireland, Poland, Romania and Spain 
(detection: six MSs, enumeration: six MSs).  
 RTE turkey meat includes data from Hungary, Ireland, Poland and Portugal (detection: two MSs, enumeration: three MSs).  
 RTE bovine meat includes data from Bulgaria, Cyprus, Czech Republic, Germany, Ireland, Luxembourg, Poland and Spain 
(detection: eight MSs, enumeration: three MSs).  
 RTE pig meat includes data from Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, Germany, Greece, Hungary, 
Ireland, Italy, Luxembourg, Poland, Portugal, Romania, Slovakia and Spain (detection: 16 MSs, enumeration: 13 MSs). 
1. Data pooled for all sampling stages for all reporting MSs (single and batch). Only investigations covering 25 or more samples are 
included. 
Cheeses 
In 2012, 16 MSs and 1 non-MS provided data on L. monocytogenes in cheeses from investigations including 
25 units or more (Tables LI8, LI9, LI10 and LI11).  
Soft and semi-soft cheeses 
Overall, in 2012, 8,372 units of soft and semi-soft cheeses were tested using detection methods and 
3,052 units were tested by enumeration methods in the reporting EU MSs. Results are presented for 
cheeses made from raw or low heat-treated milk (Table LI8) and from pasteurised milk (Table LI9) originating 
from cows, sheep and/or goats.   
In 2012, the presence of L. monocytogenes in soft and semi-soft cheeses made from raw or low heat-treated 
milk was detected in four out of nine qualitative investigations of cheeses made of cow’s milk and in both the 
qualitative investigations of cheeses made of sheep’s milk, in EU MSs. Portugal reported the highest level of 
L. monocytogenes in soft and semi-soft cheeses made from raw or low heat-treated milk from a qualitative 
investigation at processing, with 20.0 % of batch samples of cheese made from cow’s milk testing positive. 
L. monocytogenes was found in one of the six quantitative investigations of cheeses made from raw or low 
heat-treated cow’s milk.  
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Compared with 2011, the number of tested samples from soft and semi-soft cheeses made from pasteurised 
milk declined in 2012. In the reporting EU MSs, in 2012, L. monocytogenes was detected in 5 of the 
18 qualitative investigations of cheeses made from pasteurised cow’s milk, while using the enumeration 
method, L. monocytogenes was detected in levels above 100 cfu/g in only two investigations (0.3 % of single 
samples in Germany and 1.2 % of single samples in Spain). L. monocytogenes was not found in any of the 
tested samples of cheeses made from pasteurised goat’s milk, sheep’s milk or mixed, unspecified or other 
milk.  
Hard cheeses 
Overall, 12,117 units of hard cheeses were reported as tested using detection methods and 3,687 units were 
reported as tested by enumeration methods, in 2012 in the reporting EU MSs. Results are presented for 
cheeses made from raw or low heat-treated milk (Table LI10) and from pasteurised milk (Table LI11) 
originating from cows, sheep and/or goats.   
In 2012, L. monocytogenes was found in hard cheeses made from raw or low heat-treated milk from cows in 
2 of the 10 reported qualitative investigations in EU MSs. The positive findings were from samples taken at 
farm and at processing, and as hard cheeses are assumed not to support growth of L. monocytogenes 
during shelf-life, only concentrations exceeding 100 cfu/g are considered to pose a risk to public health. One 
of the six quantitative investigations of hard cheeses made from raw or low heat-treated milk from cows, in 
EU MSs, reported levels of L. monocytogenes above 100 cfu/g (1.9 % of single samples at processing, in 
France) while in one of the quantitative investigations of hard cheeses made from raw or low heat-treated 
sheep’s milk, levels above 100 cfu/g were reported.  
In 2012, L. monocytogenes was found in hard cheeses made from pasteurised milk from cows in 3 of the 
12 qualitative investigations, and at levels above 100 cfu/g in one out of nine quantitative investigations 
(0.6 % of single samples at retail in Spain). L. monocytogenes was not found in any samples of hard 
cheeses made from pasteurised milk from sheep and goats.  
A summary of tested units and the proportion of units positive for cheeses is presented in Figure LI6. 
L. monocytogenes was more often detected in samples of cheeses made from raw or low heat-treated milk 
than in samples of cheeses made from pasteurised milk.  
For further information on reported data, refer to the Level 3 Tables.  
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Table LI8.  L. monocytogenes in soft and semi-soft cheeses made from raw or low heat-treated milk, 2011-2012 
Country Description 
Sampling 
unit 
2012 2011 
Presence in  
25 g 
Enumeration 
Presence in  
25 g 
Enumeration 
N % Pos N 
% ≤100 
cfu/g 
% >100 
cfu/g 
N % Pos N 
% ≤100 
cfu/g 
% >100 
cfu/g 
Cheeses made from milk from cows 
 
                    
Austria 
At processing plant Single
1
 44 0 44 0 0 - - - - - 
At retail Single
1
 38 0 38 0 0 33 0 27 0 0 
Belgium 
At farm Batch
2
 - - - - - 32 3.1 51 17.6 2.0 
At processing plant Batch
3
 50 4.0 - - - 48 4.2 - - - 
At retail Batch
4
 - - 99 0 0 - - 97 10.3 0 
Bulgaria At processing plant Batch 650 0 - - - - - - - - 
France 
At processing plant Single 129 1.6 129 0.8 0.8 1,060 <0.1 1,060 <0.1 0 
At retail Single - - - - - 266 0.8 266 0.4 0 
Germany At retail Single 79 0 69 0 0 50 2.0 49 0 0 
Netherlands At retail Single - - - - - 30 0 33 0 0 
Poland 
At processing plant Batch 125 0 - - - - - - - - 
At processing plant Single
5
 145 0.7 - - - 198 0 30 0 0 
Portugal 
At processing plant Batch 30 20.0 - - - - - - - - 
At processing plant Single - - - - - 45 20.0 - - - 
Romania 
At processing plant Batch
6
 - - - - - 502 0 - - - 
At retail Batch
6,7
 - - 86 0 0 870 0 - - - 
Total (2012: 8 MSs, 2011: 8 MSs) 1,290 0.9 465 0.2 0.2 3,134 0.5 1,613 1.3 <0.1 
Switzerland At processing plant Single 217 0 217 0 0 98 0 - - - 
Table continued overleaf. 
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Table LI8 (continued). L. monocytogenes in soft and semi-soft cheeses made from raw or low heat-treated milk, 2011-2012 
Country Description 
Sampling 
unit 
2012 2011 
Presence in  
25 g 
Enumeration 
Presence in  
25 g 
Enumeration 
N % Pos N 
% ≤100 
cfu/g 
% >100 
cfu/g 
N % Pos N 
% ≤100 
cfu/g 
% >100 
cfu/g 
Cheeses made from milk from sheep 
 
                    
Czech Republic At processing plant Batch - - - - - 35 0 - - - 
Portugal 
At processing plant Batch 100 16.0 - - - - - - - - 
At processing plant Single - - 28 7.1 0 40 5.0 40 2.5 2.5 
At retail Batch - - - - - - - 215 2.8 7.9 
Romania 
At processing plant Batch - - - - - 360 0 - - - 
At retail Batch
6
 - - 66 0 0 149 0 - - - 
Slovakia At processing plant Batch 171 0.6 - - - 161 1.2 - - - 
Total (2012: 3 MSs, 2011:4 MSs) 271 6.3 94 2.1 0 745 0.5 255 2.7 7.1 
Cheeses, made from mixed milk from cows, sheep and/or goats           
Portugal 
At processing plant Batch 35 0 - - - - - - - - 
At retail Batch - - - - - - - 95 0 0 
Total (2012: 1 MS, 2011: 1 MS) 35 0 0 0 0 0 0 95 0 0 
Note: Data are presented only for sample size ≥25.       
 In France, for cheeses made from milk from cows, at processing plant in 2012, the enumeration analysis was carried out on samples positive with the detection method only. Of the two samples that 
were positive by detection method, one was also positive by the enumeration method with a count of less than or equal to 100 cfu/g and one was positive with a count higher than 100 cfu/g of 
L. monocytogenes.         
 For cheeses made from milk from cows, at processing plant in 2011, the enumeration analysis was carried out on samples positive with the detection method only. The one sample that was positive 
by detection method, was also positive by the enumeration method with a count of less than or equal to 100 cfu/g of L. monocytogenes.         
 For cheeses made from milk from cows, at retail in 2011, the enumeration analysis was carried out on samples positive with the detection method only. Of the two samples that were positive by 
detection method, one was also positive by the enumeration method with a count of less than or equal to 100 cfu/g of L. monocytogenes.         
 Sample weight is 25 g, unless otherwise stated.        
1. Sample weight: detection in 25 g, enumeration in 1 g.       
2. In 2011 sample weight: 200 g.        
3. In 2011 sample weight: 300 g.        
4.  In 2012 sample weight 1 g. In 2011: sample weight 200 g.       
5.  In 2011 64 samples (out of 198) tested for detection weighted 10 g.      
6.  In 2012 sample weight: 10 g.  
7.  In 2011, 32 samples from non-EU were tested for detection (included in the table), no positive were reported. 
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Table LI9.  L. monocytogenes in soft and semi-soft cheeses made from pasteurised milk, 2011-2012 
Country Description 
Sampling 
unit 
2012 2011 
Presence in 25 g Enumeration Presence in 25 g Enumeration 
N % Pos N 
% ≤100 
cfu/g 
% >100 
cfu/g 
N % Pos N 
% ≤100 
cfu/g 
% >100 
cfu/g 
Cheeses made from milk from cows 
 
                    
Austria 
At processing plant Single
1
 86 0 77 0 0 143 0 131 0 0 
At retail Single
1
 160 0.6 114 0 0 86 0 79 0 0 
Belgium 
At processing plant Batch 106 0 - - - 100 0 - - - 
At retail Batch
2
 - - 115 0 0 - - 112 2.7 0 
Bulgaria 
At processing plant Batch 680 0 - - - - - - - - 
At retail Batch - - - - - 115 0 - - - 
Cyprus At processing plant Single 35 0 - - - 35 0 - - - 
Czech Republic 
At processing plant Batch 945 0 50 0 0 2,550 1.5 743 0.8 0.4 
At retail Batch - - 85 0 0 35 0 117 0 0 
Denmark At processing plant Batch 33 0 - - - - - - - - 
France 
At processing plant Single 189 0 - - - - - - - - 
At retail Single - - - - - 1,525 0.1 1,525 0 0.1 
Germany 
At processing plant Single 110 1.8 93 1.1 0 60 0 36 0 0 
At retail Single 501 0.2 371 0.8 0.3 638 0.2 355 16.1 0 
Hungary 
At processing plant Single
3
 50 0 - - - 61 1.6 - - - 
At retail Single
3
 53 0 30 0 0 87 0 78 0 0 
Netherlands At retail Single - - - - - 375 0.5 492 0 0 
Poland 
At processing plant Batch
4
 1,095 0 334 0 0 - - - - - 
At processing plant Single
5
 605 0 221 - - 929 0 477 0 0 
Sampling stage unspecified Single
1
 167 0 29 0 0 - - - - - 
Portugal 
At processing plant Batch 83 0 - - - 55 1.8 - - - 
At retail Batch - - 25 0 0 310 0 - - - 
Romania 
At processing plant Batch - - - - - 227 0 - - - 
At retail Batch
6
 - - 91 0 0 42 0 - - - 
Slovakia 
At processing plant Batch 96 1.0 - - - 87 2.3 - - - 
At retail Batch
6
 - - 88 0 0 - - 121 0 0 
Spain At retail Single 417 0.5 420 0 1.2 - - - - - 
Total (2012: 14 MSs, 2011: 12 MSs) 5,411 0.1 2,143 0.2 0.3 7,460 0.6 4,266 1.5 0.1 
Switzerland At processing plant Single 138 0 138 0 0 - - - - - 
Table continued overleaf.  
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Table LI9 (continued). L. monocytogenes in soft and semi-soft cheeses made from pasteurised milk, 2011-2012 
Country Description 
Sampling 
unit 
2012 2011 
Presence in 25 g Enumeration Presence in 25 g Enumeration 
N % Pos N 
% ≤100 
cfu/g 
% >100 
cfu/g 
N % Pos N 
% ≤100 
cfu/g 
% >100 
cfu/g 
Cheeses made from milk from goats 
 
                    
Bulgaria At processing plant Batch
7
 60 0 - - - - - - - - 
Cyprus 
At farm Single 30 0 - - - 30 0 - - - 
At processing plant Single 75 0 - - - 75 0 - - - 
Czech Republic At processing plant Batch 35 0 - - - 55 0 - - - 
Netherlands At retail Single - - - - - 41 0 60 - - 
Poland At processing plant Batch
6
 - - 30 0 0 - - - - - 
Portugal 
At processing plant Batch 25 0 - - - 60 0 - - - 
At retail Batch - - 95 0 0 - - 35 0 0 
United Kingdom At retail Single - - - - - 31 0 31 0 0 
Total (2012: 5 MSs, 2011: 5 MSs) 225 0 125 0 0 292 0 126 0 0 
Cheeses made from milk from sheep 
 
                    
Bulgaria At retail Batch
2
 - - - - - - - 131 0 0 
Cyprus 
At processing plant Single - - - - - 85 0 - - - 
At retail Single 85 0 - - - - - - - - 
Greece 
At processing plant Single - - - - - 304 0 - - - 
At retail Single - - - - - 32 0 - - - 
Poland 
At processing plant Batch
6
 65 0 - - - - - - - - 
At retail Single - - - - - 36 0 - - - 
Portugal 
At processing plant Batch - - 225 0 0 85 0 - - - 
At retail Batch - - - - - - - 120 0 0 
Romania At processing plant Batch - - - - - 46 0 - - - 
Total (2012: 3 MSs, 2011: 6 MSs) 150 0 225 0 0 588 0 251 0 0 
Table continued overleaf.  
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Table LI9 (continued). L. monocytogenes in soft and semi-soft cheeses made from pasteurised milk, 2011-2012 
Country Description 
Sampling 
unit 
2012 2011 
Presence in 25 g Enumeration Presence in 25 g Enumeration 
N % Pos N 
% ≤100 
cfu/g 
% >100 
cfu/g 
N % Pos N 
% ≤100 
cfu/g 
% >100 
cfu/g 
Cheeses, made from mixed milk from cows, sheep and/or goats                   
Cyprus At processing plant Single 345 0 - - - 345 0 - - - 
Portugal 
At processing plant Batch 30 0 - - - - - - - - 
At retail Batch - - - - - - - 125 4.0 0 
Total (2012: 2 MSs, 2011: 2 MSs) 375 0 - - - 345 0 125 4.0 0 
Cheeses, made from unspecified milk or other animal milk                  0 
Cyprus 
At farm Single 105 0 - - - 105 0 - - - 
At processing plant Single 510 0 - - - 510 0 - - - 
Total (2012: 1 MS, 2011: 1 MS) 
 
615 0 - - - 615 0 - - - 
Note: Data are presented only for sample size ≥25. 
 Sample weight is 25 g, unless otherwise stated. 
1. Sample weight: detection in 25 g, enumeration in 1 g. 
2. Sample weight: 1 g. 
3. Sample weight not reported in 2011. 
4. All samples weighted 25 g, except for 175 (out of 334) samples tested for enumeration that weighted 10 g. 
5. All samples weighted 25 g except for the following units tested in 2011: 25 and 206 samples tested respectively for detection and enumeration weighted 10 g; 33 samples tested for detection weighted 
125 g. 
6. Sample weight: 10 g. 
7. Sample weight not reported. 
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Table LI10.  L. monocytogenes in hard cheeses made from raw or low heat-treated milk, 2011-2012 
Country Description 
Sampling 
unit 
2012 2011 
Presence in 25 g Enumeration Presence in 25 g Enumeration 
N % Pos N 
% ≤100 
cfu/g 
% >100 
cfu/g 
N % Pos N 
% ≤100 
cfu/g 
% >100 
cfu/g 
Cheeses made from milk from cows 
 
                    
Austria 
At processing plant Single
1
 34 0 34 0 0 27 0 27 0 0 
At retail Single
1
 26 0 26 0 0 - - - - - 
Bulgaria At processing plant Batch 425 0 - - - - - - - - 
Czech Republic At processing plant Batch 26 0 - - - - - - - - 
France At processing plant Single 54 9.3 54 7.4 1.9 1,305 <0.1 1,305 <0.1 0 
Germany 
At retail Single 254 0 108 0 0 51 0 25 0 0 
At processing plant Single - - - - 
 
51 2.0 29 0 0 
Poland 
At processing plant Batch 225 0 - - - - - - - - 
At farm Single 112 0.9 - - - - - - - - 
At processing plant Single 120 0 30 0 0 - - - - - 
Unspecified Single 65 0 - - - - - - - - 
At retail Single - - - - - 25 0 - - - 
Romania 
At retail Batch
2
 - - 162 0 0 89 0 - - - 
At processing plant Batch - - - - - 176 0.1 - - - 
Total hard cheeses made from milk from cows  
(2012: 7 MSs, 2011: 5 MSs) 
1,341 0.4 414 1.0 0.2 1,724 0.1 1,386 <0.1 0 
Switzerland At processing plant Single 329 0 329 0 0 300 0 - - - 
Table continued overleaf.  
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Table LI10 (continued). L. monocytogenes in hard cheeses made from raw or low heat-treated milk, 2011-2012 
Country Description 
Sampling 
unit 
2012 2011 
Presence in  
25 g 
Enumeration 
Presence in  
25 g 
Enumeration 
N % Pos N 
% ≤100 
cfu/g 
% >100 
cfu/g 
N % Pos N 
% ≤100 
cfu/g 
% >100 
cfu/g 
Cheeses made from milk from sheep and goats  
 
  
 
  
  
          
Germany 
Goat's milk, at processing plant ingle 34 0 - - - 27 3.7 - - - 
Sheep's milk, at retail Single 58 0 50 0 0 - - - - - 
Poland Sheep's milk, at processing plant Batch
2
 - - 130 0 3.8 - - - - - 
Portugal 
Sheep's milk, at processing plant Batch 65 6.2 - - - 110 0 - - - 
Sheep's milk, at retail Batch - - - - - 0 0 135 2.2 8.9 
Romania 
Sheep's milk, at retail Batch
2
 - - 164 0 0 - - - - - 
Sheep's milk, at processing plant Batch
2
 - - - - - 314 1.6 - - - 
Sheep's milk, at retail Batch
2
 - - - - - 355 0.3 - - - 
Total hard cheeses made from milk from sheep and goats  
(2012: 4 MSs, 2011: 3 MSs) 
157 2.5 344 0 1.5 806 0.9 135 2.2 8.9 
Note: Data are presented only for sample size ≥25. 
 In France, for the cheeses made from milk from cows at processing plant, the enumeration analysis was carried out on samples positive with the detection method only. For 2012 of the five samples 
that were positive by detection method, four were also positive by the enumeration method with a count of less than or equal to 100 cfu/g and one was positive with a count higher than 100 cfu/g of 
L. monocytogenes. 
 For 2011: the one sample that was found positive by detection method was also found positive by enumeration method with a count of less than or equal to 100 cfu/g of L. monocytogenes. 
 Sample weight is 25 g, unless otherwise stated. 
1. Sample weight: detection in 25 g, enumeration in 1 g.  
2. Sample weight: 10 g. 
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Table LI11.  L. monocytogenes in hard cheeses made from pasteurised milk, 2011-2012 
Country Description 
Sampling 
unit 
2012 2011 
Presence in 25 g Enumeration Presence in 25 g Enumeration 
N % Pos N 
% ≤100 
cfu/g 
% >100 
cfu/g 
N % Pos N 
% ≤100 
cfu/g 
% >100 
cfu/g 
Cheeses made from milk from cows 
          
  
Bulgaria 
At processing plant Batch 4,681 0 - - - - - - - - 
At retail Batch 215 0 - - - 76 0 - - - 
Czech Republic At processing plant Batch 105 0 - - - 238 0 - - - 
France At processing plant Single 54 0 - - - - - - - - 
Germany 
At processing plant Single 664 0.2 254 0.4 0 662 0.5 250 0.4 0 
At retail Single 2,413 0.4 1078 0.3 0 2,505 0.8 926 7.0 0.1 
Greece At retail Single - - - - - 26 0 - - - 
Latvia At retail Single - - 40 0 - - - - - - 
Lithuania At retail Batch
1
 35 0 - - - - - - - - 
Poland 
At processing plant Batch 1,018 0 160 0 0 - - - - - 
Unspecified Batch 38 0 - - - - - - - - 
At processing plant Single 648 0 162 0 0 3,179 <0.1 120 - - 
Unspecified Single
2
 122 - 106 0 0 - - - - - 
At processing plant Single
3
 - - - - - 578 0 176 0 0 
Romania 
At retail Batch
4
 - - 132 0.8 0 - - - - - 
At processing plant Batch - - - - - 545 0 - - - 
Slovakia At retail Batch
4
 - - 28 0 0 - - 31 0 0 
Spain At retail Single 133 2.3 169 0 0.6 - - - - - 
Total hard cheeses made from milk from cows  
(2012: 10 MSs, 2011: 7 MSs) 
10,126 0.1 2,129 0.2 <0.1 7,733 0.3 1,503 4.4 <0.1 
Table continued overleaf.  
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Table LI11 (continued). L. monocytogenes in hard cheeses made from pasteurised milk, 2011-2012 
Country Description 
Sampling 
unit 
2012 2011 
Presence in 25 g Enumeration 
Presence in 25 
g 
Enumeration 
N % Pos N 
% ≤100 
cfu/g 
% >100 
cfu/g 
N % Pos N 
% ≤100 
cfu/g 
% >100 
cfu/g 
Cheeses made from milk from sheep and goats                        
Bulgaria 
Goat's milk, at processing plant Batch
5
 - - 565 0 0 - - - - - 
Goat's milk, at retail Batch
6
 - - 65 0 0 - - - - - 
Sheep's milk, at processing plant Batch 290 0 - - - - - - - - 
Germany 
Goat's milk, at processing plant Single 54 0 27 0 0 69 0 27 3.7 0 
Goat's milk, at retail Single 116 0 71 0 0 99 0 41 7.3 0 
Sheep's milk, at retail Single 33 0 72 0 0 28 0 - - - 
Sheep's milk, at processing plant Single - - - - - 28 0 - - - 
Greece 
Goat's milk, at processing plant Single - - - - - 28 0 - - - 
Sheep's milk, at processing plant Single - - - - - 85 2.4 - - - 
Romania Sheep's milk, at processing plant Batch - - - - - 37 0 - - - 
Total hard cheeses made from milk from sheep and goats 
(2012: 2 MSs, 2011: 3 MSs) 
493 0 800 0 0 416 0.5 110 4.5 0 
Cheeses made from unspecified milk or other animal milk                      
Cyprus At processing plant Single 340 0 - - - 340 0 - - - 
Note: Data are presented only for sample size ≥25. 
 Sample weight is 25 g, unless otherwise stated. 
1. Sample weight: 500 g. 
2. Sample weight: 25 or 200 g. 
3. Sample weight: 10 or 250 g. 
4. Sample weight: 10 g. 
5. Sample weight not reported. 
6. Sample weight: 1 g. 
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Figure LI6.  Proportion of L. monocytogenes-positive units in soft and semi-soft cheeses, and hard 
cheeses made from raw or low heat-treated milk and pasteurised milk, 2012
1 
 
Note: Test results obtained by detection and enumeration methods are presented separately. LHT: low heat-treated milk; 
Soft and semi-soft cheeses, made from raw-LHT milk, includes data from Austria, Belgium, Bulgaria, France, Germany, 
Poland, Portugal, Romania, Slovakia and Switzerland (detection: nine MSs, enumeration: seven MSs).  
Soft and semi-soft cheeses, made from pasteurised milk, includes data from Austria, Belgium, Bulgaria, Cyprus, Czech 
Republic, Denmark, France, Germany, Hungary, Poland, Portugal, Romania, Slovakia, Spain and Switzerland (detection: 
14 MSs, enumeration: 11 MSs). 
Hard cheese, made from raw-LHT milk, includes data from Austria, Bulgaria, Czech Republic, France, Germany, Poland, 
Portugal, Romania and Switzerland (detection: eight MSs, enumeration: six MSs). 
Hard cheese, made from pasteurised milk, includes data from Bulgaria, Cyprus, Czech Republic, France, Germany, Latvia, 
Lithuania, Poland, Romania, Slovakia and Spain (detection: eight MSs, enumeration: seven MSs). 
1. Data pooled for all sampling stages for all reporting MSs (single and batch). Only investigations covering 25 or more samples are 
included. 
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Fishery products 
In 2012, 17 MSs reported data on L. monocytogenes in RTE fish or fishery products (Table LI12). The 
products tested were mainly smoked fish, and the majority were tested at the processing plant.  
In 2012, the presence of L. monocytogenes in RTE fish was detected in 12 out of 16 qualitative 
investigations. In total, L. monocytogenes was detected in 12.0 % of the 10,831 tested units, but, as the 
majority of the tested units were sampled in one MS, Poland, the lack of representativeness should be taken 
into account when interpreting the overall results. L. monocytogenes was also detected in 9 out of 
16 quantitative investigations of RTE fish in 2012 (6,141 tested units in total), and in six investigations at 
levels above 100 cfu/g. L. monocytogenes counts above 100 cfu/g were found in 1.4 % of the samples 
tested by enumeration testing in 2012 (0.5 % in 2011). However, this increase was mainly due to the results 
of one large investigation in Poland. 
In 2012, L. monocytogenes was detected in all four reported qualitative investigations of unspecified fishery 
products. In the quantitative investigations of unspecified fishery products, L. monocytogenes was found at 
levels above 100 cfu/g in only one investigation (7.1 % of batch samples in Slovenia). 
A summary of the proportion of L. monocytogenes positive units in different types of fishery products is 
presented in Figure LI7. L. monocytogenes was most often detected in RTE fish, in which the highest 
percentage of units with Listeria counts of more than 100 cfu/g was also detected. 
For further information on reported data, refer to the Level 3 Tables. 
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Table LI12.  L. monocytogenes in ready-to-eat fish and other fishery products, 2011-2012 
Country Description 
Sampling 
unit 
2012 2011 
Presence in 25 g Enumeration Presence in 25 g Enumeration 
N % Pos N 
% ≤100 
cfu/g 
% >100 
cfu/g 
N % Pos N 
% ≤100 
cfu/g 
% >100 
cfu/g 
Fish                         
Austria 
Smoked, at retail Single
1
 72 2.8 72 2.8 0 36 5.6 36 0 0 
Smoked, unspecified Single
1
 - - - - - 31 3.2 31 0 0 
Belgium  
Smoked, at processing plant Batch
2
 - - 200 0 0 - - - - - 
Smoked, at retail Batch - - 200 0 0 - - - - - 
Smoked, at retail Batch
3
 - - - - - - - 203 1.0 0.5 
Bulgaria 
Smoked, at retail Batch 50 2.0 45 0 0 - - - - - 
Smoked, at processing plant Batch - - - - - 34 5.9 - - - 
Smoked – cold smoked, at 
processing plant 
Batch
2
 - - - - - - - 65 0 0 
Cyprus Smoked, at processing plant Single 45 0 - - - 45 0 - - - 
Czech Republic 
Smoked, at retail Batch 60 0 79 0 0 - - 38 0 2.6 
Smoked, at processing plant Batch 30 0 - - - 84 2.4 47 0 6.4 
Estonia Smoked, at retail Single - - - - - - - 29 0 0 
France Smoked, at retail Single - - - - - 386 8.8 386 0 0 
Germany 
Smoked - cold smoked, at 
processing plant 
Single 44 18.2 34 17.6 2.9 55 7.3 69 0 2.9 
Smoked - hot smoked, at 
processing plant 
Single 263 3.0 253 0.4 0 - - - - - 
Smoked -  cold smoked, at 
retail  
Single 454 14.5 358 4.2 0.6 323 8.0 308 0.6 0.6 
Smoked -  hot smoked, at 
retail  
Single 929 5.1 734 0.3 0.4 663 2.7 604 27.3 0.7 
Hungary Smoked, at retail Single
4
 39 5.1 - - - 134 17.9 47 21.3 8.5 
Ireland Smoked, at processing plant Single
5
 - - - - - 182 22.5 62 3.2 4.8 
Latvia Smoked, at retail Single - - 45 0 0 - - - - - 
Lithuania Smoked, at retail Batch
6
 - - - - - 56 12.5 56 1.8 - 
Netherlands 
Smoked, at processing plant Single 91 8.8 - - - 125 8.8 133 0.8 1.5 
Smoked, at processing plant Single - - - - - - - - - - 
Smoked, at retail Single - - 91 3.3 1.1 - - 772 0.4 0.3 
Table continued overleaf.  
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Table LI12 (continued). L. monocytogenes in ready-to-eat fish and other fishery products, 2011-2012 
Country Description 
Sampling 
unit 
2012 2011 
Presence in 25 g Enumeration Presence in 25 g Enumeration 
N % Pos N 
% ≤100 
cfu/g 
% >100 
cfu/g 
N % Pos N 
% ≤100 
cfu/g 
% >100 
cfu/g 
Poland 
Smoked, at processing plant Batch
7
 195 4.1 26 0 0 8,964 9.1 2,974 4.1 0.3 
Smoked, unspecified, at 
processing plant 
Batch
8
 7,199 13.6 3,184 2.7 2.4 - - - - - 
Smoked, at processing plant Single
9
 1,144 13.4 512 0.2 0 - - - - - 
Smoked, unspecified, at 
processing plant 
Single
2
 - - 68 0 0 - - - - - 
Portugal Smoked, at retail Batch - - - - - - - 45 0 0 
Slovenia Smoked Batch 50 0 - - - - - - - - 
Spain Smoked, at retail Single 166 11.4 240 0.8 2.1 - - - - - 
Romania 
Smoked, at processing plant Batch - - - - - 103 0 - - - 
Smoked, at retail Batch - - - - - 36 0 - - - 
Total Fish (2012: 12 MSs, 2011: 15 MSs) 10,831 12.0 6,141 1.9 1.4 11,257 8.8 5,905 5.2 0.5 
Fishery products unspecified                       
Austria Ready-to-eat – chilled, at retail Single
8
 - - - - - 34 14.7 34 0 0 
Belgium 
Ready-to-eat, at processing plant Batch
10
 65 1.5 92 0 0 103 8.7 51 0 0 
Ready-to-eat, at retail Batch
11
 - - 148 0 0 0 0 179 0 0 
Estonia 
Ready-to-eat, at processing plant Single 44 4.5 - - - 36 8.3 - - - 
Ready-to-eat, at retail Single - - 41 0 0 - - - - - 
Smoked, at processing plant Single - - - - - - - - - - 
France Seafood pâté, at retail Single - - - - - 880 1.0 880 0.3 0.1 
Germany Cooked, at retail Single 62 3.2 53 1.9 0 - - - - - 
Ireland 
Smoked, at retail Single
5
 - - - - - 68 2.9 68 - - 
Ready-to-eat, at retail Single
5
 - - - - - - - 30 0 0 
Cooked, at retail Single
5
 - - 84 0 0 - - 66 0 0 
Lithuania Ready-to-eat – chilled, at retail Batch 135 4.4 - - - - - - - - 
Romania Ready-to-eat, at retail Batch
12
 - - 32 0 0 - - - - - 
Slovenia Ready-to-eat – chilled Batch - - 28 0 7.1 - - - - - 
Total Fishery products unspecified  
(2012: 7 MSs, 2011: 5 MSs) 
306 3.6 478 0.2 0.4 1,121 2.5 1308 0.2 <0.1 
Table continued overleaf.  
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Table LI12 (continued). L. monocytogenes in ready-to-eat fish and other fishery products, 2011-2012 
Country Description 
Sampling 
unit 
2012 2011 
Presence in 25 g Enumeration Presence in 25 g Enumeration 
N % Pos N 
% ≤100 
cfu/g 
% >100 
cfu/g 
N % Pos N 
% ≤100 
cfu/g 
% >100 
cfu/g 
Crustaceans                         
Bulgaria Cooked, at processing plant Batch 115 0 - - - - - - - - 
Poland 
Cooked, at processing plant Batch 221 1.4 - - - - - - - - 
Cooked, at processing plant Single - - 44 0 0 532 0.2 0 0 0 
Portugal Cooked, at retail Batch - - 100 0 0 112 0 0 0 0 
Spain Cooked, at retail Single 41 0 75 1.3 0 - - - - - 
Total Crustaceans (2012: 4 MSs , 2011: 2 MSs) 377 0.8 219 0.5 0 644 0.2 0 0 0 
Molluscan shellfish                       
Hungary Cooked, at retail Single 25 0 - - - - - - - - 
Portugal Cooked, at retail Batch - - 25 0 0 - - - - - 
Spain Cooked, at retail Single 37 0 44 0 0 - - - - - 
Total Molluscan shellfish (2012: 3 MSs) 62 0 69 0 0 - - - - - 
Note:  Data are only presented for sample size >25 
 In France, for fish smoked at retail, the enumeration analysis was carried out on samples positive with the detection method only. For 2011 of the 34 samples that were positive by detection 
method, none was positive by the enumeration method. 
 Also, for fishery products unspecified - seafood pâté, at retail, the enumeration analysis was carried out on samples positive with the detection method only. For 2011 of the nine samples positive 
by detection method, three were also positive by the enumeration method with a count of less than or equal to 100 cfu/g and one was positive with a count higher than 100 cfu/g of 
L. monocytogenes. 
 In Austria, for fish smoked at retail in 2012, the enumeration analysis was carried out only on 10 samples (which included the two samples that were positive with the detection method), 2 of which 
were positive with a count of less than or equal to 100 cfu/g of L. monocytogenes. 
 Sample weight is 25 g, unless otherwise stated 
1.   Sample weight: detection in 25 g, enumeration in 1 g . 
2.  Sample weight: 1 g. 
3.  Sample weight: >100 g . 
4.  For 2011: sample weight was 10 g or 25 g . 
5.   For 2011: sample weight is most usually 25 g but occasionally there are other sample weights recorded.  
6.  Sample weight: 25 g for detection and 1 g for enumeration. 
7.  Sample weight: 10 g or 25 g. 
8.  Sample weight: detection in 25 g, enumeration in 1 g . 
9.  Sample weight: 1 g, 10 g or 25 g . 
10.  For 2012: 1 g. For 2011: > 200 g . 
11. For 2012: 1 g. For 2011: 100 g. 
12.  Sample weight: 10 g. 
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Figure LI7.  Proportion of L. monocytogenes-positive units in ready-to-eat fishery products 
categories in EU, 2012
1
  
 
Note: Test results obtained by detection and enumeration methods are presented separately. 
 Fish includes data from Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Germany, Hungary, Latvia, Netherlands, Poland, 
Slovenia and Spain (detection: 10 MSs, enumeration: 9 MSs).  
 Crustaceans and molluscs includes data from Bulgaria, Hungary, Poland, Portugal and Spain (detection: four MSs, 
enumeration: three MSs). 
 Unspecified fishery products includes data from Belgium, Estonia, Germany, Ireland, Lithuania, Romania and Slovenia 
(detection: four MSs, enumeration: six MSs).  
1. Data pooled for all sampling stages for all reporting MSs (single and batch). Only investigations covering 25 or more samples are 
included. 
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Other ready-to-eat products 
A substantial number of investigations were reported on L. monocytogenes in other RTE products, such as 
bakery products, sandwiches, fruits and vegetables, prepared dishes and salads (Table LI13). 
In 2012, in the category bakery products, L. monocytogenes was detected in 6 of the 10 qualitative 
investigations. L. monocytogenes was not found at levels above 100 cfu/g in any of the nine quantitative 
investigations; neither was L. monocytogenes found in the relatively few reported investigations of 
confectionery products and pastes, egg products or fruits in 2012. In qualitative investigations of ‘other 
processed food products and prepared dishes’, L. monocytogenes was detected in sandwiches at 
processing and at retail. 
L. monocytogenes was detected in 6 of the 11 qualitative investigations of RTE salads. In 2012, only 1 of the 
2,285 units of RTE salads tested by enumeration method was found to contain L. monocytogenes at a level 
above 100 cfu/g. 
In 2012, there were no findings of L. monocytogenes in the relatively few tested pre-cut vegetables. 
For further information on reported data refer to the Level 3 Tables. 
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Table LI13.  L. monocytogenes in other ready-to-eat products, 2011-2012 
Country Description 
Sampling 
unit 
2012 2011 
Presence in  
25 g 
Enumeration 
Presence in  
25 g 
Enumeration 
N % Pos N 
% ≤100 
cfu/g 
% >100 
cfu/g 
N 
% 
Pos 
N 
% ≤100 
cfu/g 
% >100 
cfu/g 
Bakery products                         
Austria 
Cakes, at retail ingle
1
 59 0 55 0 0 83 0 75 0 0 
Pastry, at retail Single
1
 141 0.7 111 0 0 97 2.1 91 0 0 
Belgium 
Pastry, at processing plant Batch
2
 - - - - - - - 69 2.9 0 
Pastry, at retail Batch
2
 - - - - - - - 149 2.7 0 
Germany Cakes, at retail Single 611 1.0 697 0.1 0 829 0.4 276 94.6 0 
Hungary Cakes Single 193 0.5 89 0 0 - - - - - 
Ireland 
Cakes, at retail Single
3
 - - 48 0 0 43 2.3 122 0.8 0 
Desserts, at retail Single
3
 - - 51 0 0 - - 51 0 0 
At retail Single
3
 - - - - - - - 42 0 0 
Italy 
Pastry, at processing plant Single - - - - - 45 0 - - - 
Pastry, at catering Single 57 3.5 - - - - - - - - 
Pastry, at retail Single 75 0 - - - 325 0 - - - 
Pastry, unspecified Single - - - - - 25 0 - - - 
Portugal Cakes Batch - - - - - - - 75 0 0 
Poland At processing plant Single 34 0 - - - - - - - - 
Slovenia 
Desserts, at catering Single 50 0 50 0 0 - - - - - 
Desserts containing heat-treated 
cream, at retail 
Single 100 1.0 100 0 0 - - - - - 
Cakes, at catering Single - - - - - 100 1.0 100 1.0 0 
Spain At retail Single 224 0.4 349 0 0 - - - - 0 
Total Bakery products (2012: 8 MSs, 2011: 7 MSs) 1,544 0.8 1,550 <0.1 0 1,547 0.5 1,050 25.6 0 
Table continued overleaf. 
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Table LI13 (continued). L. monocytogenes in other ready-to-eat products, 2011-2012 
Country Description 
Sampling 
unit 
2012 2011 
Presence in  
25 g 
Enumeration 
Presence in  
25 g 
Enumeration 
N % Pos N 
% ≤100 
cfu/g 
% >100 
cfu/g 
N % Pos N 
% ≤100 
cfu/g 
% >100 
cfu/g 
Confectionery products and pastes                       
Czech Republic 
At processing plant Batch 48 0 230 0 0 - - 303 0 0 
At retail Batch - - 32 0 0 - - - - - 
Hungary At retail Single
4
 - - - - - 77 1.3 40 0 0 
Romania At retail Batch
5
 - - 96 0 0 - - - - - 
Slovakia At retail Batch
6
 - - 61 0 0 - - - - - 
Total Confectionery products and pastes (2012: 3 MSs, 2011: 2 MSs) 48 0 419 0 0 77 1.3 343 0 0 
Egg products                       0 
Bulgaria Ready-to-eat, at processing plant Batch
7
 25 0 - - - - - - - - 
Ireland Ready-to-eat, at retail Single - - 123 0 0 - - 140 0 0 
Total Egg products (2012: 2 MSs, 2011: 1 MS) 25 0 123 0.0 0.0 - - 140 0 0 
Fruits                         
Belgium Pre-cut, at retail Batch
8
 - - 114 0 0 - - - - - 
Netherlands Pre-cut, at retail Single - - 182 0 0 402 0.5 425 0 0 
Portugal Pre-cut, at retail Batch - - 95 0 0 - - 95 0 0 
Spain Pre-cut, at retail Single - - 66 0 0 - - - - - 
United Kingdom 
Products, dried, at retail Single 175 0 175 0 0 - - - - - 
Pre-cut, ready-to-eat (grapes) Single 306 0 306 0 0 - - - - - 
Total Fruits (2012: 5 MSs, 2011: 2 MSs) 481 0 938 0 0 402 0.5 520 0 0 
Fruits and vegetables                        
Belgium 
Pre-cut, at processing plant Batch
9
 - - - - - 52 0 42 7.1 0 
Pre-cut, at retail Batch
9
 - - - - - - - 148 8.1 0 
Ireland 
Pre-cut, ready-to-eat, at retail Single - - - - - 44 0 185 0 0 
Product, at retail Single - - - - - 98 0 399 0 0 
Slovenia 
Pre-cut, pre-packed, ready-to-eat, at 
retail 
Batch - - - - - 30 0 30 0 0 
Pre-cut, frozen, ready-to-eat, at retail Batch - - - - - 30 10.0 30 10.0 0 
Total Fruits and vegetables (2012: no MSs, 2011: 2 MSs) - - - - - 254 1.2 834 2.2 0 
Table continued overleaf.  
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Table LI13 (continued). L. monocytogenes in other ready-to-eat products, 2011-2012 
Country Description 
Sampling 
unit 
2012 2011 
Presence in  
25 g 
Enumeration 
Presence in  
25 g 
Enumeration 
N % Pos N 
% ≤100 
cfu/g 
% >100 
cfu/g 
N % Pos N 
% ≤100 
cfu/g 
% >100 
cfu/g 
Other processed food products and prepared dishes                        
Bulgaria Sandwiches, at retail ingle
7
 538 0 - - - - - - - - 
Czech Republic 
Sandwiches, at processing plant Batch 36 0 115 0 0 42 0 153 0 0.7 
Sandwiches, at retail Batch - - 47 0 0 - - 28 0 0 
Sandwiches, at processing plant Batch 25 16.0 35 0 0 - - - - - 
Hungary Sandwiches, at retail Single 34 2.9 - - - 194 1.5 72 1.4 0 
Ireland 
Pasta/rice salad, at retail Single
3
 - - - - - - - 28 0 0 
Sandwiches with meat, at retail Single
3
 - - 63 0 0 27 7.4 122 0.8 - 
Portugal Sandwiches, at retail Batch - - 35 0 0 - - 475 0 0 
Slovakia 
Sandwiches, at retail Single
6
 69 0 69 0 0 30 0 - - - 
Ices and similar frozen desserts, at 
retail 
Single
6
 - - - - - 38 0 - - - 
Sandwiches, at processing plant Single
6
 - - - - - - - 58 0 1.7 
Sandwiches, at retail Single
6
 - - - - - 69 0 - - - 
Slovenia Sandwiches, at retail Single 50 12.0 50 0 0 - - - - - 
United Kingdom Sandwiches, at retail Single 285 0 285 3.2 0 - - - - - 
Total Other processed food products and prepared dishes  
(2012: 9 MSs, 2011: 5 MSs ) 
1,037 1.1 699 1.3 0 400 1.3 936 0.2 0.2 
Table continued overleaf. 
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Table LI13 (continued). L. monocytogenes in other ready-to-eat products, 2011-2012 
Country Description 
Sampling 
unit 
2012 2011 
Presence in  
25 g 
Enumeration 
Presence in  
25 g 
Enumeration 
N % Pos N 
% ≤100 
cfu/g 
% >100 
cfu/g 
N % Pos N 
% ≤100 
cfu/g 
% >100 
cfu/g 
Ready-to-eat salads                        
Austria At retail Single
1
 57 0 57 0 0 -   - - - 
Belgium 
At retail Batch
10
 - - 272 0.7 0 - - - - - 
Unspecified
10
   - - - - - - - 223 6.7 0 
Bulgaria At processing plant Batch 903 0.1 - - -           
Czech Republic 
Containing mayonnaise, at 
processing plant 
Batch - - - - - 382 2.1 124 0.8 0 
At processing plant Batch 68 1.5 187 0 0 37 0 172 0 0 
At retail Batch 0 0 102 0 1.0 - - 77 0 0 
Estonia 
At processing plant Single - - 26 0 0 - - 25 0 0 
At retail Single - - 90 0 0 - - 109 0 0 
Hungary 
Unspecified Single 275 4.7 130 0 0 -         
At catering Single - - - - - 107 2.8 33 0 0 
At processing plant Single - - - - - 62 3.2 - - - 
At retail Single - - - - - 145 9.7 87 4.6 0 
Ireland Containing mayonnaise, at retail Single 41 2.4 181 0 0 - - - - - 
Netherlands Lettuce and lettuce mix, at retail. Single - - 138 0 0 - - - - - 
Poland At processing plant Batch 33 0 237 11.8 0 - - - - - 
Slovakia 
At retail Batch - - 41 0 0 - - - - - 
Containing mayonnaise, at retail Batch 107 0.9 107 0 0 411 0.5 224 0 0 
At retail Single 109 0 - - -           
Containing mayonnaise, at retail Single 27 7.4 27 0 0 168 0.6 72 0 0 
Slovenia 
 Unspecified Single 77 0 77 0 0 - - - - - 
Ready-to-eat deli dishes, at catering Single - - - - - 143 2.1 143 2.1 0 
Spain At retail Single 225 0 613 0 0 - - - - - 
Total Ready-to-eat salads (2012: 12 MSs, 2011: 6 MSs) 1,922 1.0 2,285 1.3 <0.1 1,455 2.3 1,289 1.8 0 
Table continued overleaf. 
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Table LI13 (continued). L. monocytogenes in other ready-to-eat products, 2011-2012 
Country Description 
Sampling 
unit 
2012 2011 
Presence in  
25 g 
Enumeration 
Presence in  
25 g 
Enumeration 
N % Pos N 
% ≤100 
cfu/g 
% >100 
cfu/g 
N % Pos N 
% ≤100 
cfu/g 
% >100 
cfu/g 
Sauce and dressings                        
Ireland 
At retail Single 32 0 110 0 0 36 2.8 148 - - 
Mayonnaise, at retail Single - - 26 0 0     27 0 0 
Slovenia 
Ready-to-eat deli dishes, at catering, 
including spreads 
Single - - - - - 37 0 37 0 0 
Total Sauce and dressings (2012: 1 MS, 2011: 2 MSs ) 32 0 136 0 0 73 1.4 212 0 0 
Soups                         
Ireland Ready-to-eat, at retail Single - - 41 0 0 - - 57 0 0 
Total Soups (2012: 1 MS, 2011: 1 MS)     41 0 0     57 0 0 
Spices and herbs                        
Germany 
At processing plant Single - - 46 0 0 - - - - - 
At retail Single 28 0 66 1.5 0 - - - - - 
Ireland At retail Single - - - - - 28 0 134 0 0 
Slovakia Dried, at retail Batch - - - - - - - 25 0 0 
United Kingdom 
Herbs dried, at retail Single 8 0 8 0 0 8 0 8 0 0 
Spices dried, at retail  Single 31 0 31 3.2 0 31 0 31 3.2 0 
Total Spices and herbs (2012: 3 MSs, 2011: 3 MSs) 67 0 151 1.3 0 67 0 198 0.5 0 
Surimi                         
Italy At processing plant Single - - - - - 90 0 - - - 
Total Surimi (2011: 1 MS) - - - - - 90 0 - - - 
Table continued overleaf. 
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Table LI13 (continued). L. monocytogenes in other ready-to-eat products, 2011-2012 
Country Description 
Sampling 
unit 
2012 2011 
Presence in  
25 g 
Enumeration 
Presence in  
25 g 
Enumeration 
N 
% 
Pos 
N 
% ≤100 
cfu/g 
% >100 
cfu/g 
N 
% 
Pos 
N 
% ≤100 
cfu/g 
% >100 
cfu/g 
Vegetables                         
Czech Republic Pre-cut, ready-to-eat, at retail Batch - - - - - - - 77 0 0 
Denmark Pre-cut, ready-to-eat, at retail Single - - - - - - - 167 0 0 
Estonia Products, at processing plant Single - - - - - - - - - - 
France Pre-cut, ready-to-eat, at retail Single - - - - - 972 0.7 972 0.1 0.1 
Hungary 
Pre-cut, ready-to-eat, at processing 
plant 
Single - - - - - - - - - - 
Pre-cut, ready-to-eat, at retail Single - - - - - 102 1.0 40 2.5 0 
Netherlands Pre-cut, ready-to-eat, at retail Single - - 245 0 0 - - 193 0 0 
Portugal Pre-cut, ready-to-eat, at retail Batch - - - - - - - 80 0 0 
Slovakia Pre-cut, ready-to-eat, at catering Single 58 0 58 0 0 30 0 - - - 
Slovenia Pre-cut, ready-to-eat, at retail Single 50 0 50 0 0 - - - - - 
Spain Pre-cut, ready-to-eat, at retail Single 38 0 121 0 0 537 4.1 661 1.1 0.2 
Total Vegetables (2012: 4 MSs, 2011: 9 MSs) 146 0 474 0 0 1,641 1.8 2,190 0.4 <0.1 
Note: Data are only presented for sample size ≥25.  
 In France, for pre-cut vegetables, ready-to-eat, at retail, in 2011, the enumeration analysis was carried out on samples positive with the detection method only. Of the seven samples that were positive 
by detection method, one was also positive by the enumeration method with a count of less than or equal to 100 cfu/g and one was positive with a count higher than 100 cfu/g of L. monocytogenes. 
 In Austria, for ready-to-eat salads at retail, in 2012, not all 57 samples tested by detection method were also tested by enumeration method. Only 10 samples were examined by enumeration method 
and they were all negative for L. monocytogenes. 
 Sample weight is 25 g, unless otherwise stated. 
1. Sample weight: 1 g or 25 g for both years’ data. 
2. Sample weight: >200g or >100g for 2011 data. 
3. Sample weight is most usually 25 g but occasionally there are other sample weights recorded for both years’ data. 
4. Sample weight: 10 or 25 g for both years’ data. 
5. Sample weight is 10 g for 2012 data. 
6. Sample weight is 10 g for both years’ data. 
7. Sample weight is 250 g for 2012 data. 
8. Sample weight is 1 g for 2012 data. 
9. Sample weight: >200 g or 200 g for both years’ data. 
10. Sample weight is 1 g for 2012 data and 200 g for 2011 data. 
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3.3.3. Listeria in animals 
In 2012, 10 MSs reported qualitative data on Listeria in animals, including samples from investigations in 
which suspect sampling had been applied and samples from clinical investigations. The main Listeria 
species was L. monocytogenes, but most isolates were of unspecified species. Two additional Listeria 
species, L. innocua and L. ivanovii, were identified by Slovakia and Ireland.  
L. monocytogenes was detected by several MSs in cattle, fowl, sheep and goats, but not in pigs. As in 
previous years the highest proportions of positive findings were reported from goats and sheep, especially 
from Germany, where 13.3 % of the goat herds and 14.5 % of the sheep herds were positive. Also in 
Germany, a large number of other animals were tested, and L. monocytogenes was isolated from one cat 
and a few horses (1.2 %), but not from dogs.  
Most of the investigations on Listeria in animals were reported as clinical investigations, suspect samplings 
or the sampling strategy was not specified. However, in Slovakia all cases of abortion in cattle, sheep and 
goats are officially tested for Listeria. In these investigations, reported as objective sampling, the occurrence 
of Listeria among cattle (0.4 %) and sheep (2.9 %) was lower than among the cattle (6.3 %) and sheep 
(12.4 %) tested as suspect sampling.  
A summary of number of tested and percentage of Listeria positive units from the different animal species is 
set out in Table LI14. For further information on reported data, refer to the Level 3 Tables.  
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Table LI14.  L. monocytogenes and other species in animals, 2011-2012 
Country Description 
Sampling 
unit 
2012 2011 
Presence in  
25 g 
Listeria species 
Presence in  
25 g 
Listeria species 
N % Pos 
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Cattle (bovine animals)                              
Estonia 
At farm Animal 60 6.7 4 - - - - - - - - - - 
Dairy cows, at farm Animal - - - - - - 37 10.8 2 - - 1 1 
Germany 
At farm Animal 4,881 2.8 138 - - - - - - - - - - 
At farm Herd/flock 706 8.9 63 - - - - - - - - - - 
Calves (under 1 year), at farm Animal 432 6.3 27 - - - - - - - - - - 
Calves (under 1 year), at farm Herd/flock 254 7.1 18 - - - 119 1.7 2 - - - - 
Dairy cows, at farm Animal 200 9.0 18 - - - - - - - - - - 
Dairy cows, at farm Herd/flock 76 11.8 9 - - - 59 22.0 13 - - - - 
Ireland 
At farm Animal 13,173 0.6 79 - 1 - 10,451 0.7 68 3 1 - - 
Dairy cows, at farm Animal 933 0 - 0 - - 942 0 - 0 - - - 
Italy 
At farm Animal 392 0.3 - 1 - - 305 2.0 - 0 - 4 - 
At farm Herd/flock 34 0 - 0 - - 31 0 - 0 - - - 
Latvia 
At farm Animal 348 0.9 3 - - - - - - - - - - 
Dairy cows, at farm Animal 89 16.9 15 - - - 48 25.0 11 1 - - - 
Netherlands At farm Animal 2,845 <0.1 - 2 - - 2,686 0.1 - 4 - - - 
Slovakia 
At farm Animal 559 3.6 18 1 - 1 - - - - - - - 
Dairy cows, at farm Animal - - - - - - 531 2.8 15 - - - - 
Spain 
Dairy cows, at farm Herd/flock 850 0.1 1 - - - - - - - - - - 
Dairy cows, at farm Animal - - - - - - 97 3.1 1 2 - - - 
Total Cattle (2012: 8 MSs, 2011: 8 MSs) 25,832 1.5 393 4 1 1 15,306 0.9 112 10 1 5 1 
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Table LI14 (continued). L. monocytogenes and other species in animals, 2011-2012 
Country Description 
Sampling 
unit 
2012 2011 
Presence in  
25 g 
Listeria species 
Presence in  
25 g 
Listeria species 
N % Pos 
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Fowl (Gallus gallus)                              
Germany 
Broilers, at farm Animal 163 0 0 - - - - - - - - - - 
Broilers, at farm Herd/flock 30 0 0 - - - - - - - - - - 
Laying hens, at farm Animal 435 0.7 3 - - - - - - - - - - 
Laying hens, at farm Herd/flock 57 0 0 - - - 104 1.0 1 - - - - 
Laying hens - adult, at farm Herd/flock - - - - - - 65 0 0 - - - - 
Netherlands At farm Herd/flock - - - - - - 1,430 0 - - - - - 
Total Fowl (2012: 1 MSs, 2011: 2 MSs) 685 0.4 3 0 0 0 1,599 <0.1 1 0 0 0 0 
Goats                               
Germany 
At farm Animal 368 10.1 37 - - - - - - - - - - 
At farm Herd/flock 113 13.3 15 - - - 97 22.7 22 - - - - 
Greece At farm   - - - - - - 44 4.5 2 - - - - 
Ireland At farm Animal 67 0 - 0 - - 32 0 - 0 - - - 
Italy At farm Herd/flock 62 0 - 0 - - 28 3.6 - 1 - - - 
Netherlands At farm Animal 221 8.6 - 19 - - - - - - - - - 
Slovakia At farm Animal 39 0 - - - - - - - - - - - 
Total Goats (2012: 5 MSs, 2011: 4 MSs) 870 8.2 52 19 0 0 201 12.4 24 1 0 0 0 
Table continued overleaf. 
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Table LI14 (continued). L. monocytogenes and other species in animals, 2011-2012 
Country Description 
Sampling 
unit 
2012 2011 
Presence in  
25 g 
Listeria species 
Presence in  
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Listeria species 
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Pigs                               
Germany 
At farm Animal 3,119 <0.1 1 - - - - - - - - - - 
At farm Herd/flock 111 0 0 - - - 735 0 0 - - - - 
Ireland At farm Animal 675 0 - 0 - - 381 0 - 0 - - - 
Latvia At farm Animal 25 0 - - - - - - - - - - - 
Netherlands At farm Animal 2,811 0 - - - - 3,341 0 - - - - - 
Total Pigs (2012: 4 MSs, 2011: 3 MSs) 6,741 <0.1 1 0 0 0 4,457 0 0 0 0 0 0 
Sheep                               
Germany 
At farm Animal 1,619 7.0 113 - - - - - - - - - - 
At farm Herd/flock 373 14.5 54 - - - 190 14.7 28 - - - - 
Ireland At farm Animal 1,651 1.6 23 3 1 - 1,568 0.6 6 3 - - - 
Italy 
At farm Animal 49 0 - 0 - - 64 0 - 0 - - - 
At farm Herd/flock 235 0.4 - 1 - - 160 1.9 - 2 1 - - 
Latvia At farm Animal 29 0 - - - - - - - - - - - 
Netherlands At farm Animal 467 1.1 - 5 - - - - - - - - - 
Slovakia At farm Animal 376 6.4 24 - - - 356 3.7 13 - - - - 
Total Sheep (2012: 6 MSs, 2011: 4 MSs) 4,799 4.7 214 9 1 0 2,338 2.3 47 5 1 0 0 
Table continued overleaf. 
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Table LI14 (continued). L. monocytogenes and other species in animals, 2011-2012 
Country Description 
Sampling 
unit 
2012 2011 
Presence in 
25 g 
Listeria species 
Presence in 25 
g 
Listeria species 
N % Pos 
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Sheep and goats                              
Italy At farm Animal - - - - - - 94 13.8 - 2 1 5 - 
Other animals                              
Germany 
Cats, unspecified Animal 1,043 <0.1 1 - - - - - - - - - - 
Dogs, unspecified Animal 1,672 0 0 - - - - - - - - - - 
Other poultry, at farm Animal 226 0 0 - - - - - - - - - - 
Solipeds, domestic - horses, at farm Animal 2,075 1.2 25 - - - - - - - - - - 
Solipeds, domestic - horses, at farm Herd/flock 61 1.6 1 - - - 65 15.4 10 - - - - 
Turkeys, at farm Animal 490 0 0 - - - - - - - - - - 
Greece Other ruminants - farmed, at farm   - - - - - - 64 1.6 - - - 1 - 
Ireland 
Birds - wild, at farm Animal 88 0 - 0 - - 84 0 - 0 - - - 
Dogs, at farm Animal 131 0 - 0 - - 137 0 - 0 - - - 
Rabbits, at farm Animal 39 0 - 0 - - 26 0 - 0 - - - 
Solipeds, domestic - horses, at farm Animal 219 0 - 0 - - 168 0 - 0 - - - 
Italy Water buffaloes, at farm Animal 39 0 - 0 - - 142 0 - 0 - - - 
Netherlands Rabbit  Animal - - - - - - 344 0.3 1 - - - - 
Spain Rodents - wild Animal - - - - - - 343 0.3 - 1 - - - 
United 
Kingdom 
Alpacas Animal 742 0.1 1 0 - - - - - - - - - 
Squirrels - wild Animal - - - - - - 69 1.4 1 0 - - - 
Zoo animals, red kangaroo and 
miscellaneous antelope 
Animal - - - - - - 26 7.7 2 0 - - - 
Total Other animals (2012: 7 MSs, 2011: 7 MSs) 6,825 0.4 28 0 0 0 1,468 1.1 14 1 0 0 0 
Note: Data are presented only for sample size ≥25. 
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3.3.4. Discussion 
Human listeriosis is a relatively rare but serious zoonotic disease, with high morbidity, hospitalisation and 
mortality rates in vulnerable populations. In 2012, 1,642 confirmed human cases were reported in the EU, 
which was a 10.5 % increase compared with 2011 (1,486). The highest notification rates were observed in 
male cases 74 years and older. This could potentially be due to differences in food consumption habits 
between men and women, particularly in the elderly, and should be investigated further. In women of fertile 
age (15-44 years), the majority of cases were associated with pregnancy. Of all the zoonotic diseases under 
EU surveillance, listeriosis caused the most severe human disease, with 91.6 % of the cases hospitalised 
and 198 of cases being fatal (case fatality rate 17.8 %). This also reflects the focus of EU surveillance on 
severe, systemic infections. 
In 2012, five strong-evidence food-borne outbreaks caused by L. monocytogenes were reported by three 
MSs; four were general and one was a household outbreak (for further information, see Chapter 4, Food-
borne outbreaks). The outbreaks resulted in 55 cases, 47 hospitalisations and nine deaths, i.e. 37.5 % of all 
deaths due to reported strong-evidence food-borne outbreaks in 2012. Mixed food (sandwiches), bakery 
products (pork pies), bovine meat and products thereof (pressed beef), cheese and other or mixed red meat 
and products thereof (meat jelly) were the implicated foods. 
A wide range of different foodstuffs can be contaminated with L. monocytogenes which is widespread in the 
environment and has a propensity to form biofilms on food processing equipment. For a healthy human 
population, foods in which L. monocytogenes levels do not exceed 100 cfu/g are considered to pose a 
negligible risk. Therefore, the EU microbiological criterion for L. monocytogenes in RTE food is set as 
≤100 cfu/g for RTE products on the market. 
Also in 2012, a substantial number of food samples were tested for L. monocytogenes. At retail as well as at 
processing, the non-compliance for different RTE food categories was at a level comparable to previous 
years. However, it must be noted that these results are highly influenced by the MSs reporting and the 
sample sizes in their investigations. As in previous years, the level of non-compliance at retail was lower than 
at processing, one reason being the different thresholds for non-compliance applied at processing and at 
retail. At retail, food samples containing up to 100 cfu/g are also in compliance with the L. monocytogenes 
criterion. As in previous years, the highest proportion of non-compliant units were observed in RTE fishery 
products, at levels of 8.0 % and 0.5 % in single samples, at processing and at retail, respectively. Overall, 
the EU level findings based on the monitoring of L. monocytogenes in certain retail foods are consistent with 
the results of the baseline survey on the EU level prevalence of L. monocytogenes in certain RTE foods at 
retail
30
, which was carried out in 2010 and 2011. In this baseline survey it was found that, at the end of shelf-
life, the EU level prevalence of Listeria monocytogenes was highest in fish products (10.3 %) and clearly 
lower in meat and cheese products: 2.1 % and 0.47 % respectively. However, the proportion of samples 
exceeding the level of 100 cfu/g at the end of shelf-life was 1.7 % for smoked and gravad fish, 0.43 % for 
meat products and 0.06 % for soft and semi-soft cheeses.  
In 2012, Listeria was also reported, from several MSs, in cattle, fowl, sheep and goats. The main reported 
Listeria species was L. monocytogenes, but most isolates were of unspecified species. As the bacterium is 
widespread in the environment, isolation from animals is to be expected, but clinical disease in animals can 
follow increased exposure.  
 
                                                 
30
 European Food Safety Authority, 2013. Analysis of the baseline survey on the prevalence of Listeria monocytogenes in certain 
ready-to-eat (RTE) foods in the EU, 2010-2011 Part A: Listeria monocytogenes prevalence estimates. EFSA Journal 
2013;11(6):3241, 75 pp. doi:10.2903/j.efsa.2013.3241 
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3.  INFORMATION ON SPECIFIC ZOONOSES AND ZOONOTIC AGENTS 
3.4. Verocytoxigenic Escherichia coli 
Verocytoxigenic Escherichia coli (VTEC) are a group of Escherichia coli (E. coli) that are characterised by 
the ability to produce toxins, designated verocytotoxins (synonym Shiga-like toxin)
31
. Human pathogenic 
VTEC usually harbour additional virulence factors which are important in the development of the disease in 
man. A large number of serogroups of E. coli have been recognised as verocytotoxin producers. Human 
VTEC infections are, however, most often associated with a limited number of O:H serogroups. Of these, 
O157:H7 and O157:H- (VTEC O157) are the pathogens most frequently reported to be associated with 
human disease. The terms VTEC and STEC (Shiga toxin-producing E. coli) are synonymous. 
The majority of reported human VTEC infections are sporadic cases. The symptoms associated with VTEC 
infection in humans vary from mild to bloody diarrhoea, which is often accompanied by abdominal cramps, 
usually without fever. VTEC infections can result in haemolytic-uraemic syndrome (HUS). HUS is 
characterised by acute renal failure, anaemia and lowered platelet counts. HUS develops in up to 10 % of 
patients infected with VTEC O157 and is the leading cause of acute renal failure in young children. 
Human infection may be acquired through the consumption of contaminated food or water, by direct 
transmission from person to person or from infected animals or faecally-contaminated environments to 
humans. 
VTEC (including VTEC O157) have been isolated from many different animal species. The gastrointestinal 
tract of healthy ruminants, which includes cows, goats, sheep and wild ruminants, seems to be the most 
important reservoir for VTEC, and these bacteria are shed in the animals’ faeces. Foods of bovine and ovine 
origin are frequently reported as a source of human VTEC infections. Other important food sources include 
faecally contaminated vegetables and drinking water. For many VTEC serogroups isolated from animals and 
foodstuffs, the significance for human infections is not yet clear. 
According to an opinion from EFSA’s BIOHAZ Panel on the VTEC-seropathotype and scientific criteria 
regarding pathogenicity assessment
32
, the human pathogenic potential of many VTEC serogroups remains 
unknown. For public health investigation of VTEC infection, clinical and/or food samples should be screened 
by PCR or other suitable method (e.g. microarray, sequencing) for the presence of the vtx genes. If positive, 
all efforts should be made to isolate and characterise the causative organism. According to a previous 
opinion from EFSA’s BIOHAZ Panel on the monitoring of VTEC
33
, the serogroups which are currently 
considered the most important regarding pathogenicity in humans are: O26, O91, O103, O111, O145 and 
O157. In 2012, with the exception of O111, all of these serogroups were isolated from fresh bovine meat and 
cattle. 
In order to improve the quality of the data from VTEC monitoring in the EU, EFSA issued technical 
specifications for the monitoring and reporting of VTEC in animals and food in 2009
34
. These guidelines were 
developed to facilitate the generation of data which would enable a more thorough analysis of VTEC in food 
and animals in the future. The specifications encourage MSs to monitor and report data on serogroups 
defined by the BIOHAZ Panel as most important regarding human pathogenicity.  
Table VT1 presents the countries reporting data for 2012. Regarding food and animal data, only the 
information reported on VTEC in bovine meat and bovine animals are included in this report.  
                                                          
31
 Verotoxigenic E. coli (VTEC) is also known as verocytotoxigenic E. coli, verocytotoxinproducing E. coli and Shiga toxin-producing 
E. coli (STEC).  
32
 European Food Safety Authority, 2013. Scientific Opinion on VTEC-seropathotype and scientific criteria regarding pathogenicity 
assessment. EFSA Journal 2013;11(4):3138, 106 pp. doi:10.2903/j.efsa.2013.3138 
33
 European Food Safety Authority, 2007. Scientific Opinion of the Panel on Biological Hazards (BIOHAZ) on monitoring of 
verotoxigenic Escherichia coli (VTEC) and identification of human pathogenic VTEC types. The EFSA Journal 2007, 579, 1-61. 
34
 European Food Safety Authority, 2009. Scientific Report of EFSA on technical specifications for the monitoring and reporting of 
verotoxigenic Escherichia coli (VTEC) on animals and food (VTEC surveys on animals and food). EFSA Journal 2009;7(11):1366, 
43 pp. doi:10.2903/j.efsa.2009.1366 
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Table VT1. Overview of countries reporting data on VTEC for 2012 
Data 
Total number of  
reporting MSs 
Countries 
Human 26 
All MSs except PT 
Non-MSs: CH, IS, NO 
Food 21 
All MSs except BG, DK, EE, LU, MT, UK 
Non-MS: CH 
Animal 11 MSs: AT, DE, DK, EE, FI, IT, LV, NL, SK, SE, UK 
Note:  The overview table includes all data reported by MSs. 
3.4.1. VTEC in humans 
In 2012, the total number of confirmed VTEC cases in the EU was 5,671 based on 22 MSs reporting at least 
one confirmed case and four MSs reporting zero cases. This represents a decrease of 40 % compared with 
2011 (N = 9,487), when a large outbreak of STEC/VTEC O104:H4 occurred in Germany. The outbreak was 
associated with the consumption of contaminated raw sprouted seeds affecting more than 3,800 persons 
alone in Germany and linked cases in an additional 15 countries
35
. 
The EU notification rate was 1.15 cases per 100,000 population in 2012 (Table VT2). The highest country-
specific notification rates were observed in Ireland, the Netherlands and Sweden (8.99, 6.27 and 4.98 cases 
per 100,000 population, respectively). The lowest rates were reported in Bulgaria, Cyprus, the Czech 
Republic, Greece, Hungary, Italy, Latvia, Lithuania, Poland, Romania and Spain (<0.1 cases per 100,000).  
Most (81 %) of the VTEC cases reported in the EU, with known data, were infected within their own country, 
with the highest proportion of domestic cases (83.3-100 %) reported in the Czech Republic, Germany, 
Ireland, Slovakia and Spain (Figure VT1). Only three countries (Denmark, Estonia and Sweden) reported a 
higher proportion of travel-associated cases than domestic cases with the highest proportion in Estonia 
(67 % of the three cases).  
There was a clear seasonal trend in the confirmed VTEC cases reported in the EU in 2008-2012 with more 
cases reported in the summer months (Figure VT2). A dominant peak in the summer of 2011 (Figure VT2, 
top) was attributed to the large STEC/VTEC O104:H4 outbreak mentioned above. A statistically significant 
increasing EU trend of confirmed VTEC cases was observed in 2008-2010 with the 2011 outbreak data 
removed (p = 0.001 with linear regression) (Figure VT2, bottom). By countries, increasing trends in 2008-
2012 were observed in 12 MSs: Austria, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, 
the Netherlands, Slovenia, Sweden and the United Kingdom. Decreasing trends were observed in only one 
MS, Malta.  
Thirteen MSs provided information on hospitalisation, covering 37.5 % of all confirmed VTEC cases in 2012. 
Of the cases with this information provided, on average 36.5 % of cases were hospitalised. The highest 
hospitalisation rates 87.8 %, 55.6 % and 46.4 %, were reported in Italy, the Czech Republic and the United 
Kingdom, respectively. Two of these countries also reported among the lowest notification rates of VTEC, 
which indicates that the surveillance systems in these countries primarily capture the more severe cases. 
Two confirmed VTEC cases, each reported by Poland and Romania, were also hospitalised.  
In 2012, 12 deaths due to VTEC infection were reported by 18 MSs (four MSs reported two to five fatal 
cases each, the other 14 MSs none). This resulted in an EU case fatality rate of 0.36 % among the 
3,332 confirmed cases for which this information was provided (58.7 % of all reported confirmed cases). 
  
                                                          
35
 EFSA (European Food Safety Authority) and ECDC (European Centre for Disease Prevention and Control), 2013. The European 
Union Summary Report on Trends and Sources of Zoonoses, Zoonotic Agents and Food-borne Outbreaks in 2011. EFSA Journal 
2013;11(4):3129, 250 pp. doi:10.2903/j.efsa.2013.3129 
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Table VT2. Reported VTEC cases in humans, 2008-2012 and notification rates for confirmed cases, 
2012 
Country 
2012 2011 2010 2009 2008 
Report 
Type
1
 
Cases 
Confirmed 
cases 
Confirmed 
cases/ 
100,000 
Confirmed cases 
Austria C  131 130 1.54 120 88 91 69 
Belgium C  105 105 0.95 100 84 96 103 
Bulgaria U 0 0 0 1 0 0 0 
Cyprus U 0 0 0 0 0 0 0 
Czech Republic
2
 C 9 9 0.09 7 - - - 
Denmark C  193 193 3.46 215 178 160 161 
Estonia C  3 3 0.22 4 5 4 3 
Finland C  30 30 0.56 27 21 29 8 
France C  208 208 0.32 221 103 93 85 
Germany C  1,587 1,573 1.93 5,558 955 887 876 
Greece U 0 0 0 1 1 0 0 
Hungary C  3 3 0.03 11 7 1 0 
Ireland C  554 412 8.99 275 197 237 213 
Italy C  68 50 0.08 51 33 51 26 
Latvia U 0 0 0 0 0 0 0 
Lithuania C 2 2 0.07 0 1 0 0 
Luxembourg C  21 21 4.00 14 7 5 4 
Malta C  1 1 0.24 2 1 8 8 
Netherlands C  1,049 1,049 6.27 845 478 314 92 
Poland C  3 1 <0.01 5 3 0 3 
Portugal
3
 - - - - - - - - 
Romania C  1 1 <0.01 2 2 0 4 
Slovakia C  9 9 0.17 5 10 14 8 
Slovenia C  29 29 1.41 25 20 12 7 
Spain C  31 31 0.07 20 18 14 24 
Sweden C  472 472 4.98 477 334 228 304 
United Kingdom C  1,339 1,339 2.17 1,501 1,110 1,339 1,164 
EU Total   5,848 5,671 1.15 9,487 3,656 3,583 3,162 
Iceland C  1 1 0.31  2 2 8 4 
Liechtenstein - -   -       0 
Norway C  75 75 1.50 47 52 108 22 
Switzerland
4
 C  63 63 0.79 71 31 40 72 
1. C: case-based data reported; -: no report; U: unspecified.  
2. Mandatory notification of VTEC in 2008 and reported to ECDC from 2011. 
3. No surveillance system. 
4. Switzerland provided data directly to EFSA.      
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Figure VT1.  Notification rates and origin of VTEC infections in humans in the EU/EFTA, 2012 
 
Note: The map shows the distribution of human cases shaded according to incidence rate per 100,000 based on quartile 
classification method (EUROSTAT population data 2012). 
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Figure VT2.  Trend in reported confirmed cases of human VTEC infections in the EU, 2008-2012 (top) 
and 2008-2010 (bottom) 
 
 
 
 
Source: Data for EU trend from 23 MSs: Austria, Belgium, Cyprus, Denmark, Estonia, Finland, Greece, France, Germany, Hungary, 
Ireland, Italy, Lithuania, Luxembourg, Malta, Netherlands, Poland, Romania, Slovakia, Slovenia, Spain, Sweden, and United 
Kingdom. Bulgaria was excluded as only monthly data were reported. The Czech Republic did not report cases for all five 
years. Latvia reported zero cases throughout the period and Portugal does not have surveillance systems for this disease. 
Data on O antigens of strains were reported for 3,483 (61 %) of the confirmed VTEC cases in 2012. The 
most commonly reported serogroup was O157 (41.1 %), followed by O26 (12.0 %) and O91 (3.6 %). As in 
previous years, the highest numbers of O157-associated confirmed cases (accounting for 75.2 % of all 
confirmed O157 cases) were reported by the United Kingdom and Ireland (Table VT3). This can be due to a 
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higher proportion of confirmed VTEC cases being serotyped in the United Kingdom and Ireland compared 
with some other countries. Serogroup VTEC O104 was reported in significantly lower numbers than in 2011. 
Seven confirmed cases of serogroup O104 were reported in 2012 in five countries (Austria, Belgium, France, 
Germany and the Netherlands) (data not shown).  
Table VT3. VTEC serogroups in humans by EU MS, 2012 
Country 
Serogroup 
O157 O26 O91 O103 O145 O146 O111 O128 O113 NT Other 
Austria 17 23 0 7 9 1 5 1 4 19 23 
Belgium 65 8 1 3 3 - 1 1 1 - 22 
Denmark 38 8 7 8 19 18 3 6 1 2 68 
Czech Republic 5 4 - - - - - - - - - 
France 68 37 7 1 4 - 18 3 - 47 20 
Germany
1
 84 50 72 34 26 14 14 1 4 47 125 
Hungary 1 - 1 - - - - - - 1 - 
Ireland 187 147 - 5 21 2 6 - - 24 1 
Italy 14 17 - 4 3 - 5 - - - - 
Lithuania 1 1 - - - - - - - - - 
Luxembourg - 2 - 1 - - - 1 - - 1 
Netherlands 89 29 30 9 9 10 2 1 3 30 74 
Poland 1 - - - - - - - - - - 
Romania - 1 - - - - - - - - - 
Slovakia - - - - - - - - - 9 - 
Slovenia 5 2 - 3 - 1 - - 1 5 5 
Spain 24 1 - - - - 3 - - - 3 
Sweden 71 60 7 37 8 8 9 6 8 21 57 
United Kingdom 1,277 21 - 4 2 2 - - 2 - 9 
EU Total 1,947 411 125 116 104 56 66 20 24 205 408 
Iceland 1 - - - - - - - - - - 
Norway 12 6 5 17 8 2 - - - 21 4 
EU/EEA Total 1,960 417 130 133 112 58 66 20 24 226 412 
1. DataSource = ‘DE-SURVNET@RKI-7.1’ 
 
3.4.2. VTEC in food  
In total, 21 MSs and 1 non-MS (Switzerland) reported data on VTEC in food for 2012. When interpreting the 
VTEC data it is important to note that data from different investigations are not necessarily directly 
comparable owing to differences in sampling strategies and the analytical methods applied. Belgium, 
Hungary and Poland reported having used the ISO 16654:2001 analytical method, which is designed to 
detect only VTEC O157. Romania used real-time PCR. Austria, Belgium, the Czech Republic, France and 
the Netherlands reported using the ISO/PRF TS 13136:2012 method specifically for testing seed samples. 
This method aims to detect the VTEC serogroups O157, O111, O26, O103 and O145. Germany did not 
provide information on the analytical method used for testing food samples.  
Bovine meat  
Contaminated bovine meat is considered to be a major source of food-borne VTEC infections in humans. In 
2012, nine MSs reported data on VTEC in fresh bovine meat from 10 investigations with 25 or more 
samples. VTEC was detected in seven of these 10 investigations. A total of 4,603 bovine meat units (single 
or batch) were tested for VTEC and 58 units (1.3 %) were found to be VTEC-positive and six units (0.1 %) 
VTEC O157-positive (Table VT4).  
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The Czech Republic and Romania reported testing batches of carcases at the slaughterhouse. Only the 
Czech Republic reported 1.3 % of the batches positive for VTEC. Both countries used carcase swabs, but in 
the Czech Republic investigation, the area swabbed was larger. The Czech Republic also tested for the 
presence of other human pathogenic VTEC serogroups in the bovine meat samples and detected isolates 
from the VTEC O103, O104 and O145 serogroups. Belgium and Germany reported investigations of single 
carcases for VTEC at the slaughterhouse. Belgium found 0.9 % of the carcase surface samples positive for 
VTEC and 0.2 % positive for VTEC O157, and Germany reported 5.7 % of carcases positive for VTEC, but 
none for VTEC O157.  
 
 
 
 
At point of processing, Belgium found 0.5 % of samples from batches of fresh meat positive for VTEC and 
VTEC O157, France found 0.4 % of samples of fresh meat positive for VTEC and 0.2 % for VTEC O157, 
while Hungary did not find any positive samples. 
Austria and the Netherlands reported investigations of fresh bovine meat at retail; 1.8 % and 3.2 %, 
respectively, were found positive for VTEC but none was positive for VTEC O157. 
The other data reported on bovine meat and products thereof are presented in the Level 3 Tables. 
 
  
In the Czech Republic, the sampling for monitoring of VTEC, in fresh bovine meat, was performed at 
slaughterhouses during June, July and August. The samples were taken as swabs from the carcases of 
cattle. Swabs were taken from four places on the carcase. The sampling area of the swab was 100 cm
2
. 
VTEC was detected in 8 of 622 swabs from carcases (1.3 %) (Table VT4). 
Source: The Czech Republic National Zoonoses Summary Report, 2012. 
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Table VT4. VTEC in fresh bovine meat, 2012 
Country Description 
Sample 
unit 
Sample 
weight 
N 
VTEC VTEC O157 
VTEC serogroups 
N pos % pos N pos % pos 
Austria Fresh, at retail Single 25 g 56 1 1.8 0 0 
O51:H49 eae 
positive vtx1 
negative vtx2 
positive 
Belgium 
Carcase swab, at 
slaughterhouse 
Single 1,600 cm
2
 453 4 0.9 1 0.2 
  
Fresh, at 
processing 
Batch  25 g 374 2 0.5 2 0.5 
  
Czech Republic 
Carcase swab, at 
slaughterhouse 
Batch  400 cm
2
 622 8 1.3 0 0 
O103 eae positive 
vtx2 positive (1), 
O103 eae positive 
vtx1 positive (1), 
O104 (3), O145 
eae positive vtx1 
positive (1), O145 
(2) 
France 
Fresh, at 
processing 
Single 25 g 1,923 7 0.4 3 0.2 
O103:H2 eae 
positive and stx1 
positive (2), 
O26:H11 eae 
positive and stx2 
positive (2), 
O157:H7 eae 
positive, stx1 and 
stx2 positive (2),  
O157:H7 eae 
positive and stx2 
positive (1) 
Germany 
Carcase swab, at 
slaughterhouse  
Single 25 g 315 18 5.7 0 0 
  
Hungary 
Fresh, at 
processing 
Single  25 g 77 0 0 0 0 
  
Netherlands Fresh, at retail Single  25 g 555 18 3.2 0 0   
Poland 
Fresh, at 
unspecified 
sampling level 
Batch  25 g 25 0 0 0 0 
  
Romania 
Carcase swab - 
chilled, at 
slaughterhouse 
Batch  100 cm
2
 203 0 0 0 0 
  
Total (9 MSs)         4,603 58 1.3 6 0.1   
Note: Data presented include only investigations with sample size ≥25. 
 Figures in parentheses are the number of isolates from the non-VTEC O157 strains. 
Other submitted data on VTEC, in meat from other animal species and products thereof, are reported in the 
Level 3 Tables.  
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3.4.3. VTEC in animals 
In total, 11 MSs provided data on VTEC in animals. When interpreting these data it is important to note that 
data from different investigations are not necessarily directly comparable owing to differences in sampling 
strategies and the analytical methods applied. In the case of cattle samples, Denmark, Estonia and Finland 
reported having used the ISO 16654:2001 analytical method, which is intended to detect only VTEC O157. 
Italy used a method based on ISO 16654:2001. Sweden used NMKL 164:2005, which is designed to detect 
only VTEC O157. Austria used enzyme-linked immunosorbent assay (ELISA) to screen the samples for 
presence of verotoxins. The toxin-positive samples were then cultivated to isolate VTEC and, finally, real-
time fluorescent Polymerase Chain Reaction (PCR) was used to detect the toxin genes. Germany reported 
the results of tests in which toxin production was examined by means of Shiga-like toxin-PCR (SLT-PCR), 
ELISA or cytotoxin testing.  
Cattle 
Altogether seven MSs provided data on VTEC in cattle for the year 2012 from investigations with 25 or more 
samples (Table VT5). In all reported investigations VTEC was detected from the animals tested. 
All countries reported data from animals sampled in slaughterhouses. Austria found 32.1 % of the tested 
cattle, over two years old, and 35.7% of the young cattle (one to two years old), positive for VTEC and 1.8 % 
of the young cattle positive for VTEC O157, using recto-anal swabs. Austria used an analytical method that 
is able to detect many VTEC serogroups, and this is very likely the reason why Austria reported a higher 
VTEC prevalence than other MSs.  
Denmark, Estonia, Finland, Italy and Sweden reported a low prevalence of VTEC and VTEC O157, at levels 
ranging from 1.7 % to 8.4 %. Denmark and Finland sampled faeces, while Estonia used hide samples in 
accordance with EFSA’s VTEC monitoring specifications.  
 
 
 
 
Germany provided data at herd level and found 12.9 % of farms with calves under one year and 14.2 % of 
herds with unspecified cattle positive for VTEC, while both types of herds were 0.3 % positive for VTEC 
O157. At farm, Germany reported 2.2 % of calves under one year and 13.7 % of unspecified cattle positive 
for VTEC. Germany also reported 0.4 % and 0.2 % of these animals positive for VTEC O157, respectively. At 
slaughterhouse, at animal level, Germany found 24.0 % of calves under one year positive for VTEC, but 
none of them positive for O157. 
Austria and Germany detected VTEC O26, O91 and O103 serogroups, which are other human pathogenic 
VTEC serogroups, in cattle.  
The other submitted data on VTEC in cattle are reported in the Level 3 Tables.  
Other animals 
Additional information on VTEC findings in animals can be found in the Level 3 Tables.  
 
In Sweden, in an abattoir survey conducted during 2011-2012, VTEC O157 was detected in 73 of 2,376 
faecal samples (3.1 %). In this study, VTEC O157:H7 was isolated predominantly from cattle in southern 
Sweden but rarely from the northern two-thirds of the country. 
Source: Sweden National Zoonoses Summary Report, 2012. 
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Table VT5.  VTEC in cattle, 2012 
Country Description 
Sample 
unit 
Sample 
weight 
N 
VTEC VTEC O157 
VTEC serogroups 
N pos % pos N pos % pos 
Austria 
Adult cattle over 2 years, at 
slaughterhouse,  
recto-anal swab 
Animal 
    
56 18 32.1 0 0 
eae negative vtx1 negative vtx2 positive: O113:H21 (2), 
O178:HNM (1), O39:H48 (1), O113:H4 (1), O46:H2 (1), 
O43:Hrough (1), O178:H19 (1), ONT:H21 (1) 
eae negative vtx1 positive vtx2 positive: O183:H18 (2), 
O91:H21 (1), Orough:H28 (1), O178:H19 (1), O179:HNM (1), 
O15:H2 (1), Orough:H2 (1) 
eae positive vtx1 positive vtx2 negative: O129:HNM (1) 
Young cattle (1-2 years), at 
slaughterhouse,  
recto-anal swab  
Animal 
    
56 20 35.7 1 1.8 
eae negative vtx1 negative vtx2 positive: Orough:H21 (1), 
O91:H10 (1), O91:H21 (1), O179:H8 (2), O39:H48 (2), 
ONT:Hrough (1), O36:Hrough (1), O179:Hrough (1), O109:H16 
(1), O113:H4 (1) 
eae negative vtx1 positive vtx2 negative: O168:H8 (2) 
eae negative vtx1 positive vtx2 positive: O15:HNM (1), 
O91:H21 (1), O178:H12 (1), O22:H8 (2), Orough:HNM (1), 
O185:H5 (1), O36:H2 (1) 
eae positive vtx1 positive vtx2 negative: O103:H2 (1), 
O26:HNM (3) 
eae positive vtx1 positive vtx2 positive: O157:HNM (1) 
Denmark At slaughterhouse, faeces Animal 25 g 251 21 8.4 21 8.4   
Estonia At slaughterhouse, hide Animal   cm
2
 246 13 5.3 13 5.3   
Finland At slaughterhouse, faeces Animal 10 g 1,553 27 1.7 27 1.7   
Germany 
At farm, domestic Animal     925 127 13.7 2 0.2 VTEC O103 (2), VTEC O26 (1), VTEC O91 (1) 
At farm, domestic Herd     709 101 14.2 2 0.3 VTEC O103 (2), VTEC O26 (1), VTEC O91 (1) 
Calves (under 1 year), at 
farm, domestic 
Animal     542 12 2.2 2 0.4 VTEC O103 (2), VTEC O26 (1) 
Calves (under 1 year), at 
slaughterhouse, caecum, 
domestic 
Animal 25 g 325 78 24.0 0 0 
  
Calves (under 1 year), at 
farm, domestic 
Herd     692 89 12.9 2 0.3 VTEC O103 (2), VTEC O26 (1) 
Italy At slaughterhouse, domestic Animal   g 112 2 1.8 2 1.8   
Sweden 
At slaughterhouse, faeces, 
domestic 
Animal     2,376 73 3.1 73 3.1 VTEC O157:H (73) 
Total (7 MSs)   
 
    7,843 581 7.4 145 1.8   
Note: Data presented include only investigations with sample size ≥25. 
 Figures in parentheses are the number of isolates from the non-VTEC O157 strains. 
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3.4.4. Discussion 
In 2012, the number of reported human cases of VTEC infections decreased by 40 % compared with 2011, 
when the largest STEC/VTEC outbreak ever reported in the EU occurred. The outbreak, caused by an 
enteroaggregative Shiga toxin–producing E. coli O104:H4 in raw sprouted seeds, affected more than 
3,800 persons in Germany alone, and additional cases in 15 other countries. There was an increasing EU 
trend of confirmed human VTEC infections in 2008–2012. Even without the 2011 outbreak, the EU trend for 
VTEC infections during 2008–2010 was significantly increasing. The increase in the number of reported 
cases in 2012 compared with 2010 is most likely due to a generally increased awareness of the disease and 
increased detection and reporting by the countries as a result of the 2011 outbreak. Increasing trends in 
2008–2012 were observed in more than half of the reporting MSs, and only one MS observed a significant 
decreasing trend. For example, in the Netherlands the increase in VTEC is mainly caused by more and more 
laboratories testing for all VTEC instead of VTEC O157 only. The trend of VTEC O157 in the Netherlands 
showed a small increase in 2011 and 2012. 
On average, one-third of the VTEC cases in the EU were hospitalised. However data were available for less 
than 40 % of the confirmed cases. Some countries reported very high proportions of hospitalised cases but 
among the lowest notification rates, indicating that the surveillance systems in these countries primarily 
capture the more severe cases. A low case-fatality rate (0.36 %) was reported based on information provided 
by 18 MSs covering almost 60 % of the confirmed VTEC cases. As in previous years, the most commonly 
reported serogroup was O157, followed by O26, O91, O103 and O145. In contrast to 2011, only seven 
confirmed cases of serogroup VTEC O104 were reported in 2012, in five countries. 
Only data reported on VTEC in bovine meat and bovine animals are included in this report. This is because 
cattle and meat thereof are considered the major sources of human VTEC infections. VTEC pathogenic for 
humans were detected by the reporting MSs from fresh bovine meat occasionally and at low levels. The 
human pathogenic VTEC serogroups isolated from bovine meat and cattle samples included VTEC O157, 
O26, O91, O103 and O145.  
The importance of bovine meat as a source of human VTEC infections in humans was also illustrated by the 
reported food-borne outbreak data from 2012. Twelve VTEC outbreaks were reported. Nine outbreaks were 
due to VTEC O157, one to VTEC O113:H4, one to ‘other’ VTEC serogroups, and one to non-grouped E. coli 
positive for LT genes. Half (six out of 12) of the VTEC outbreaks, in which information on the implicated food 
vehicle was provided, were linked to bovine meat and products thereof. Moreover, 10 strong-evidence VTEC 
waterborne outbreaks were reported, all by Ireland, and seven were reported to be linked to private water 
supplies or wells. 
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3.  INFORMATION ON SPECIFIC ZOONOSES AND ZOONOTIC AGENTS 
3.5. Tuberculosis due to Mycobacterium bovis 
Tuberculosis is a serious disease of humans and animals caused by species in the 
Mycobacterium tuberculosis (M. tuberculosis) complex. This group includes M. bovis, responsible for bovine 
tuberculosis, which is a highly contagious disease that can easily spread from one cow to another. M. bovis 
is capable of infecting a wide range of mammals, including humans. In humans, infection with M. bovis 
causes a disease that is indistinguishable from that caused by M. tuberculosis, the primary agent of human 
tuberculosis.  
The main transmission routes of M. bovis to humans are through contaminated food, especially through 
drinking raw milk from infected cows, or eating raw milk products. However, as pasteurisation of milk 
products kills M. bovis, cases of food-borne transmission of this bacterium to humans are extremely rare. 
M. bovis can also be transmitted to humans through direct contact with infected animals. A number of wildlife 
animal species, such as deer, wild boar, badgers and the European bison, may contribute to the spread 
and/or maintenance of M. bovis infection in cattle. 
This chapter focuses on zoonotic tuberculosis caused by M. bovis. 
Table TB1 presents the countries reporting data for 2012. 
Table TB1. Overview of countries that reported data for tuberculosis due to M. bovis for humans and 
animals, 2012 
Data 
Total number of  
reporting MSs  
Countries 
Human 25 
All MSs except FR, GR 
Non-MSs: CH, IS, NO 
Animal 27 
All MSs  
Non-MSs: CH, NO 
Note:  The overview table contains all data reported by MSs and non-MSs. 
3.5.1. M. bovis in humans 
In 2012, 25 MSs provided information on human tuberculosis due to M. bovis (Table TB2). In total, 
125 confirmed cases were reported by 9 MSs while 16 MSs reported zero cases. The number of confirmed 
cases reported decreased in the EU by 15.5 % compared with 2011. Most cases were reported in Germany, 
the United Kingdom and Spain, while the highest notification rate, 0.07 cases per 100,000 population, was 
reported in Ireland. The EU notification rate in 2012 was 0.03 cases per 100,000 population (Table TB2). 
As tuberculosis is a chronic disease with a long incubation period, it is not possible to assess travel-
associated cases in the same way as diseases with acute onset. Instead, the distinction is made between 
cases born in the reporting country (native infection) and those moving there at a later stage (foreign 
infection). In a few cases the distinction is also made on nationality of the cases. On average, 62.2 % of the 
cases reported in 2012 were native to the reporting country, 31.5 % were foreign and 6.3 % were of 
unknown origin (Figure TB1). Among cases with origin provided, there was a somewhat larger proportion 
(72.2 %) of native cases in countries not free of bovine tuberculosis than in countries officially bovine 
tuberculosis free (OTF) (61.5 %).  
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Table TB2. Reported cases of human tuberculosis due to M. bovis in 2008–2012 and notification 
rates for confirmed cases in the EU, in 2012; OTF
1
 status is indicated 
Country 
2012 2011 2010 2009 2008 
Report 
Type
2
 
Cases 
Confirmed 
cases 
Confirmed 
cases/ 
100,000 
Confirmed cases 
Austria (OTF) C 1 1 0.01 0 4 2 3 
Belgium (OTF) C 5 5 0.05 5 9 3 2 
Bulgaria C 0 0 0 2 0 0 0 
Cyprus  U 0 0 0 0 0 0 0 
Czech Republic (OTF) U 0 0 0 4 0 0 0 
Denmark (OTF) U 0 0 0 1 2 0 1 
Estonia (OTF) U 0 0 0 0 0 0 0 
Finland (OTF) C 0 0 0 1 0 0 0 
France (OTF)
3
 ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ 
Germany (OTF) C 44 44 0.05 42 44 57 47 
Greece
3
 ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ 
Hungary  U 0 0 0 0 0 0 0 
Ireland C 3 3 0.07 6 12 8 12 
Italy
4,5
 C 9 9 0.01 15 15 6 4 
Latvia (OTF) U 0 0 0 0 0 0 0 
Lithuania U 0 0 0 0 0 0 0 
Luxembourg (OTF) U 0 0 0 0 0 0 0 
Malta U 0 0 0 0 0 0 0 
Netherlands (OTF) C 8 8 0.05 11 13 11 19 
Poland (OTF) U 0 0 0 0 0 0 0 
Portugal C 0 0 0 0 0 1 1 
Romania U 0 0 0 0 0 0 0 
Slovakia (OTF) U 0 0 0 0 0 0 0 
Slovenia (OTF) U 0 0 0 0 0 0 0 
Spain  C 15 15 0.03 23 34 17 11 
Sweden (OTF) C 5 5 0.05 2 2 5 2 
United Kingdom
6
 C 35 35 0.06 36 33 23 21 
EU Total    125 125 0.03 148 168 133 123 
Iceland
7
 U 0 0 0 0 0 0 0 
Liechtenstein (OTF) ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ 
Norway (OTF) C 2 2 0.04 2 2 1 0 
Switzerland (OTF)
8
 C 5 5 0.06 13 6 4 5 
1. OTF: Officially Tuberculosis Free.  
2. C: case-based report; –: no report; U: unspecified.  
3. Not reporting species of the M. tuberculosis complex (France) or only reporting for M. tuberculosis (Greece).   
4. In Italy, 6 regions and 15 provinces are OTF.  
5. All cases reported from Italy to TESSy in 2008–2012 were without laboratory results but were still included in the table since 
reported as M. bovis. 
6. In the United Kingdom, Scotland is OTF. 
7. In Iceland, which has no special agreement concerning animal health (status) with the EU, the last outbreak of bovine 
tuberculosis was in 1959.  
8. Switzerland reported data directly to EFSA. 
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Figure TB1.  Notification rates and origin of infection in tuberculosis due to M. bovis in the EU/EFTA, 
2012 
 
Note: The map shows the distribution of human cases shaded according to incidence rate per 100,000 based on quartile 
classification method (EUROSTAT population data 2012). 
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3.5.2. Tuberculosis due to M. bovis in animals 
Cattle 
The status regarding freedom from bovine tuberculosis (OTF) and the occurrence of the disease in MSs and 
non-MSs, in 2012, is presented in Figures TB2 and TB3. As in 2011, Austria, Belgium, the Czech Republic, 
Denmark, Estonia, Finland, France, Germany, Latvia, Luxembourg, the Netherlands, Poland, Slovakia, 
Slovenia, Sweden, Norway and Switzerland were OTF in accordance with EU legislation. Liechtenstein has 
the same status (OTF) as Switzerland. In Iceland, which has no special agreement concerning animal health 
(status) with the EU, the last outbreak of bovine tuberculosis was in 1959. Moreover, in Italy the provinces of 
Asti and Biella in the region of Piemonte were declared OTF as well as all administrative regions within the 
superior administrative unit of Algarve in Portugal (Decision 2012/204/EU
36
). Italy now has 6 OTF regions 
and 15 OTF provinces. In the United Kingdom, Scotland is OTF. 
Vaccination of cattle against bovine tuberculosis is prohibited in all MSs and in reporting non-MSs.  
All data submitted by MSs and other reporting countries are presented in the Level 3 Tables of the report. 
Figure TB2.  Status of countries regarding bovine tuberculosis, 2012 
 
  
                                                        
36 
Commission Implementing Decision 2012/204/EU of 19 April 2012 amending the Annexes to Decision 2003/467/EC as regards the 
declaration of Latvia as officially brucellosis-free Member State and of certain regions of Italy, Poland and Portugal as officially 
tuberculosis-free, brucellosis-free and enzootic-bovine-leukosis-free regions. OJ L 109, 21.4.2012, p. 26–32.
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Figure TB3.  Proportion of existing cattle herds infected with or positive for M. bovis, country based-
data, 2012 
 
 
Trend indicators for tuberculosis due to M. bovis 
To assess the annual EU trends in bovine tuberculosis and to complement the MS-specific figures, two 
epidemiological trend indicators have been used since 2005.  
The first indicator, ‘% existing herds infected/positive’ is ‘the number of infected herds’ (or ‘the 
number of positive herds’, respectively) divided by ’the number of existing herds in the country’. This 
indicator describes the situation in the whole country during the reporting year. 
A second indicator ‘% tested herds positive’ is ‘the number of test-positive herds’ divided by ‘the 
number of tested herds’. This indicator gives a more precise picture of the testing results and also 
estimates the herd prevalence during the whole reporting year. This information is available only from 
countries or regions with EU co-financed eradication programmes. 
Infected herds means all herds under control which are not OTF at the end of the reporting period. This 
figure summarises the results of different activities (tuberculin testing, meat inspection, follow-up 
investigations and tracing). Data on infected herds are reported from countries and regions that do not 
receive EU co-financing for eradication programmes. 
Positive herds are herds with at least one bacteriological or tuberculin skin test-positive animal during 
the reporting year, independent of the number of times the infection status of each herd has been 
checked. Data for positive herds are reported from countries and regions that receive EU co-financing for 
eradication programmes. 
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During the years 2006–2012, the proportion of existing cattle herds infected or positive for M. bovis in the EU 
(all MSs) was relatively stable at a very low level and ranging from 0.37 % in 2007 to 0.67 % in 2012 
(Figure TB4). In the non-OTF MSs the proportion of M. bovis-positive herds increased from very low (0.46 %) 
in 2007 to low (1.26 %) in 2012. 
Figure TB4.  Proportion of existing cattle herds infected with or positive for M. bovis, 2006–2012 
 
Source:  All reporting countries that are MSs during the current year are included. Data from Bulgaria only for 2008 and 2009, Romania 
 for 2007-2009. Data missing from Lithuania (2007) and Malta (2006). 
1.  OTF: Officially Tuberculosis Free. 
Officially Tuberculosis-Free Member States and non-Member States 
Bovine tuberculosis was not detected in cattle herds in nine of the 15 OTF MSs and Norway and 
Switzerland, during 2012. However, in total, out of the 1,311,492 existing herds in the OTF MSs, 203 herds 
were infected with M. bovis: in Belgium (one herd), France (169 herds), Germany (23 herds), Poland (seven 
herds), the Netherlands (two herds) and in Slovenia (one herd). Three herds were positive for M. caprae in 
Austria.  
Non-Officially Tuberculosis-Free Member States 
All reporting non-OTF MSs have national eradication programmes for bovine tuberculosis in place. 
Table TB3 shows the reported results from MSs that did not receive EU co-financing for their eradication 
programmes in 2012, while Table TB4 shows results from those MSs with eradication programmes co-
financed by the EU. In 2012, Ireland, Italy, Portugal, Spain and the United Kingdom received EU co-financing 
(Decision 2011/807/EU
37
). 
Among the non-co-financed non-OTF MSs, four, Bulgaria, Cyprus, Lithuania and Malta, did not report any 
infected herds during 2012 (Table TB3). 
In total, the 12 non-OTF MSs reported 1,443,690 existing bovine herds, with 18,208 of them (1.26 %) 
infected with or positive for M. bovis in 2012. 
                                                        
37 Commission Implementing Decision 2011/807/EU of 30 November 2011 approving annual and multiannual programmes and the 
financial contribution from the Union for the eradication, control and monitoring of certain animal diseases and zoonoses presented 
by the Member States for 2012 and following years. OJ L 322, 6.12.2011, p. 11–22. 
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Among the non-co-financed non-OTF MSs, Greece reported the highest number of infected herds (166), 
followed by Romania (75). Compared with the data from 2011, the overall prevalence of infected herds in the 
MS group that did not receive EU co-financing for their eradication programmes increased slightly (from 
0.02 % to 0.03 %). 
Table TB3. Mycobacterium bovis in cattle herds in non-co-financed non-OTF MSs, 2012 
Non-officially free MSs 
No of existing 
herds 
No of officially free 
herds 
No of infected 
herds 
% existing herds 
infected 
Bulgaria 98,177 98,177 0 0 
Cyprus
1
 309 277 0 0 
Greece 40,376 11,656 166 0.41 
Hungary 16,645 16,632 1 0.01 
Lithuania 79,242 79,242 0 0 
Malta 121 121 0 0 
Romania 682,802 682,728 75 0.01 
Total (7 MSs) 917,672 888,833 242 0.03 
1. The total number of existing bovine herds refers to the number of herds under the bovine tuberculosis control programme. 
The non-OTF MSs with eradication programmes co-financed by the EU were the same as in 2011: Ireland, 
Italy, Portugal, Spain and the United Kingdom. For these five MSs there was an overall slight increase in 
both indicators (the proportions of positive herds among the existing herds and among the tested herds): 
from 3.23 % and 4.36 %, respectively, in 2011, to 3.42 % and 4.72 % respectively, in 2012. The United 
Kingdom had the highest percentages of existing positive herds and herds testing positive (10.4 % and 
16.16 %, respectively) (Table TB4). Ireland reported the next highest percentages of existing positive herds 
(4.37 %) and herds testing positive (4.37 %). 
Table TB4. Mycobacterium bovis in cattle herds in co-financed non-OTF MSs
1
, 2012 
Non-officially free MSs 
No of existing 
herds 
No of tested 
herds 
No of positive 
herds 
% existing 
herds positive 
% tested 
herds positive 
Ireland 115,787 115,787 5,063 4.37 4.37 
Italy
2
 123,661 54,157 414 0.33 0.76 
Portugal
3
 57,704 31,570 113 0.20 0.36 
Spain 123,826 111,636 1,457 1.18 1.31 
United Kingdom
4
 105,040 67,549 10,919 10.40 16.16 
Total (5 MSs) 526,018 380,699 17,966 3.42 4.72 
1. Only tested and positive herds from regions that have co-financed eradication programmes are included. The number of existing 
herds includes all herds from all regions in the MS. 
2. In Italy, 6 regions and 15 provinces are OTF. In the provinces that are OTF or do not have a co-financed eradication programme, 
one of the 46,925 existing herds was found infected. 
3. In Portugal, all administrative regions (distritos) within the superior administrative unit (região) of Algarve were recognized as 
OTF in 2012. In that superior administrative unit none of the 311 herds was found infected. 
4. During 2009, Scotland obtained status as OTF (Decision 2009/761/EC). In Scotland, 5 of the 12,982 existing herds were found 
infected in 2012.  
The MS-specific trends in test-positive herds in the three non-OTF MSs with continued co-financing from 
2004 to 2012 are shown in Figure TB5. Over the nine years reported, the trends seem to be decreasing in 
Italy and Spain. For Portugal the trend is less clear but is at a lower level than in the two other non-OTF MSs.  
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Figure TB5.  Prevalence and 95 % CI for M. bovis test-positive cattle herds, at MS level, in three co-
financed non-OTF MSs, 2004–2012
1
 
 
1. Vertical bars indicate the exact binomial 95 % Confidence Interval. 
Animal species other than cattle 
Where performed, surveillance of tuberculosis due to M. bovis in animal species other than cattle mainly 
entails post-mortem meat inspection. In addition, results from clinical investigations or from other specific 
local studies are also reported. 
In 2012, 15 MSs and 1 non-MS sampled animal species other than cattle. M. bovis was detected in alpacas, 
badgers, bison, cats, farmed and hunted wild and park deer (roe deer, red deer and fallow deer), dogs, 
goats, lamas, pigs, sheep and wild boar. 
All data submitted by MSs and other reporting countries are presented in the Level 3 Tables.  
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3.5.3. Discussion 
Tuberculosis due to M. bovis is a rare infection in humans in the EU, with 125 confirmed human cases 
reported in 2012. The case numbers in the EU have decreased in the last two years. There was no clear 
association between a country’s status as officially free from bovine tuberculosis (OTF) and notification rates 
in humans. This could be due to many of the cases in both OTF and non-OTF countries being persons who 
have immigrated to the country; thus, the infection might have been acquired in their country of origin. Cases 
native to the country could have been infected before the disease was eradicated from the animal population 
as it may take years before disease symptoms develop.  
Fifteen MSs have OTF status and nine of them did not report any infected cattle herds. The reported 
proportion of infected or positive herds in the 12 non-OTF MSs increased slightly in 2012 compared with 
2011. Four of the 12 non-OTF MSs reported no infected cattle herds in 2012. Of the eight non-OTF MSs 
reporting herds infected with or positive for M. bovis, the prevalence of bovine tuberculosis remained at a 
level comparable to or lower than in 2011, except in the United Kingdom which reported an increase in the 
prevalence of bovine tuberculosis and accounted for the highest proportion of positive herds. This was the 
fourth consecutive year that the United Kingdom reported an increase in bovine tuberculosis.  
In 2012, 15 MSs and 1 non-MS sampled animal species other than cattle and detected M. bovis in several 
domestic and wildlife species. These findings demonstrate that wild animals are infected and may constitute 
a reservoir for M. bovis, which is in line with a technical report submitted to EFSA in October 2009
38
. 
                                                        
38
 European Food Safety Authority, 2009.Technical report submitted to EFSA. Scientific review on Tuberculosis in wildlife in the EU. 
Available online: http://www.efsa.europa.eu/en/supporting/pub/12e.htm 
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3.  INFORMATION ON SPECIFIC ZOONOSES AND ZOONOTIC AGENTS 
3.6. Brucella 
Brucellosis is an infectious disease caused by some bacterial species of the genus Brucella. There are six 
species known to cause human disease, and each of these has a specific animal reservoir: 
Brucella melitensis (B. melitensis) in goats and sheep, B. abortus in cattle, B. suis in pigs, B. canis in dogs 
and B. ceti and B. pinnipedialis in marine mammals.  
In humans, brucellosis is characterised by flu-like symptoms such as fever, headache and weakness of 
variable duration. However, severe infections of the central nervous system or endocarditis may occur. 
Brucellosis can also cause long-lasting or chronic symptoms including recurrent fever, joint pain, arthritis and 
fatigue. Of the six species known to cause disease in humans, B. melitensis is the most virulent and has the 
largest public health impact in the EU owing to the prevalence of this Brucella species in small ruminant 
populations in many areas of the world and in certain European MSs. Humans can be infected from direct 
contact with infected animals or with animal tissue contaminated with the organisms (occupational 
exposure). Transmission to humans also occurs through ingestion of contaminated products, such as 
drinking raw (unpasteurised) milk from infected animals, or eating raw milk products. In animals, the 
organisms are localised in the reproductive organs, causing infertility and abortions, and are shed in large 
numbers in urine, milk and placental fluid. 
Table BR1 presents the countries reporting data for 2012.  
Table BR1.  Overview of countries reporting Brucella data, 2012 
Data 
Total number of  
reporting MSs  
Countries 
Human 26 
All MSs except DK 
Non-MSs: CH, NO 
Food 3 MSs: BE, ES, IT  
Animal 27 
All MSs 
Non-MSs: CH, IS, NO 
Note: The overview table contains all data reported by MSs and non-MSs. 
 
3.6.1. Brucellosis in humans 
In 2012, 26 MSs provided information on brucellosis in humans. Eleven MSs (Cyprus, the Czech Republic, 
Estonia, Hungary, Latvia, Lithuania, Luxembourg, Malta, Poland, Romania and Slovenia) reported no human 
cases. In total, 359 cases of human brucellosis, of which 328 were confirmed, were reported in the EU in 
2012 (EU notification rate 0.07 cases per 100,000 population) (Table BR2). This was a 2.4 % decrease in 
confirmed cases compared with 2011.  
 
As in previous years, MSs with the status officially free of bovine brucellosis (Officially Brucellosis Free, OBF, 
see map in animal section, figure BR3) as well as officially free of ovine and caprine brucellosis caused by 
B. melitensis (Officially B. melitensis Free, ObmF) reported low numbers of human cases, whereas the non-
OBF/non-ObmF MSs Greece, Portugal and Spain, accounted for 67.7 % of all confirmed cases in 2012 
(Table BR2). The highest notification rates were observed in Greece (1.09 cases per 100,000 population), 
Portugal (0.36), Sweden (0.14), Spain (0.13) and Norway (0.08), but while the majority of cases were 
domestically acquired in the non-OBF/non-ObmF MSs, the majority of cases in Sweden and Norway, as in 
other OBF and OBmF countries, were travel associated (Figure BR1). In addition to travel-associated cases, 
OBF and OBmF countries may also experience domestically acquired cases (Figure BR1). These can occur 
in immigrants from endemic areas or be due to (private) import of unpasteurised dairy products from 
endemic areas.  
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Table BR2.  Reported cases of human brucellosis in 2008-2012, and notification rates for confirmed 
cases in 2012, OBF and ObmF status
1
 is indicated 
Country 
2012 2011 2010 2009 2008 
Report 
Type
2
 
Cases 
Confirmed 
cases 
Confirmed 
cases/ 
100,000 
Confirmed cases 
Austria  (OBF/ObmF) C 3 2 0.02 5 3 2 5 
Belgium (OBF/ObmF) C 4 4 0.04 5 0 1 1 
Bulgaria A 1 1 0.01 2 2 3 8 
Cyprus U 0 0 0 0 0 0 0 
Czech Republic (OBF/ObmF) U 0 0 0 0 1 0 1 
Denmark
3 
(OBF/ObmF) - - - - - - - - 
Estonia (OBF/ObmF) U 0 0 0 0 0 0 0 
Finland (OBF/ObmF) U 1 1 0 0 0 1 0 
France
4
(OBF) C 32 28 0.04 21 20 19 21 
Germany  (OBF/ObmF) C 28 28 0.03 24 22 19 24 
Greece C 123 123 1.09 98 97 106 304 
Hungary (ObmF) U 0 0 0 0 0 0 0 
Ireland  (ObmF) C 2 2 0.04 1 1 0 2 
Italy
5
 C 9 9 0.01 21 10 23 163 
Latvia U 0 0 0 0 0 0 0 
Lithuania U 0 0 0 0 0 1 0 
Luxembourg (OBF/ObmF) C 0 0 0 1 1 0 0 
Malta U 0 0 0 0 0 0 0 
Netherlands (OBF/ObmF) C 3 3 0.02 1 6 3 3 
Poland (ObmF) U 0 0 0 0 0 3 1 
Portugal
6
 C 48 37 0.36 76 88 80 56 
Romania (ObmF) C 0 0 0 1 2 3 2 
Slovakia (OBF/ObmF) U 1 1 0 0 1 0 1 
Slovenia (ObmF) C 0 0 0 1 0 2 2 
Spain
7
 C 77 62 0.13 43 78 114 120 
Sweden (OBF/ObmF) C 13 13 0.14 11 12 7 8 
United Kingdom (OBF/ObmF)
8
 C 14 14 0.02 25 12 17 13 
EU Total 
 
359 328 0.07 336 356 404 735 
Iceland
9
 - - - - 0 0 0 0 
Liechtenstein - - - - - - - - 
Norway (OBF/ObmF) C 4 4 0.08 2 2 0 0 
Switzerland (OBF/ObmF)
10
 C 3 3 0.04 8 5 14 5 
1. OBF/ObmF: Officially Brucellosis free/Officially B. melitensis free in cattle or sheep/goat population. 
2. A: aggregated data report; C: case-based report; –: no report; U: unspecified.  
3. No surveillance system.  
4. In France, 64 departments are ObmF and no cases of brucellosis have been reported in small ruminants since 2003. 
5. In Italy, 10 regions and 11 provinces are OBF and also 11 regions and 8 provinces are ObmF.  
6. In Portugal, six islands of the Azores and the superior administrative unit of Algarve are OBF whereas all nine Azores islands are 
ObmF. 
7. In Spain, two provinces of the Canary Islands are OBF/ObmF and the Balearic Islands are ObmF. 
8. In the United Kingdom, England, Scotland and Wales in Great Britain and the Isle of Man are OBF and the whole of the United 
Kingdom is ObmF. 
9. In Iceland, which has no special agreement concerning animal health (status) with the EU, brucellosis (B. abortus, B. melitensis, 
B. suis) has never been reported.  
10. Switzerland provided data directly to EFSA.  
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Figure BR1.  Notification rates and origin of infection in human brucellosis in the EU/EFTA, 2012 
 
Note: The map shows the distribution of human cases shaded according to incidence rate per 100,000 based on quartile 
classification method (EUROSTAT population data 2012). 
 
There was some seasonality observed in the number of confirmed brucellosis cases reported in the EU in 
2008-2012 (Figure BR2, top), with a dominant peak in 2008 attributed to a large outbreak on the Greek 
island of Thassos, in which 98 people fell ill with brucellosis. Consumption of locally produced raw cheese 
was identified as the most likely source of infection
39
. When removing the year 2008 (Figure BR2, bottom), 
no significant increasing or decreasing EU trend could be observed for the remainder of the period 
(2009-2012). Significant decreasing trends by country over the period 2008–2012 were observed in Italy and 
Spain, although in the case of Spain the case numbers rose again in 2012 (Greece not tested due to the 
effect of the outbreak in 2008). No increasing trends were observed in any country and many countries had 
too few cases to enable trend analysis. 
Six MSs provided data on hospitalisation for all or some of their cases. On average, 78.0 % of the confirmed 
brucellosis cases were hospitalised, but hospitalisation status was provided for only 51.2 % of the confirmed 
cases in the EU.  
Seven MSs provided information on the outcome of the cases. One death due to brucellosis was reported in 
Portugal in 2012. This resulted in an EU case fatality rate of 0.93 % among the 108 confirmed cases for 
which this information was reported (32.9 % of all confirmed cases). 
Species information was provided for 99 of the 332 confirmed cases reported in the EU and Norway. Of 
these, 83.8 % were reported to be B. melitensis, 10.1 % B. abortus, 3.0 % B. suis and 3.0 % other Brucella 
species.  
  
                                                          
39
 Karagiannis I, Mellou K, Gkolfinopoulou K, Dougas G, Theocharopoulos G, Vourvidis D, Ellinas D, Sotolidou M, Papadimitriou T and 
Vorou R, 2012. Outbreak investigation of brucellosis in Thassos, Greece, 2008. Euro Surveillance, 17(11):pii=20116. Available 
online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20116 
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Figure BR2.  Trend in reported confirmed cases of human brucellosis in the EU,  
2008-2012 (top) and 2009-2012 (bottom)  
 
 
 
Source: 25 MSs: Austria, Belgium, Bulgaria, Czech Republic, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Lithuania, 
Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, and United Kingdom. Cyprus, Estonia, Latvia and 
Malta reported zero cases throughout the period. Luxembourg data were excluded as only cases per year were reported. 
Denmark does not have a surveillance system for this disease. 
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3.6.2. Brucella in food 
In 2012, one MS (Belgium) reported investigations on Brucella in raw cow’s milk for manufacture. Belgium 
tested all dairy herds following brucellosis outbreaks in March–May 2012 and one herd was found to be 
infected with Brucella suis biovar 2, using an ELISA of tank milk. This raw milk from cows was intended for 
the manufacture of heat-treated products at a processing plant. Findings of Brucella spp. were also reported 
by Italy in samples of ‘milk from other animal species or unspecified’, at processing plant. 
All data on Brucella in food submitted by MSs are presented in the Level 3 Tables. 
3.6.3. Brucella in animals 
Cattle 
The status regarding freedom from bovine brucellosis (Officially Brucellosis Free, OBF) and the occurrence 
of the disease in MSs and non-MSs, in 2012, is presented in Figures BR3 and BR4. As in 2011, Austria, 
Belgium, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Ireland, Luxembourg, the 
Netherlands, Poland, Slovakia, Slovenia and Sweden, as well as Norway and Switzerland, were OBF in 
accordance with EU legislation. In 2012, Latvia was also declared OBF (Decision 2012/204/EU). 
Liechtenstein has the same status (OBF) as Switzerland. Moreover, in the non-MS Iceland, which has no 
special agreement concerning animal health (status) with the EU, brucellosis (B. abortus, B. melitensis, 
B. suis) has never been reported. In the United Kingdom, England, Scotland and Wales in Great Britain have 
been classified as OBF (Decision 2003/467/EC
40
), as also has the Isle of Man (Decision 2011/277/EU
41
). In 
Italy, the region of Valle d’Aosta was recognised as OBF during 2012 (Decision 2012/204/EU) so there are 
now 10 regions and 11 provinces OBF in Italy. In Portugal, six of the nine islands of the Azores (Pico, 
Graciosa, Flores, Corvo, Faial and Santa Maria) are OBF (Decision 2003/467/EC and Decision 
2009/600/EC
42
), while in 2012 all administrative regions within the superior administrative unit of Algarve 
were declared OBF (Decision 2012/204/EU). In Spain, two provinces of the Canary Islands (Santa Cruz de 
Tenerife and Las Palmas) are OBF (Decision 2009/600/EC). 
All data submitted by MSs and other reporting countries are presented in the Level 3 Tables. 
 
 
  
 
                                                          
40 
Commission Decision 2003/467/EC of 23 June 2003 establishing the official tuberculosis, brucellosis, and enzootic-bovine-leukosis-
free status of certain Member States and regions of Member States as regards bovine herds, OJ L 156, 25.6.2003, p. 74–78. 
41
  Commission Implementing Decision 2011/277/EU of 10 May 2011 amending Annex II to Decision 93/52/EEC as regards the 
recognition of certain regions in Italy as officially free of brucellosis (B. melitensis) and amending the Annexes to Decision 
2003/467/EC as regards the declaration that certain regions of Italy, Poland and the United Kingdom are officially free of bovine 
tuberculosis, bovine brucellosis and enzootic bovine leukosis. OJ L 122, 11.5.2011, p. 100–106.  
42 
Commission Decision 2009/600/EC of 5 August 2009 amending Decision 2003/467/EC as regards the declaration that certain 
Member States and regions thereof are officially free of bovine brucellosis. OJ L 204, 6.8.2009, p. 39–42. 
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Figure BR3.  Status of countries regarding bovine brucellosis, 2012 
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Figure BR4.  Proportion of existing cattle herds infected with or positive for Brucella, country based-
data, 2012 
 
 
 
Trend indicators for brucellosis 
To assess the annual EU trends in bovine and ovine/caprine brucellosis and to complement the MS-
specific figures, two epidemiological trend indicators have been used since 2005. 
The first indicator, ‘% existing herds infected/positive’, is ‘the number of infected herds’ (or ‘the 
number of positive herds’, respectively) divided by ‘the number of existing herds in the country’. This 
indicator describes the situation in the whole country during the reporting year. 
The second indicator, ‘% tested herds positive’ is ‘the number of herds test-positive’ divided by ‘the 
number of tested herds’. This indicator gives a more precise picture of the testing results and also 
estimates the herd prevalence during the whole reporting year. This information is available only from 
countries with EU co-financed eradication programmes. 
Infected herds are all herds under control, which are not free or officially free at the end of the reporting 
period. This figure summarises the results of different activities (notification of clinical cases, routine 
testing, meat inspection, follow-up investigations and tracing). Infected herds are reported by countries 
and regions that do not receive EU co-financing for eradication programmes. 
Positive herds are herds with at least one positive animal during the reporting year, independent of the 
number of times the herds have been checked. Positive herds are reported from countries and regions 
that receive EU co-financing for eradication programmes. 
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Over the years 2005–2012, the overall proportion of existing brucellosis-infected or -positive cattle herds in 
the EU decreased steadily to very low levels, and since 2007 bovine brucellosis has been rare, with the 
proportion of infected or positive herds in 2012 being 0.05 % (Figure BR5). The percentage of existing 
infected or positive herds in the non-OBF MSs also decreased between 2005 and 2007, then stabilised until 
2011, after which it further decreased in 2012. In 2012, bovine brucellosis was rare also in the non-OBF MSs 
(0.09 %). 
Figure BR5.  Proportion of existing cattle herds infected with or positive for Brucella, 2005-2012
1 
 
1.  Missing data from OBF MS: Germany (2008) and non-OBF MSs: Hungary (2005), Malta (2006) and Lithuania (2007). Romania 
included data for the first time in 2007 and Bulgaria in 2008. 
2. OBF: Officially Brucellosis Free. 
Officially Bovine Brucellosis-Free Member States and non-Member States 
During 2012, bovine brucellosis was not detected in cattle herds in 13 of the 16 OBF MSs or in Iceland, 
Norway and Switzerland. However, in total, out of the 1,281,730 existing herds in the OBF MSs, 9 herds 
were infected with Brucella: 6 in Belgium, 2 in France and 1 in Germany.  
Non-Officially Bovine Brucellosis-Free Member States 
In 2012, the 11 non-OBF MSs reported a total population of 1,315,895 bovine herds, of which 0.09 % were 
found to be infected with or positive for bovine brucellosis, and this level was comparable to the level 
reported in 2007–2011. 
Greece was the only non-OBF MS without an EU co-financed eradication programme in which positive herds 
(391) were detected during 2012. The percentage of positive existing cattle herds in Greece was 0.97 %, 
which was higher than in 2011 (264 positive herds; 0.86 %). The remaining six non-co-financed non-OBF 
MSs (Bulgaria, Cyprus, Hungary, Lithuania, Malta and Romania) reported no infected or positive cattle herds 
out of 877,413 existing bovine herds in 2012. 
As regards non-OBF MSs with eradication programmes co-financed by the EU, compared with 2011, there 
was an overall decrease in both indicators (the proportions of positive herds among the existing herds and 
among the tested herds): from 0.39 % and 0.60 %, respectively, in 2011 to 0.25 % and 0.39 %, respectively, 
in 2012 (Table BR3). Also at the MS level, in all four co-financed non-OBF MSs both indicators decreased, in 
comparison with 2011. For further details see the Level 3 Tables. 
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Table BR3.  Brucella in cattle herds in four co-financed non-OBF MSs
1
, 2012 
Non-officially free 
MSs 
No of existing 
herds 
No of tested 
herds 
No of positive 
herds 
% existing 
herds positive 
% tested herds 
positive 
Italy
2
 112,080 35,055 576 0.51 1.64 
Portugal
3
 57,704 35,020 108 0.19 0.31 
Spain
4
 123,372 109,719 83 0.07 0.08 
United Kingdom
5
 25,776 22,691 23 0.09 0.10 
Total (4 MSs) 318,932 202,485 790 0.25 0.39 
1. Only tested and positive herds from regions that have co-financed eradication programmes are included. The number of existing 
herds includes all herds from all regions in the MS. 
2. In Italy 10 regions and 11 provinces are OBF. In the provinces that are OBF or do not have a co-financed eradication 
programme, none of the 68,594 existing herds was found to be infected. 
3. In Portugal the Azores islands of Santa Maria, Pico, Graciosa, Faial, Flores and Corvo as well as all administrative regions 
(distritos) within the superior administrative unit (região) of Algarve are OBF and none of their 2,775 existing herds was found 
infected. No specific data were available for Madeira. 
4. In Spain the two provinces of the Canary Islands, Santa Cruz de Tenerife and Las Palmas, are OBF and none of their 
1,130 existing herds was found to be infected. 
5. Only Northern Ireland data are presented. 
The MS-specific trends in positive tested herds in four co-financed non-OBF MSs from 2004 to 2012 are 
shown in Figure BR6. Since 2004, the prevalence of bovine brucellosis test-positive cattle herds (the second 
epidemiological indicator) appears to have decreased or remained at a low level in most of the co-financed 
non-OBF MSs (Northern Ireland, Portugal and Spain). The exception is Italy, where a considerable increase 
in prevalence was observed between 2006 and 2007, which has been followed by a decrease since 2008 to 
1.64 % in 2012. Several Italian provinces were declared OBF between 2004 and 2012, and in some other 
provinces the occurrence was so low that they did not receive co-financing for eradication programmes. 
Therefore, the Italian data, as they originate from non-OBF co-financed regions, reflect the results of regions 
having the highest prevalence instead of the situation in the whole country. Italy did not report any positive 
herds in its OBF regions in 2012. 
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Figure BR6.  Prevalence and 95 % CI
1
 of Brucella test-positive cattle herds, at MS level
2
, in four non 
OBF co-financed MSs, 2004–2012 
 
1. Vertical bars indicate the exact binomial 95 % Confidence Interval. 
2. For Italy the displayed prevalence reflects the results from non-OBF co-financed regions instead of the situation in the whole 
country. 
 
Sheep and goats 
The status of the countries regarding freedom from ovine and caprine brucellosis caused by B. melitensis 
(Officially Brucella melitensis Free, ObmF) and the occurrence of the disease in MSs and non-MSs in 2012 
are presented in Figures BR7 and BR8. In 2012, as in 2011, Austria, Belgium, the Czech Republic, 
Denmark, Estonia, Finland, Germany, Hungary, Ireland, Latvia, Lithuania, Luxembourg, the Netherlands, 
Poland, Romania, Slovakia, Slovenia, Sweden and the United Kingdom, as well as Norway and Switzerland, 
were ObmF in accordance with EU legislation. Liechtenstein has the same status (ObmF) as Switzerland. 
Moreover, in the non-MS Iceland, which has no special agreement concerning animal health status with the 
EU, brucellosis (B. abortus, B. melitensis, B. suis) has never been reported.  
Regions have previously been granted ObmF status also in France (64 departments), Portugal (the Azores 
Islands), and Spain (two provinces of the Canary Islands and the Balearic Islands). In addition, Italy has 
11 regions and 8 provinces ObmF.  
All data submitted by MSs are presented in the Level 3 Tables. 
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Figure BR7.  Status of countries regarding ovine and caprine brucellosis, 2012 
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Figure BR8.  Proportion of existing sheep and goat herds infected with or positive for Brucella, 
country-based data, 2012 
 
Over the years 2005–2012, the overall proportion of existing sheep and goat herds infected with or positive 
for B. melitensis in the EU was at a very low level, decreased until 2010 and then stabilised at a level of 
0.17 % in 2011, with a further slight decrease in 2012 (0.14 %). A slight decrease was observed in the 
proportion of existing sheep and goat herds infected with or positive for B. melitensis in the non-ObmF MSs 
from 2010 (0.42 %) to 2011 (0.36 %) and 2012 (0.30 %) (Figure BR9).  
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Figure BR9.  Proportion of existing sheep and goat herds infected with or positive for Brucella, 
2005-2012
1 
 
1. Data missing from Bulgaria (2005-2007), Germany (2005-2007, 2012), Hungary (2005), Lithuania (2005, 2007, 2010), 
Luxembourg (2005-2006, 2008-2009, 2011), Malta (2005-2006) and Romania (2005-2006, 2008). Romania reported data at 
animal level in 2008. 
2. ObmF: Officially B. melitensis Free. 
 
Officially B. melitensis-Free Member States and non-Member States 
During 2012, brucellosis due to B. melitensis was not detected in any of the 630,342 sheep and goat herds 
in the 18 reporting ObmF MSs (Germany did not report), or in Iceland, Norway or Switzerland. 
Non-Officially B. melitensis-Free Member States 
In 2012, the eight non-ObmF MSs reported a total of 573,860 sheep and goat herds, of which 0.30 % were 
found to be infected with or positive to B. melitensis, and this level was comparable to the level reported in 
2011 (Figure BR9). 
The three non-ObmF MSs without EU co-financed eradication programmes (Bulgaria, France and Malta) 
reported no infected or positive sheep and goat herds out of 245,739 existing ones in 2012. 
As regards non-ObmF MSs with eradication programmes co-financed by the EU, compared with 2011, there 
was an overall slight decrease in both indicators (the proportions of positive herds among the existing herds 
and among the tested herds): from 0.74 % and 1.16 %, respectively, in 2011 to 0.52 % and 0.81 %, 
respectively, in 2012 (Table BR4). Also at the MS level, in Italy, Portugal and Spain both indicators 
decreased. In the Greek islands, where an eradication programme is implemented, Greece had a prevalence 
of existing B. melitensis-positive sheep and goat herds of 0.12 %, which was lower than in 2011 (0.25 %), 
whereas the proportion of positive herds among the tested herds increased from 5.38 % in 2011 to 8.64 % in 
2012. Cyprus was the only non-ObmF with an EU co-financed eradication programme that reported no 
positive sheep and goat herds in 2012. 
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Table BR4.  Brucella in sheep and goat herds in co-financed non-ObmF MSs
1
, 2012 
Non-officially 
free MSs 
No of existing 
herds 
No of tested 
herds 
No of positive 
herds 
% existing 
herds positive 
% tested herds 
positive 
Cyprus 3,367 2,921 0 0 0 
Greece
2
 28,246 382 33 0.12 8.64 
Italy
3
 115,471 39,431 642 0.56 1.63 
Portugal
4
 65,283 61,695 746 1.14 1.21 
Spain
5
 115,754 104,888 272 0.23 0.26 
Total (5 MSs) 328,121 209,317 1,693 0.52 0.81 
1. Only tested and positive herds from regions that have co-financed eradication programmes are included. The number of existing 
herds includes all herds from all regions in the MS. 
2. The ovine and caprine B. melitensis eradication programme covers only the islands of Greece. For The remaining country 
regions, the mainland, a mass vaccination programme was carried out in 2012 with co-financing by the EU.  
3. In Italy 11 regions and 8 other provinces are ObmF. In these areas that are ObmF or do not have a co-financed eradication 
programme, 5 of the 72,640 existing herds were found infected. 
4. In Portugal the Azores islands are ObmF and none of the 953 existing sheep and goat herds was found infected. 
5. In Spain the two provinces of the Canary Islands (Santa Cruz de Tenerife and Las Palmas) and the Balearic Islands are ObmF. 
In 2012, none of the 8,546 existing herds in these areas tested positive. 
The MS-specific trends in tested herds positive in four co-financed non-ObmF MSs from 2004 to 2012 are 
shown in Figure BR10. Since 2004, the prevalence of sheep and goat herds testing positive for B. melitensis 
(the second epidemiological indicator) has decreased in Cyprus, and more markedly in Spain. Following an 
increase between 2004 and 2005, a decrease was observed in the proportion of positive tested herds in 
Portugal between 2005 and 2009. In the following years the proportion of positive tested herds stabilised. In 
Italy, an increase was observed from 2004 to 2006, which was followed by a continuous decrease up to, and 
including, 2012 (Figure BR10). This increase in positive tested herds was due to progress made in the 
eradication programme, whereby the declared ObmF provinces and regions are no longer counted in co-
financed programmes. Therefore, Italian data, as they originate from non-ObmF co-financed regions, reflect 
the results of regions having the highest prevalence instead of the situation in the whole country. 
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Figure BR10.  Prevalence and 95 % CI
1
 of Brucella melitensis test-positive sheep and goat herds, at 
MS level
2
, in four non-ObmF co-financed MSs, 2004-2012 
 
1. Vertical bars indicate the exact binomial 95 % Confidence Interval. 
2. For Italy the displayed prevalence reflects the results from non-ObmF co-financed regions instead of the situation in the whole 
country. 
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Other animals 
In 2012, 18 MSs and 2 non-MSs provided data on the occurrence of Brucella spp. in animals other than 
cattle, goats and sheep. The data originated from a wide range of sources including clinical investigations, 
surveillance, monitoring, surveys and control and eradication programmes. In addition, results from other 
specific local studies are reported for smaller numbers of animals.  
B. suis was found in hares, in pigs and in wild boar, B. canis in dogs, B. melitensis in wild Alpine chamois 
and wild Alpine ibex and Brucella spp. in pigs, hares, wild boar, dogs, water buffaloes, zoo animals and wild 
‘other animals’. 
All data submitted by MSs and other reporting countries are presented in the Level 3 Tables.  
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3.6.4. Discussion 
Brucellosis is a rare infection in humans in the EU. The highest notification rates and the majority of the 
indigenous cases were reported from Mediterranean countries that are still not OBF in animals. There were 
also indigenous cases reported in OBF and OBmF countries, but these are normally due to immigrants from 
endemic areas or import of dairy products from endemic areas
43
. The EU trend in human brucellosis cases in 
the last five years was dominated by a large outbreak in one MS in 2008. When removing the effect of this 
outbreak, no significant increasing or decreasing trend could be observed at the EU level. Significant 
decreasing trends by country were, however, observed in two MSs, Italy and Spain, which is in accordance 
with the findings on the animal side. Almost four out of five of the human brucellosis cases (of the 51.2 % of 
cases for which hospitalisation information was available) had been hospitalised, but only one fatal case was 
reported in 2012. 
There was one Brucella-positive finding in a sample of raw milk reported by one MS. However, the one 
strong-evidence food-borne outbreak reported from France (two human cases, implicated food vehicle: 
cheese) and the four food-borne outbreaks for which there was weak evidence (involving 11 hospitalised 
cases) reported from Greece in 2012 illustrate the health risk still associated with consumption of food 
contaminated with Brucella. 
Concomitant with the significant decreasing EU trend in human brucellosis cases, the prevalence of both 
bovine and small ruminant brucellosis has continued to decrease within the EU. Both bovine and small 
ruminant brucellosis-infected herds are mostly geographically concentrated in southern European MSs. In 
2012, brucellosis remained a rare event at the EU level in cattle herds (0.05 %) while the prevalence in 
sheep and goat herds was at a very low level (0.14 %). Bovine brucellosis in non-OBF MSs decreased 
between 2005 and 2007 and then stabilised at around 0.11 % in 2011, with a further small decrease at 
0.09 % in 2012. Analogously, small ruminant brucellosis in the non-ObmF MSs decreased every year 
between 2005 and 2012, reaching a prevalence of 0.30 % in 2012. The decrease in small ruminant 
brucellosis prevalence in co-financed non-ObmF MSs was statistically significant for the years 2004–2012. 
Much of the overall decrease in bovine and small ruminant brucellosis at EU level, as well as within co-
financed MSs, appears to have been driven by Italy and Spain, which are also the two MSs having a 
significant decreasing trend for Brucella infection in humans. On the other hand, the non-OBF/non-ObmF 
MSs Greece and Portugal, which reported the highest prevalence of Brucella in cattle (Greece: 0.97 %) and 
in sheep and goats (Portugal: 1.14 %) respectively, among the reporting MSs for 2012, reported also the 
highest notification rates of confirmed human brucellosis cases. 
In 2012, 18 MSs and 2 non-MSs provided data on the occurrence of Brucella spp. in animals other than 
cattle, goats and sheep. B. suis was found in hares, in pigs and in wild boar, B. canis in dogs, B. melitensis in 
wild Alpine chamois and wild Alpine ibex and Brucella spp. in pigs, hares, wild boar, dogs, water buffaloes, 
zoo animals and wild ‘other animals’. 
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  Pappas G, Papadimitriou P, Akritidis N, Christou L and Tsianos EV, 2006. The new global map of human brucellosis. The Lancet 
Infectious Diseases, 6(2), 91-99. 
DRAFT 
FOR 
CONSULTA TION 
EU summary report on zoonoses, zoonotic agents and 
food-borne outbreaks 2012 
 
EFSA Journal 2014;12(2):3547 192 
3.  INFORMATION ON SPECIFIC ZOONOSES AND ZOONOTIC AGENTS 
3.7. Trichinella 
Trichinellosis is a zoonotic disease caused by parasitic nematodes of the genus Trichinella. The parasite has 
a wide range of host species, mostly mammals. Trichinella spp. undergoes all stages of the life cycle, from 
larva to adult, in the body of a single host (Figure TR1). 
Figure TR1.  Life cycle of Trichinella 
 
Source: Gottstein B, Pozio E and Nöckler, 2009. Epidemiology, Diagnosis, Treatment, and Control of Trichinellosis. Clinical 
Microbiology Reviews, 22, 127-145. 
Trichinella spp. life cycle. (A) Main sources of Trichinella spp. infections in humans (including pigs, horses, wild boar, dogs, walruses, 
foxes and bears). (B) Trichinella spp. cycle in the host body. In the enteric phase, muscle tissues are digested in the stomach, and 
larvae are released (1); larvae penetrate the intestinal mucosa of the small intestine and reach the adult stage within 48 hours post 
infection (p.i.), and male and female mate (2); female worm releases newborn larvae in the lymphatic vessels (from the fifth day p.i. 
onwards; the length of newborn production, from one week to several weeks, is under the influence of host immunity) (3); in the 
parenteral phase, the newborn larvae reach the striated muscle and actively penetrate in the muscle cell (4); larvae grow to the infective 
stage in the nurse cell (the former muscle cell) (5); and, after a period of time (weeks, months, or years), a calcification process occurs 
(6). (Modified from www.iss.it/site/Trichinella/index.asp with the permission of the publisher) 
In Europe, trichinellosis has been described as a re-emerging disease over recent decades. Worldwide, nine 
species and three genotypes have been described: Trichinella spiralis (T. spiralis), T. nativa, T. britovi, 
T. murrelli, T. nelsoni, T. pseudospiralis, T. papuae, T. zimbabwensis and T. patagoniensis, Trichinella T6, 
Trichinella T8 and Trichinella T9. The majority of human infections in Europe are caused by T. spiralis, and 
T. britovi, while a few cases caused by T. pseudospiralis and T. nativa have also been described. In a 
human outbreak caused by the consumption of horse meat imported from the United States of America to 
France in 1985, the aetiological agent was T. murrelli. 
Humans typically acquire the infection by eating raw or inadequately cooked meat infested with infectious 
Trichinella larvae. The most common sources of human infection are pig meat, wild boar meat and other 
game meat. Horse and dog meat as well as meat from many other animals have also transmitted the 
infection. Horse meat was identified as the source of infection in a number of human outbreaks recorded in 
the EU from the mid-1970s until 2005, including some of the largest outbreaks recorded in decades. 
Freezing of the meat minimises the infectivity of the parasite, although some Trichinella species/genotypes 
(T. nativa, T. britovi and Trichinella genotype T6) have demonstrated resistance to freezing.  
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The clinical signs of acute trichinellosis in humans are characterised by two phases. In the first stage of 
trichinellosis symptoms may include nausea, diarrhoea, vomiting, fatigue, fever and abdominal discomfort. 
However, this phase is often mild or asymptomatic. Thereafter, in a second phase, symptoms including 
muscle pains, headaches, fever, swelling of the eyes, aching joints, chills, cough, itchy skin and diarrhoea or 
constipation may follow. In more severe cases, difficulties with coordinating movements as well as heart and 
breathing problems may occur. A small proportion of people die from Trichinella infection. Systematic clinical 
signs usually appear about 8–15 days after consumption of infested meat.  
An overview of the data reported in 2012 is presented in the following tables and figures. 
Table TR1.  Overview of countries reporting data on Trichinella spp., 2012 
Data 
Total number of  
reporting MSs  
Countries 
Humans 26 
All MSs except DK 
Non-MSs: CH, NO 
Animals 27 
All MSs  
Non-MSs: CH, IS, NO 
Note: The overview table contains all data reported by MSs and non-MSs. 
3.7.1. Trichinellosis in humans 
In 2012, 378 cases of trichinellosis were reported by 26 MSs. Of these cases, 301 (79.6 %) were reported as 
confirmed (Table TR2). Only 11 of the 26 MSs had notified cases. The difference between the total number 
of cases and the number of confirmed cases may be due to not all outbreak cases being laboratory 
confirmed and the remaining cases being considered epidemiologically linked to the confirmed cases.  
The number of human trichinellosis cases increased by 12.3 % in the EU in 2012 compared with 2011 but 
was still at a much lower level than in 2008-2009, when several hundred trichinellosis cases were reported 
from both Bulgaria (in 2009) and Romania (Table TR2). The EU notification rate, in 2012, was 0.06 cases 
per 100,000 population, and the highest notification rates were reported in Latvia (2.01 cases per 100,000), 
followed by Lithuania, Romania and Bulgaria (0.93, 0.70 and 0.41 cases per 100,000, respectively). These 
four countries accounted for 82.4 % of all confirmed cases reported in 2012. Only one case of trichinellosis 
was reported as travel-associated and was related to travel to another EU country. The remaining cases 
were either known to be domestically acquired or were of unknown origin (Figure TR2).  
The temporal trend of trichinellosis in the EU, in 2008-2012, was greatly influenced by a number of smaller 
and larger outbreaks, particularly in the first two years of the period (Figure TR3, top). Romania, for example, 
reported 31 outbreaks with a total of 406 cases (probable and confirmed) in 2009
44
, but only three outbreaks, 
with a total of 145 cases (probable and confirmed), in 2010
45
. When removing the years 2008-2009 (Figure 
TR3, bottom), no increasing or decreasing EU trend could be observed for the remainder of the period 
(2010-2012). Decreasing trends by country, in 2008-2012, were observed in Lithuania and Romania, while 
an increasing trend was observed in Latvia, mainly as a result of outbreaks in 2011 and 2012 in one of the 
eastern regions (Antra Bormane, Centre for Disease Prevention and Control of Latvia, personal 
communication, October 2013). A noticeable increase in reported cases was also observed in Italy in the last 
two years, but there were too few cases reported over the whole period for trend analysis to be possible. 
Five of the 11 MSs which reported cases in 2012 provided information on hospitalisation for all of their cases 
(corresponding to 73.1 % of all confirmed cases reported in the EU). On average, 80.5 % of the cases were 
hospitalised. No deaths due to trichinellosis were reported in 2012 from the seven MSs that provided 
                                                          
44
  EFSA (European Food Safety Authority) and ECDC (European Centre for Disease Prevention and Control), 2011. The European 
Union Summary Report on Trends and Sources of Zoonoses, Zoonotic Agents and Food-borne Outbreaks in 2009. EFSA Journal 
2011;9(3):2090, 378 pp. doi:10.2903/j.efsa.2011.2090 
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  EFSA (European Food Safety Authority) and ECDC (European Centre for Disease Prevention and Control), 2012. The European 
Union Summary Report on Trends and Sources of Zoonoses, Zoonotic Agents and Food-borne Outbreaks in 2010. EFSA Journal 
2012;10(3):2597, 442 pp. doi:10.2903/j.efsa.2012.2597 
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information. The species of Trichinella, detected in 2012, were T. spiralis for 72 cases and T. britovi for 
25 cases. For the remainder of cases no species information was provided. 
Table TR2.  Reported cases of human trichinellosis in 2008-2012, and notification rate for confirmed 
cases in the EU, 2012 
Country 
2012 2011 2010 2009 2008 
Report 
Type
1
 
Cases 
Confirmed 
cases 
Confirmed 
cases/ 
100,000 
Total confirmed cases 
Austria C 0 0 0 1 5 0 0 
Belgium
2
 U 0 0 ‒ 0 3 0 5 
Bulgaria A 30 30 0.41 27 14 407 67 
Cyprus U 0 0 0 0 0 0 0 
Czech Republic U 1 1 0.01 0 0 0 0 
Denmark
3
 ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ 
Estonia U 0 0 0 0 0 0 0 
Finland U 0 0 0 0 0 0 0 
France A 0 0 0 2 0 9 3 
Germany C 2 2 <0.01 3 3 1 1 
Greece U 0 0 0 0 4 2 0 
Hungary U 0 0 0 0 0 9 5 
Ireland U 0 0 0 0 0 0 0 
Italy C 33 33 0.05 6 0 1 0 
Latvia C 45 41 2.01 50 9 9 4 
Lithuania C 30 28 0.93 29 77 20 31 
Luxembourg U 0 0 0 0 0 0 0 
Malta U 0 0 0 0 0 0 0 
Netherlands C 0 0 0 1 0 1 1 
Poland C 1 1 <0.01 10 14 18 4 
Portugal U 0 0 0 0 0 0 0 
Romania C 220 149 0.70 107 82 265 503 
Slovakia C 5 5 0.09 13 2 0 18 
Slovenia C 1 1 0.05 1 0 1 1 
Spain C 10 10 0.02 18 10 7 27 
Sweden U 0 0 0 0 0 0 0 
United Kingdom U 0 0 0 0 0 0 0 
EU Total   378 301 0.06 268 223 750 670 
Iceland
3
 ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ 
Liechtenstein ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ 
Norway U 0 0 0 0 0 0 0 
Switzerland
4
 C 1 1 0.01 0 1 4 ‒ 
1. A: aggregated data report; C: case-based report; –: no report; U: unspecified. 
2. Disease not under formal surveillance. 
3. No surveillance system. 
4. Switzerland provided data directly to EFSA.   
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Figure TR2.  Notification rates and origin of infection in human trichinellosis in the EU/EFTA, 2012 
 
 
Note: The map shows the distribution of human cases shaded according to incidence rate per 100,000 based on quartile classification 
method (EUROSTAT population data 2012). 
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Figure TR3.  Trend in reported confirmed cases of human trichinellosis in the EU,  
2008-2012 (top) and 2010-2012 (bottom)  
 
 
Source: 25 MSs: Austria, Bulgaria, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, 
Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, and United 
Kingdom. Belgium and Denmark do not have any formal surveillance system for the disease. 
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3.7.2. Trichinella in animals 
All MSs and three non-MSs submitted data on Trichinella in animals for 2012, and these data are presented 
in Tables TR3–TR6 and Figures TR4–TR6. In the following sections, investigations with fewer than 25 units 
tested are included, unless stated otherwise. Moreover, results from suspect and/or selective samplings 
were taken into account when analysing Trichinella in hunted wild boar and in wildlife other than wild boar. 
All reported data are presented in the Level 3 Tables.  
The results are presented for the most important animal species that serve as sources of human 
trichinellosis cases in MSs. According to Commission Regulation (EC) No 2075/2005
46
, carcases of domestic 
swine, horses, wild boar and other farmed or wild animal species, susceptible to Trichinella infestation, are 
systematically sampled at slaughter as part of meat inspection and tested for Trichinella. Thus, most of the 
reported data are derived from meat inspection. Animals (both domestic and wild) slaughtered for own 
consumption are outside the scope of the mentioned Regulation but subject to national rules, which may 
differ between MSs. Another source of data is the monitoring of Trichinella in wildlife animal species not 
intended for human consumption.  
In 2012, 26 MSs and 3 non-MSs provided information on Trichinella in farm animals (pigs, farmed wild boar 
and horses). Nine MSs isolated Trichinella from farm animals: Romania reported 50.6 % of all these positive 
findings, followed by Spain with 34.6 % of the positive findings. The prevalence of Trichinella in farm animals 
was highest in farmed wild boar (0.09 %), followed by pigs (0.00016 %). Out of the187,352 investigated 
horses in the EU, one (0.0005 %) was found to be Trichinella positive. 
Twenty-six MSs and the three non-MSs provided data on Trichinella in pigs (breeding and fattening pigs). 
Nine MSs reported positive findings, giving an overall EU prevalence of 0.00016 % (Table TR3), which is 
similar to the prevalence observed in 2011 (0.00017 %).  
Romania accounted for 51.5 % of all the Trichinella-positive findings in pigs in 2012, in a similar way as in 
2010 and 2011 (Figure TR4). All positive findings from pigs were from non-controlled housing conditions. In 
total, 73.6 % (245) of the positive results from pigs were reported as Trichinella spp. In addition, there were 
56 reports of T. spiralis and 32 reports of T. britovi (Table TR3).  
Eight MSs reported data on samplings of farmed wild boar. One positive boar (0.11 %) was detected in Italy 
and four were detected in Finland (1.29 %) (Table TR4). The prevalence (0.09 %) was lower in 2012 than in 
2011 (0.4 %) and at the same level as in 2010 (0.07 %). 
In 2012, 18 MSs and 3 non-MSs reported data on horses; in total, 187,352 were tested for Trichinella and 
one was found positive in Spain (0.001 %).  
Twenty-two MSs and two non-MSs provided data on hunted wild boar (Table TR5). Fourteen MSs reported 
positive findings, giving an overall EU animal-level prevalence of 0.13 %, similar to 2011. At the animal level, 
Poland, Spain and Romania accounted for 40.3 %, 22.4 % and 9.8 % of the positives, respectively. The 
highest animal-level prevalence was reported by Bulgaria (10.6 %) (Figure TR5). As in pigs, most (71.8 %) 
results were reported as Trichinella spp. but there were also 182 reports of T. spiralis, 119 reports of 
T. britovi, six reports of T. pseudospiralis and four reports of T. nativa. 
Twenty MSs and one non-MS provided data on wildlife other than wild boar (Table TR6). Fifteen MSs 
reported positive findings. Overall, in 2012, Finland was responsible for 52.7 % of reported positive findings 
in wildlife other than wild boar (Figure TR6). As in 2011, 15 MSs reported data on Trichinella in foxes. Of 
these, 11 MSs had positive results. Most of positive foxes were reported as Trichinella spp., but there were 
also findings of T. britovi, T. nativa and T. spiralis.  
Seven MSs reported data on Trichinella in bears, with a total prevalence within these countries of 3.7 %. 
Positive bears were from Estonia, Finland, Romania and Sweden. T. nativa was most commonly reported 
from bears, but there were also a number of reports of T. britovi, T. spiralis and Trichinella spp. 
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In addition, Trichinella were detected from raccoon dogs, badgers, lynx, martens, wolverines and wolves. 
Figure TR4.  Findings of Trichinella in pigs, 2012  
 
Note:  In France, the positive units were from free-range pigs from Corsica. 
 In Germany, the positive pig was not raised under controlled housing conditions; it was raised in a privately owned fenced free-
range area. 
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Table TR3.  Findings of Trichinella in pigs, animal-level data, 2012 
Country 
Species 
(n. of isolates) 
Sample  
unit 
N Pos % Pos Additional information 
Austria   Fattening pigs 5,396,345 0 0   
Belgium   Fattening pigs 11,724,297 0 0   
Bulgaria 
  Breeding animals 47 0 0 Pigs not raised under controlled housing conditions 
  Breeding animals 2,215 0 0 Pigs raised under controlled housing conditions 
T. spp. (6) Fattening pigs 22,075 6 0.02718 Pigs not raised under controlled housing conditions 
  Fattening pigs 184,876 0 0 Pigs raised under controlled housing conditions 
Cyprus 
  Breeding animals 14,442 0 0 Pigs raised under controlled housing conditions 
  Fattening pigs 630,910 0 0   
Czech Republic   Fattening pigs 2,769,396 0 0   
Denmark 
  Breeding animals 423,338 0 0 Pigs raised under controlled housing conditions 
  Fattening pigs 18,883,606 0 0 Pigs raised under controlled housing conditions 
Estonia   Fattening pigs 436,421 0 0 Pigs not raised under controlled housing conditions 
Finland 
  Breeding animals 49,637 0 0 Pigs not raised under controlled housing conditions 
  Fattening pigs 2,108,797 0 0 Pigs not raised under controlled housing conditions 
France 
  Breeding animals 343,105 0 0   
T. britovi (5) Fattening pigs 326,085 5 0.00153 
Pigs not raised under controlled housing conditions. The 
positive units were from free-range pigs from Corsica 
  Fattening pigs 81,043 0 0 Pigs raised under controlled housing conditions 
Germany T. spiralis (1)   59,291,100 1 0.000002 
The positive pig was not raised under controlled housing 
conditions; it was raised in a privately owned fenced free-
range area 
Table continued overleaf. 
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Table TR3 (continued). Findings of Trichinella in pigs, animal-level data, 2012 
Country 
Species 
(n. of isolates) 
Sample  
unit 
N Pos % Pos Additional information 
Greece 
  Breeding animals 23,406 0 0 Pigs raised under controlled housing conditions 
T. britovi (16) Fattening pigs 7,133 16 0.22431 Pigs not raised under controlled housing conditions 
  Fattening pigs 1,163,843 0 0 Pigs raised under controlled housing conditions 
Hungary   Fattening pigs 4,058,146 0 0   
Ireland 
    4,110 0 0   
  Breeding animals 97,038 0 0   
  Fattening pigs 2,874,569 0 0   
Italy 
  Breeding animals 3,202 0 0 Pigs raised under controlled housing conditions 
  Fattening pigs 13,114 0 0   
  Fattening pigs 9,695,873 0 0 Pigs raised under controlled housing conditions 
Latvia     406,438 0 0   
Lithuania T. spp.(2) Fattening pigs 779,118 2 0.00026 Pigs not raised under controlled housing conditions 
Luxembourg 
  Fattening pigs 2,024 0 0 Pigs not raised under controlled housing conditions 
  Fattening pigs 138,303 0 0 Pigs raised under controlled housing conditions 
  Breeding animals 70 0 0 Pigs raised under controlled housing conditions 
Netherlands   Fattening pigs 14,689,622 0 0 Pigs raised under controlled housing conditions 
Poland 
T. spiralis (7),  
T. spp. (7) 
  19,917,895 14 0.00007 Pigs not raised under controlled housing conditions 
  Fattening pigs 208 0 0   
Table continued overleaf. 
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Table TR3 (continued). Findings of Trichinella in pigs, animal-level data, 2012 
Country 
Species 
(n. of isolates) 
Sample  
unit 
N Pos % Pos Additional information 
Portugal 
    17,020 0 0   
  Breeding animals 35,982 0 0   
  Breeding animals 322 0 0 Pigs not raised under controlled housing conditions 
  Breeding animals 7,413 0 0 Pigs raised under controlled housing conditions 
  Fattening pigs 2,914,230 0 0   
  Fattening pigs 27,038 0 0 Pigs not raised under controlled housing conditions 
  Fattening pigs 520,812 0 0 Pigs raised under controlled housing conditions 
Romania
1
 
  Breeding animals 105 0 0 Pigs not raised under controlled housing conditions 
  Breeding animals 20,410 0 0 Pigs raised under controlled housing conditions 
T. britovi (11),  
T. spiralis (47),  
T. spp. (115) 
Fattening pigs 179,469 171 0.09528 Pigs not raised under controlled housing conditions 
  Fattening pigs 3,356,471 0 0 Pigs raised under controlled housing conditions 
Slovakia     689,142 0 0   
Slovenia   Unspecified 253,412 0 0   
Spain 
T. spiralis (1)   32,987 1 0.00303 
Pigs not raised under controlled housing conditions 
slaughtered for own consumption 
T. spp. (115) Fattening pigs 40,783,578 115 0.00028 Pigs not raised under controlled housing conditions 
Sweden   Unspecified 2,585,665 0 0   
United Kingdom   Breeding animals 177,751 0 0 Pigs raised under controlled housing conditions 
EU Total   Animal 208,163,654 331 0.00016   
Iceland   Fattening pigs 72,146 0 0   
Norway   Fattening pigs 1,602,000 0 0 Pigs raised under controlled housing conditions 
Switzerland     2,561,131 0 0   
Note: Data presented include only investigations with sample size ≥25. 
1. In Romania both T. britovi and T. spiralis were found in two samples. 
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Table TR4.  Findings of Trichinella in farmed wild boar, animal-level data, 2012 
Country Description Species N Pos % Pos 
Austria Official sampling, Surveillance, Census   731 0 0 
Bulgaria Official sampling, Surveillance, Census   639 0 0 
Denmark Official sampling, Surveillance, Census   654 0 0 
Finland Official sampling, Surveillance T. pseudospiralis 311 4 1.29 
France 
Official sampling, Surveillance, 
Objective sampling 
  861 0 0 
Italy Official sampling, Monitoring, Census T. pseudospiralis 970 1 0.10 
Romania 
Official sampling, Surveillance, 
Objective sampling   
78 0 0 
United Kingdom Official sampling, Surveillance, Census   1,478 0 0 
Total (8 MSs)   5,722 5 0.09 
Note: Data presented include investigations with sample size <25. 
 
Figure TR5.  Finding of Trichinella in hunted wild boar, 2012 
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Table TR5.  Findings of Trichinella in hunted wild boar, animal-level data, 2012 
Country Description 
Species 
(n. of isolates) 
N Pos % Pos 
Austria 
Official sampling, Control and 
eradication programmes, Census 
  33,426 0 0 
Belgium 
Official sampling, Surveillance, 
Census 
Trichinella spp., 
unspecified (2) 
11,691 2 0.017 
Bulgaria 
Industry sampling, Surveillance, 
Census, hunters samples 
T. britovi (6), 
Trichinella spp., 
unspecified (73) 
747 79 10.576 
Czech Republic Surveillance   98,852 0 0 
Estonia 
Official sampling, Surveillance, 
Census 
T. britovi (20),  
T. nativa (1),  
T. pseudospiralis 
(2),  
Trichinella spp., 
unspecified (3) 
3,976 26 0.654 
Census
1
 
T. britovi (2),  
T. nativa (1), 
Trichinella spp.,  
unspecified (1) 
190 3 1.579 
Finland  Official sampling, Surveillance   9 0 0 
France
2
 
Official sampling, Surveillance, 
Objective sampling 
T. britovi (2) 40,746 2 0.005 
Germany Official sampling T. spiralis (6) 178,662 6 0.003 
Greece 
Official sampling, Surveillance, 
Census 
  19 0 0 
Hungary 
Official sampling, Surveillance, 
Census 
T. britovi (12),  
T. spiralis (3), 
Trichinella spp.,  
unspecified (1) 
69,171 16 0.023 
Italy 
Official sampling, Monitoring, 
Census
3
 
  58,604 2 0 
Clinical investigations T. britovi (1) 2,137 1 0.047 
Official sampling, Monitoring 
T. britovi (1),  
Trichinella spp., 
unspecified (1) 
2,455 1 0.041 
Survey - national survey   3,938 0 0 
Latvia 
Official sampling, Surveillance, 
Census 
Trichinella spp., 
unspecified (68) 
3,836 68 1.773 
Lithuania 
Official and industry sampling, 
Surveillance, Objective sampling 
T. spiralis (9), 
Trichinella spp., 
unspecified (73) 
26,655 82 0.308 
Luxembourg 
Official sampling, Surveillance, 
Objective sampling 
  1,561 0 0 
Netherlands 
Official sampling, Surveillance, 
Census 
  3,903 0 0 
Poland 
Not applicable, Survey-national 
survey, Census 
T. spiralis (131), 
Trichinella spp., 
unspecified (311) 
108,605 442 0.407 
Portugal 
Official and industry sampling, 
Surveillance, Census 
  270 0 0 
Official sampling, Surveillance   2 0 0 
Romania
4
 
Official sampling, Surveillance, 
Objective sampling 
T. britovi (57),  
T. spiralis (19), 
Trichinella spp.,  
unspecified (33) 
6,017 107 1.778 
Table continued overleaf. 
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Table TR5 (continued). Findings of Trichinella in hunted wild boar, animal-level data, 2012 
Country Description 
Species 
(n. of isolates) 
N Pos % Pos 
Slovakia 
Official sampling, Monitoring, 
Objective sampling 
T. britovi (7),  
T. nativa (2), 
Trichinella spp., 
unspecified (1) 
14,377 10 0.070 
Spain 
Official sampling, Surveillance, 
Census 
T. britovi (10),  
T. spiralis (14), 
Trichinella spp., 
unspecified (221) 
123,597 245 0.198 
Sweden 
Official sampling, Monitoring, 
Objective sampling 
T. britovi (1), 
T. pseudospiralis 
(4) 
66,399 5 0.008 
United Kingdom 
Official sampling, Surveillance, 
Census 
  308 0 0 
EU Total   860,153 1,097 0.128 
Norway Monitoring, Selective sampling   1 0 0 
Switzerland Surveillance   3,439 0 0 
Note: Data presented include investigations with sample size <25. 
1. In Estonia, in one sample both T. britovi and T. nativa were found. Samples originated from other MSs. 
2 In France, the positive units were from one wild boar hunted in Alpes-Maritimes (France), the other one was hunted in Spain. 
3. In Italy, one positive finding was from a pig not identified and living in the wild. 
4. In Romania, both T. britovi and T. spiralis were found in two samples. 
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Table TR6.  Findings of Trichinella in wildlife other than wild boar, 2012 
Country 
Foxes Bears Raccoon dogs Other wildlife
1
 
Description N Pos % Pos Description N Pos % Pos Description N Pos % Pos Description N Pos % Pos 
Austria   - - -   - - -   - - - Unspecified 28 0 0 
Belgium 
Official sampling, 
Monitoring, 
Objective sampling 
506 2 0.4   - - -   - - -   - - - 
Bulgaria 
Monitoring,  
Industry sampling, 
Census 
4 3 75.0 
Surveillance, 
Industry 
sampling, 
Census 
2 0 0   - - - 
Surveillance, 
Official/Industry 
sampling, Census 
4 2 50.0 
Denmark Objective sampling 768 0 0   - - - 
Monitoring, 
Objective 
sampling 
111 0 0 
Official sampling, 
Objective 
sampling 
17 0 0 
Estonia   - - - 
Surveillance, 
Official 
sampling, 
Census 
74 8 10.8   - - - 
Surveillance, 
Official sampling, 
Census 
26 11 42.3 
Finland Monitoring 152 27 17.8 
Surveillance, 
Official sampling 
46 1 2.2 Monitoring 259 85 32.8 Monitoring 463 214 46.2 
France   - - -    - - -   - - - 
Official sampling, 
Suspect sampling 
1 1 100 
Germany Official sampling 1,705 38 2.2   - - -   - - - Official sampling 89 0 0 
Hungary 
Monitoring, Official 
sampling, Objective 
sampling 
615 12 2.0   - - -   - - -   - - - 
Ireland 
Monitoring, Official 
sampling, 
Convenience 
sampling 
418 2 0.5   - - -   - - -   - - - 
Italy
2
 
Clinical 
investigations, 
Monitoring, Survey - 
national survey 
3,405 10 0.3 
Monitoring, 
Survey - national 
survey 
5 0 0   - - - 
Clinical 
investigations, 
Monitoring, Survey 
- national survey 
200 5 2.5 
Latvia Monitoring 177 100 56.5   - - - Monitoring 57 17 29.8   8 5 62.5 
Lithuania 
Monitoring,  
Objective sampling 
6 2 33.3   - - -   - - -   - - - 
Luxembourg 
Monitoring, Official 
sampling, Objective 
sampling 
32 0 0   - - -   - - -   - - - 
Table continued overleaf.  
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Table TR6 (continued). Findings of Trichinella in wildlife other than wild boar, 2012 
Country 
Foxes Bears Raccoon dogs Other wildlife
1
 
Description N Pos % Pos Description N Pos % Pos Description N Pos % Pos Description N Pos % Pos 
Poland 
Monitoring, 
Census 
259 11 4.2   - - -   - - -   - - - 
Romania   - - - 
Surveillance, 
Official 
sampling, 
Objective 
sampling 
58 9 15.5   - - -   - - - 
Slovakia 
Monitoring, 
Official 
sampling, 
Selective 
sampling 
425 42 9.9 
Monitoring, 
Official 
sampling, 
Objective 
sampling 
26 0 0 
Monitoring, 
Official 
sampling, 
Selective 
sampling 
1 0 0 
Monitoring, 
Official 
sampling, 
Selective 
sampling 
3 0 0 
Spain   - - -   - - -   - - - 
Official 
sampling, 
Census 
184 0 0 
Sweden 
Monitoring, 
Official 
sampling, 
Convenience 
sampling 
72 0 0 
Monitoring, 
Official 
sampling, 
Convenience 
sampling 
303 1 0.3 
Monitoring, 
Official 
sampling, 
Convenience 
sampling 
3 0 0 
Monitoring, 
Official 
sampling, 
Convenience 
sampling 
324 13 4.0 
United Kingdom 
Monitoring, 
Official 
sampling, 
Convenience 
sampling 
420 0 0   - - -   - - - 
Monitoring, 
Official 
sampling, 
Convenience 
sampling 
90 0 0 
EU Total   8,964 249 2.8   514 19 3.7   431 102 23.7   1,437 251 17.5 
Norway   - - -   - - -   - - - 
Monitoring, 
Official 
sampling, 
Selective 
sampling 
1 0 0 
Note: Data presented include investigations with sample size <25.  
 In Switzerland two lynx were found to be positive for Trichinella britovi, but the number of the tested wildlife was not reported. 
1. Other 'wildlife' includes badgers, beavers, birds (including falcons), cantabrian chamois, deer, hedgehogs, jackals, lynx, martens, muskrats, other mustelids, otter, raccoons, wolverine and wolves. 
2. Italy reported for the same sampling context different sampling strategies: 'census' and 'unspecified' and sampler: 'official sampling' and 'not applicable'. 
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Figure TR6.  Findings of Trichinella in wildlife (including hunted wild boar), 2012 
 
Note: In Switzerland two lynx were found positive for Trichinella britovi, but the number of the tested wildlife was not reported. 
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3.7.3. Discussion 
The number of reported human trichinellosis cases increased by 12.3 % in the EU in 2012 compared with 
2011. The majority of the confirmed cases, in 2012, were reported from five MSs: Bulgaria, Italy Latvia, 
Lithuania and Romania. Four of these countries (Bulgaria, Latvia, Lithuania and Romania) and Spain 
reported in total 25 food-borne outbreaks due to Trichinella in 2012, affecting 150 persons, of whom 84 were 
hospitalised. On average, 80.5 % of all the confirmed human trichinellosis cases were hospitalised; however, 
no deaths due to trichinellosis were reported in 2012.  
All human cases, with information on travel status, had acquired the infection within the EU. The two main 
sources of human trichinellosis in the EU are pork (pig meat), produced from backyard pigs that are not 
examined for Trichinella, and wild boar meat. In Romania, which usually reports the highest number of 
human cases in the EU, the slaughtering and consumption of meat from backyard pigs occurs mostly in the 
winter months, especially before Christmas. This explains the seasonal pattern, with a peak in reported 
cases in January and February (Lavinia Cipriana Zota, National Institute of Public Health, Romania, personal 
communication, July 2013).  
Trichinella was very rarely detected in 2012 from pigs in the EU, and the positive findings reported by all MSs 
were from pigs from non-controlled housing conditions. he reported data derive mostly from official meat 
inspection, which does not always cover pigs raised in backyards and slaughtered for own consumption. In 
pigs raised indoors, the risk of infection is mainly related to the lack of compliance with rules on the treatment 
of animal waste. In such farms, infection could occur due to the breakdown of the biosecurity barriers around 
the farm, allowing the introduction of infected rodents
46
. The overall EU prevalence of Trichinella-positive 
pigs was 0.00016 %. Romania was responsible for the majority of Trichinella findings in pigs in 2012. 
Eighteen MSs and three non-MSs reported data on horses and one (0.0005 %) was found to be positive for 
Trichinella, in 2012. 
Eight MSs provided data on samplings of farmed wild boar and the proportion of positive farmed wild boar 
was higher than the prevalence in pigs, which is expected as controlled housing conditions are typically not 
applied to the farming of wild boar.  
Trichinella is often reported in wildlife species by some Eastern and Northern European MSs where the 
parasite is circulating in wildlife populations. The overall Trichinella prevalence in hunted wild boar in 2012, 
was higher than in pigs and in farmed wild boar. The prevalence in wildlife, other than in wild boar, was 
noticeably high during 2012 in some Northern European MSs where positive findings were found in foxes, 
bears, raccoon dogs, lynx and other species.  
Twenty-five food-borne outbreaks caused by Trichinella were reported by five MSs, of which nine were 
supported by strong evidence and were linked to the consumption of pig meat and wild boar meat, and/or 
products thereof. The food-borne outbreaks, supported by strong evidence, were reported by two MSs, 
Romania and Spain, which also reported positive findings in pigs and wild boar. 
There is no sign of a decreasing trend in Trichinella in wildlife, even though this is the case in pigs; thus, it is 
vital to continue educating hunters to enable them to ensure the safety of meat from hunted game, and raise 
their awareness about the risks of eating undercooked bear, badger, lynx, wild boar or other carnivore or 
omnivore game meat. 
 
                                                          
46
 European Food Safety Authority, 2011. Scientific Report on Technical specifications on harmonised epidemiological indicators for 
public health hazards to be covered by meat inspection of swine. EFSA Journal 2011;9(10):2371, 125 pp. 
doi:10.2903/j.efsa.2011.2371 
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3.8. Toxoplasma 
Toxoplasma infection is common in animals and humans. The causative agent is an obligate intracellular 
protozoan parasite, Toxoplasma gondii. Nearly all warm-blooded animals can act as intermediate hosts, and 
seemingly all animals may be carriers of tissue cysts of this parasite (Figure TO1). However, the parasite 
only matures in domestic and wild cats, which are the definitive hosts.  
Figure TO1. Life cycle of Toxoplasma gondii 
 
Source: http://www.dpd.cdc.gov/dpdx/HTML/Toxoplasmosis.htm 
Humans may be infected through the consumption of undercooked meat containing intermediate cysts or 
food/water contaminated with oocysts from cat faeces or from handling contaminated soil or cat litter trays. 
Most human infections are asymptomatic or cause mild flu-like symptoms resulting in long-lasting immunity. 
Lymphadenitis accompanied by fever and headache is the most frequent clinical sign of infection in humans. 
About 50 %-80 % of the European population are estimated to be infected. Occasionally the parasite may 
cause a serious foetal infection resulting in abortion or congenital lesions in the child’s brains, eyes or other 
organs, particularly if the mother acquires her first infection during the first trimester of pregnancy.  
In animals, Toxoplasma is an important cause of abortion in sheep and goats, but may be controlled by 
proper management practices and vaccination.  
3.8.1. Toxoplasma in animals 
In total 15 MSs and two non-MSs provided data on Toxoplasma in animals from the years 2011-2012 (Table 
TO1). Only the data covering at least 25 samples are summarised in the following tables, whereas all the 
reported data are presented in the level 3 tables. The data on the human toxoplasmosis cases in 2011 and 
2012 are not included in this report. 
Most of the reporting countries provided information on the type of specimen taken and the analytical method 
used in testing. This facilitated a better interpretation of the data. Some countries tested meat or other 
tissues for the presence of Toxoplasma cysts, while other countries tested serologically blood or meat juice 
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samples for the presence of Toxoplasma antibodies. Furthermore, some results derive from monitoring and 
specific national surveys while other results are from clinical investigations. Because of the use of different 
tests and analytical methods as well as different sampling schemes, the results from different countries are 
not directly comparable.  
Furthermore, the prevalence of Toxoplasma infection in farm animals is strongly influenced by the age of the 
tested animals and the type of husbandry conditions applied at the farm. 
Only four MSs provided data on Toxoplasma in pigs for the years 2011-2012, which covered more than 
25 samples (Table TO2). Most of these data derived from monitoring, objective sampling or specific surveys. 
Germany and Poland tested for the tissue cysts, Germany finding no positive samples out of 837 samples 
tested, while Poland detected five (1 %) positive samples for the cysts from the 500 investigated in 2012. 
The Netherlands and the United Kingdom both reported less than 1 % of the samples positive for 
Toxoplasma antibodies from farm level monitoring. 
Six MSs reported data on Toxoplasma in cattle with more than 25 samples for the years 2011-2012 (Table 
TO3). Both Germany and Poland found low to moderate levels of samples positive for tissue cysts. Several 
MSs reported a very high proportion of serologically positive samples from clinical investigations of cattle at 
farm.  
More MSs and non-MSs reported information on Toxoplasma in sheep and goats, likely because of the 
clinical importance of the parasite in these animal species (Table TO4). High proportions of serological 
samples were found positive by many countries, particularly from clinical investigations and suspect 
sampling. Finland, Germany, the Netherlands and Norway also detected tissue cysts in samples from sheep, 
these samples deriving mainly from clinical investigations.  
Several MSs and non-MSs provided data on Toxoplasma in cats and dogs, mainly from clinical 
investigations, and found often positive samples (Table TO5).  
In addition, six MSs and one non-MS provided data (over 25 samples) on other animal species, reporting 
Toxoplasma positive samples from horses, hares, muskrats, coypu, foxes, wild boar, pigeons, water 
buffaloes and deer (Table TO6). Particularly, in wild boar, high proportions of seropositive samples were 
detected by Italy and Poland. France tested imported (from outside EU) horse meat at border inspections 
and found that 31.2% of the slaughter batches tested positive. Among the investigations covering less than 
25 samples, Toxoplasma positive findings were detected from zoo animals, finches, wallabies, mouflons, 
rabbits, wild birds and poultry.  
Table TO1. Overview of countries reporting data for Toxoplasma, 2012-2011 
Data 
Total number of  
 reporting MSs 
Countries 
Human  
2012 - 24 
All MSs except AT, DK, IT 
Non-MSs: IS, NO 
2011 - 24 
All MSs except AT, DK, IT 
Non-MSs: IS, NO 
Animal 
2012 - 17 
All MSs except AT, BG, DE, EE, FR, GR, LT, LU, MT, PT 
Non-MSs: CH, NO 
2011 - 21 
All MSs except EE, FR, GR, HU, LT, MT 
Non-MSs: CH, NO 
Note: The overview table contains all data reported by MSs and non-MSs. 
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Table TO2. Findings of Toxoplasma in pigs, 2011-2012  
Country Description 
Sample  
unit 
Analytical 
method  
2012 2011 
N N pos % pos N N pos % pos 
Germany 
At farm, 
domestic 
production 
Animal 
Microbiological 
test
1
 
559 0 0 278 0 0 
Netherlands 
At farm, 
monitoring 
Animal, 
blood 
ELISA 780 7 0.9 - - - 
Poland 
At 
slaughterhouse, 
survey, 
objective 
sampling
2
 
Animal, 
organ/tissue 
Direct 
agglutination 
500 61 12.2 500 51 10.2 
Testing of 
samples found 
positive with 
direct 
agglutination 
Animal, 
organ/tissue 
PCR 61 5 8.2 - - - 
United Kingdom 
At farm, 
monitoring, 
convenience 
sampling,  
Great Britain 
Animal, 
blood 
Direct 
agglutination 
154 1 0.6 - - - 
Note: Data presented only for sample sizes ≥25. 
1.  Microscopy followed by immuno histo-chemistry.  
2.  2011 at farm, monitoring, selective sampling. 
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Table TO3. Findings of Toxoplasma in cattle, 2011-2012  
Country Description 
Sample  
unit 
Analytical 
method  
2012 2011 
N N pos % pos N N pos % pos 
Germany 
Calves (under 1 
year),  
at farm, 
domestic 
production 
Animal 
Microbiological 
test
1 
 
299 0 0 148 0 0 
Dairy cows,  
at farm, 
domestic 
production 
Animal 
Microbiological 
test 
33 0 0 26 0 0 
Total,  
at farm, 
domestic 
production 
Animal 
Microbiological 
test 
496 11 2.2 235 3 1.3 
Ireland  
At farm, 
domestic 
production, 
clinical 
investigations, 
suspect 
sampling 
Animal, 
blood 
Latex 
agglutination
2
 
50 0 0 32 0 0 
Italy  
At farm, 
domestic 
production, 
clinical 
investigations 
Animal ELISA
3
 21 0 0 159 4 2.5 
Poland 
At 
slaughterhouse, 
survey, 
objective 
sampling 
Animal, 
organ/ 
tissue
4
 
Direct 
agglutination 
400 80 20.0 400 59 14.8 
Testing of 
samples found 
positive with 
direct 
agglutination 
Animal, 
organ/ 
tissue 
PCR 80 14 17.5 - - - 
Spain 
At farm, 
monitoring, 
convenience 
sampling 
Herd, 
blood5 
ELISA 40 0 0 68 0 0 
United Kingdom 
At farm, 
clinical 
investigations, 
suspect 
sampling, 
Northern 
Ireland  
Animal, 
blood 
Latex 
agglutination 
34 25 73.5 - - - 
Note: Data presented only for sample sizes ≥25. 
1.  Microscopy followed by immuno histo-chemistry.  
2.  2011, microbiological test. 
3.  2011, national survey, analytical method not given.  
4.  2011, monitoring, selective sampling, animal - blood sample. 
5.  2011, animal. 
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Table TO4. Findings of Toxoplasma in sheep and goats, 2011-2012  
Country Description 
Sample  
unit 
Analytical method  
2012 2011 
N N pos % pos N N pos % pos 
Sheep                  
Finland At farm, clinical investigations Animal 
Histology, Immuno 
Histo Chemistry, PCR 
166 0 0 81 2 2.5 
France 
At farm, clinical investigations, convenience 
sampling 
Animal, blood Modified agglutination  - - - 223 170 76.2 
Germany Unspecified, at farm, domestic production Animal Microbiological test
1
 588 19 3.2 198 8 4.0 
Ireland  
At farm, domestic production, clinical investigations, 
suspect sampling 
Animal, blood Latex agglutination
2
 972 93 9.6 1,012 103 10.2 
Italy  
At farm, domestic production, clinical investigations Animal ELISA 70 51 72.9 - - - 
At farm, domestic production, survey Animal ELISA
3
 582 2 0.3 199 102 51.3 
At farm, domestic production, survey Animal Several methods 128 57 44.5 131 24 18.3 
Latvia At farm, clinical investigations, suspect sampling Animal, blood Latex agglutination - - - 57 33 57.9 
Malta At farm, monitoring, selective sampling Animal, blood ELISA - - - 400 311 77.8 
Netherlands  
At farm, monitoring  Animal, blood   89 36 40.4 0 0 0 
At farm, clinical investigation Animal, organ/tissue
4
 
 
 467 8 1.7 564 0 0 
Spain 
At farm, clinical investigations, suspect sampling Animal, blood 
ELISA, direct 
agglutination 
- - - 44 11 25.0 
At farm, monitoring, convenience sampling Animal, blood ELISA - - - 6,327 2,041 32.3 
United Kingdom 
At farm, clinical investigations, suspect sampling, 
Northern Ireland  
Animal, blood Latex agglutination  533 455 85.4 - - - 
At farm, monitoring, convenience sampling Animal, blood Latex agglutination  533 455 85.4 655 285 43.5 
Norway 
At farm, domestic production, clinical investigation Animal sample - blood Direct agglutination  50 26 52.0 - - - 
At farm, domestic production, clinical investigation 
Animal sample - 
organ/tissue 
Immuno Histo 
Chemistry 
48 13 27.1 - - - 
Table continued overleaf.  
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Table TO4 (continued). Findings of Toxoplasma in sheep and goats, 2011-2012  
Country Description 
Sample  
unit 
Analytical method  
2012 2011 
N N pos % pos N N pos % pos 
Goat                 
Germany Unspecified, at farm, domestic production Animal Microbiological test 71 0 0 55 0 0 
Italy  
At farm, domestic production, survey
5
 Animal ELISA 25 1 4.0 25 0 0 
At farm, domestic production, clinical investigations 
herd/flock, animal 
sample 
- - - - 49 0 0 
Malta At farm, monitoring, selective sampling Animal, blood ELISA - - - 409 273 66.7 
Netherlands  
At farm, monitoring Animal, blood - 31 1 3.2 0 0 0 
At farm, clinical investigations Animal, organ/tissue
4
 
 
 221 4 1.8 214 0 0 
Spain At farm, clinical investigations, suspect sampling Animal, blood 
ELISA, direct 
agglutination 
- - - 32 18 56.3 
United Kingdom 
At farm, monitoring, convenience sampling Animal, blood Latex agglutination 44 7 15.9 46 25 54.3 
At farm, clinical investigations, suspect sampling Animal Several methods 46 1 2.2 - - - 
Sheep and goats                 
Cyprus At farm, clinical investigation, suspect sampling Animal, blood ELISA 111 34 30.6 111 34 30.6 
Italy  At farm, domestic production, survey Animal - - - - 41 0 0 
Note: Data presented only for sample sizes ≥25. 
1. Microscopy followed by immuno histo-chemistry.  
2. 2011, microbiological test. 
3. 2011, analytical method unknown. 
4. 2011, blood samples, ELISA method. 
5. 2011, at farm, domestic production, analytical method unknown. 
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Table TO5. Findings of Toxoplasma in cats and dogs, 2011-2012  
Country Description 
Sample  
unit 
Analytical method  
2012 2011 
N N pos % pos N N pos % pos 
Cats                   
Finland Clinical investigation Animal 
Histology, Immuno Histo 
Chemistry, PCR 
335 4 1.2 335 4 1.2 
Germany Domestic production Animal Microbiological test
1
 761 3 0.4 686 3 0.4 
Italy Domestic production, clinical investigation Animal   - - - 38 0 0 
Latvia Clinical investigation Animal, blood Latex agglutination 68 6 8.8 75 18 24.0 
Netherlands  Surveillance Animal, blood ELISA - - - 450 91 20.2 
Poland 
Clinical investigation Animal, blood Immunofluorescence antibody  101 63 62.4 107 80 74.8 
Clinical investigation Animal, faeces Immunofluorescence antibody  - - - 31 0 0 
Portugal   Animal, blood Direct agglutination  - - - 89 23 25.8 
Slovakia 
Clinical investigation, suspect sampling Animal, blood   - - - 120 18 15.0 
Clinical investigations
2
, suspect sampling Animal, faeces Flotation method 261 1 0.4 77 5 6.5 
Switzerland Clinical investigation Animal   252 1 0.4 484 2 0.4 
Dogs                   
Finland Clinical investigation Animal 
Histology, Immuno Histo 
Chemistry, PCR 
739 0 0 620 0 0 
France 
Clinical investigation, convenience sampling, 
Corsica 
Animal Modified agglutination test  - - - 281 183 65.1 
Germany Domestic production Animal Microbiological test 325 0 0 159 5 3.1 
Italy  Domestic production, clinical investigation Animal Immunofluorescence antibody
3
 185 90 48.6 197 83 42.1 
Latvia Clinical investigation Animal, blood Latex agglutination     3.8 54 13 24.1 
Netherlands  Clinical investigation Animal ELISA 52 1 1.9 77 9 11.7 
Slovakia Clinical investigation, suspect sampling Animal, blood Complement fixation
3
 39 8 20.5 40 5 12.5 
Spain Clinical investigation, suspect sampling
4
 Animal, blood ELISA 939 329 35.0 39 1 2.6 
Note: Data presented only for sample sizes ≥25. 
1. Microscopy followed by immuno histo-chemistry.  
2. 2011, monitoring.  
3. 2011, analytical method unknown.  
4. 2011, monitoring, convenience sampling.  
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Table TO6. Findings of Toxoplasma in other animal species, 2011-2012  
Country Description 
Sample  
unit 
Analytical 
method  
2012 2011 
N N pos % pos N N pos % pos 
Finland 
Hares, clinical 
investigation 
Animal 
Histology, 
Immuno Histo 
Chemistry, 
PCR 
96 10 10.4  - -  -  
France 
Horses, border 
control, 
imported, 
monitoring, 
objective 
sampling 
Slaughter 
batch, meat 
Modified 
agglutination  
269 84 31.2 -  -  -  
Muskrats, wild, 
surveillance, 
convenience 
sampling 
Animal, 
blood 
Modified 
agglutination  
-   -  - 546 148 27.1 
Coypu, 
surveillance, 
convenience 
sampling 
Animal, 
blood 
Modified 
agglutination 
-  -   - 193 60 31.1 
Germany 
Horses, at farm, 
domestic 
production 
Animal 
Microbiological 
test 
60 0 0 43 0 0 
Foxes, domestic 
production 
Animal 
Microbiological 
test 
 - -  -  377 1 0.3 
Italy  
Wild boar, 
survey 
Animal 
Immuno 
fluorescence 
antibody
1
 
218 185 84.9 267 1 0.4 
Wild boar, wild, 
clinical 
investigation 
Animal ELISA 35 0 0 183 8 4.4 
Pigeons, survey Animal   -  -   - 30 24 80.0 
Rodents, wild, 
survey 
Animal    - -   - 56 0 0 
Water buffaloes, 
at farm, survey 
Animal   -  -  -  34 2 5.9 
Poland 
Deer, from 
hunting  
Animal, 
organ/tissue 
Direct 
agglutination 
34 3 8.8 -  -  -  
Deer, from 
hunting  
Animal, 
organ/tissue 
PCR 43 5 11.6 -  -  -  
Wild boar, from 
hunting  
Animal, 
organ/tissue 
Direct 
agglutination 
586 201 34.3 -  -  -  
Wild boar, from 
hunting  
Animal, 
organ/tissue 
PCR 105 8 7.6  - -  -  
Slovakia 
Hares, 
monitoring, 
suspect 
sampling 
Animal, 
blood 
Complement 
fixation 
95 0 0 -  -  -  
Rodents, 
laboratory 
animals, 
monitoring, 
suspect 
sampling 
Animal   -  -  -  120 0 0 
Norway 
Foxes, farmed, 
export control, 
selective 
sampling  
Animal, 
blood 
   - -  -  110 0 0 
Note: Data presented only for sample sizes ≥25. 
1.  2011, analytical method unknown.  
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3.8.2. Discussion 
The importance of Toxoplasma as a risk for human health was recently highlighted by EFSA’s opinions on 
modernisation of meat inspection, where Toxoplasma was identified as a relevant hazard to be addressed in 
revised meat inspection systems for pigs, sheep, goats, farmed wild boar and farmed deer
48,49,50
. 
Toxoplasma was reported by the MSs from pigs, sheep, goats, hunted wild boar and hunted deer, in 2011 
and 2012. In addition, positive findings were detected in cats (the natural hosts), cattle and dogs as well as 
several other animal species, indicating the wide distribution of the parasite among different animal and 
wildlife species.  
                                               
48
 EFSA Panels on Biological Hazards (BIOHAZ), on Contaminants in the Food Chain (CONTAM), and on Animal Health and Welfare 
(AHAW), 2011. Scientific Opinion on the public health hazards to be covered by inspection of meat (swine). EFSA Journal 
2011;9(10):2351, 198 pp. doi:10.2903/j.efsa.2011.2351 
49
 EFSA BIOHAZ Panel (EFSA Panel on Biological Hazards), 2013. Scientific Opinion on the public health hazards to be covered by 
inspection of meat from sheep and goats. EFSA Journal 2013;11(6):3265, 186 pp. doi:10.2903/j.efsa.2013.3265 
50
 EFSA BIOHAZ Panel (EFSA Panel on Biological Hazards), 2013. Scientific Opinion on the public health hazards to be covered by 
inspection of meat from farmed game. EFSA Journal 2013;11(6):3264, 181 pp. doi:10.2903/j.efsa.2013.3264 
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3.  INFORMATION ON SPECIFIC ZOONOSES AND ZOONOTIC AGENTS 
3.9. Rabies 
Rabies is a neurological disease caused by a rhabdovirus of the genus Lyssavirus. This virus can infect all 
warm-blooded animals and is generally transmitted through contact with saliva from infected animals, in 
Europe typically from foxes and racoon dogs, but also from domestic carnivores, via bites. The disease 
causes swelling in the central nervous system of the host and is normally fatal.  
The majority of rabies cases are caused by the classical sylvatic rabies virus (RABV, species). In addition, 
four species of Lyssavirus virus are detected in bats in Europe: WCB (West Caucasian Bat virus), BBLV 
(Bokeloh Bat Lyssavirus), EBLV-1 (European Bat Lyssavirus) and EBLV-2, of which the last three were 
reported in 2012. Although rare in Europe, bats can transmit rabies to other mammals, including humans. 
Symptoms in humans include a sense of apprehension, headache and fever, leading to death. Although 
occurring worldwide, rabies is uncommon in humans. Human cases are extremely rare in the EU, and mostly 
relate to travel to endemic countries. However, those working with bats and other wildlife are encouraged to 
seek advice on vaccination against rabies. 
In animals, the pathogenicity and infectivity of the virus vary greatly among different species. Infected 
animals may exhibit a wide range of symptoms, including drooling, difficulty in swallowing, irritability, strange 
behaviour, alternating excitative and apathy stages and increasing paralysis of the lower jaw and hind parts. 
Animals may excrete the virus during the incubation period, up to 14 days prior to the onset of clinical 
symptoms. 
Table RA1 presents the countries reporting data for 2012. 
Table RA1.  Overview of countries reporting data on Lyssavirus, 2012 
Data 
Total number of  
reporting MSs  
Countries 
Human 27 
All MSs  
Non-MSs: CH, IS, NO 
Animal 24 
All MSs except CY, IE, MT 
Non-MSs: CH, NO 
Note: The overview table contains all data reported by MSs and non-MSs. 
3.9.1. Rabies in humans 
Generally, very few cases of rabies in humans are reported in the EU, and most MSs have not had any 
indigenous cases for decades. In 2012, Romania reported one domestically acquired case in a five-year-old 
girl. The girl had been bitten by a stray dog in a village in eastern Romania. She was initially misdiagnosed 
and died in February 2012
51
. In addition, in May 2012, one travel-associated case of rabies was reported in 
the EU, from the United Kingdom (Table RA2). The patient was a woman, resident in the United Kingdom, 
who visited her country of origin, India, where she was bitten by a dog
52
. Another case was reported from 
Switzerland: a USA citizen, who probably contracted the disease in July 2012, after previous exposure to a 
bat in the USA
53
. 
                                                          
51 http://www.promedmail.org/direct.php?id=20120308.1064096 
52
  http://www.hpa.org.uk/webw/HPAweb&HPAwebStandard/HPAweb_C/1317134331244 
53
  Deubelbeiss AN, Trachsel Ch, Bachli EB, Kuffer A, Budka H, Eniseyskiy P, Zimmermann H, Wallace RM, Farley S and Zanoni RG, 
2013. Imported human rabies in Switzerland, 2012: a diagnostic conundrum. Journal of Clinical Virology, 57, 178-181. 
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Table RA2.  Human rabies cases in the EU, 2008-2012 
Year Country Case 
2008 
France 1 case (French Guyana) 
Romania 1 case (fatal) 
United Kingdom 1 imported case 
2009 Romania 
1 fatal case. A 69-year-old woman from a rural area was bitten by 
a fox. The patient did not visit a hospital or report it to the 
veterinary authorities 
2010 Romania 
2 fatal cases. One 10- and one 11-year-old girl, both from rural 
areas. Possible transmission was in one case a cat bite and in the 
other was unknown 
2011 Portugal 
1 fatal case imported from Guinea-Bissau. Case was a 41-year-
old woman bitten by a dog. No vaccine was available in the 
country at the time of the bite. The person visited the hospital in 
Portugal two and a half months after the bite 
2012 
Romania 
1 fatal case. A five year-old girl was bitten by a stray dog in a 
village in eastern Romania and was initially mis-diagnosed; she 
died in February 2012. 
United Kingdom 
1 fatal case. A British woman died of rabies in May 2012 in the 
United Kingdom, contracted from a dog in India. 
Switzerland 
1 fatal case. An American citizen died of rabies in July 2012; he 
was bitten by a bat in California three months before the 
symptoms started. 
 
3.9.2. Rabies in animals 
Rabies is a notifiable disease in all MSs. In 2012, 12 MSs had their annual or multiannual plan of rabies 
eradication co-financed by the EC (Decision 2011/807/EU). Eradication plans comprise oral vaccination of 
wild animals, sampling of wild and domestic animals (suspected of having been infected by rabies and/or 
those found dead) for rabies, and surveillance and monitoring of wild animals for vaccine efficacy. 
The vaccination programmes can be conducted nation-wide or in at-risk areas only and these programmes 
may vary in frequency: ordinary vaccination campaigns (twice a year) or extraordinary campaigns (as many 
campaigns as required depending on the epidemiological situation). For rabies surveillance, the majority of 
the samples from wild and domestic animals are taken based on suspicion of rabies infection, including 
animals found dead. In addition, countries carrying out oral vaccination programmes of wildlife monitor the 
efficacy of vaccination campaigns. This involves the sampling of healthy (rabies unsuspected) hunted foxes 
and raccoon dogs randomly and homogeneously sampled from the vaccination areas. These hunted animals 
are tested for vaccine intake and for specific immunity, as well as for the presence of the rabies virus. 
With the exception of Cyprus, Ireland and Malta, all MSs and two non-MSs (Norway and Switzerland) 
provided information on rabies in animals (Table RA1). Six MSs and one non-MS (Norway) reported rabid 
wild animals other than bats (Table RA4), and four of these MSs also reported rabies  in domestic animals; 
two MSs reported rabies only in domestic animals (Table RA3). Six MSs reported rabies-infected bats 
(Table RA5).  
In October 2012, 25 years after the last reported case, Greece detected one rabid fox in the northern part of 
the Greek territory, followed by the detection of eight additional cases (six rabid foxes and two rabid dogs) 
before the end of 2012. Italy did not report any rabies cases in animals in 2012, indicating that the rabies 
epidemic that the country experienced in 2008-2011 may be over.  
In 2012, 712 animals other than bats tested positive for either classical rabies virus or unspecified Lyssavirus 
in eight MSs and one non-MS. The number of cases reported in 2012 increased compared with 2011, when 
512 cases where detected in animals other than bats (Figure RA1).  
Three MSs and one non-MS reported their findings at the regional level, two of them covering rabies 
surveillance of the whole national territory (Figure RA2). 
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Lyssavirus was speciated for around 75 % of the 745 rabies-positive animals (including bats) reported, while 
the remaining 187 cases were reported as unspecified Lyssavirus.  
Domestic animals 
In 2012, 23 MSs and 2 non-MSs (Norway and Switzerland) reported data on rabies testing in domestic 
animals (Table RA3).  
Overall, 180 domestic animals, in six MSs, were found to be infected with either classical rabies virus or 
unspecified Lyssavirus. Except for the Netherlands, classical rabies was not reported in domestic animals in 
Central and Western EU MSs. The number of countries which reported positive findings in domestic animals 
increased in comparison with the previous year (three MSs). At the EU level, the number of cases reported in 
farm animals increased in 2012 compared with previous year, and this is mainly explained by an increase in 
the number of cases reported by Romania. In 2012, Poland and Romania recorded the vast majority of 
positive findings in domestic animals, accounting for 96 % of all domestic animals found infected. 
Wildlife  
In 2012, 21 MSs and 2 non-MS (Norway and Switzerland) reported data on rabies in wild animals other than 
bats (Table RA4). 
Overall, 532 wild animals (excluding bats) testing positive, for either classical rabies virus or unspecified 
Lyssavirus, were reported by Lithuania, Poland, Bulgaria, Greece, Romania and Slovenia; most of the cases 
(around 97 %) were reported by Poland and Romania. Norway also reported one positive polar fox in the 
Svalbard archipelago. 
There was a decrease in cases in wildlife compared with 2010, when 725 cases were reported by MSs and 
the two reporting non-MSs, but an increase compared with 2011, when 385 cases were reported. Rabies 
findings in foxes (504) increased compared with 2011 when 336 foxes were reported to be infected; in 2012 
the rabid foxes reported by Romania accounted for 60 % of all foxes found infected with rabies. 
Four raccoon dogs were found positive for rabies in 2012, and this figure is lower than that reported in 2011, 
when 11 rabid raccoon dogs were reported. Twenty-four cases occurred in other wildlife species, more than 
half of them in martens. 
Bats 
In 2012, 19 MSs and 1 non-MS (Switzerland) reported data on rabies in bats (Table RA5). Bats infected with 
rabies virus were found in six MSs (France, Germany, Hungary, the Netherlands, Poland and Spain) 
(Figure RA3). These countries also reported positive findings in bats in 2010 and 2011. France and Germany 
reported one finding each, of the Bokeloh Bat Lyssavirus. Of the reported findings of Lyssavirus in bats in the 
EU almost half (45.5 %) were found in the Netherlands.  
 
  
 
 
Sweden (since 1988) and the United Kingdom (since 1987) have had a passive surveillance programme for 
EBLV in bats. No cases were detected in 2012, 2011 and 2010. Sweden, in addition, implemented an active 
surveillance programme for rabies in bats in 2008. 
For additional information on rabies in animals, refer to the Level 3 Tables. 
The Bokeloh Bat Lyssavirus (BBLV) was found in Myotis nattereri in north-eastern France for the first 
time in July 2012. This French isolate showed 98.7 % nucleotide identity with the first BBLV strain 
isolated in 2010 in Germany. Distribution investigations of Lyssavirus in the bat lead to detection of the 
infectious virus in the salivary glands, which suggested a possible transmission pathway for the virus. 
Source: France National Zoonoses Summary Report, 2012. 
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Table RA3.  Number of tested animals and positive cases of rabies in domestic animals, 2012 
 Country  Description of sampling strategy
1
 
Classical rabies (RABV) virus or unspecified Lyssavirus (u. L.) 
Farm animals
2
 Cats
3
 Dogs
3
 
N 
RABV u. L. all L.
 
 
N 
RABV u. L. all L.
 
 
N 
RABV u. L. all L.
 
 
Pos Pos Total Pos Pos Pos Total Pos Pos Pos Total Pos 
Austria Suspect sampling 14 0 0 0 58 0 0 0 53 0 0 0 
Belgium Selective sampling 346 0 0 0 13 0 0 0 15 0 0 0 
Bulgaria Suspect sampling and objective sampling 1 0 0 0 2 0 0 0 10 0 0 0 
Czech Republic Selective sampling 3 0 0 0 140 0 0 0 96 0 0 0 
Denmark 
Suspect sampling and clinical 
investigations 
- - - - 2 0 0 0 1 0 0 0 
Estonia Suspect sampling and clinical investigations 13 0 0 0 22 0 0 0 12 0 0 0 
Finland Suspect sampling 1 0 0 0 11 0 0 0 24 0 0 0 
France Suspect sampling 14 0 0 0 564 0 0 0 659 0 0 0 
Germany Unspecified 112 0 0 0 218 0 0 0 222 0 0 0 
Greece Selective sampling and surveillance 7 0 0 0 2 0 0 0 38 2 0 2 
Hungary Unspecified 45 0 0 0 347 0 0 0 285 0 0 0 
Italy 
Clinical investigations, monitoring and 
unspecified 
122 0 0 0 261 0 0 0 344 0 0 0 
Latvia Suspect sampling 15 1 0 1 39 0 0 0 23 1 0 1 
Lithuania Suspect sampling, unspecified 26 0 1 1 74 0 1 1 78 0 0 0 
Luxembourg Suspect sampling 3 0 0 0 1 0 0 0 - - - - 
Netherlands Suspect sampling 689 0 0 0 14 0 0 0 11 1 0 1 
Poland Suspect sampling and selective sampling 60 6 5 11 1,065 9 5 14 666 7 6 13 
Portugal Suspect sampling - - - - - - - - 2 0 0 0 
Romania Surveillance 414 0 57 57 154 0 30 30 329 0 0 48 
Slovakia 
Suspect sampling, clinical investigation 
and objective sampling 
8 0 0 0 94 0 0 0 148 0 0 0 
Slovenia Suspect sampling, surveillance 20 0 0 0 55 0 0 0 30 0 0 0 
Spain Suspect sampling and monitoring - - - - 23 0 0 0 - - - - 
Sweden  Suspect sampling and surveillance - - - - 3 0 0 0 2 0 0 0 
United Kingdom 
Suspect sampling, selective sampling and 
monitoring 
- - - - 4 0 0 0 2 0 0 0 
EU Total     1,899 7 63 70 3,108 9 36 45 2,997 11 6 65 
Norway 
Suspect sampling and clinical 
investigations 
- - - - 1 0 0 0 - - - - 
Switzerland Unspecified, clinical investigations 9 0 0 0 7 0 0 0 31 0 0 0 
Note: Data from imported animals are not included in the table. No exclusion was made on the sample size. RABV: rabies virus; u. L.: unspecified Lyssavirus; all. L.: total Lyssavirus reported. 
1. The description of the sampling strategy refers to farm animals, cats and dogs.  
2. Data include: cattle (bovine animals), pigs, unspecified poultry, unspecified, sheep, goats, domestic solipeds. 
3. Including both pets and stray cats and dogs. 
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Table RA4.  Number of tested animals and positive cases of rabies in wild animals other than bats, 2012 
  Country Description of sampling strategy1 
Classical rabies (RABV) virus or unspecified Lyssavirus (u. L.) 
Foxes Raccoon dogs Other wild2 
N 
RABV u. L. all L.  
N 
RABV u. L. all L.  
N 
RABV u. L. all L.  
Pos Pos Total Pos Pos Pos Total Pos Pos Pos Total Pos 
Austria Suspect sampling 2,8423 0 0 0 - - - - 43 0 0 0 
Belgium Selective sampling and monitoring 48 0 0 0 - - - - - - - - 
Bulgaria Objective sampling and monitoring 461 0 1 1 - - - - 322 0 0 0 
Czech Republic Selective sampling, monitoring and unspecified 3,196 0 0 0 - - - - 66 0 0 0 
Denmark 
Suspect sampling, survey - national survey and 
clinical investigations 
2 0 0 0 - - - - 13 0 0 0 
Estonia 
Suspect sampling, control and eradication 
programmes  
54 0 0 0 73 0 0 0 14 0 0 0 
Finland Census, monitoring and surveillance 155 0 0 0 248 0 0 0 237 0 0 0 
France Suspect sampling and monitoring 43 0 0 0 - - - - 28 0 0 0 
Germany Unspecified 3,518 0 0 0 - - - - 93 0 0 0 
Greece Selective sampling, monitoring and surveillance 140 7 0 7 - - - - 47 0 0 0 
Hungary Objective sampling, monitoring and unspecified 4,136 0 0 0 - - - - 41 0 0 0 
Italy Monitoring and unspecified 5,021 0 0 0 - - - - 753 0 0 0 
Latvia Suspect sampling and monitoring 123 0 0 0 56 0 0 0 29 0 0 0 
Lithuania Suspect sampling and monitoring 198 0 1 1 103 0 2 2 92 0 0 0 
Luxembourg Objective sampling and monitoring 27 0 0 0 - - - - - - - - 
Netherlands Suspect sampling 3 0 0 0 - - - - 1 0 0 0 
Poland Suspect sampling, census, and monitoring 21,696 189 0 189 71 2 0 2 185 5 7 12 
Romania Monitoring and surveillance 2,280 302 0 302 - - - - 66 6 6 12 
Slovakia 
Suspect sampling, control and eradication 
programmes, objective sampling, surveillance 
3,371 0 0 0 5 0 0 0 35 0 0 0 
Slovenia Suspect sampling, monitoring and surveillance 1,992 3 0 3 - - - - 61 0 0 0 
Spain Suspect sampling and monitoring 15 0 0 0 - - - - 41 0 0 0 
Sweden  Suspect sampling and surveillance 3 0 0 0 - - - - - - - - 
EU Total   46,482 501 2 503 556 2 2 4 2,124 11 13 24 
Norway4 
Suspect sampling, clinical investigations, 
objective sampling and monitoring 
120 0 0 1 - - - - 5 0 0 0 
Switzerland Clinical investigations and unspecified 10 0 0 0 1 0 0 0 4 0 0 0 
Note: RABV: rabies virus; u. L.: unspecified Lyssavirus; all. L.: total Lyssavirus reported. Zoo animals and unspecified species are not included in the table. Fifty zoo animals were tested for rabies in 2012 (three in 
Romania and 47 in the United Kingdom), but with no positive findings. The Czech Republic (36 samples), Italy (155 samples), Latvia (one sample), Poland (221 samples) and Slovakia (two samples) reported other 
wild animals tested for rabies, but only one positive finding was reported by Poland. 
1. Sampling strategy refers to foxes, raccoon dogs and other wildlife.  
2. Data included are from Alpine chamois, budgerigars, badgers, beavers, chinchillas, chipmunks, deer, dormice, ermine, elk, ferrets, guinea pigs, hares, hamster, hedgehogs, jackals, lynxes, martens, mice, mink, 
monkeys, moose, moles, mouflons, muskrats, unspecified mustelids, otters, other wild carnivores, other mustelids, bears, polar bears, polecats, rabbits, rats, raccoons, reindeer, rodents, seals, squirrels, voles, 
weasel, wild boar, wild cats (Felis silvestris), wolverines, wolves and other wild animals. Pets other than dog and cat pets are also included here. 
3. Of these, 2,747 samples were foxes tested in context of monitoring, objective sampling. 
4. In 2012 one red fox from mainland Norway was investigated and found to be negative for rabies. From the Svalbard area, 119 polar foxes (Vulpes lagopus) were investigated. One polar fox tested positive for 
rabies. No information on the type of virus detected was reported. 
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Table RA5.  Number of tested animals and positive cases of rabies in bats, 2012 
Country Description of sampling strategy 
European Bat Lyssavirus (EBLV-1 and 
EBLV-2) or unspecified Lyssavirus (u. L.) 
N 
EBLV-1 or 
EBLV-2 
u. L. all L. 
Pos Pos Total Pos 
Austria Surveillance, passive 17 0 0 0 
Belgium Selective sampling, monitoring 108 0 0 0 
Bulgaria Objective sampling, monitoring 1 0 0 0 
Czech Republic Selective sampling, monitoring 11 0 0 0 
Estonia 
Suspect sampling, control and eradication 
programmes 
2 0 0 0 
Finland Suspect sampling, monitoring 32 0 0 0 
France
1
 Suspect sampling, monitoring 228 4 0 5 
Germany
2
 Unspecified 325 4 2 7 
Greece Selective sampling, monitoring 2 0 0 0 
Hungary Unspecified, monitoring 15 1 0 1 
Italy Unspecified, monitoring 3 0 0 0 
Luxembourg Objective sampling, monitoring 1 0 0 0 
Netherlands Suspect sampling, monitoring 194 0 15 15 
Poland Suspect sampling 107 1 2 3 
Romania Suspect sampling, surveillance 1 0 0 0 
Slovakia Suspect sampling, surveillance 1 0 0 0 
Slovenia Census, monitoring 162 0 0 0 
Spain Suspect sampling, monitoring 93 1 1 2 
Sweden  Suspect sampling, surveillance 112 0 0 0 
United Kingdom 
Suspect sampling, monitoring;  
Selective sampling, surveillance 
573 0 0 0 
EU Total   1,971 11 20 33 
Switzerland Unspecified, clinical investigations 15 0 0 0 
Note: EBLV-1 and EBLV-2: European Bat Lyssavirus 1 or 2; u. L.: unspecified Lyssavirus. all. L.: total Lyssavirus reported. 
1. In France, one of the positive was for Bokeloh Bat Lyssavirus. This has been included in the total number of positives. 
2. In Germany, one of the positive was for Bokeloh Bat Lyssavirus. This has been included in the total number of positives. 
 
  
DRAFT 
FOR 
CONSULTA TION 
EU summary report on zoonoses, zoonotic agents and 
food-borne outbreaks 2012 
 
EFSA Journal 2014;12(2):3547  224 
Figure RA1.  Reported cases
1
 of classical rabies or unspecified Lyssavirus in animals other than 
bats, in the Member States and non-MSs, 2006-2012 
 
Note: The number of reporting MSs and non-MSs is indicated at the bottom of each bar. The total number of rabid cases is reported at 
the top of each bar. 
1. Imported cases are not included.  
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Figure RA2.  Classical rabies or unspecified Lyssavirus cases in wild animals other than bats, 2012 
 
Note: In 2012, one red fox from mainland Norway was investigated and found negative for rabies. From the Svalbard area, 119 polar 
foxes (Vulpes lagopus) were investigated. One polar fox was found positive for rabies. 
 The blue highlighted areas indicate MSs, non-MS or regions reporting rabies cases in wild animals other than bats. 
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Figure RA3.  European Bat Lyssavirus (EBLV) or unspecified Lyssavirus cases in bats, 2012 
 
Note: The blue highlighted areas indicate MSs reporting rabies cases in bats.  
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3.9.3. Discussion 
Human rabies is a rare and vaccine-preventable zoonosis in Europe but the disease is invariably fatal in 
infected unvaccinated humans. Every year, one or two human cases are reported in European citizens, 
either travel related or indigenous. In 2012, one indigenous case and one case in a patient who travelled to a 
country where rabies is endemic were reported in the EU. This highlights the importance of public 
information and education about the risk of contracting rabies if bitten by animals while travelling to rabies-
endemic countries or to MSs which have not eradicated the disease in their animal population.  
In 2012, except for the Netherlands, classical rabies was not reported in domestic animals in Central and 
Western EU MSs, but this disease still occurs in wildlife and, albeit less frequently, in domestic animals, in 
the Baltic MSs and some Eastern and Southern MSs. Most of the latter MSs are now carrying out rabies 
eradication plans which are co-financed by the EU. In some of these MSs, cases occurred mostly in regions 
bordering Eastern European non-EU countries affected by rabies epidemics. 
The general decreasing trend in the total number of rabies cases in animals observed in previous years was 
reversed in 2012, as there was an increase in the rabies cases reported in animals. In the EU, the number of 
cases reported in farm animals and foxes increased. In 2012, Greece detected rabies in domestic and wild 
animals 25 years after the last recorded case which could be the result of ongoing epidemics in neighbouring 
countries
54
. 
Poland and Romania accounted for the vast majority of positive findings in 2012 in all domestic animals and 
wild animals other than bats. 
As in previous years, 2010 and 2011, the same six Central and Western MSs reported Lyssavirus cases 
from bats. These findings should be interpreted with caution because the extent of bat rabies surveillance is 
often not comparable between countries and/or sometimes no tests are carried out
55
. 
Three MSs and one non-MS reported their findings at regional level. Two MSs submitted regional data on 
rabies surveillance, covering the entire national area. Reporting of surveillance data, including negative 
findings, at regional level is important for evaluating rabies trends over time.  
 
 
                                                          
54
 Hellenic Center for Disease Control and Prevention. E-bulletins - Epidemiology of rabies in the countries sharing borders with 
Greece. Available online: http://www2.keelpno.gr/blog/?p=4060&lang=en 
55
  The World Health Organization Rabies Bulletin Europe. Rabies Information System of the WHO Collaboration Center for Rabies 
Surveillance and Research. Available online: http://www.who-rabies-
bulletin.org/About_Rabies/Bats/Information_Bat%20rabies_%20Europe.pdf  
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3.  INFORMATION ON SPECIFIC ZOONOSES AND ZOONOTIC AGENTS 
3.10. Q fever  
Q fever, or query fever, is a zoonotic disease caused by the bacterium Coxiella burnetii. Goats, sheep and 
cattle are the primary domestic animal reservoirs, and the bacteria are excreted in milk, urine and faeces and 
in high numbers in the amniotic fluid, aborted tissues and placenta at birth. Clinical disease in these animals 
is rare, although abortion in goats, sheep and cattle as well as metritis and infertility in cattle have been 
associated with C. burnetii infections. Humans are considered accidental hosts. 
C. burnetii can survive for long periods in the environment and is very resistant to physical and chemical 
stress. Humans are most often infected when inhaling airborne dust contaminated by placental material, birth 
fluids or faeces. Low levels of organisms may cause infection. Infection by ingestion of contaminated milk 
may also be possible. 
Only about 40 % of people infected with C. burnetii show clinical signs. Symptoms of acute Q fever may 
include fever, severe headache, muscle pain, discomfort, sore throat, chills, sweats, non-productive cough, 
nausea, vomiting, diarrhoea, abdominal pain and chest pain. The fever usually lasts for one to two weeks 
and may be followed by life-long immunity. Acute Q fever is fatal in less than 2 % of cases. Chronic Q fever 
is uncommon, but may develop in persons with a previous history of acute Q fever. A serious complication of 
chronic Q fever is inflammation of the heart valves, and case fatality rate even with appropriate treatment is 
about 10 %
56
. 
Table QF1 presents the countries reporting data for 2012. 
Table QF1.  Overview of countries reporting data on Q fever, 2011-2012 
Data 
Total number of  
 reporting MSs 
Countries 
Human  
2012 - 24 
All MSs except AT, DK, IT 
Non-MSs: IS, NO 
2011 - 24 
All MSs except AT, DK, IT 
Non-MSs: IS, NO 
Animal 
2012 - 18 
All MSs except BG, DE, EE, FR, GR, LT, LU, MT, PT 
Non-MSs: CH, NO 
2011 - 21 
All MSs except EE, FR, GR, HU, LT, MT 
Non-MSs: CH, NO 
Note: The overview table contains all data reported by MSs and non-MSs. 
3.10.1. Q fever in humans 
In 2012, 24 MSs provided information on Q fever in humans. Belgium and Spain have a sentinel surveillance 
system, which in Spain covers an estimated 25 % of the population. Seven MSs (Estonia, Finland, Lithuania, 
Luxembourg, Malta, Poland and Slovakia) reported no human cases. A total of 643 confirmed cases of 
Q fever in humans were reported in the EU and 17 in Switzerland (Table QF2). The EU notification rate was 
0.17 per 100,000 population. There was an overall 15.3 % decrease in the number of reported confirmed 
cases compared with 2011 (759 cases). The largest decrease in reported cases (72 %) was observed in the 
United Kingdom but case numbers were small. Cases in the Netherlands continued to decrease in 2012 
compared with 2011 (-21 %) and were 63 in 2012 compared with 2,354 in 2009. The highest case numbers 
were reported from Germany and France (198 and 168 respectively). However, the highest notification rate 
was observed in Spain (0.50 cases per 100,000 population).  
                                                        
56
 Maurin M and Raoult D, 1999. Q fever. Clinical Microbiology Reviews, 12, 518–553. 
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Table QF2.  Reported cases of human Q fever in 2008-2012, and notification rates for confirmed 
cases in 2012 
Country 
2012 2011 2010 2009 2008 
Report 
Type
1
 
Cases 
Confirmed 
cases 
Confirmed 
cases/ 
100,000 
Confirmed cases 
Austria
2
 ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ 
Belgium
3
 C  18 18 ‒ 6 30 33 27 
Bulgaria A  29 29 0.40 12 14 22 17 
Croatia ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ 
Cyprus C  4 4 0.46 5 4 2 31 
Czech Republic C  1 1 0.01 1 0 0 0 
Denmark
2
 ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ 
Estonia U 0 0 0 0 0 0 0 
Finland C  0 0 0 4 5 1 2 
France C  168 168 0.26 228 286     
Germany C  200 198 0.24 287 326 191 370 
Greece C  11 11 0.10 3 1 3 3 
Hungary C  36 36 0.37 36 68 19 11 
Ireland C  6 5 0.11 4 9 17 10 
Italy ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ 
Latvia C  1 1 0.05 1 2 0 1 
Lithuania U 0 0 0 0 0 0 0 
Luxembourg U 0 0 0 0 0 0 0 
Malta U 0 0 0 0 0 0 0 
Netherlands C  63 63 0.38 80 504 2,354 1039 
Poland A  0 0 0 0 0 3 4 
Portugal C  26 20 0.19 5 13 14 12 
Romania C  16 16 0.07 6 7 2 3 
Slovakia U 0 0 0 0 0 0 0 
Slovenia C  1 1 0.05 0 1 0 0 
Spain
4
 C  58 58 0.50 33 69 34 119 
Sweden C  2 2 0.02 5 11 5 7 
United Kingdom C  12 12 0.02 43 30 19 56 
EU Total   652 643 0.17 759 1,380 2,719 1,712 
Iceland U 0 0 0 0 0 0 0 
Liechtenstein ‒ ‒ ‒ ‒ ‒ ‒ ‒ 0 
Norway U 0 0 0 0 0 0 0 
1. A: aggregated data report; C: case-based report; U: unknown; –: no report. 
2. Not notifiable, no surveillance system exists. 
3. Sentinel surveillance; coverage unknown and notification rate cannot be estimated. 
4. Surveillance system covers only 25 % of the total population. 
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The large majority of cases in the EU were locally acquired (Figure QF1). Only Belgium, Germany, the 
Netherlands and Sweden reported travel-associated cases, but these all represented less than 10 % of the 
total cases, except in Sweden (both cases imported). Of the 21 travel-associated cases reported in total, 
9 were acquired within another EU country.  
Figure QF1. Notification rates and origin of infection in human Q fever in the EU, 2012 
 
Note: The map shows the distribution of human cases shaded according to incidence rate per 100,000 based on quartile 
classification method (EUROSTAT population data 2012). 
There was a decreasing EU trend of confirmed Q fever cases in 2008–2012 (Figure QF2, top). The peaks in 
2008 and 2009 were attributed to a large outbreak occurring in the Netherlands between 2007 and 2010 but 
which is now considered over. The specific epidemiology of Q fever during the outbreak was most likely 
related to intensive dairy goat farming, resulting in Q fever-related abortion waves as early as in 2005, in the 
proximity of densely populated areas in the south of the Netherlands. From 2007 to 2010, more than 
4,000 human cases were notified
57
. Trend analysis was also performed on the period 2010–2012, to remove 
the effect of the outbreak, and the decreasing trend was even more obvious (Figure QF2, bottom). There is a 
seasonal variation in Q fever cases, and the peak occurs mostly between April and August. Decreasing 
trends in 2008–2012 by country were observed in two MSs: the Netherlands and Spain. An increasing trend 
was observed in Hungary but the trend line was influenced by the higher case number reported in 2010. 
Many countries had too few cases to enable trend analysis. One death due to Q fever was reported in 
Germany in 2012. This resulted in an EU case-fatality rate of 0.28 % among the 361 confirmed cases for 
which this information was reported (56.1 % of all confirmed cases). 
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 Van der Hoek W, Morroy G, Renders NH, Wever PC, Hermans MH, Leenders AC and Schneeberger PM, 2012. Epidemic Q fever in 
humans in the Netherlands. Advances in Experimental Medicine and Biology, 984, 329–364.  
EU summary report on zoonoses, zoonotic agents and 
food-borne outbreaks 2012 
 
EFSA Journal 2014;12(2):3547  231 
Figure QF2. Trend in reported confirmed cases of human Q fever in the EU,  
2008-2012 (top) and 2010-2012 (bottom)  
 
Source: TESSy data from 20 MSs (Belgium, Cyprus, Czech Republic, Finland, Germany, Greece, Hungary, Ireland, Netherlands, 
Poland, Portugal, Romania, Slovenia, Spain and Sweden. Estonia, Lithuania, Luxembourg, Malta and Slovakia reported zero 
cases throughout the period). Austria, Bulgaria, Denmark, France, Italy, Latvia and United Kingdom were excluded since they 
either did not report over the whole period or reported cases that were not confirmed or had an unknown month of occurrence. 
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3.10.2. Q fever in animals 
In total, 22 MSs and 2 non-MSs provided data on Q fever (C. burnetii) in animals from the years 2011-2012 
(Table QF1). Only data coming from at least 25 samples are summarised in the following tables, whereas all 
the reported data are presented in the Level 3 Tables.  
Most of the reporting countries provided information on the type of specimen taken and the analytical method 
used in testing. This facilitated a better interpretation of the data. Some countries tested tissues, such as 
aborted fetuses, stillborn animals, placental or vaginal swabs, for direct detection of C. burnetii, while other 
countries serologically tested blood (serum) or milk samples for the presence of C. burnetii antibodies. Most 
of the results came from clinical investigations and suspect sampling but some results originated from 
serological monitoring and specific surveys. Because of this use of different tests and analytical methods as 
well as different sampling schemes, the results from different countries are not directly comparable.  
In total, 15 MSs and 1 non-MS reported investigations of Q fever in cattle with more than 25 samples for the 
years 2011–2012 (Table QF3). Many of these investigations tested high numbers of animals, and most of the 
results came from clinical investigations or sampling of suspect animals which had aborted, or from farms 
with abortions. However, some results were from monitoring activities. All reporting countries reported 
positive findings. Finland detected one positive animal from monitoring covering fewer than 25 samples. Four 
MSs reported very high proportions of positive samples (up to 86.3 %) from the serological testing of blood 
(serum) at animal level or milk at herd level. None of the countries reported clinically affected
58
 cattle herds.  
Fifteen MSs and two non-MSs provided information on tests of sheep and goats (Table QF4) for 2011–2012 
(with more than 25 samples). The majority of the results were from clinical investigations. Q fever was 
frequently detected in both sheep and goats, but not by all reporting countries. Finland and Slovakia did not 
report any positive findings from goats, while eight countries did not find positive sheep or sheep herds. 
Poland reported testing of substantial numbers of sheep and goats for both years and only found one 
positive goat in 2011 out of the 1,102 tested animals.  
Cyprus, Spain and Hungary reported a few clinically affected herds of cattle, goats or sheep.  
In addition, four MSs and one non-MS provided data (over 25 samples) from other animal species (Table 
QF5), reporting positive samples only from pigs and wild boar. Among the investigations covering fewer than 
25 samples, Q fever was detected in alpacas.  
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Table QF3.  Findings of Q fever in cattle, 2011-2012 
Country 
 
Description 
Sample  
unit 
Analytical method  
2012 2011 
N N pos % pos Herds N N pos % pos Herds 
Austria  
At farm, clinical investigations, 
suspect sampling 
Animal, blood Complement fixation 508 13 2.6 - 441 11 2.5 - 
Belgium  
At farm, clinical investigations, 
suspect sampling
1
 
Animal, blood
1
 ELISA 422 108 25.6 - 1,052 756 71.9 - 
At farm, clinical investigations, 
suspect sampling 
Animal, 
foetus/stillbirth 
Real-Time PCR 9,699 147 1.5 - 7,120 108 1.5 - 
Bulgaria  
at farm, monitoring, objective 
sampling  
Animal, blood Complement fixation  - - - - 1,256 97 7.7 - 
Czech Republic 
At farm, surveillance, suspect 
sampling, aborted animal 
Animal, blood ELISA 4,456 1,306 29.3 0 4,882 406 8.3 - 
Denmark 
Dairy cows - adult, at farm, 
surveillance, suspect sampling 
Animal, blood ELISA 139 33 23.7 - 178 13 7.3 - 
Dairy cows - adult, at farm, clinical 
investigations, suspect sampling 
Animal, milk ELISA 111 11 9.9 - - - - - 
Dairy cows - adult, at farm, 
surveillance, suspect sampling 
Herd, milk ELISA 74 48 64.9 - 47 36 76.6 - 
Finland 
At farm, clinical investigations, 
suspect sampling 
Animal, blood ELISA 292 0 0 0 59 0 0 - 
Germany  
Dairy cows - at farm, domestic 
production  
Animal 
Microbiological standard 
tests 
- - - - 553 44 8.0 - 
At farm, domestic production  Herd
2
 ELISA 878 123 14.0 123 10,251 1,699 16.6 - 
At farm, domestic production  Herd
2
 
Microbiological standard 
tests 
302 20 6.6 20 459 12 2.6 - 
At farm, domestic production  Herd
2
 PCR 579 32 5.5 32 1,497 90 6.0 - 
Table continued overleaf. 
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Table QF3 (continued). Findings of Q fever in cattle, 2011-2012 
Country Description 
Sample  
unit 
Analytical method  
2012 2011 
N N pos % pos Herds N N pos % pos Herds 
Ireland  
At farm, domestic production, clinical 
investigations, suspect sampling 
Animal, blood ELISA 402 20 5.0 0 272 28 10.3 0 
Italy  
Dairy cows - at farm, domestic 
production, clinical investigations  
Animal ELISA 30 0 0 0 - - - - 
At farm, domestic production, clinical 
investigations  
Animal Several methods  612 4 0.7 0 2,060 2 <0.1 0 
At farm, domestic production, survey Animal 
ELISA and other 
methods  
2,779 44 1.6 0 617 40 6.5 0 
At farm, domestic production, 
monitoring  
Animal Several methods  29 0 0 0 - - - - 
At farm, domestic production, 
monitoring  
Herd Several methods  121 27 22.3 0 - - - - 
  Herd Several methods  29 6 20.7 0 - - - - 
Latvia 
At farm, clinical investigations, 
suspect sampling 
Animal, blood ELISA 336 49 14.6 - - - - - 
Poland 
At farm, clinical investigations Animal, blood Complement fixation 53 4 7.5 - - - - - 
at farm, monitoring, objective 
sampling  
Animal, blood Complement fixation  712 0 0 0 814 4 0.5 0 
Slovakia 
At farm, clinical investigations, 
suspect sampling 
Animal, blood Complement fixation  57 0 0 - - - - - 
At farm, monitoring, suspect 
sampling 
Animal, blood Complement fixation
3
 3,274 78 2.4 0 3,797 95 2.5 0 
Table continued overleaf. 
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Table QF3 (continued). Findings of Q fever in cattle, 2011-2012 
Country Description 
Sample  
unit 
Analytical method  
2012 2011 
N N pos % pos Herds N N pos % pos Herds 
Slovenia  
At farm, monitoring, objective sampling  Holding, milk Real-Time PCR 124 34 27.4 - - - - - 
At farm, clinical investigations, suspect 
sampling 
Animal, blood ELISA - - - - 107 0 0 - 
Sweden 
Adult, dairy cows, at farm, survey, 
selective sampling  
Herd, milk 
ELISA, indirect ELISA  
(I-ELISA) 
- - - - 119 86 72.3 - 
Adult, dairy cows, at farm, survey, 
selective sampling  
Herd, milk Real-Time PCR - - - - 117 89 76.1 - 
United Kingdom  
At farm, survey, convenience sampling 
Animal, 
placental 
swab 
Real-Time PCR - - - - 124 9 7.3 - 
At farm, monitoring, objective sampling Herd, milk Real-Time PCR - - - - 95 82 86.3 - 
Norway  At farm, surveillance, suspect sampling Animal, blood ELISA 55 0 0.0 0         
Switzerland Clinical investigations Animal   3,782 49 1.3 - 2,579 58 2.2 - 
Note:  Herds: clinically affected herds.  
 Data presented only for sample sizes ≥25. 
1. 2011, monitoring, objective sampling, herd blood. 
2. 2011, the sampling unit is animal. 
3. 2011, the analytical method not defined.  
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Table QF4.  Findings of Q fever in sheep and goats, 2011-2012  
Country Description 
Sample  
unit 
Analytical method  
2012 2011 
N N pos % pos Herds N N pos % pos Herds 
Goat                     
Austria  
At farm, clinical investigations, suspect 
sampling 
Animal, blood Complement fixation 46 3 6.5 - 43 2 4.7 - 
Belgium 
At farm, clinical investigations, suspect 
sampling 
Animal, blood ELISA 1,676 796 47.5 - - - - 0 
At farm, domestic production, survey
1
 
Animal, 
foetus/stillbirth 
Real-Time PCR 1,069 110 10.3 - 39 2 5.1 0 
At farm, monitoring, selective sampling, 
milk-producing herds  
Herd, milk Real-Time PCR 108 12 11.1 0 0 0 0 0 
Cyprus 
At farm, clinical investigations, 
convenience sampling 
Animal PCR 37 2 5.4 - 71 29 40.8 1 
Finland 
Mixed herds, at farm, survey, objective 
sampling 
Animal, blood ELISA - - - - 676 0 0 0 
Germany  
At farm, domestic production  Animal ELISA - - - - 1,462 108 7.4 - 
At farm, domestic production  Herd
4
 PCR 41 2 0 2.0 57 0 0 - 
At farm, domestic production  Herd 
Microbiological 
standard tests 
33 4 12.1 4.0 - - - - 
Italy 
At farm, domestic production, clinical 
investigations  
Herd 
Immunofluorescence 
antibody  
31 14 45.2 0 0 0 0 0 
At farm, domestic production , survey  Animal   - - - - 49 6 12.2 0 
At farm, domestic production  Animal   - - - - 2,372 428 18.0 0 
Netherlands  
At farm, clinical investigations 
Animal, 
organ/tissue 
Immuno Histo 
Chemistry  
221 0 0 - 0 0 0 0 
At farm, monitoring Herd, milk 
Immuno Histo 
Chemistry  
346 26 7.5 - 0 0 0 0 
Poland  
At farm, clinical investigations 
Animal, 
vaginal swab 
PCR - - - - 214 0 0 0 
At farm, monitoring, objective sampling Animal, blood Complement fixation 1,311 0 0 - 1,102 1 
<0.
1 
0 
Slovakia  At farm, monitoring, suspect sampling Animal, blood Complement fixation  116 0 0 - 0 0 0 0 
Spain 
At farm, monitoring, convenience 
sampling 
Animal, blood ELISA 284 133 46.8 - 0 0 0 0 
United Kingdom At farm, monitoring, objective sampling Animal, blood ELISA - - - - 226 105 46.5 1 
Switzerland  Clinical investigations Animal   180 18 10.0 - 116 7 6.0 0 
Table continued overleaf.  
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Table QF4 (continued). Findings of Q fever in sheep and goats, 2011-2012 
Country Description 
Sample  
unit 
Analytical method  
2012 2011 
N N pos % pos Herds N N pos % pos Herds 
Sheep                      
Austria  
At farm, clinical investigations, suspect 
sampling 
Animal, blood Complement fixation  1,120 6 0.5 - 83 7 8.4 - 
Belgium 
At farm, clinical investigations, suspect 
sampling 
Animal, blood ELISA 77 5 6.5 - - - - - 
At farm, clinical investigations, suspect 
sampling 
Animal, 
foetus/stillbirth 
Real-Time PCR 503 1 0.2 - 143 1 0.7 - 
Bulgaria  At farm, monitoring, objective sampling Animal, blood Complement fixation  - - - - 640 71 11.1 - 
Cyprus 
At farm, clinical investigations, 
convenience sampling 
Animal PCR 71 25 35.2 3 71 25 35.2 3 
Finland 
Mixed herds, at farm, survey, objective 
sampling 
Animal, blood ELISA - - - - 5,197 0 0 - 
Germany  
At farm, domestic production  Herd
4
 ELISA 66 10 15.2 10 5,560 234 4.2 - 
At farm, domestic production  Herd
4
 Microbiological test 155 13 8.4 13 108 2 1.9 - 
At farm, domestic production  Herd
4
 PCR 182 9 4.9 9 5,523 323 5.8 - 
Ireland  
At farm, domestic production, clinical 
investigations, suspect sampling 
Animal, 
placental swab 
ELISA - - - - 29 0 0 - 
Italy 
At farm, domestic production, clinical 
investigations  
Herd 
Immunofluorescence 
antibody
1
 
88 40 45.5 0 54 22 40.7 - 
At farm, domestic production, clinical 
investigations  
Animal   - - - - 45 0 0 - 
At farm, domestic production, survey  Animal   - - - - 341 15 4.4 - 
Netherlands  
At farm, clinical investigations 
Animal, 
organ/tissue
2
 
Immuno Histo 
Chemistry
2
 
467 0 0 0 564 0 0 - 
At farm, monitoring Herd, milk 
Immuno Histo 
Chemistry  
32 1 3.1 - 0 0 0 - 
Poland  At farm, clinical investigations Animal, blood Complement fixation 3,249 0 0 0 3,450 0 0 - 
Table continued overleaf.  
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Table QF4 (continued). Findings of Q fever in sheep and goats, 2011-2012 
Country Description 
Sample  
unit 
Analytical method  
2012 2011 
N N pos % pos Herds N N pos % pos Herds 
Romania  
At farm, clinical investigations, objective 
sampling  
Animal, blood I-ELISA - - - - 31 0 0 - 
Slovakia  At farm, monitoring, suspect sampling Animal, blood Complement fixation  46 0 0 - - - - - 
Spain 
At farm, monitoring, convenience 
sampling 
Animal, blood ELISA 185 0 0 - - - - - 
Sweden 
Over 1 year age, at farm, domestic 
production, survey, objective sampling   
Herd, vaginal 
swabs 
Real-Time PCR - - - - 80 0 0 - 
Norway 
At farm, domestic production, clinical 
investigation, suspect sampling
3
 
Animal, blood ELISA 25 0 0 - 39 0 0 - 
Switzerland  Clinical investigations Animal   247 6 2.4 0 150 0 0 - 
Sheep and goats                   
Italy  
At farm, domestic production, clinical 
investigations  
Animal Complement fixation
1
 315 0 0 0 66 0 0 - 
At farm, domestic production, clinical 
investigations  
Animal ELISA 953 160 16.8 0 - - - - 
At farm, domestic production, monitoring  Animal Several methods  1,617 0 0 0 - - - - 
At farm, domestic production, survey  Animal ELISA
1
 1,525 253 16.6 0 150 14 9.3 - 
At farm, domestic production, survey  Animal PCR - Real-time PCR  28 0 0 0 - - - - 
At farm, domestic production, survey  Animal Several methods  110 5 4.5 0 - - - - 
Note: herds: clinically affected herds.  
 Data presented only for sample sizes ≥25. 
1. 2011, analytical method not defined.  
2. 2011, placental swabs, PCR method. 
3. 2011, import control, selective sampling. 
4. 2011, the sampling unit is animal. 
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Table QF5.  Findings of Q fever in other animal species, 2011-2012 
Country Description 
Sample  
unit 
Analytical method  
2012 2011 
N N pos % pos herds N N pos % pos herds 
Germany  
Pigs, at farm, domestic production  Herd
1
 PCR 50 0 0 50 60 1 1.67 - 
Pigs, at farm, domestic production  Animal Microbiological test - - - - 43 0 0 - 
Horses, at farm, domestic production  Animal PCR - - - - 36 0 0 - 
Italy  
Wild boar, domestic production, survey Animal 
Immunofluorescence 
antibody 
192 14 7.29 0 - - - - 
Water buffaloes, at farm, domestic 
production, survey  
Animal ELISA
2
 33 0 0 0 151 0 0 0 
Water buffaloes, at farm, domestic 
production, survey  
Animal Nested PCR 127 0 0 0 - - - - 
Slovakia 
Hares, from hunting, monitoring, 
suspect sampling 
Animal, blood Complement fixation 95 0 0 - - - - - 
Sweden 
Moose, from hunting, surveillance, 
objective sampling 
Animal, blood Complement fixation  - - - - 99 0 0 - 
Norway 
Alpacas, farmed, border control, 
monitoring, selective sampling  
Animal, blood ELISA 60 0 0 0 115 0 0 0 
Note: Herds: clinically affected herds.  
 Data presented only for sample sizes ≥25. 
1. 2011, the sampling unit is animal. 
2. 2011, analytical method not specified. 
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3.10.3. Discussion 
In 2012, the number of confirmed human cases of Q fever decreased by 15.3 % compared with 2011. 
France, together with the Netherlands and Germany, accounted for 65 % of the total number of confirmed 
cases reported in 2012. A decreasing trend was noted in the Netherlands and Spain, while Hungary showed 
an increasing tendency. This is, however, probably also influenced by modified diagnostic processes and 
improved surveillance (Katalin Krisztalovics, Hungarian National Centre for Epidemiology, personal 
communication, 14/11/2013). Interestingly, an outbreak was reported from Hungary (Baranya county, 
southern Hungary) in June 2013, with 91 cases affected mainly by pneumonia 
(http://www.promedmail.org/direct.php?id=20130607.176053). 
The number of MSs providing data on Q fever in cattle, sheep and goats has continued to be high, reflecting 
increased interest in Q fever following recent outbreaks in humans in the EU. All but one of the 22 reporting 
MSs found animals positive for C. burnetii, which demonstrates that the pathogen is widely distributed in the 
EU. Positive findings were often detected in cattle, sheep as well as in goats. However, since the results 
were not derived from harmonised sampling schemes, the situations in different MSs cannot be directly 
compared. Very few clinically affected herds were reported. In general, the quality of the data provided by 
the MSs has improved as most countries gave detailed information on the sampling schemes and the 
specimens investigated and analytical methods used.  
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3.  INFORMATION ON SPECIFIC ZOONOSES AND ZOONOTIC AGENTS 
3.11. West Nile virus  
West Nile virus (WNV) is a mosquito-borne zoonotic arbovirus belonging to the genus Flavivirus in the family 
Flaviviridae. This flavivirus is found in temperate and tropical regions of the world. The virus was first isolated 
in 1937 from East Africa and has since spread to other parts of Africa, Eastern and Southern Europe, Asia, 
the Middle East, and North America. West Nile fever was first recognised in Europe in the 1960s
59
 and re-
appeared in 1996
60
. Viruses of lineage 1 were the first identified in Europe, but viruses of lineage 2 have also 
been reported in Europe since 2004 in birds and more recently in humans
61
. 
The main mode of WNV transmission is via various species of mosquitoes (mainly Culex spp.), which are the 
prime vectors, with birds being the most commonly infected animals and serving as the reservoir hosts. WNV 
also infects various mammal species (including humans and equines), which are considered dead-end hosts. 
Infection with the virus can trigger a range of symptoms in humans, from none at all to mild, flu-like 
symptoms to encephalitis, a potentially fatal inflammation of the brain. 
In Europe, clinical signs of WNV are mostly seen in horses. Approximately 10 % of horses infected with WNV 
present neurological disorders. In Europe, birds mortality related to WNV infection is rare (unlike in North 
America). European birds usually do not show any symptoms when infected, which is taken to indicate that 
the virus has been circulating amongst both migrant and resident birds for many years, producing herd 
immunity or selecting the more resistant individuals. WNV infection in symptomatic birds was confirmed, in 
Hungary, in domestic goose showing ataxia and other neurological signs, and in goshawks and sparrow 
hawks in a rehabilitation centre
62
. 
Table WNV1 presents the countries reporting data for 2012. 
Table WNV1. Overview of countries reporting data for West Nile virus, 2012 
Data 
Total number of  
 reporting MSs 
Countries 
Human 24 
All MSs except DE, DK, PT 
Non-MSs: CH, NO 
Animal 12 
MSs: BE, CZ, DE, FR, GR, HU, IT, PL, RO, SK, ES, UK 
Non-MS: CH 
Note: The overview table contains all data reported by MSs and non-MSs. 
3.11.1. West Nile fever in humans 
In 2012, 24 MSs provided information on West Nile fever in humans. Belgium and France have a sentinel 
surveillance system, which covers only part of the population, so no rates could be calculated for these 
countries. Eight MSs (Belgium, Bulgaria, France, Greece, Hungary, Italy, Romania and Sweden) reported 
human cases. A total of 232 cases of West Nile fever in humans were reported in the EU, 119 being 
confirmed, acquired either locally or during travel in or outside Europe (Table WNV2).  
The EU notification rate was 0.07 per 100,000 population. There was an overall 75.8 % increase in the 
number of reported cases compared with 2011 (132 cases), but a 33.5 % decrease compared with 2010 
(349 cases). These variations are influenced by the incidence in Greece, where 70 % of all cases are 
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reported. In 2012, Greece had the highest notification rate (1.44 cases per 100,000 population). Greece also 
reported the highest number of cases in both 2011 and 2012. In 2011 and 2012, transmission was no longer 
limited to a specific region (Central Macedonia) but occurred in a large part of the continental territory 
including the capital, Athens. In 2012, the infection also spread to some islands (Samos, Lefkada and 
Kerkyra).  
In 2012 the largest increase in reported cases (325 %) was observed in Hungary, but case numbers were 
still relatively small. Small outbreaks were reported across the country.  
Cases doubled in Italy. The island of Sardinia was affected for the first time in 2011. Transmission continued 
in 2012 and the province of Matera, in the south of the mainland, was affected. 
In Romania case numbers were stable compared with 2011 and much lower than in 2010. Outbreaks were 
reported from counties located in the south-eastern part of the country and in the capital, Bucharest, in both 
2011 and 2012.  
The vast majority of cases reported in Greece, Italy, Hungary and Romania were domestically acquired 
(Figure WNV1). Belgium, France, Sweden and Switzerland reported travel-associated cases, representing all 
their cases. Greece reported both locally acquired cases and travel-associated cases. Of the eight travel-
associated cases reported in Europe in total, only three were acquired within Europe and three cases 
contracted the infection from the North American continent.  
West Nile fever has been reportable at the EU level since 2008. Since then, the number of cases has varied 
from year to year but there was no overall increasing trend (Figure WN2). As stated above, the 
epidemiological curve is largely dominated by the situation in Greece, where the highest peak was observed 
in 2010, followed by fewer cases in 2011 and then an increase again in 2012. In Hungary, variations in case 
numbers seem to show a two-year cycle, with peaks observed in 2008, 2010 and 2012 (Table WNV2). In 
Italy, an increasing incidence has been observed since 2008, with a larger number of cases reported in 
2009. Special surveillance for West Nile fever was implemented in 2010 in the Veneto Region. The 
systematic nucleic acid screening of tissue and organ donations also implemented there in 2012 and carried 
out between 15 July and 30 November, in accordance with the National Blood Directive and the National 
Transplant Coordination, enabled detection of the first 2012 West Nile case (blood donor) in Italy
63
. In 
Greece enhanced surveillance was implemented for WNV infection in human and animals. During the West 
Nile fever transmission periods, measures of blood safety to prevent WNV infection were implemented in the 
affected areas, including blood donor deferral, blood screening for WNV-RNA and haemovigilance 
procedures (Theano Georgakopoulou, Hellenic Centre for Disease Control and Prevention, personal 
communication, 15/01/2014). 
Two MSs (Hungary and Romania) provided data on hospitalisation for all of their cases. On average, 84.4 % 
of the West Nile cases were hospitalised, but hospitalisation status was provided for only 13.8 % of the 
cases reported in the EU.  
Five MSs provided information on the outcome of the disease, but Italy reported information only on fatal 
cases. The overall EU case-fatality rate was 11.1 % among the 198 cases for which this information was 
reported (85.3 % of all cases). This figure could be an overestimate. 
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Table WNV2. Reported cases of human West Nile fever in 2008–2012, and notification rates for 
confirmed cases in 2012 
Country 
2012 2011 2010 2009 2008 
Report 
Type
1
 
Cases 
Confirmed 
cases 
Total 
cases/ 
100,000 
Total 
cases 
Austria U 0 0 0.00 0 0 0 0 
Belgium
3
 C  2 2 ‒ 0 0 0 0 
Bulgaria A  4 4 0.05 ‒ ‒ ‒ 0 
Croatia ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ 
Cyprus U 0 0 0 0 0 0 0 
Czech Republic U 0 0 0 0 0 0 0 
Denmark
2
 ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ 
Estonia U 0 0 0 0 0 0 0 
Finland U 0 0 0 0 0 0 0 
France
3
 C  3 3 - 1 3 1 0 
Germany
2
 ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ 
Greece C  162 50 1.44 100 262 0 0 
Hungary C  17 17 0.17 4 19 7 19 
Ireland C  0 0 0 1 0 0 0 
Italy C  28 28 0.05 14 5 18 3 
Latvia U 0 0 0 0 0 0 0 
Lithuania U 0 0 0 0 0 0 0 
Luxembourg U 0 0 0 0 0 0 0 
Malta U 0 0 0 0 0 0 0 
Netherlands U 0 0 0 1 1 0 0 
Poland A  0 0 0 1 0 0 0 
Portugal
2
 ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ 
Romania C  15 14 0.07 11 57 2 2 
Slovakia U 0 0 0 0 0 0 0 
Slovenia U 0 0 0 0 0 0 0 
Spain C  0 0 0 0 2 0 0 
Sweden C  1 1 0.01 0 0 0 0 
United Kingdom U 0 0 0 0 0 0 0 
EU Total   232 119 0.07 132 349 28 24 
Iceland ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ 
Liechtenstein ‒ ‒ ‒ ‒ ‒ ‒ ‒ ‒ 
Norway U 0 0 0 0 0 0 0 
Switzerland
4
 C  1 1 0.01   1     
1. A: aggregated data report; C: case-based report; –: no report; U: unspecified.  
2. Not notifiable, no surveillance system exists. 
3. Sentinel surveillance; coverage unknown and notification rate cannot be estimated. 
4. Switzerland provided data directly to EFSA. 
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Figure WNV1.  Notification rates and origin of infection in human West Nile fever in the EU/EEA, 2012 
 
Note Belgium, the Czech Republic, Sweden and France have only imported cases; Belgium and France appear in dark grey as 
surveillance of WN is based on a sentinel system. 
 The map shows the distribution of human cases shaded according to incidence rate per 100,000 based on quartile classification 
method (EUROSTAT population data 2012). 
Figure WNV2.  Trend in reported cases of human West Nile fever in the EU,  
2009–2012 
 
Source: TESSy data from 22 MSs (Belgium, France, Greece, Hungary, Italy, the Netherlands and Sweden. Austria, Cyprus, Czech 
Republic, Estonia, Finland, Ireland, Latvia, Lithuania, Luxembourg, Malta, Poland, Slovakia, Slovenia, Spain and United 
Kingdom reported zero cases throughout the period). Bulgaria, Denmark, Germany, Portugal and Romania were excluded 
since they either did not report over the whole period, or cases had an unknown month of occurrence.  
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3.11.2. West Nile virus in animals 
2012 was the first year when MSs were specifically invited to report data on WNV in animals. Twelve MSs 
and one non-MSs submitted data, which is a substantial achievement, particularly as not all MSs yet have a 
monitoring system in place. Reporting of WNV in animals is not mandatory, but is to be carried out based on 
the epidemiological situation. Most of the reported data were from domestic solipeds and birds, but some 
other animal species were also included. 
Of the 11 MSs reporting data on horses and donkeys, all except Germany and Poland found animals that 
tested positive for WNV (Table WNV3). In the United Kingdom, both positive horses were imported. France 
and Italy reported a proportion of test-positive horses of above 10 %. Spain found four test-positive horses in 
the region of Andalusia. Switzerland tested two horses which were found to be negative. Some of the 
reported data derived from clinical investigations whereas some data were collected from active or passive 
monitoring.  
Most of the test-positive findings in solipeds were made in the Southern European countries, particularly in 
Italy (Figure WNV3). However, Belgium, the Czech Republic and Slovakia also reported test-positive 
animals.  
Four MSs and one non-MS provided data on WNV in domestic and wild birds (Table WNV3 and Figure 
WNV4). Belgium did not find any positive samples in the substantial numbers of wild birds and poultry tested, 
as did Germany. Italy reported positive findings from Gallus gallus and other farmed birds, but not from 
ducks. Spain found one positive wild bird in the region of Catalonia. 
In addition, Belgium tested cattle without any positive test results. Hungary reported one positive finding of 
the virus in wild animals and Slovakia three positive samples from farmed deer.  
Since 2010, Greece has had a surveillance programme in place for West Nile fever involving regular testing 
of sentinel horses, dispersed throughout the country, testing of all clinically suspect equidae, and 
examination of samples from wild birds. 
In 2012, the programme involved the examination of 750 sentinel (non-vaccinated) horses placed in 
36 different regional units throughout Greece, each animal being subject to three samplings within the period 
15 May to 30 September. During July–September a total of 14 outbreaks were reported in solipeds (except 
for one single case in a donkey, all other affected animals were horses). Clinical signs were reported in only 
three of these outbreaks (all in horses). In 2012 testing of serum/blood samples was carried out using ELISA 
for initial screening and then positives were tested with IgM (capture) ELISA to detect recent (IgM) antibodies 
and eventually confirm a recent infection (outbreak). The majority of the IgM-positive samples were also 
tested for virus detection using Real-time RT PCR, with negative results. 
 
The first animal outbreak of West Nile disease (WND) in Italy took place in the late summer of 1998, when 
some clinical cases of WND occurred in horses stabled in the area surrounding the Fucecchio Marshes in 
Tuscany. 
In August 2008, WND re-appeared in Italy in the Po river delta. Further outbreaks occurred in 2009, 2010, 
2011 and 2012, involving new areas in central and southern Italy. The infection caused clinical symptoms, 
not only in equines, but also in humans and in some birds. In the Veneto Region (northern Italy) WNV has 
been recently detected every year in either humans or animals. Clinical cases were generally observed from 
July to October. In 1998–2012, the case-fatality rate in horses was 23.9 % (95 % CI 17.6–31.6 %). Clinical 
signs were also reported in 2011 for the first time in birds. Moreover, 46 mosquito pools tested RT-PCR 
positive, and a few positive serological samples were detected in poultry. Both lineage 1 and 2 viruses were 
detected in birds and mosquito pools. 
The recurrence of WND, involving humans and equines, is likely to be linked to the endemisation of the 
infection in some territories, as well as the new introduction of the virus by migratory birds. The co-circulation 
of WNV strains belonging to lineage 1 and lineage 2 enhances the possible occurrence of homologous or 
heterologous recombination which may affect the diagnosis, virulence and transmission of these strains. The 
most common vectors are mosquitoes of the Culex genus, feeding mostly on birds and mammals. 
The Italian West Nile Disease Summary Report 2012 is available at 
http://sorveglianza.izs.it/emergenze/west_nile/pdf/Bollettino_riassuntivo_2012ENG_DEF.pdf. In this report 
the number of cases in equines and the number of outbreaks reported are presented. 
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Table WNV3. Findings of West Nile virus infection in animals, 2012  
Country Description 
Sample  
unit 
Analytical method  
2012 
N N pos % pos 
Solipeds 
     
  
Belgium 
Horses, domestic, objective 
or suspect sampling  
Animal, blood 
IgG ELISA and 
seroneutralisation as 
confirmation test  
746 24 3.2 
Horses, domestic, clinical 
investigation 
Animal, brain Real Time PCR 5 0 0 
Czech Republic 
Horses, active monitoring, 
selective sampling  
Animal ELISA 783 4 0.5 
France  
Horses, at farm, clinical 
investigations or passive 
monitoring  
Animal, blood IgG ELISA 94 15 16.0 
Germany 
Horses, at farm, domestic 
production 
Animal 
Microbiological 
standard tests 
2,14
5 
0 0 
Greece  
Horses, at farm, active 
monitoring  
Animal, blood 
ELISA for initial 
screening, and IgM-
capture ELISA as 
confirmation test
1
 
1,64
0 
16 1.0 
Italy  
Horses, at farm, domestic 
production, monitoring, 
objective sampling 
Animal Several methods  
1,65
9 
322 19.4 
Horses, at farm, domestic 
production, monitoring, 
suspect sampling 
Animal Several methods  332 167 50.3 
Donkeys, at farm, domestic 
production, monitoring, 
objective sampling 
Animal Several methods  95 7 7.4 
Donkeys, at farm, domestic 
production, monitoring, 
suspect sampling 
Animal Several methods  4 3 75.0 
Poland 
Horses, at slaughterhouse, 
active monitoring, census 
Animal, blood ELISA 287 0 0 
Romania 
Horses, at farm, active 
monitoring, objective 
sampling   
Animal, blood 
IgM-capture ELISA 
(MAC-ELISA) 
328 1 0.3 
Slovakia 
Horses, at farm, clinical 
investigations or monitoring, 
suspect and objective 
sampling  
Animal, blood   504 24 4.8 
Spain 
Horses, at farm, clinical 
investigations or active or 
passive monitoring, suspect 
and selective sampling  
Animal, blood 
IgG ELISA; and 
MAC-ELISA and RT-
PCR as confirmation 
tests
2
 
557 4 0.7 
United Kingdom  
Horses, at farm, clinical 
investigations, suspect 
sampling  
Animal, blood IgG ELISA 11 0 0 
Horses, at farm, imported, 
expert testing, surveillance, 
selective sampling  
Animal, blood IgG ELISA 2 2 100 
Switzerland  
Horses, at farm, clinical 
investigations 
Animal 
Real-Time PCR, 
ELISA 
2 0 0 
Table continued overleaf. 
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Table WNV3 (continued). Findings of West Nile virus in animals, 2012  
Country Description 
Sample  
unit 
Analytical method  
2012 
N N pos % pos 
Birds             
Belgium  
Wild birds, surveillance or 
monitoring, objective, 
selective or suspect 
sampling  
Animal, blood, 
brains, organs/ 
tissues 
Real Time PCR, IgG 
ELISA 
2,283 0 0 
Poultry, at farm, 
surveillance objective 
sampling 
Animal, blood IgG ELISA 1,600 0 0 
Germany 
Parrots, at farm, domestic 
production 
Animal 
Microbiological 
standard tests 
22 0 0 
Italy  
Gallus gallus, at farm, 
domestic production, 
monitoring, objective 
sampling 
Flock  Several methods  321 62 19.3 
Ducks, at farm, domestic 
production, monitoring, 
objective sampling 
Flock  Several methods  13 0 0 
Birds, at farm, domestic 
production, monitoring, 
objective sampling 
Animal Several methods  1,200 8 0.7 
Spain 
Birds, at farm, active or 
passive monitoring, 
selective sampling 
Animal, blood 
IgG ELISA and 
seroneutralisation or 
RT-PCR as 
confirmation test
3
  
70 0 0 
Wild birds, active or 
passive monitoring, 
selective or convenience 
sampling 
Animal, blood 
IgG ELISA and 
seroneutralisation or 
RT-PCR as 
confirmation test
4
 
2,059 1 <0.1 
Switzerland  
Wild birds, passive 
monitoring 
Animal Real-Time PCR 1 0 0 
Other animals              
Belgium  
Cattle (bovine animals) - 
adult cattle over 2 years, at 
farm, surveillance objective 
sampling 
Animal, blood IgG ELISA 1,670 0 0 
Hungary Wild animals Animal 
Immuno Histo 
Chemistry (IHC) 
15 1 6.7 
Slovakia  
Deer, farmed, at farm, 
monitoring, objective 
sampling 
Animal, blood   12 3 25.0 
1. Testing of serum / blood samples is carried out using ELISA for initial screening and then testing of positives with IgM (capture) 
ELISA to detect recent antibodies and eventually confirm a recent infection ( = outbreak). The majority of the IgM-positive 
samples were also tested for virus detection using Real-time RT PCR, with negative results. 
2. Of the 14 IgG ELISA-positive samples, four tested positive with MAC-ELISA. 
3. The one IgG ELISA-positive sample tested negative with the seroneutralisation test. 
4. Of the 11 IgG ELISA-positive samples, one tested positive with the seroneutralisation test. 
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Figure WNV3.  Findings of West Nile virus in solipeds in the EU, 2012  
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Figure WNV4.  Findings of West Nile virus in birds in the EU, 2012  
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3.11.3. Discussion 
In 2011, the number of human cases of West Nile fever was lower than in 2010, but it increased again in 
2012. Four countries in the EU have been affected for three consecutive years and the figures have steadily 
increased in Italy. Moreover, the geographic distribution in each country has expanded to affect new areas. 
The increase in case reports can be partly explained by the substantial efforts made to strengthen the level 
of detection in the affected countries or in newly affected countries, as soon as the first cases are identified. 
Health professionals (including blood safety authorities) are alerted at the beginning of the season, as are 
the stakeholders involved in animal and entomological surveillance. It is important to point out that variations 
and differences in case numbers are partly due to variations and differences in surveillance systems. A 
detailed overview for both the EU and neighbouring countries, including at the regional level, is published on 
the ECDC website
64
 with an epidemiological update summarising the West Nile fever season and the last 
weekly update of the ECDC West Nile risk map. 
2012 was the first year when MSs were specifically invited to report data on WNV in animals. Eleven MSs 
and one non-MS have already submitted data, which is an achievement, particularly as not all MSs yet have 
a monitoring system in place. Most data were reported from surveillance and monitoring in horses and other 
solipeds and less information was reported from surveillance and monitoring in birds and other animal 
species. WNV test-positive solipeds were reported by Southern European MSs but few test-positive horses 
were reported by Central and Western European MSs. Seropositivity in animals, for example, horses, can 
indicate exposure to infection, whether domestically acquired or related to travel (movement) to WNV 
endemic areas. Alternatively, seropositivity in horses can also result from vaccination against WNV. In this 
context, it is worthwhile to mention that horses can be employed in leisure or sport activities, utilised in the 
agricultural industry or reared specifically for meat production
65
. Two Southern MSs reported positive WNV  
findings in birds. 
In light of the reported findings in solipeds, WNV may present in Central Europe and, therefore, Central and 
Northern European countries may consider a need to establish a monitoring system in their animal 
populations in order to prepare for the emergence of the disease and subsequent increased potential for 
human exposure. 
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3.  INFORMATION ON SPECIFIC ZOONOSES AND ZOONOTIC AGENTS 
3.12. Other zoonoses 
Anisakis  
Slovakia provided information on Anisakis parasites in food (fish) from the year 2011. In total, 23 fish batches 
were sampled at retail and Anisakis was not found in any of the samples. The fish samples derived from 
monitoring of fish of non-EU origin using objective sampling.  
Cysticercus  
Belgium and Sweden reported information on Cysticercus in slaughter animals for both 2011 and 2012.   
In the case of findings of Taenia saginata cysts in cattle at the slaughterhouse, in Belgium, 859,390 animals 
were inspected and 1,347 (0.16 %) carcases were found positive in 2011, of which 11 were heavily 
contaminated. In 2012, the number of inspected animals was 824,511, of which 1,214 (0.15 %) were positive 
and nine heavily contaminated.   
Sweden inspected 456,120 bovine carcases for Cysticercus cysts (T. saginata) with one (0.0002 %) positive 
finding. In 2012, a total of 419,939 carcases were tested, and once again one (0.0002 %) was found positive.   
Sweden also reported data on Taenia solium cysts in pigs at slaughter. In 2011, out of 2,845,390 pig 
carcases, none was found to be positive. Nor were any positive carcases detected in 2012, out of the 
2,585,665 animals inspected.  
Francisella tularensis  
Two MSs, Spain and Sweden, reported on the occurrence of Francisella tularensis in animals during the 
years 2011–2012. In 2011, Spain investigated wild hares from hunting and did not find any positive samples 
from the 51 animals tested. Spain also tested 306 wild rodents without positive findings. All these samples 
derived from surveillance and convenience sampling.  
Sweden reported data on F. tularensis in wild hares for both years. In 2011, 11 animals (18.0 %) were found 
positive out of the 61 tested, whereas in 2012 Sweden detected 12 positive hares (29.3 %) from the 
41 animals tested. The hare samples were derived from passive monitoring and suspect sampling. 
Sarcocystis  
Belgium reported data on Sarcocystis in bovine carcases from meat production animals at the 
slaughterhouse in 2012. Of the 824,511 carcases inspected, 61 (0.007 %) were found to be positive. 
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4. FOOD-BORNE OUTBREAKS 
4.1. General overview 
The reporting of investigated food-borne outbreaks has been mandatory for EU MSs since 2005. Starting in 
2007, harmonised specifications on the reporting of food-borne outbreaks at EU level have been applied. In 
2012, as in 2010 and 2011, revised reporting specifications for food-borne outbreaks were implemented and 
the distinction between ‘verified’ and ‘possible’ food-borne outbreaks was abandoned; instead, outbreaks 
were categorised as having ‘strong evidence’ or ‘weak evidence’ based on the strength of evidence 
implicating a suspected food vehicle. In the former case, i.e. where the evidence implicating a particular food 
vehicle was strong, based on an assessment of all available evidence, a detailed dataset was reported for 
outbreaks. In the latter case, i.e. where no particular food vehicle was suspected or for food-borne outbreaks 
where the evidence implicating a particular food vehicle was weak, only a limited dataset was reported. This 
minimal dataset included the number of outbreaks per causative agent and the number of human cases, 
hospitalisations and deaths. In this chapter the term ‘weak-evidence outbreak’ also covers outbreaks for 
which no particular food vehicle was suspected. It is important to note that the food-borne outbreak 
investigation systems at national level are not harmonised among MSs. Therefore, the differences in the 
number and type of reported outbreaks, as well as in the causative agents, may not necessarily reflect the 
level of food safety among MSs; rather they may indicate differences in the sensitivity of the national systems 
in identifying and investigating food-borne outbreaks.  
Data from 2012 provide information on the total number of reported food-borne outbreaks attributed to 
different causative agents, including food-borne outbreaks for which the causative agent was unknown. 
In this general overview, all reported food-borne outbreaks, including waterborne outbreaks, are included in 
the tables and figures. In subsequent sections, outbreaks are presented in more detail and categorised by 
the causative agent, but excluding waterborne outbreaks where the evidence was strong. All waterborne 
outbreaks with strong evidence are addressed separately in section 4.13. 
In 2012, 25 MSs and 2 non-MSs provided data on food-borne outbreaks; this is the same as in 2011. No 
outbreak data were reported by Luxembourg and Cyprus for 2012. An overview of countries reporting data 
on food-borne outbreaks is provided in Table OUT1.  
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Table OUT1. Overview of countries reporting data on food-borne outbreaks, 2012 
Causative agent 
Total number of 
reporting MSs  
Countries 
Salmonella 24 
All MSs except CY, LU, PT                                                                                 
Non-MSs: CH, IS, NO 
Campylobacter 19 
MSs: AT, BE, CZ, DE, DK, EE, ES, FI, FR, HU, IE, IT, LT, 
MT, NL, PL, SE, SK, UK                                     
Non-MSs: CH, NO 
Pathogenic E. coli 10 MSs: AT, BE, DE, DK, FI, FR, IE, PT, SE, UK 
Other bacterial agents
1
 12 
MSs: AT, CZ, DE, ES, FI, FR, GR, HU, LV, PL, SK, UK                                     
Non-MS: NO 
Bacterial toxins
2
 17 
MSs: BE, DE, DK, ES, FI, FR, HU, IT, LV, NL, PL, PT, RO, 
SE, SI, SK, UK                        
Non-MSs: CH, IS, NO 
Viruses 20 
MSs: AT, BE, CZ, DE, DK, ES, FI, FR, GR, HU, IE, IT, LV, 
MT, NL, PL, SE, SI, SK, UK         
Non-MSs: IS, NO 
Parasites 11 MSs: AT, BG, DE, ES, FI, IE, LT, LV, RO, SK, UK 
Other causative agents
3
 12 
MSs: BE, DE, DK, ES, FI, FR, LV, MT, PL, SE, SI, UK 
Non MS: NO 
Unknown 19 
MSs: BE, DE, DK, EE, ES, FI, FR, GR, HU, IE, IT, LT, LV, 
MT, NL, PL, SE, SI, UK 
Non MSs: CH, NO 
Note: The overview table contains all data reported by MSs. 
1. Includes Listeria, Shigella, Yersinia, Brucella, Francisella, Vibrio parahaemolyticus and other bacterial agents. 
2. Includes Bacillus, Clostridium and staphylococcal enterotoxins. 
3. Includes atropine, histamine, mushroom toxins, marine biotoxins, mycotoxins, escolar fish (wax esters) and other agents. 
Number of outbreaks 
In 2012, a total of 5,363 food-borne outbreaks, including both weak- and strong-evidence outbreaks, were 
reported by the 25 reporting MSs. This represents a decrease of 5.0 % compared with 2011, when 
5,648 outbreaks (including the 11 strong-evidence waterborne outbreaks) were reported in total by 25 MSs. 
The overall reporting rate in 2012 at EU level was 1.07 outbreaks per 100,000 population (Table OUT2), 
similar to that observed in 2011 (1.12). Latvia had the highest reporting rate (23.36 outbreaks per 100,000 
population), followed by Slovakia (13.53 outbreaks per 100,000 population) and Malta (11.26 outbreaks per 
100,000). It is important to note that the food-borne outbreak investigation systems at national level are not 
harmonised among MSs. Therefore, the differences in the number and type of reported outbreaks, as well as 
in the reporting rates, may not necessarily reflect the level of food safety among MSs; rather they may 
indicate differences in the sensitivity of the national systems in identifying and investigating food-borne 
outbreaks. In addition, some MSs implemented changes in reporting between different years; in 2012 Latvia 
reported viral outbreaks with two or more cases, as compared to only outbreaks with at least five human 
cases in 2011.  
In 2012, France accounted for 23.8 % (1,279) of all reported outbreaks (Table OUT2) and was also the MS 
reporting the largest number of outbreaks in the previous years (1,153 in 2011). The MS reporting the 
second highest number of outbreaks was Slovakia, with 731 outbreaks reported (13.6 % of the total). Poland, 
Latvia and Spain reported 490, 477 and 447 outbreaks, respectively, and these countries, together with 
France and Slovakia, accounted for 63.8 % of all outbreaks reported within the EU. However, the reporting 
rate per 100,000 population in Spain, Poland and France was quite low (between 0.97 and 1.96), whereas 
the reporting rate in Latvia and Slovakia was relatively high (23.36 and 13.53 respectively) (Table OUT2 and 
Figure OUT1). 
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A total of 763 strong-evidence outbreaks were reported by 21 MSs, representing 14.2 % of the total number 
of food-borne outbreaks recorded in 2012 (Table OUT2). This was higher than the number of strong- 
evidence outbreaks reported in 2011 (701). 
France, Spain and Poland accounted for 60.6 % of the total number of reported strong-evidence outbreaks 
(Table OUT2). These were the same countries reporting the highest number of strong-evidence outbreaks in 
2011.  
In the non-MSs, Norway, Iceland and Switzerland, 53 outbreaks were reported in total, of which eight were 
reported with strong evidence.   
Strong- and weak-evidence outbreaks 
The classification of outbreaks as either strong- or weak-evidence outbreaks was based on an assessment 
of all available evidence, and more than one type of evidence is often reported in one outbreak. 
MSs varied in the proportion of strong- and weak-evidence outbreaks reported in 2012 (Figure OUT2). For 
example, Portugal, Romania and Slovenia reported only outbreaks supported by strong evidence, whereas 
the majority of outbreaks reported by the other MSs were supported by weak evidence. This variation may 
be due to differences between the MSs’ specific outbreak investigation and reporting systems, and 
consequently the type of information available for each outbreak. 
The MSs reporting the highest proportions of strong-evidence outbreaks out of the total outbreaks reported in 
the country were Denmark, Portugal, Romania, Slovenia and the United Kingdom, where the proportions of 
these outbreaks were 75.3 %, 100 %, 100 %, 100 % and 66.7 %, respectively (Table OUT2 and 
Figure OUT2). 
Human cases 
For the 5,363 outbreaks at EU level, 55,453 human cases were reported, as well as 5,118 hospitalisations 
and 41 deaths (case fatalities) (0.07 % out of the reported cases). The 53 outbreaks reported in total by the 
non-MSs (Iceland, Switzerland and Norway) comprised 1,181 human cases with 25 hospitalisations and one 
fatality (Table OUT2). It is important to note that the number of human cases may be unknown for some 
outbreaks.  
With regard to the 763 strong-evidence outbreaks reported by MSs, a total of 26,247 human cases were 
involved; of these cases, 1,515 people (5.8 %) were admitted to hospital and 24 people died (0.09 %) 
(Table OUT2). However, these high numbers of cases were dominated by a large norovirus outbreak 
associated with frozen strawberries in Germany that affected 10,950 people. 
In the non-MSs, Norway, Iceland and Switzerland, eight strong-evidence outbreaks were reported involving 
500 human cases with 18 hospitalisations and one fatality (Table OUT2).  
Of the 24 fatalities related to strong-evidence outbreaks, 10 were associated with Salmonella, two with 
Clostridium perfringens toxins, two with norovirus, one with mycotoxins and nine with ‘Other bacterial agents’ 
(Listeria monocytogenes) (Table OUT4). 
Of the 17 fatalities reported in weak-evidence outbreaks, 10 were associated with Clostridium toxins, three 
with Bacillus cereus toxins and one each with staphylococcal enterotoxins, norovirus and unspecified other 
agents. For one fatality the causative agent was unknown. 
The case fatality reported by Switzerland was caused by Campylobacter. 
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Table OUT2. Number of all food-borne outbreak and human cases in the EU, 2012 
Country 
Total 
outbreaks 
Reporting 
rate per 
100,000 
Strong-evidence outbreaks Weak-evidence outbreaks  
N 
Human cases 
N 
Human cases 
Cases Hospitalised Deaths Cases Hospitalised Deaths 
Austria 122 1.44 3 217 22 0 119 344 75 0 
Belgium 327 2.95 31 386 25 0 296 1,000 30 1 
Bulgaria 2 0.03 - - - - 2 82 - - 
Czech Republic 23 0.22 - - - - 23 520 117 0 
Denmark 85 1.52 64 1,710 23 0 21 474 12 0 
Estonia 17 1.27 1 87 20 0 16 94 29 0 
Finland 45 0.83 22 1,103 36 3 23 308 8 0 
France 1,279 1.96 208 2,329 176 1 1,071 7,889 527 5 
Germany 393 0.48 56 11,988 245 3 337 1,143 207 0 
Greece 32 0.28 3 650 2 0 29 166 85 0 
Hungary 115 1.18 10 544 133 0 105 897 73 0 
Ireland 38 0.83 13 89 6 0 25 152 11 0 
Italy 20 0.03 - - - - 20 111 - - 
Latvia 477 23.36 1 16 - 0 476 1,629 203 0 
Lithuania 93 3.09 5 69 22 0 88 285 187 0 
Malta 35 11.26 - - - - 35 203 20 0 
Netherlands 273 1.63 12 1,449 32 4 261 1,146 6 0 
Poland 490 1.27 78 876 354 0 412 4,868 1,215 10 
Portugal 7 0.07 7 135 42 0 - - - - 
Romania 10 0.05 10 119 59 0 - - - - 
Slovakia 731 13.53 5 162 42 0 726 2,284 546 0 
Slovenia 10 0.49 10 490 15 0 - - - - 
Spain 447 0.97 176 2,442 212 3 271 3,902 197 1 
Sweden 232 2.45 8 351 - 1 224 1,240 8 - 
United Kingdom 60 0.10 40 1,035 49 9 20 469 47 0 
EU Total 5,363 1.07 763 26,247 1,515 24 4,600 29,206 3,603 17 
Iceland  4 1.25 1 25 0 0 3 31 - - 
Norway 44 0.88 3 419 6 0 41 623 7 0 
Switzerland 5 0.06 4 56 12 1 1 27 0 0 
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Figure OUT1. Reporting rate per 100,000 population in Member States and non-Member States, 2012 
 
Figure OUT2. Distribution of food-borne outbreaks in Member States and non-Member States, 2012 
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Causative agents  
Within the EU, the causative agent was known in 72.4 % of the total number of outbreaks reported 
(Table OUT3 and Figure OUT3). Salmonella remained the most frequently detected causative agent in the 
food-borne outbreaks reported (28.6 % of outbreaks), followed by bacterial toxins, viruses and 
Campylobacter, which accounted for 14.5 %, 14.1 % and 9.3 % of the outbreaks, respectively. Other agents 
each accounted for 2.6 % or less of the number of food-borne outbreaks. 
Salmonella outbreaks increased slightly, from 1,501 outbreaks in 2011 to 1,533 outbreaks in 2012. An 
increase was observed in the numbers of outbreaks caused by viruses, from 525 outbreaks in 2011 to 756 in 
2012. A slight increase was observed in the number of outbreaks caused by bacterial toxins (from 730 in 
2011 to 777 in 2012) and a decrease in the number of outbreaks caused by Campylobacter (598 in 2011 to 
501 in 2012). The number of outbreaks in which the causative agent was unknown decreased from 2,023 in 
2011 to 1,478 in 2012, representing a decrease of 26.9 % (Figure OUT4). 
Considering the outbreaks reported for each causative agent, the highest proportion of strong-evidence 
outbreaks was reported for the group of other causative agents (45.3 %), followed by E. coli (43.1 %) and 
parasites (36.8 %) (Table OUT3 and Figure OUT3). 
Table OUT3. Causative agents in all food-borne outbreaks in the EU, 2012 
Causative agent 
Totale outbreaks 
Strong-evidence 
outbreaks 
Weak-evidence 
outbreaks  
N % N % N % 
Salmonella 1,533 28.6 347 45.5 1,186 25.8 
Bacterial toxins 777 14.5 127 16.6 650 14.1 
Viruses 756 14.1 105 13.8 651 14.2 
Campylobacter 501 9.3 25 3.3 476 10.3 
Other causative agents 137 2.6 62 8.1 75 1.6 
Other bacterial agents 80 1.5 10 1.3 70 1.5 
Escherichia coli, pathogenic 51 1.0 22 2.9 29 0.6 
Parasites 38 0.7 14 1.8 24 0.5 
Yersinia 12 0.2 0 0.0 12 0.3 
Unknown 1,478 27.6 51 6.7 1,427 31.0 
EU Total 5,363 100 763   4,600   
Note:  Bacterial toxins include toxins produced by Bacillus, Clostridium and Staphylococcus. Food-borne viruses include calicivirus, 
hepatitis A virus, flavivirus, rotavirus and other unspecified viruses. Other causative agents include mushroom toxins, marine 
biotoxins, histamine, mycotoxins, atropine and other unspecified agents. Parasites include primarily Trichinella, but also 
Cryptosporidium, Giardia, Anisakis and other unspecified parasites. Other bacterial agents include Listeria, Brucella, Shigella, 
Vibrio and Francisella. Pathogenic Escherichia coli includes also verotoxigenic Escherichia coli. 
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Figure OUT3. Distribution of all food-borne outbreaks per causative agent in the EU, 2012 
 
Note:  Bacterial toxins include toxins produced by Bacillus, Clostridium and Staphylococcus. Food-borne viruses include calicivirus, 
hepatitis A virus, flavivirus, rotavirus and other unspecified viruses. Other causative agents include mushroom toxins, marine 
biotoxins, histamine, mycotoxins, atropine and other unspecified agents. Parasites include primarily Trichinella, but also 
Cryptosporidium, Giardia, Anisakis and other unspecified parasites. Other bacterial agents include Listeria, Brucella, Shigella, 
Vibrio and Francisella. Pathogenic Escherichia coli includes also verotoxigenic Escherichia coli. 
 
Figure OUT4. Total number of food-borne outbreaks in the EU, 2008-2012  
 
Note: Bacterial toxins include toxins produced by Bacillus, Clostridium and Staphylococcus. Food-borne viruses include calicivirus, 
hepatitis A virus, flavivirus, rotavirus and other unspecified viruses. Other causative agents include mushroom toxins, marine 
biotoxins, histamine, mycotoxins, atropine and other unspecified agents. Parasites include primarily Trichinella, but also 
Cryptosporidium, Giardia, Anisakis and other unspecified parasites. Other bacterial agents include Listeria, Brucella, Shigella, 
Vibrio and Francisella. Pathogenic Escherichia coli includes also verotoxigenic Escherichia coli.  
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Strong-evidence outbreaks 
Within the EU, the causative agent of the strong-evidence outbreaks was known in 93.3 % of the reported 
outbreaks (Table OUT4).  
Salmonella was the most frequent causative agent (45.5 % of outbreaks), followed by bacterial toxins, 
viruses and other causative agents, responsible for 16.6 %, 13.8 % and 8.1 % of outbreaks, respectively. 
Other agents were each reported in less than 4.0 % of food-borne outbreaks. However, outbreaks caused by 
viruses were responsible for the highest number of human cases, accounting for 56.7 % of the reported 
cases in all strong-evidence outbreaks. However, it should be noted that a large outbreak in Germany, due to 
norovirus, affected 10,950 people.  
In addition, Salmonella outbreaks accounted for the majority of hospitalisations (65.0 % of all hospitalised 
cases) and deaths (41.7 % of all deaths) related to strong-evidence outbreaks (Table OUT4). Five outbreaks 
caused by Listeria monocytogenes resulted in 55 cases, 47 hospitalisations and 9 deaths (i.e. 37.5 % of all 
deaths).  
The proportion of hospitalisations out of the reported cases for each causative agent was low for outbreaks 
due to viruses (Table OUT4).  
Table OUT4. Number of outbreaks and human cases per causative agent in strong-evidence food-
borne outbreaks (including strong-evidence waterborne outbreaks) in the EU, 2012 
Causative agent 
Strong-evidence outbreaks  
N % 
Human cases 
Cases Hospitalised Deaths 
Salmonella 347 45.5 5,787 985 10 
Bacterial toxins 127 16.6 2,938 121 2 
Viruses 105 13.8 14,892 124 2 
Other causative agents 62 8.1 478 39 1 
Campylobacter 25 3.3 198 17 0 
Escherichia coli, pathogenic 22 2.9 160 81 0 
Parasites 14 1.8 639 40 0 
Other bacterial agents 10 1.3 156 52 9 
Unknown 51 6.7 999 56 0 
EU total 763 100 26,247 1,515 24 
Note: Data from 763 outbreaks are included: Austria (3), Belgium (31), Denmark (64), Estonia (1), Finland (22), France (208), Germany 
(56), Greece (3), Hungary (10), Ireland (13), Latvia (1), Lithuania (5), Netherlands (12), Poland (78), Portugal (7), Romania (10), 
Slovakia (5), Slovenia (10), Spain (176), Sweden (8) and United Kingdom (40). 
Bacterial toxins include toxins produced by Bacillus, Clostridium and Staphylococcus. Food-borne viruses include calicivirus, 
hepatitis A virus, flavivirus and rotavirus. Other causative agents include mushroom toxins, marine biotoxins, histamine, 
mycotoxins and atropine. Parasites include primarily Trichinella, but also Cryptosporidium, Giardia and Anisakis. Other bacterial 
agents include Listeria, Brucella, Shigella, Vibrio and Francisella. 
 
 
 
  
EU summary report on zoonoses, zoonotic agents and  
food-borne outbreaks 2012 
 
EFSA Journal 2014;12(2):3547 260 
Types of evidence supporting the outbreaks 
Types of evidence supporting the strong-evidence outbreaks are summarised here below.   
Epidemiological evidence 
- Descriptive epidemiological evidence 
- Analytical epidemiological evidence 
Microbiological evidence 
- Detection in food vehicle or its component and Detection of indistinguishable causative agent in 
humans 
- Detection in food chain or its environment and Detection of indistinguishable causative agent in 
humans  
- Detection in food vehicle or its component and Symptoms and onset of illness pathognomonic of the 
causative agent found in food vehicle or its component or in food chain or its environment 
- Detection in food chain or its environment and Symptoms and onset of illness pathognomonic of the 
causative agent found in food vehicle or its component or in food chain or its environment   
The types of evidence reported for the strong-evidence outbreaks, including strong-evidence waterborne 
outbreaks, are presented in Table OUT5.   
Analytical epidemiological evidence supported the link between human cases and food vehicles in 30.0 % of 
strong-evidence outbreaks, and convincing descriptive epidemiological evidence was reported in 33.9 % of 
strong-evidence outbreaks.  
Seventy-four strong-evidence outbreaks (9.7 %) were supported by detection of the causative agent in the 
food chain or its environment in combination with detection in humans or the case had pathognomonic 
symptoms. In 339 strong-evidence outbreaks (44.4 %) the pathogen was detected in the food vehicle or its 
component and either detected in cases or cases had symptoms and onset of illness pathognomonic of the 
causative agent (Table OUT5). 
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Table OUT5. Evidence in strong-evidence food-borne outbreaks (including strong-evidence waterborne outbreaks) in the EU, 2012 
Country N 
Analytical 
epidemiological 
evidence 
Descriptive 
epidemiological 
evidence (this 
evidence alone) 
Detection of 
causative agent in 
food vehicle or its 
component - 
Detection of 
indistinguishable 
causative agent in 
humans 
Detection of causative 
agent in food chain or 
its environment - 
Detection of 
indistinguishable 
causative agent in 
humans (this 
evidence alone) 
Detection of 
causative agent in 
food vehicle or its 
component - 
Symptoms and 
onset of illness 
pathognomonic to 
causative agent 
Detection of 
causative agent in 
food chain or its 
environment - 
Symptoms and onset 
of illness 
pathognomonic to 
causative agent (this 
evidence alone) 
Austria 3 1 -   3 -   - -   
Belgium 31 1 13 (13) 3 1 (1) 13 -   
Denmark 64 19 57 (12) 13 3   10 36   
Estonia 1 - -   1 -   - -   
Finland 22 3 22 (9) 3 5   4 -   
France 208 - 55 (55) 11 -   142 -   
Germany 56 5 24 (17) 14 13 (5) 11 3 (2) 
Greece 3 3 -   - -   - -   
Hungary 10 5 -   1 -   3 1 (1) 
Ireland 13 - 2 (2) 11 -   - -   
Latvia 1 - -   1 -   - -   
Lithuania 5 5 5   - -   - -   
Table continued overleaf. 
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Table OUT5 (continued). Evidence in strong-evidence food-borne outbreaks (including strong-evidence waterborne outbreaks) in the EU, 2012 
Country N 
Analytical 
epidemiological 
evidence 
Descriptive 
epidemiological 
evidence (this 
evidence alone) 
Detection of 
causative agent in 
food vehicle or its 
component - 
Detection of 
indistinguishable 
causative agent in 
humans 
Detection of causative 
agent in food chain or 
its environment - 
Detection of 
indistinguishable 
causative agent in 
humans (this 
evidence alone) 
Detection of 
causative agent in 
food vehicle or its 
component - 
Symptoms and 
onset of illness 
pathognomonic to 
causative agent 
Detection of 
causative agent in 
food chain or its 
environment - 
Symptoms and onset 
of illness 
pathognomonic to 
causative agent (this 
evidence alone) 
Netherlands 12 3 4 (4) 2 2 (2) 1 -   
Poland 78 9 28 (28) 31 6 (6) 4 -   
Portugal 7 2 -   - -   5 -   
Romania 10 - -   2 -   8 -   
Slovakia 5 1 4 (1) 4 -   - -   
Slovenia 10 1 8 (8) - -   1 -   
Spain 176 164 0   0 0   35 0   
Sweden 8 1 5 (3) - 1   1 2 (1) 
United Kingdom 40 6 32 (32) 1 1 (1) - -   
EU Total 763 229 259 (184) 101 32 (15) 238 42 (4) 
Norway 3 1 - 
 
- -   2 -   
Switzerland 4 - 4 (4) - -   - -   
Note: Data from waterborne outbreaks included. 
The evidence types 'Detection of causative agent in food chain or its environment - Detection of indistinguishable causative agent in humans'/'Detection of causative agent in food chain or its 
environment - Symptoms and onset of illness pathognomonic  of causative agent' in combination with 'Descriptive epidemiological evidence' were the only types of evidence reported in 24 outbreaks.  
More than one type of evidence can be reported per outbreak. 
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Food vehicle  
The food vehicle was reported in all 763 strong-evidence outbreaks, even though in 38 outbreaks (5.0 %) it 
was reported as ‘Other food’. 
In 2012, the majority of the strong-evidence outbreaks were associated with foodstuffs of animal origin 
(Figure OUT5). As in previous years, the most common single foodstuff category reported as food vehicle 
was eggs and egg products, responsible for 168 outbreaks (22.0 %). Mixed foods were the next most 
common single category (15.6 %), followed by fish and fish products (9.2 %) (Figure OUT5).  
 
Figure OUT5. Distribution of strong-evidence outbreaks by food vehicle in the EU, 2012 
 
Note: Data from 763 outbreaks are included: Austria (3), Belgium (31), Denmark (64), Estonia (1), Finland (22), France (208), Germany 
(56), Greece (3), Hungary (10), Ireland (13), Latvia (1), Lithuania (5), Netherlands (12), Poland (78), Portugal (7), Romania (10), 
Slovakia (5), Slovenia (10), Spain (176), Sweden (8) and United Kingdom (40). 
 Other foodstuffs (N = 68) include: canned food products (1), cereal products including rice and seeds/pulses (nuts, almonds) (4), 
dairy products (other than cheeses) (4), drinks (1), fruit, berries and juices and other products thereof (6), herbs and spices (2), 
milk (7), sweets and chocolate (5) and other foods (38). 
 
 
Setting 
The setting of the outbreak was provided in 690 of strong-evidence outbreaks (Figure OUT6), whereas for 
73 outbreaks the setting was unknown. The setting ‘restaurant, café, pub, bar, hotel’ decreased from 34.4 % 
in 2011 to 23.9 % in 2012. The category ‘household/domestic kitchen’ (39.7 %) was the most commonly 
reported setting. Apart from restaurants and households, the next most common settings in strong-evidence 
outbreaks were other settings (8.0 %) and school, kindergarten (6.3 %).  
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Figure OUT6. Distribution of strong-evidence outbreaks by settings in the EU, 2012 
 
Note: Data from 763 outbreaks are included: Austria (3), Belgium (31), Denmark (64), Estonia (1), Finland (22), France (208), Germany 
(56), Greece (3), Hungary (10), Ireland (13), Latvia (1), Lithuania (5), Netherlands (12), Poland (78), Portugal (7), Romania (10), 
Slovakia (5), Slovenia (10), Spain (176), Sweden (8) and United Kingdom (40). 
 Other settings (N = 61) include: camp, picnic (3), mobile retailer, market/street vendor (4), farm (primary production) (2) and other 
settings (52). 
Detailed information on causative agents in selected food vehicles 
The following section provides a more detailed view of different food vehicles identified in the outbreaks and 
shows the distribution of the causative agents related to strong-evidence outbreaks implicating eggs and egg 
products (Figure OUT7); mixed foods (Figure OUT8); fish and fish products (Figure OUT9); crustaceans, 
shellfish, molluscs and products thereof (Figure OUT10); food of non-animal origin (Figure OUT11); and 
vegetables (Figure OUT12).  
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Figure OUT7. Distribution of strong-evidence outbreaks, implicating eggs and egg products, by 
causative agent in the EU, 2012 
 
Note:  Data from 168 outbreaks are included: France (33), Germany (3), Netherlands (1), Poland (51), Slovakia (3), Spain (74) and 
United Kingdom (3). 
Figure OUT8. Distribution of strong-evidence outbreaks, implicating mixed food, by causative agent 
in the EU, 2012 
 
Note: Data from 119 outbreaks are included: Belgium (6), Denmark (25), Estonia (1), France (26), Germany (17), Netherlands (3), 
Poland (14), Portugal (3), Slovenia (6), Spain (10), Sweden (2) and United Kingdom (6).  
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Figure OUT9. Distribution of strong-evidence outbreaks, implicating fish and fish products, by 
causative agent in the EU, 2012 
 
Note: Data from 70 outbreaks are included: Belgium (5), Denmark (3), Finland (1), France (36), Germany (2), Latvia (1), Netherlands 
(1), Slovenia (1), Spain (16), Sweden (2) and United Kingdom (2).  
Figure OUT10. Distribution of strong-evidence outbreaks, implicating crustaceans, shellfish, 
molluscs and products thereof, by causative agent in the EU, 2012 
 
Note: Data from 35 outbreaks are included: Belgium (5), Denmark (3), France (7), Ireland (1), Netherlands (1), Spain (15) and United 
Kingdom (3).    
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Figure OUT11. Distribution of strong-evidence outbreaks, implicating food of non-animal origin, by 
causative agent in the EU, 2012 
 
Note: Data from 58 outbreaks are included: Belgium (2), Denmark (8), Finland (3), France (4), Germany (5), Hungary (1), Ireland (1), 
Netherlands (1), Poland (7), Slovenia (1), Spain (17), Sweden (3) and United Kingdom (5). 
 Food of non-animal origin includes: cereal products including rice and seeds/pulses (nuts, almonds) (4), drinks (1), fruit, berries 
and juices and other products thereof (6), herbs and spices (2), sweets and chocolate (5), vegetables and juices and other 
products thereof (38), mixed food (1) and other foods (1). For the last two categories, the outbreaks were included only when it 
was clearly stated that the food vehicle was of non-animal origin.  
Figure OUT12. Distribution of strong-evidence outbreaks, implicating vegetables, by causative agent 
in the EU, 2012 
 
Note: Data from 39 outbreaks are included: Belgium (1), Denmark (6), Finland (2), France (2), Germany (3), Netherlands (1), Poland 
(2), Spain (17), Sweden (3) and United Kingdom (2).  
Vegetables includes: vegetables and juices and other products thereof (38) and other foods (1). For the last category, the 
outbreaks were included only when it was clearly stated that the food vehicle was of vegetable origin.  
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Egg and egg products were implicated in 168 outbreaks (22 %), of which 93.5 % were caused by 
Salmonella spp. (Figure OUT7). The majority of these outbreaks were associated with S. Enteritidis (66.7 %), 
as in previous years. Two outbreaks were caused by bacterial toxins (one by Bacillus and one by 
staphylococcal toxins). In addition, one calicivirus outbreak was attributed to eggs and egg products.  
Mixed foods were implicated in 119 outbreaks. Calicivirus, Salmonella and Clostridium perfringens were the 
most frequently detected causative agents in these outbreaks (26.9 %, 21.0 % and 20.2 %, respectively), 
followed by staphylococcal enterotoxins (9.2 %) and Bacillus (9.2 %) (Figure OUT8). In 9.2 % of cases the 
causative agent was unknown. 
In 2012, fish and fish products were implicated in 70 outbreaks (Figure OUT9). The majority of these 
outbreaks were caused by histamine (34 outbreaks, 48.6 %). Other reported causative agents were marine 
biotoxins and Salmonella (18.6 % and 11.4 %, respectively) and in 5.7 % of outbreaks the agent was not 
identified. 
In 2012, there were 35 outbreaks attributed to crustaceans, shellfish, molluscs and products thereof 
(Figure OUT10). The majority were caused by calicivirus (45.7 %), followed by marine biotoxins (14.3 %). A 
relevant percentage of outbreaks was reported with unknown causative agent (25.7 %).   
Food of non-animal origin was reported as the food vehicle in 58 strong-evidence outbreaks (Figure OUT11). 
This category includes: cereal products including rice and seeds/pulses; drinks; fruit, berries and juices and 
other products thereof; herbs and spices; sweets and chocolate; and vegetables and juices and other 
products thereof. In addition, some outbreaks related to mixed food or other foods were included when it was 
clearly indicated that the food vehicle was of non-animal origin. 
Salmonella and viruses were the most frequently detected causative agents (29.3 % and 22.4 %, 
respectively) in the food of non-animal origin outbreaks, followed by mycotoxins (13.8 %) and Bacillus 
(10.3 %).  
In 2012, vegetables were implicated in 39 outbreaks (Figure OUT12). The causative agents were primarily 
viruses (25.6 %), Salmonella (23.1 %) and mycotoxins (20.5 %).   
 
  
EU summary report on zoonoses, zoonotic agents and 
food-borne outbreaks 2012 
 
EFSA Journal 2014;12(2):3547 269 
4.2. Salmonella 
In 2012, 24 MSs reported a total of 1,533 food-borne outbreaks of human salmonellosis, which constituted 
28.6 % of the total number of reported outbreaks of food-borne illness in the EU (Table OUT3). This is a 
small increase compared with 2011 (1,501 outbreaks). Within the EU, the majority of Salmonella outbreaks 
(78.0 %) were reported by Slovakia, Spain, France, Germany and Poland. The overall reported incidence 
was 0.31 outbreaks per 100,000 population, ranging from <0.01 per 100,000 population in Italy and Romania 
to 7.51 per 100,000 population in Slovakia. Norway reported four outbreaks and Switzerland reported one 
outbreak (Table OUT6).  
 
In total, 18 MSs reported 347 Salmonella outbreaks supported by strong evidence. These were mainly 
reported by France, Spain and Poland, which accounted for 76.7 % of strong-evidence Salmonella outbreaks 
(29.4 %, 27.4 % and 19.9 %, respectively). One strong-evidence Salmonella outbreak was reported by 
Switzerland. 
As in previous years, S. Enteritidis was the predominant serovar associated with the Salmonella outbreaks, 
accounting for 179 outbreaks (51.6 % of all strong-evidence Salmonella outbreaks) and 2,177 human cases 
(37.6 % of all cases in Salmonella outbreaks).  
S. Typhimurium was associated with 49 outbreaks (14.1 % of the strong-evidence Salmonella outbreaks) 
and 792 human cases (13.7 % of human cases due to Salmonella). Of these outbreaks, seven were caused 
by monophasic S. Typhimurium.  
For 97 strong-evidence outbreaks caused by Salmonella (28.0 %), the serovar was not reported or unknown. 
 
The annual total number of Salmonella outbreaks within the EU has decreased markedly during recent 
years. From 2008 to 2012, the total number of Salmonella outbreaks decreased by 19 %, from 1,888 to 
1,533 outbreaks. This reduction parallels the general decline in notified human salmonellosis cases 
observed within the EU over the same period.  
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Table OUT6. Strong- and weak-evidence food-borne outbreaks caused by Salmonella in the EU, 2012 
Country 
Total outbreaks Strong-evidence outbreaks Weak-evidence outbreaks 
N 
Reporting 
rate per 
100,000 
N 
Human cases 
N 
Human cases 
Cases Hospitalised Deaths Cases Hospitalised Deaths 
Austria 53 0.63 2 214 22 0 51 148 39 0 
Belgium 6 0.05 6 43 3 0 - - - - 
Bulgaria 1 0.01 - - - - 1 47 - - 
Czech Republic 19 0.18 - - - - 19 391 59 0 
Denmark 11 0.20 5 117 10 0 6 24 1 0 
Estonia 13 0.97 1 87 20 0 12 51 26 0 
Finland 2 0.04 1 97 2 0 1 13 2 0 
France 198 0.30 102 669 126 1 96 692 70 0 
Germany 176 0.22 29 803 166 3 147 552 146 0 
Greece 20 0.18 - - - - 20 92 46 0 
Hungary 80 0.80 9 517 133 0 71 373 43 0 
Ireland 4 0.09 1 3 - 0 3 6 2 0 
Italy 2 <0.01 - -  - 2 7 - - 
Latvia 26 1.17 - - - - 26 174 46 0 
Lithuania 50 1.54 5 69 22 0 45 138 109 0 
Malta 8 1.44 - . - - 8 19 2 0 
Netherlands 13 0.08 4 1,223 30 4 9 30 5 0 
Poland 188 0.49 69 596 230 0 119 929 287 0 
Romania 1 <0.01 1 7 0 0 - - - - 
Slovakia 408 7.51 4 150 30 0 404 1,277 224 0 
Slovenia 4 0.20 4 78 14 0 - - - - 
Spain 225 0.49 95 940 162 0 130 1,062 158 0 
Sweden 9 0.10 1 34 - - 8 58 2 - 
United Kingdom 16 0.03 8 140 15 2 8 25 31 0 
EU Total 1,533 0.31 347 5,787 985 10 1,186 6,108 1,298 0 
Norway 4 0.08     4 25 5 0 
Switzerland 1 0.01 1 4 1 0 - - - - 
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Detailed information from strong-evidence Salmonella outbreaks 
Figure OUT13 shows the distribution of the most common food vehicles implicated in the strong-evidence 
Salmonella outbreaks in 2012. As in previous years, eggs and egg products were the most frequently 
identified food vehicles, associated with 45.2 % of these outbreaks. The proportion of strong-evidence 
Salmonella outbreaks, implicating contaminated eggs and egg products, was lower than in 2011 (50.5 %) but 
similar to 2010 (43.7 %) and previous years. Most of these outbreaks were reported by three MSs (France, 
Spain and Poland). The next most commonly implicated single food vehicle category, in the Salmonella 
outbreaks, was cheese (7.8 % of strong-evidence outbreaks), followed by mixed food (7.2 %). The outbreaks 
associated with consumption of cheese were reported by one MS, France. No additional information was 
provided on the type of cheese implicated and on the contributing factors.  
A decrease was observed both in the proportion and in the numbers of outbreaks related to sweets and 
chocolate from 6.7 % in 2011 to 1.4 % in 2012. In 2011 most of the outbreaks in this category were reported 
by one country, Poland. The number of outbreaks implicating bakery products decreased to 2.3 % from 
4.2 % in 2011. In addition, the proportion and number of outbreaks linked to bovine meat slightly decreased 
since 2011 (from 2.8 % to 2.0 %) but the proportion of outbreaks associated with broiler meat and pig meat 
increased. For broiler meat the proportion was 3.2 % in 2011 and 3.7 % in 2012 and for pig meat the 
proportion in 2011 was 4.6 % compared with 5.8 % in 2012.   
Figure OUT13. Distribution of food vehicles in strong-evidence outbreaks caused by Salmonella in 
the EU, 2012 
 
Note: Data from 347 outbreaks are included: Austria (2), Belgium (6), Denmark (5), Estonia (1), Finland (1), France (102), Germany 
(29), Hungary (9), Ireland (1), Lithuania (5), Netherlands (4), Poland (69), Romania (1), Slovakia (4), Slovenia (4), Spain (95), 
Sweden (1) and United Kingdom (8). 
 Other foodstuffs (N = 29) include: crustaceans, shellfish, molluscs and products thereof (3), dairy products (2), fruits and juices 
and other products thereof (2), herbs and spices (1) and other foods (21). 
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Figure OUT14. Distribution of food vehicles in strong-evidence outbreaks caused by S. Enteritidis in 
the EU, 2012 
 
Note: Data from 179 outbreaks included: Austria (1), Belgium (2), Estonia (1), France (22), Germany (16), Hungary (5), Lithuania (5), 
Poland (67), Slovakia (4), Slovenia (2), Spain (50) and United Kingdom (4). 
 Other foodstuffs (N = 18) include: cheese (1), dairy products (other than cheeses) (2), fish and fish products (1), herbs and spices 
(1), meat and product thereof, unspecified (2), other, mixed or unspecified poultry meat (2), other or mixed red meat and products 
thereof (1) and other foods (8). 
In 2012, 179 outbreaks, in total, with strong evidence were caused by S. Enteritidis. Most of these outbreaks 
were attributed to eggs and egg products (112 strong-evidence S. Enteritidis outbreaks, 62.6 %, compared 
with 108 outbreaks in 2011). Buffet meals and bakery products were implicated in 4.5 % and 3.4 % of 
outbreaks, respectively. Sweets and chocolate were implicated in 2.8 % of outbreaks, a decrease of 73.7 % 
compared with 2011, when sweets and chocolate were implicated in 10.0 % of S. Enteritidis outbreaks 
(Figure OUT14). 
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Figure OUT15. Distribution of food vehicles in strong-evidence outbreaks caused by S. Typhimurium 
in the EU, 2012 
 
Note: Data from 49 outbreaks are included: France (22), Denmark (3), Germany (8), Hungary (3), Netherlands (1), Poland (1), Spain 
(8), Sweden (1) and United Kingdom (2). 
 Other foodstuffs (N = 9) include: bakery products (1), fish and fish products (1), other, mixed or unspecified poultry meat (1), and 
other foods (6). 
 Number after the label refers to the number of outbreaks. 
In total, 49 strong-evidence outbreaks were caused by S. Typhimurium (Figure OUT15), a substantial 
increase compared with 2011 when 29 strong-evidence outbreaks were caused by S. Typhimurium. The 
food vehicle most frequently reported was pig meat and products thereof (12 outbreaks, compared with 10 in 
2011). Other important vehicles were eggs and egg products (eight outbreaks).   
The seven outbreaks due to monophasic S. Typhimurium were associated with the consumption of pig meat 
(three outbreaks), bovine meat (two outbreaks), vegetables, juices and other products thereof (one outbreak) 
and mixed food-doner kebab (one outbreak). 
The type of outbreak was reported in 340 (98.0 %) of Salmonella outbreaks: altogether 173 of these (50.9 %) 
were classified as household and 167 (49.1 %) as general. The setting was reported as household/domestic 
kitchen in 200 (57.6 %) of the 347 Salmonella outbreaks, followed by restaurant, café, bar, hotel in 
65 outbreaks (18.7 %) and school/kindergarten in 18 (5.2 %).  
Many contributory factors, either alone or in combination, were reported in 185 Salmonella outbreaks. The 
most common were unprocessed contaminated ingredient (in 63 outbreaks), inadequate heat treatment (in 
53 outbreaks), inadequate chilling (in 35 outbreaks) storage time/temperature abuses (in 34 outbreaks) and 
infected food handlers (in 30 outbreaks).    
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Between 2011 and 2012, an outbreak of Salmonella Stanley infection occurred in Austria, Belgium, the 
Czech Republic, Germany, Hungary, Slovak Republic and the United Kingdom, involving 167 confirmed and 
254 probable cases. The descriptive epidemiology of human cases indicated a transmission originating from 
a persistent common source or multiple sources, in the EU, which were contaminated with isolates 
indistinguishable by XbaI-PFGE. Food and veterinary investigations, conducted in Austria, Belgium, 
Germany, the Czech Republic, Poland and Hungary, identified an indistinguishable XbaI-PFGE fingerprint 
and a common resistance to nalidixic acid with concomitant decreased susceptibility to ciprofloxacin, among 
isolates originating from the turkey production chain (turkeys and turkey meat). Isolates with indistinguishable 
PFGE patterns were also detected in some cases from broiler flocks (breeding and fattening chicken flocks) 
and meat from other animal species (broiler meat, beef and pork) The epidemiological and microbiological 
information gathered through the public health, food and veterinary investigations strongly suggested that the 
turkey production chain was the source of the outbreak. However, the contribution of other food and animal 
sources, such as beef, pork and broiler meat, to the outbreak cannot be ruled out. 
More information on this outbreak can be found at: http://www.efsa.europa.eu/en/efsajournal/pub/2893.htm  
4.3. Campylobacter 
Within the EU, 19 MSs reported a total of 501 food-borne Campylobacter outbreaks (Table OUT7), a 
decrease compared with 2011, when a total of 596 outbreaks were reported. This represents 9.3 % of the 
total reported food-borne outbreaks in the EU, a decrease compared with 2011, when Campylobacter 
outbreaks constituted 10.6 % of the total reported food-borne outbreaks in the EU.  The overall reporting rate 
in the EU was 0.10 per 100,000 population, similar to that reported in 2011 (0.12) and in 2010 (0.10). As was 
the case in 2011, Austria, Germany and Slovakia reported the majority of outbreaks (78.2 %). In addition, 
Norway and Switzerland reported two outbreaks each.  
Only 25 (5.0 %) Campylobacter outbreaks were classified as strong-evidence outbreaks. In addition, 
Switzerland reported two strong-evidence outbreaks, one of which involved a fatal case.  
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Table OUT7. Strong- and weak-evidence food-borne outbreaks caused by Campylobacter in the EU, 2012 
Country 
Total outbreaks Strong-evidence outbreaks Weak-evidence outbreaks 
N 
Reporting 
rate per 
100,000 
N 
Human cases 
N 
Human cases 
Cases Hospitalised Deaths Cases Hospitalised Deaths 
Austria 61 0.72 - - - - 61 137 30 0 
Belgium 2 0.02 1 2 0 0 1 2 0 0 
Czech Republic 2 0.02 - - - - 2 31 1 0 
Denmark 3 0.05 3 31 1 0 - - - - 
Estonia 3 0.22 - - - - 3 8 3 0 
Finland 4 0.07 3 44 6 0 1 3 0 0 
France 18 0.03 5 14 3 0 13 80 8 0 
Germany 134 0.16 5 27 5 0 129 345 34 0 
Hungary 16 0.16 - - - - 16 40 2 0 
Ireland 2 0.04 - - - - 2 5 0 0 
Italy 3 <0.01 - - - - 3 8 - - 
Lithuania 8 0.27 - - - - 8 16 13 0 
Malta 16 3.35 - - - - 16 39 14 0 
Netherlands 14 0.08 1 15 2 0 13 55 0 0 
Poland 5 0.01 - - - - 5 10 4 0 
Slovakia 197 3.65 - - - - 197 500 66 0 
Spain 3 <0.01 0 0 0 0 3 298 5 0 
Sweden 3 0.03 - - - - 3 26 - - 
United Kingdom 7 0.01 7 65 0 0 - - - - 
EU Total 501 0.10 25 198 17 0 476 1,603 180 0 
Norway 2 0.04 - - - - 2 5 1 0 
Switzerland 2 0.03 2 44 3 1 - - - - 
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Detailed information from strong-evidence Campylobacter outbreaks 
Of the 25 strong-evidence Campylobacter outbreaks, 19 were categorised as general outbreaks, four as 
household outbreaks and two outbreaks were classified as unknown.  
Figure OUT16 shows the distribution of the most common food vehicles implicated in the strong-evidence 
Campylobacter outbreaks in 2012. As in previous years, broiler meat was the most frequently identified food 
vehicle, associated with 44.0 % of these outbreaks. The proportion of strong-evidence Campylobacter 
outbreaks implicating broiler meat was similar to that in 2011 (45.9 %). The next most commonly implicated 
food vehicle was milk with 20.0 %, an increase compared with 2011, when 13.5 % of outbreaks implicated 
milk. 
Seven outbreaks were reported by the United Kingdom, and six of these were associated with broiler meat. 
Five outbreaks were reported by France, and two of these were associated with broiler meat and the other 
three were associated with bovine meat, mixed red meat and turkey meat. The five outbreaks reported by 
Germany were associated with raw minced pig meat (one outbreak), carpaccio from raw duck meat (one 
outbreak) and raw milk (three outbreaks). 
In 21 outbreaks the setting was identified: the most frequently reported was restaurant, café, pub, bar, hotel, 
catering service (10 outbreaks), followed by household/domestic kitchen (six outbreaks). Farm was the 
setting in two outbreaks and the place of origin of the problem reported in five outbreaks, and the food 
vehicle in these outbreaks was raw/unpasteurised milk. Many contributory factors, either alone or in 
combination, were reported in 14 outbreaks. The most common factor was inadequate heat treatment, 
reported in five outbreaks, followed by unprocessed contaminated ingredient, reported in four outbreaks. 
Two outbreaks were reported by Switzerland. Both were general outbreaks and associated with broiler meat. 
The settings were a residential institution and a mass catering establishment and the contributory factors 
were storage time/temperature abuse and cross-contamination, respectively. 
Figure OUT16. Distribution of food vehicles in strong-evidence outbreaks caused by Campylobacter 
in the EU, 2012 
 
Note: Data from 25 outbreaks are included: Belgium (1), Denmark (3), Finland (3), France (5), Germany (5), Netherlands (1) and United 
Kingdom (7). 
 Number after the label refers to the number of outbreaks.  
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4.4. Verotoxigenic Escherichia coli and other pathogenic Escherichia coli  
Nine MSs reported 41 outbreaks caused by human pathogenic E. coli, excluding 10 strong waterborne 
outbreaks (Table OUT16). This is a decrease since 2011 when 12 MSs reported a total of 60 food-borne 
outbreaks. This represents 0.8 % of the total number of reported food-borne outbreaks in the EU. 
Detailed information from strong-evidence E. coli outbreaks 
Twelve E. coli outbreaks were supported by strong evidence, and these outbreaks were reported by six MSs, 
by the United Kingdom (four outbreaks), Belgium (three), Denmark (two), Austria (one), Finland (one) and 
Portugal (one). Nine outbreaks were due to VTEC O157, one to VTEC O113:H4, one to other VTEC 
serotypes, and one to E. coli positive for LT genes.  
Ten outbreaks were general and two household. These resulted in 117 cases, 78 hospitalisations and no 
fatalities.  
The main food vehicle was bovine meat and products thereof, reported in six outbreaks; pig meat (roasted 
pork) was the food vehicle reported in two outbreaks linked to temporary mass catering. Each of the 
remaining four outbreaks was associated with raw milk, herbs and spices, mixed food, and other or mixed 
red meat. 
The setting in five outbreaks was household. Two outbreaks were linked to temporary mass catering (fairs, 
festivals), one was associated with restaurant, café, pub, bar, hotel, catering service, and one with residential 
institutions. Information on setting was not provided in three outbreaks. Contributing factors were 
unprocessed contaminated ingredients in five outbreaks, inadequate heating in two outbreaks and cross-
contamination in one outbreak. For three outbreaks the contributing factors were either not reported or were 
unknown.  
Ten waterborne outbreaks attributable to pathogenic E. coli were also reported by Ireland (Table OUT16). 
In Belgium, an outbreak of bloody diarrhoea and haemolytic-uraemic syndrome (HUS) caused by 
Escherichia coli O157 involved 24 cases, of which 17 were laboratory-confirmed. Four patients developed 
HUS, two children and two middle-aged women. The source of the outbreak could be traced back to the 
slaughterhouse by sampling and laboratory analyses, exploratory interviews and a case-control study. The 
patients were most frequently infected through the consumption of raw bovine meat products such as ‘steak 
tartare’. 
 
4.5. Other bacterial agents  
Under the category ‘other bacterial agents’, outbreaks due to Listeria, Shigella, Brucella, Francisella, Vibrio 
parahaemolyticus and other bacterial agents are reported. In addition, a specific category was used for 
reporting outbreaks caused by Yersinia.  
In 2012, 92 outbreaks caused by these bacteria were reported by 12 MSs, representing 1.7 % of all 
outbreaks reported in the EU. Ten of them (10.9 %), reported by four MSs, were supported by strong 
evidence. In addition, one non-MS reported one weak-evidence outbreak. 
Five of the strong-evidence outbreaks were caused by Listeria monocytogenes (L. monocytogenes), four 
of which were general and the fifth was a household outbreak. Three general outbreaks were reported by the 
United Kingdom, resulting in 24 cases, 24 hospitalisations and five deaths. One of these outbreaks took 
place in a hospital/care home setting and mixed food (sandwiches) was implicated. In one outbreak the 
cases were disseminated, the implicated food was bakery products (pork pies) and cross-contamination was 
reported as a contributory factor. Mobile retailer/street vendor was the setting in the third outbreak; bovine 
meat and products thereof were implicated (pressed beef also called potted beef or beef stew) and cross- 
contamination was reported as a contributory factor.  
In Spain a general household outbreak caused by L. monocytogenes resulted in 11 cases, three 
hospitalisations and one death. Cheese was the implicated food vehicle.   
EU summary report on zoonoses, zoonotic agents and 
food-borne outbreaks 2012 
 
EFSA Journal 2014;12(2):3547 278 
A L. monocytogenes outbreak in Finland was associated with other or mixed red meat and products thereof 
(meat jelly) and accounted for 20 cases and three deaths (see specific text box).  
 
In July in Finland, a total of 10 cases with L. monocytogenes serotype IIa PFGE type 225 were identified in 
one ward of a municipal hospital. All cases presented with diarrhoea and two of them with septicaemia. One 
patient died 20 days after the onset of gastrointestinal listeriosis. Meat jelly was considered to be the 
probable source of the infection since the outbreak was limited to the wards where this product had been 
served. According to staff interviews, only a half of a meat jelly package was consumed after opening, and 
the other half was served within 24 hours or destroyed. However, the staff recalled that in July one opened 
package was stored in the refrigerator and was still used for serving one week later. No pathogens were 
found in any food or environmental samples taken at the hospital. From the middle of June to the middle of 
August, 10 cases with the same L. monocytogenes serotype were reported from various municipalities 
across Finland. Stool testing or diarrhoeal symptoms were not mentioned in the medical records of these 
cases. Two patients died within four to five days after the onset of illness. Among the 10 cases, seven had 
been in institutional care during June and July. Local health inspectors reported that all seven had had an 
opportunity to consume the suspected meat jelly product at the care facility. The sliced meat jelly was 
produced in 500kg batches on a biweekly basis and delivered to customers across the country through a 
distribution company. Internal quality control samples yielded negative results for Listeria at the production 
plant from March to May except for one finding of L. monocytogenes different from the outbreak strain. 
During an inspection carried out by the local food safety authority, at the beginning of August, a pooled 
sample taken from a floor drain and a wagon wheel in the food processing environment was found positive 
for the outbreak strain of L. monocytogenes. 
   
 
Two strong-evidence outbreaks caused by Shigella were reported by France. Both were general outbreaks 
and resulted in 45 cases and five hospitalisations. There were no fatalities. Broiler meat was implicated in 
one outbreak which was linked to a restaurant, café, pub, bar, hotel setting and mixed food was implicated in 
the other outbreak. The setting for this latter outbreak was a residential institution. Contributory factors were 
reported as unknown.  
One strong-evidence outbreak due to Brucella was reported by France. This was a household outbreak with 
a household/domestic kitchen setting and affected two people. Cheese was implicated and contributory 
factors were reported as unknown.   
One outbreak of Francisella was reported by France. This was a household outbreak and was associated 
with other, mixed or unspecified poultry meat and products thereof. Three people were affected and there 
were no hospitalisations or deaths. The setting was household/domestic kitchen and an infected food 
handler was reported as a contributing factor.  
One strong-evidence general outbreak due to Vibrio parahaemolyticus was reported by Spain. This 
resulted in 51 cases with no hospitalisations or deaths. It was a general outbreak and the setting was 
canteen/workplace catering and crustaceans, shellfish, molluscs and products thereof were implicated. 
Contributory factors were reported as unknown.  
 
No strong-evidence food-borne outbreaks caused by Yersinia were reported. 
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4.6. Bacillus 
This section details food-borne outbreaks in which the causative agent was reported as Bacillus toxins. 
In 2012, 10 MSs reported 259 outbreaks (in 2011: 11 MSs reported 220 outbreaks) in which Bacillus toxins 
were the causative agent, representing 4.8 % of all outbreaks reported within the EU. The overall reporting 
rate in the EU was 0.05 per 100,000. France reported the majority (84.2 %) of these outbreaks, which 
involved 2,022 human cases, 126 hospitalisations and three deaths (Table OUT9). In addition, two non-MSs 
reported two outbreaks. 
In total, 38 strong-evidence outbreaks caused by Bacillus toxins were reported in the EU, with the majority 
(20 outbreaks) reported by France. All these outbreaks were caused by B. cereus toxins, but two outbreaks, 
reported by Germany and Spain, were due to toxins of Bacillus spp. unspecified. These outbreaks affected 
712 people,  of whom 2.2 % were hospitalised. One strong-evidence outbreak due to B. cereus was reported 
by Switzerland and affected eight people, all hospitalised. 
 
Detailed information from strong-evidence Bacillus outbreaks 
In strong-evidence Bacillus outbreaks, mixed food was the most commonly implicated food vehicle (28.9 % 
of outbreaks). The second most frequently reported implicated single food vehicle was fish and fish products 
(13.2 % of outbreaks), followed by cereal products (10.5 %) (Figure OUT17).  
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Table OUT8. Strong- and weak-evidence food-borne outbreaks caused by Bacillus toxins in the EU, 2012 
Country 
Total outbreaks Strong-evidence outbreaks Weak-evidence outbreaks 
N 
Reporting 
rate per 
100,000 
N 
Human cases 
N 
Human cases 
Cases Hospitalised Deaths Cases Hospitalised Deaths 
Belgium 3 0.03 2 24 0 0 1 3 0 0 
Denmark 3 0.05 3 43 0 0 - - - - 
Finland 5 0.09 3 13 0 0 2 50 0 0 
France 218 0.33 20 349 11 0 198 1,673 115 3 
Germany
1
 5 0.01 4 22 3 0 1 - - - 
Hungary 1 0.01 - - - - 1 13 0 0 
Netherlands 12 0.07 - - - - 12 43 0 0 
Spain 8 0.02 4 56 2 0 4 15 0 0 
Sweden 3 0.03 1 5 - - 2 9 - - 
United Kingdom 1 <0.01 1 200 0 0 - - - - 
EU Total 259 0.05 38 712 16 0 221 1,806 115 3 
Norway 1 0.02 - - - - 1 6 0 0 
Switzerland 1 0.01 1 8 8 0 - - - - 
1. The number of human cases was known only for two out of the four strong- evidence outbreaks reported. No information was reported for the other two outbreaks. 
.
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Figure OUT17. Distribution of food vehicles in strong-evidence outbreaks caused by Bacillus toxins 
in the EU, 2012 
 
Note: Data from 38 outbreaks are included: Belgium (2), Denmark (3), Finland (3), France (20), Germany (4), Spain (4), Sweden (1) 
and United Kingdom (1).  
 Other foodstuffs (N = 8) include: bakery products (1), broiler meat (Gallus gallus) and products thereof (1), eggs and egg 
products (1), other or mixed red meat and products thereof (1), poultry meat (1), turkey meat and products thereof (1) and other 
foods (2). 
 Number after the label refers to the number of outbreaks. 
Information on the type of outbreak was available for 36 outbreaks. Twenty-seven were classified as general 
and nine as household. For 35 outbreaks, information on the setting was provided: restaurant, café, pub, bar, 
hotel was the most frequently reported (11 outbreaks), followed by household/domestic kitchen 
(10 outbreaks). In five outbreaks the setting was a school/ kindergarten. 
Many contributory factors, either alone or in combination, were reported in 18 outbreaks: inadequate chilling 
was reported as a contributing factor in seven outbreaks and storage time/temperature abuses in six 
outbreaks. Other factors included an infected food handler (in three outbreaks), inadequate heat treatment 
(in three outbreaks), cross-contamination (in one outbreak) and an unprocessed contaminated ingredient (in 
one outbreak). 
In a kindergarten in Belgium, 20 out of 22 children started vomiting within 30 minutes after the consumption 
of rice containing cucumber and chicory. The rice was stored for 24 hours before preparation of the meal. 
High levels of Bacillus cereus (10
7
 cfu/g) positive for the gene encoding the emetic toxin could be isolated 
from leftovers of the meal. Interestingly, the level of cereulide was quantified using liquid chromatography-
mass spectroscopy (LC-MS) and was between 0.35 and 4.2 μg/g. 
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4.7. Clostridium 
Thirteen MSs reported 172 food-borne outbreaks caused by Clostridium perfringens, C. botulinum or other 
Clostridia (Table OUT9). This represents 3.2 % of all outbreaks, compared with 2.9 % in 2011 (15 MSs, 
165 outbreaks). However, it is an increase of almost 100 % compared with outbreaks reported in 2010 
(88 outbreaks). As in 2011, the overall reported rate in EU was 0.03. France reported 53.5 % (92) of the 
outbreaks (Table OUT9). In addition, two non-MSs reported three outbreaks. Twelve fatalities were reported 
by three MSs, two in strong-evidence outbreaks and 10 in weak-evidence outbreaks (Table OUT9). 
Fifty-four of these outbreaks (31.4 %) had strong evidence, and 25 of these (46.3 %) were reported by 
France. The rest were reported fairly evenly among the other seven reporting MSs. Two non-MSs each 
reported one strong-evidence outbreak (Table OUT9). 
Detailed information from strong-evidence Clostridium outbreaks 
Mixed food was the most frequently identified food vehicle, associated with 44.4 % of strong-evidence 
Clostridium outbreaks. The next most frequently reported food vehicles were bovine and pig meat and 
products thereof (9.3 %) (Figure OUT18). 
Information on the type of outbreak was available for 53 out of 54 strong-evidence outbreaks: 45 were 
general outbreaks, and eight were household/domestic kitchen outbreaks. The settings most frequently 
reported were residential institution (nine outbreaks) and canteen or workplace catering (nine outbreaks), 
followed by restaurant, café, pub, bar, hotel (eight outbreaks), household/domestic kitchen (seven outbreaks) 
and school/ kindergarten (six outbreaks). The setting was unknown or not reported in 10 outbreaks. 
Many contributory factors, either alone or in combination, were reported in 23 outbreaks. These included 
storage time/temperature abuses (10 outbreaks), inadequate heat treatment (eight outbreaks), inadequate 
chilling (eight outbreaks), cross-contamination (two outbreaks), and unprocessed contaminated ingredient 
(one outbreak). Contributory factors were reported as unknown in 31 outbreaks. 
In the United Kingdom one death was reported from a C. perfringens outbreak that affected 22 people and 
was supported by analytical epidemiological evidence. The setting was a restaurant, the food vehicle was 
turkey meat and the contributory factors were unknown. In Spain one outbreak due to C. perfringens, 
associated with ‘Other food’, accounted for 57 human cases, two hospitalisations and one death.   
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Table OUT9. Strong- and weak-evidence food-borne outbreaks caused by Clostridium toxins in the EU, 2012 
Country 
Total outbreaks Strong-evidence outbreaks Weak-evidence outbreaks 
N 
Reporting 
rate per 
100,000 
N 
Human cases 
N 
Human  cases 
Cases Hospitalised Deaths Cases Hospitalised Deaths 
Denmark 8 0.14 8 175 0 0 - - - - 
France 92 0.14 25 712 8 0 67 1,105 15 0 
Germany 5 0.01 5 66 0 0 - - - - 
Hungary 1 0.01 - - - - 1 13 0 0 
Italy 2 <0.01 - - - - 2 5 - - 
Latvia 1 0.05 - - - - 1 2 2 0 
Netherlands 4 0.02 - - - - 4 11 1 0 
Poland 31 0.08 - - - - 31 244 147 9 
Portugal 4 0.04 4 52 2 0 - - - - 
Slovenia 1 0.05 1 105 0 0 - - - - 
Spain 15 0.03 6 439 4 1 9 1,113 3 1 
Sweden 3 0.03 1 118 - - 2 17 - - 
United Kingdom 5 0.01 4 62 3 1 1 17 0 0 
EU Total 172 0.03 54 1,729 17 2 118 2,527 168 10 
Iceland 1 0.31 1 25 0 0 - - - - 
Norway 2 0.04 1 78 0 0 1 1 0 0 
Note: Data include outbreaks caused by Clostridium botulinum, Clostridium perfringens and Clostridium spp., unspecified. 
 
EU summary report on zoonoses, zoonotic agents and 
food-borne outbreaks 2012 
 
EFSA Journal 2014;12(2):3547 284 
Figure OUT18. Distribution of food vehicles in strong-evidence outbreaks caused by Clostridium 
toxins (including Clostridium botulinum toxins) in the EU, 2012 
 
Note: Data from 54 outbreaks are included: Denmark (8), France (25), Germany (5), Portugal (4), Slovenia (1), Spain (6), Sweden (1) 
and United Kingdom (4). 
 Other foodstuffs (N = 8) include: buffet meals (1), canned food products (1), turkey meat and products thereof (1) and other foods 
(5). 
 Number after the label refers to the number of outbreaks. 
 
C. botulinum 
In total, six outbreaks caused by C. botulinum were reported by three MSs; France, Portugal and Spain. Five 
of them, supported by strong evidence, were household outbreaks and accounted for eight human cases 
and seven hospitalisations (Table OUT10).  
Portugal reported two outbreaks without detailed information on the food vehicle. The setting was also 
reported as unknown, as were the contributory factors. In France, one outbreak was associated with a 
canned food product and one with vegetables and juices. The setting in both outbreaks was 
household/domestic kitchen, and contributory factors were reported as unknown. Spain reported one 
outbreak, which was associated with ’Other foods’. Contributing factors were storage time/temperature 
abuses, inadequate heat treatment and inadequate chilling. 
No outbreaks due to C. botulinum, with either strong or weak evidence, were reported by non-MSs (Table 
OUT10). 
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Table OUT10. Strong-evidence food-borne outbreaks caused by Clostridium botulinum toxins in the 
EU, 2012 
Country 
Strong-evidence outbreaks 
N 
Human cases 
Cases Hospitalised Deaths 
France 2 4 4 0 
Portugal 2 2 2 0 
Spain 1 2 1 0 
EU Total 5 8 7 0 
4.8. Staphylococcal enterotoxins 
Fourteen MSs reported 346 outbreaks caused by staphylococcal toxins, representing 6.4 % of all outbreaks 
reported in the EU. This is similar to 2011, when 345 outbreaks were reported. As in 2011, the overall 
reporting rate was 0.07 per 100,000. The highest number of outbreaks was reported by France, 
300 (86.7 %), even though, for most of these outbreaks (291), only weak evidence was provided. One case 
fatality was reported by France in one weak-evidence outbreak (Table OUT11). No non-MS reported an 
outbreak.  
Thirty-five (10.1 %) of the outbreaks were strong-evidence outbreaks, reported by nine MSs. The majority of 
these, 57.1 %, were reported by Spain and France. All strong-evidence outbreaks accounted for 497 cases, 
of whom 88 (17.7 %) were hospitalised, but no case fatalities were reported (Table OUT11). 
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Table OUT11. Strong- and weak-evidence food-borne outbreaks caused by staphylococcal toxins in the EU, 2012 
Country 
Total outbreaks Strong-evidence outbreaks Weak-evidence outbreaks 
N 
Reporting 
rate per 
100,000 
N 
Human cases 
N 
Human cases 
Cases Hospitalised Deaths Cases Hospitalised Deaths 
Belgium 4 0.04 4 39 1 0 - - - - 
Denmark 1 0.02 1 68 0 0 - - - - 
Finland 2 0.04 1 2 0 0 1 4 0 0 
France 300 0.46 9 92 6 0 291 1,842 175 1 
Germany 3 <0.01 3 12 3 0 - - - - 
Italy 1 <0.01 - - - - 1 22 - - 
Latvia 1 0.05 - - - - 1 18 15 0 
Netherlands 2 0.01 - - - - 2 5 0 0 
Poland 5 0.01 3 105 54 0 2 45 2 0 
Portugal 2 0.02 2 43 0 0 - - - - 
Romania 1 <0.01 1 66 24 0 - - - - 
Slovakia 2 0.04 - - - - 2 6 1 0 
Spain 20 0.04 11 70 0 0 9 89 6 0 
Sweden 2 0.02 - - - - 2 4 1 - 
EU Total 346 0.07 35 497 88 0 311 2,035 200 1 
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Detailed information from strong-evidence Staphylococcus enterotoxin outbreaks 
The first most frequently single food category reported was mixed foods (31.4 %) (Figure OUT19), followed 
by cheese (20.0 %). 
The type of outbreak was provided for 34 outbreaks: 26 were general outbreaks and eight were household 
outbreaks. The most commonly reported settings were restaurant, café, pub, bar, hotel (11 outbreaks), 
followed by household/domestic kitchen in nine outbreaks. 
Many contributory factors, either alone or in combination, were reported in these outbreaks. These include 
storage time/temperature abuses (in four outbreaks), inadequate chilling (in three outbreaks), inadequate 
heat treatment (in two outbreaks), an infected food handler (in two outbreaks) and unprocessed 
contaminated ingredient (in one outbreak). For 20 outbreaks, contributory factors were reported as unknown.  
 
Figure OUT19. Distribution of food vehicles in strong-evidence outbreaks caused by staphylococcal 
toxins in the EU, 2012 
 
 
Note:  Data from 35 outbreaks are included: Belgium (4), Denmark (1), Finland (1), France (9), Germany (3), Poland (3), Portugal (2), 
Romania (1) and Spain (11).  
 Other foodstuffs (N = 12) include: bovine meat and products thereof (1), buffet meals (1), crustaceans, shellfish, molluscs and 
products thereof (1), eggs and egg products (1), meat and product thereof, unspecified (1), milk (1), other or mixed red meat and 
products thereof (1), poultry meat and products thereof (1) and other foods (4). 
 Number after the label refers to the number of outbreaks. 
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4.9. Viruses 
Twenty MSs reported a total of 752 food-borne outbreaks caused by viruses (Table OUT12), excluding four 
strong-evidence waterborne outbreaks (Table OUT16). This represents 14.0 % of all outbreaks reported in 
the EU and an increase of 44.3 % compared with 2011 (521 outbreaks). At the national level, a substantial 
increase in the number of outbreaks due to viruses was observed in Latvia (29 outbreaks in 2011, compared 
with 311 in 2012). The overall reporting rate in the EU was 0.15 outbreaks per 100,000 population. Latvia 
reported the majority of the outbreaks (41.4 %), followed by Poland (17.8 %). One case fatality was reported 
by France in one weak-evidence outbreak (Table OUT12). In addition, two non-MSs reported 15 outbreaks. 
Only 13.4 % (101) of reported viral outbreaks had strong evidence, and these were reported by 12 MSs 
(Table OUT12). Denmark reported 32.7 % of all virus strong-evidence outbreaks in the EU. The proportion of 
total outbreaks with strong evidence within each country varied greatly amongst the MSs; the lowest rate 
was reported by Slovakia (1.1 %), whereas Belgium and Slovenia reported the highest proportion (100 %). 
One non-MS reported one viral strong-evidence outbreak (Table OUT12). 
Of particular note was one strong-evidence norovirus outbreak, reported by Germany, in which 
10,950 people were affected and 38 hospitalised. This outbreak was reported as having school/kindergarten 
as a setting and was associated with one batch of frozen strawberries from China mainly distributed through 
one big catering company.  
Two deaths associated with calicivirus were reported, one in an outbreak in the United Kingdom and one in 
an outbreak in Sweden. In the United Kingdom, the outbreak was associated with raw oysters, was linked to 
a restaurant and affected six people. In Sweden, the outbreak was also linked to a restaurant and was 
associated with cabbage. This outbreak affected 27 people. A likely contributory factor to the latter outbreak 
was an infected food handler. 
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Table OUT12. Strong- and weak-evidence food-borne outbreaks caused by viruses (excluding strong-evidence waterborne outbreaks) in the EU, 2012 
Country 
Total outbreaks Strong-evidence outbreaks Weak-evidence outbreaks 
N 
Reporting 
rate per 
100,000 
N 
Human cases 
N 
Human  cases 
Cases Hospitalised Deaths Cases Hospitalised Deaths 
Austria 3 0.04 - - - - 3 49 1 0 
Belgium 9 0.08 9 110 0 0 - - - - 
Czech Republic 1 0.01 - - - - 1 36 2 0 
Denmark 46 0.82 33 1,021 2 0 13 435 8 0 
Finland 12 0.22 8 404 2 0 4 50 1 0 
France 48 0.07 14 303 8 0 34 640 37 1 
Germany 37 0.05 8 11,058 68 0 29 134 18 0 
Greece 1 0.01 - - - - 1 23 17 0 
Hungary 8 0.08 - - - - 8 336 21 0 
Ireland 1 0.02 - - - - 1 60 0 0 
Italy 1 <0.01 - - - - 1 12 - - 
Latvia 311 15.23 - - - - 311 1,099 105 0 
Malta 2 0.24 - - - - 2 23 0 0 
Netherlands 12 0.07 6 202 0 0 6 108 0 0 
Poland 134 0.35 3 96 28 0 131 2,000 427 0 
Slovakia 88 1.63 1 12 12 0 87 374 223 0 
Slovenia 2 0.10 2 58 0 0 - - - - 
Spain 13 0.03 8 263 2 0 5 252 2 0 
Sweden 11 0.12 2 149 - 1 9 510 1 - 
United Kingdom 12 0.02 7 177 0 1 5 169 0 0 
EU Total 752 0.15 101 13,853 122 2 651 6,310 863 1 
Iceland 2 0.63 - - - - 2 28 - - 
Norway 13 0.26 1 41 0 0 12 363 0 0 
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Table OUT13. Strong-evidence food-borne outbreaks caused by viruses (excluding strong-evidence 
waterborne outbreaks) in the EU, 2012 
Agent Country 
Strong-evidence outbreaks 
N 
Human cases 
Cases Hospitalised Deaths 
Calicivirus - norovirus (Norwalk-like virus) 
Belgium 9 110 0 0 
Denmark 33 1,021 2 0 
Finland 8 404 2 0 
France 12 269 1 0 
Germany 7 10,976 39 0 
Netherlands 6 202 0 0 
Poland 3 96 28 0 
Slovenia 2 58 0 0 
Spain 8 263 2 0 
Sweden 2 149 - 1 
United Kingdom 7 177 0 1 
EU Total 97 13,725 74 2 
Norway 1 41 0 0 
Flavivirus 
Slovakia 1 12 12 0 
EU Total 1 12 12 0 
Hepatitis virus - Hepatitis A virus 
France 2 34 7 0 
Germany 1 82 29 0 
EU Total 3 116 36 0 
 
 
 
 
Detailed information from strong-evidence virus outbreaks 
Of the 101 strong-evidence outbreaks due to viruses, four were caused by viruses other than calicivirus. One 
outbreak reported by Slovakia was caused by flavivirus and accounted for 12 human cases, all of whom 
were admitted to the hospital. This outbreak was classified as a household outbreak, in a household setting, 
and was associated with the consumption of cheese. Inadequate heat treatment contributed to this outbreak 
and the place of origin of the problem was a farm.  
Three outbreaks of hepatitis A were reported. All were general outbreaks. In one outbreak, reported by 
Germany, food vehicles were various bakery products consumed in different households. The causative 
agent was detected on different surfaces in the bakery. Contributory factors were infected food handler and 
cross-contamination.  
Two outbreaks of hepatitis A were reported by France. Both implicated ‘other foods’ and contributory factors 
were unknown. The setting in one outbreak was restaurant, café, pub, bar, hotel and eight people were 
affected and six hospitalised. The second outbreak accounted for 26 human cases and one hospitalisation; 
the setting was not specified. 
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Caliciviruses (including norovirus) 
A total of 97 strong-evidence food-borne outbreaks, caused by calicivirus, were reported by 11 MSs 
(Table OUT13). Of these, 83 were reported as general outbreaks and 13 were characterised as household 
outbreaks. No information on type was provided for one outbreak.  
Information on the food vehicle was provided for all of the strong-evidence outbreaks caused by caliciviruses. 
The distribution of food vehicles for these outbreaks was split between mixed food (33.0 %), buffet meals 
(20.6 %), crustaceans, shellfish and molluscs (16.5 %), and vegetables, juices and products thereof (10.3 %) 
(Figure OUT20). The two fatal cases were associated with the consumption of raw oysters and cabbage. 
The most commonly reported settings for the virus outbreaks were restaurant, café, pub, bar or hotel 
(33 outbreaks), but other settings were also identified, including household/domestic kitchen (nine) 
schools/kindergarten (six outbreaks), canteen or workplace (five outbreaks), hospital/care homes (two 
outbreaks) and temporary mass catering establishments (two outbreaks).   
Many contributory factors, either alone or in combination, were reported in 66 outbreaks; among the most 
common was infected food handlers (42 outbreaks). 
Four strong-evidence waterborne outbreaks were also reported: three attributable to calicivirus (including 
norovirus) and one to rotavirus (Table OUT16). 
 
 
Figure OUT20. Distribution food vehicles in strong-evidence outbreaks caused by calicivirus, 
including norovirus (excluding strong-evidence waterborne outbreaks) in the EU, 2012 
 
Note: Data from 97 outbreaks are included: Belgium (9), Denmark (33), Finland (8), France (12), Germany (7), Netherlands (6), Poland 
(3), Slovenia (2), Spain (8), Sweden (2) and United Kingdom (7). 
 Other foods (N = 7) include: broiler meat and products thereof (1), cheese (2), eggs and egg products (1), pig meat and products 
thereof (1) and other foods (2). 
 Number after the label refers to the number of outbreaks. 
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4.10. Parasites  
A total of 37 food-borne outbreaks caused by parasites were reported by 11 MSs, excluding one strong- 
evidence waterborne outbreak, compared with 30 outbreaks by parasites in 2011. These outbreaks 
accounted for 0.7 % of food-borne outbreaks reported in 2012. The majority of the outbreaks (25) were 
caused by Trichinella (67.6 %). Only 13 of these outbreaks were supported by strong evidence, and the 
majority of these outbreaks (nine) were caused by Trichinella and reported by two MSs (eight by Romania 
and one by Spain). Identification of the agent species was provided in four outbreaks (T. spiralis).  
For the nine strong-evidence Trichinella outbreaks reported, two were classified as general and the other 
seven as household.  Seven were linked to consumption of pig meat, one with wild boar meat and one with 
unspecified meat and meat products thereof. The setting for all outbreaks was household, and 48 people 
were affected, of whom 37 were hospitalised. The contributory factor listed for eight outbreaks was 
inadequate heat treatment and for one outbreak the contributing factor was reported as unknown.  
Two food-borne strong-evidence outbreaks, caused by Cryptosporidium spp., were reported by two MSs, 
Finland and the United Kingdom. In the Finnish outbreak, 264 people were affected and salad, served in five 
different restaurants in four towns, was suspected as having caused the outbreak. Some samples from 
affected cases were positive for Cryptosporidium spp. Trace-back investigations found that salad was the 
common food source served in all of the restaurants.  An outbreak that occurred in the United Kingdom also 
implicated salad (loose leaf salad) and resulted in 305 cases. Contributing factors were unknown.  
In addition, an outbreak of Giardia intestinalis (also known as Giardia lamblia) was reported by the United 
Kingdom and was associated with mixed food, probably salads. Five people were affected and the setting 
was workplace catering or canteen. An infected food handler was a contributing factor.  
One Anisakis outbreak was reported by Spain. This was a general outbreak, linked to consumption of fish 
and fish products, and affected six people.  
One strong-evidence waterborne outbreak attributable to Cryptosporidium parvum was also reported 
(Table OUT16). 
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4.11. Other causative agents 
In this report the category ‘other causative agents’ includes histamine, marine biotoxins, mushroom toxins, 
mycotoxins and atropine as well as unspecified toxins. 
Twelve MSs reported a total of 137 food-borne outbreaks due to other causative agents (Table OUT14). This 
represents 2.6 % of all outbreaks reported at EU level and an increase of 21.2 % compared with 2011 
(113 outbreaks). This increase is mainly due to an increased number of outbreaks reported by France (43 in 
2011 compared with 82 in 2012). The reporting rate was 0.03 per 100,000 population, with the highest rate 
reported by Malta (0.48). France and Spain together reported 78.8 % of these outbreaks. In addition, one 
non-MS reported one outbreak (Table OUT14). 
In total, 62 strong-evidence outbreaks were reported by 10 MSs, and 69.4 % of these outbreaks were 
reported by France and Spain.  
Detailed information from strong-evidence outbreaks 
The majority (54.8 %) of strong-evidence outbreaks due to other causative agents were caused by histamine 
and accounted for 50.4 % of human cases and 35.9 % of hospitalisations reported in these outbreaks. Other 
agents included marine biotoxins (29.0 %), mushroom toxins (11.3 %), mycotoxins (3.2 %), and atropine 
(1.6 %) (Table OUT15). The majority (75.8 %) were associated with consumption of fish and fishery products 
(Figure OUT21).  
Histamine   
All 34 outbreaks were linked to fish and fish products. The majority of outbreaks, 30, were general and only 
four were household outbreaks. The main setting was reported as restaurant, café, pub, hotel (in 
17 outbreaks) followed by canteen/workplace (four outbreaks) and school/kindergarten (three outbreaks). 
The main contributory factor, either alone or in combination, was storage time/temperature abuses 
(10 outbreaks).  
Marine biotoxins 
Of the 18 outbreaks reported, the main food vehicle implicated in the outbreaks was fish and fish products 
(72.2 %). Crustaceans, shellfish, molluscs and products thereof were implicated in the remaining outbreaks 
(five outbreaks). Nine outbreaks were household and nine were general. The main setting was 
household/domestic kitchen in 10 outbreaks, followed by restaurant, café, pub, bar, hotel, in five outbreaks. 
Contributory factors were reported as unknown in 15 outbreaks. An unprocessed contaminated ingredient 
was reported as a contributory factor in two outbreaks. 
Mushroom toxins  
One outbreak associated with mushroom toxins was reported by Poland. This was a household outbreak 
associated with the consumption of Amanita phalloides and the setting was household/domestic kitchen. 
Three persons were affected, all admitted to hospital. Spain reported six outbreaks: all were household 
outbreaks and all implicated vegetables, juices and products thereof. In one of them, a fatal case was 
reported. 
Mycotoxins 
Two general outbreaks, reported by Denmark, were associated with lectin through consumption of 
vegetables. The settings for these outbreaks were restaurant, café, pub, bar, hotel.  
Atropine  
France reported one outbreak due to atropine. This was a household outbreak and associated with 
consumption of mixed food. The setting was household/domestic kitchen.   
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Table OUT14. Strong- and weak-evidence food-borne outbreaks caused by other causative agents in the EU, 2012 
Country 
Total outbreaks Strong-evidence outbreaks Weak-evidence outbreaks 
N 
Reporting 
rate per 
100,000 
N 
Human cases 
N 
Human cases 
Cases Hospitalised Deaths Cases Hospitalised Deaths 
Belgium 6 0.05 6 138 2 0 - - - - 
Denmark 5 0.09 5 35 1 0 - - - - 
Finland 1 0.02 - - - - 1 28 0 0 
France 82 0.13 26 111 9 0 56 198 22 0 
Germany 1 <0.01 1 - - - - - - - 
Latvia 1 0.05 1 16 - 0 - - - - 
Malta 2 0.48 - - - - 2 8 0 0 
Poland 2 0.01 1 3 3 0 1 2 2 1 
Slovenia 1 0.05 1 3 1 0 - - - - 
Spain 26 0.06 17 150 20 1 9 58 3 0 
Sweden 7 0.07 2 15 . . 5 10 - - 
United Kingdom 3 <0.01 2 7 3   1 3 0 0 
EU Total 137 0.03 62 478 39 1 75 307 27 1 
Norway 1 0.02 - - - - 1 2 0 0 
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Table OUT15. Strong-evidence food-borne outbreaks caused by other causative agents in the EU, 
2012 
Agent Country 
Strong-evidence outbreaks 
N 
Human cases 
Cases Hospitalised Deaths 
Histamine 
Belgium 4 28 2 0 
Denmark 3 9 1 0 
France 13 62 6 0 
Latvia 1 16 - 0 
Slovenia 1 3 1 0 
Spain 8 101 1 0 
Sweden 2 15 - - 
United Kingdom 2 7 3 0 
EU Total 34 241 14 0 
Marine biotoxins 
Belgium 2 110 0 0 
France 12 47 1 0 
Germany 1 - - - 
Spain 3 27 1 0 
EU Total 18 184 2 0 
Mushroom toxins 
Poland 1 3 3 0 
Spain 6 22 18 1 
EU Total 7 25 21 1 
Mycotoxins 
Denmark 2 26 0 0 
EU Total 2 26 0 0 
Atropine 
France 1 2 2 0 
EU Total 1 2 2 0 
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Figure OUT21. Distribution food vehicles in strong-evidence outbreaks caused by other causative 
agents in the EU, 2012 
 
Note: Data from 62 outbreaks are included: Belgium (6), Denmark (5), France (26), Germany (1), Latvia (1), Poland (1), Slovenia (1), 
Spain (17), Sweden (2) and United Kingdom (2). 
 Number after the label refers to the number of outbreaks. 
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4.12. Unknown agents 
Nineteen MSs reported 1,478 outbreaks in 2012 (27.6 % of all outbreaks) in which the causative agent was 
unknown (Table OUT3), excluding one strong-evidence waterborne outbreak. This represents a decrease of 
26.9 % in the proportion of total outbreaks due to unknown agents compared with 2011 (N = 2,022). Of 
these, 51 were supported by strong evidence (6.7 % of all strong-evidence outbreaks).   
One strong-evidence waterborne outbreak attributable to an unknown agent was also reported 
(Table OUT16). 
 
4.13. Waterborne outbreaks  
Waterborne outbreaks may potentially be large, especially if the public drinking water supply is 
contaminated.  
In waterborne outbreaks, several zoonotic agents are often detected in the water as well as in human 
samples as a result of unspecific contamination, e.g. with sewage water.   
In 2012, four MSs reported 16 strong-evidence waterborne outbreaks involving 1,113 human cases, of whom 
eight were hospitalised (Table OUT16). No deaths were reported. Four different pathogens were detected 
from these 16 outbreaks: calicivirus, verotoxigenic E. coli, Cryptosporidium parvum and rotavirus. There was 
one waterborne outbreak in which the causative agent was unknown. 
All 10 VTEC outbreaks were reported by Ireland, and seven were reported to be linked to private water 
supplies or wells. 
Water treatment failure was listed as a contributory factor in four general outbreaks. The largest outbreak 
occurred in Greece and affected 552 people, of whom two were hospitalised (see box below).   
 
In March 2012, a gastroenteritis outbreak was notified in a district with 37,264 inhabitants in central Greece.  
Consumption of tap water was a risk factor for acquiring infection (odds ratio (OR) 2.18, 95% (CI) 1.11–4.28). 
Descriptive data on low gastroenteritis incidence in adjacent areas with different water supply systems, and 
water-quality data further supported the hypothesis of a waterborne outbreak. Thirty-eight stool samples 
were positive for rotavirus. Bacterial indicators of recent faecal contamination were detected in samples from 
the water source and ice cubes from a local production enterprise. Molecular epidemiology of rotavirus 
strains, apart from the common strain, G3[P8], identified the unusual G/P combination G2P[8].  
A paper regarding this outbreak investigation can be found at:  
http://www.ncbi.nlm.nih.gov/pubmed/23632123. 
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Table OUT16. List of reported strong-evidence waterborne outbreaks in the EU, 2012 
Agents Country Setting 
Strong-evidence outbreaks 
Additional information 
N Cases Hospitalised Deaths 
Calicivirus - norovirus (Norwalk-
like virus) 
Denmark   1 183 0 0 
Contaminated drinking water after repairment 
work on a water pipe 
Greece School, kindergarten 1 79 0 0 Tap water in a primary school 
Calicivirus - sapovirus (Sapporo-
like virus) 
Finland 
Household/domestic 
kitchen 
1 225 0 0 Water distribution system 
Cryptosporidium - C. parvum Ireland Disseminated cases 1 11 3 0 Treated public surface water supply 
Escherichia coli, pathogenic - 
Verotoxigenic E. coli (VTEC) - 
VTEC O157 
Ireland 
Household/domestic 
kitchen 
2 2 1 0   
Household/domestic 
kitchen 
1 2 - - Private water supply 
Disseminated cases 1 27 - - Treated well water 
Household/domestic 
kitchen 
3 3 2 0 Well water 
Other setting 1 6 0 0 Well, untreated ground water 
Escherichia coli, pathogenic - 
Verotoxigenic E. coli (VTEC) - 
VTEC O26 
Ireland 
Household/domestic 
kitchen 
1 1 0 0   
Household/domestic 
kitchen 
1 2 - 0 Well, ground water 
Rotavirus Greece 
Household/domestic 
kitchen 
1 552 2 0 
Treated tap water from a rural area’s water supply 
system 
Unknown Finland 
Household/domestic 
kitchen 
1 20 0 0   
EU Total     16 1,113 8 0   
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4.14. Discussion  
In 2012, a total of 5,363 food-borne outbreaks were reported by 25 MSs, representing a decrease of 5.0 % 
compared with 2011 (5,648 outbreaks). The main causative agents in these outbreaks in 2012 were 
Salmonella, bacterial toxins, viruses and Campylobacter.  
In 2012, a slight increase was observed in the number of outbreaks caused by Salmonella, after a decline 
from 2008 to 2011. Compared with the previous year, the number of outbreaks due to viruses increased, and 
these are now classified as the third most frequently reported causative agents (they were ranked fourth in 
2011). However, the increase in numbers of virus outbreaks is mainly related to the reporting from one MS. 
On the other hand, the number of outbreaks due to Campylobacter decreased in 2012, even though only few 
countries reported fewer outbreaks than the previous year. Outbreaks caused by pathogenic Escherichia coli 
also decreased compared with 2011. It is noteworthy that in 2012 fewer outbreaks due to unknown causative 
agents were reported than in the previous year. 
The food vehicle categories most frequently implicated in strong-evidence outbreaks were eggs and egg 
products, followed by mixed food, and fish and fish products, as in 2011. Interestingly, strong-evidence 
outbreaks associated with cheese increased significantly. The majority of these outbreaks were reported by 
one MS. Additional information on the type of cheese implicated and/or contributing factors was provided in 
three outbreaks. One outbreak, caused by staphylococcal enterotoxin, was associated with goat milk 
cheese. Storage time/temperature abuses were listed as contributing factors. Another MS reported an 
outbreak of flavivirus associated with inadequate heat treatment of cheese at a farm. In one outbreak of 
listeriosis implicating cheese, an infected food handler was reported as a contributory factor. Outbreaks 
associated with sweets and chocolate decreased compared with the previous year. However, in 2011 all 
sweets and chocolate-related outbreaks were reported by a single MS.  
The majority of outbreaks implicating eggs and egg products and cheese were caused by Salmonella spp. Of 
note is the fact that the proportion of Salmonella outbreaks associated with cheese increased considerably. 
However, all these outbreaks were reported by one MS. Contributing factors in all of these outbreaks were 
reported as ‘unknown’ and the type of cheese was not reported 
Broiler meat was the main food vehicle implicated in Campylobacter outbreaks. This is consistent with 
EFSA’s BIOHAZ Panel Scientific Opinion that handling, preparation and consumption of broiler meat may 
account for 20-30 % of human cases. The majority of outbreaks associated with raw/unpasteurised milk were 
caused by Campylobacter. Of note is the fact that farm was the place of origin of the problem reported in 
most of these outbreaks, reinforcing the need to educate consumers about the risks of drinking 
unpasteurised milk. 
The largest food-borne outbreak in terms of number of human cases in 2012 was a norovirus outbreak, in 
which 10,950 people were affected. This was associated with one batch of frozen strawberries imported from 
a non–EU country.  
The number of reported strong-evidence waterborne outbreaks increased compared with 2011. Most of 
these outbreaks were associated with private water/well water supplies. 
As in previous years, the data reported on food-borne outbreaks demonstrate that the reporting of single or a 
small number of MSs can have a strong influence on the distribution of causative agents and food vehicles at 
EU level. It also appears that, within the MSs, there may be large differences with regard to the reported 
causative agents and implicated food vehicles between years.  
The revised food-borne outbreak reporting specifications were implemented for the third year in 2012. The 
two new evidence categories that could support the reporting of a detailed dataset (i.e. a strong-evidence 
outbreak) are descriptive epidemiological evidence and the detection of the causative agent in the food chain 
or its environment. Similar to 2010 and 2011 reporting, approximately one-third of the strong-evidence 
outbreaks in 2012 were supported only by these new evidence categories. Approximately one-third were 
supported by analytical evidence. This shows that the MSs had implemented the revised reporting 
specifications and that these specifications had an impact on the reported outbreaks. The number of 
outbreaks in which a detailed dataset was provided increased compared with 2011 (763 in 2012 compared 
with 701 in 2011). Also, these outbreaks as a proportion of the total number of outbreaks reported increased 
compared with the previous year (14.2 % in 2012 compared with 12.4 % in 2011). 
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5.  MATERIALS AND METHODS 
5.1. Data received in 2012 
Human data 
The human data analyses in the EU Summary Report for 2012 were prepared by the Food- and Waterborne 
Diseases and Zoonoses programme at the ECDC and were based on the data submitted to the TESSy, 
hosted at ECDC. Please note that the numbers presented in the report may differ from national reports owing 
to differences in case definitions used at EU and national level or to different dates of data submission and 
extraction. The latter may also result in some divergence in case numbers presented in different ECDC 
reports. 
TESSy is a software platform that has been operational since April 2008 and in which data on 52 diseases 
and special health issues are collected. Both aggregated and case-based data were reported to TESSy. 
Although aggregated data did not include individual case-based information, both reporting formats were 
included where possible to calculate country-specific notification rates, case-fatality rates, proportion of 
hospitalised cases and trends in diseases. Human data used in the report were extracted from TESSy on 
3 September 2013 with the following exceptions: campylobacteriosis 10 September; West Nile fever and 
tuberculosis due to M. bovis 1 October. The denominators used for the calculation of the notification rates 
were the human population data from EUROSTAT as extracted on 28 June 2013. 
Data on human zoonoses cases were received from all 27 MSs and also from 2 non-MSs: Iceland and 
Norway. Switzerland sent its data on human cases directly to EFSA. 
Data on foodstuffs, animals and feedingstuffs 
All MSs submitted national zoonoses reports for 2012. In addition, reports were submitted by the three non-
MSs, Iceland, Norway and Switzerland. For the eighth consecutive year, countries submitted data on 
animals, food, feed and food-borne outbreaks using a web-based zoonoses reporting system maintained by 
EFSA. In addition, many countries submitted their data electronically, through the DCF. 
In 2012, data were collected on a mandatory basis on the following eight zoonotic agents: Salmonella, 
thermotolerant Campylobacter, L. monocytogenes, VTEC, M. bovis, Brucella, Trichinella and Echinococcus. 
Mandatory reported data also included antimicrobial resistance in isolates of Salmonella and Campylobacter, 
food-borne outbreaks and susceptible animal populations. Furthermore, based on epidemiological situations 
in each MS, data were reported on the following agents and zoonoses: Yersinia, Lyssavirus (rabies), 
Toxoplasma, Cysticercus, Sarcocystis, Coxiella burnetii (Q fever), West Nile virus, Francisella, 
Staphylococcus, Anisakis and antimicrobial resistance in indicator E. coli and enterococci isolates. Finally, 
data concerning compliance with microbiological criteria were also reported on the staphylococcal 
enterotoxins, Enterobacter sakazakii (Cronobacter spp.) and histamine. 
In this report, data are presented on the eight mandatory zoonotic agents, except Echinococcus, and also on 
rabies, Toxoplasma, Q fever, West Nile virus, Francisella, Anisakis, Cysticercus and Sarcocystis. 
For each pathogen, an overview table presenting all MSs reporting data is included in the beginning of each 
chapter. However, for the detailed tables, data from industry own-control programmes and HACCP sampling 
and, unless stated otherwise, data from suspect sampling, selective sampling and outbreak or clinical 
investigations are excluded. The general rule is to exclude data from investigations with a sample size of 
fewer than 25 units. Exceptions to this rule are data from investigations presented in the following tables: 
compliance with the food safety criteria for Salmonella and Listeria; Salmonella in poultry species in 
countries implementing control programmes; number of tested animals and positive cases of rabies in 
domestic animals, wildlife species and bats; Trichinella in farmed and hunted wild boar and in wildlife other 
than wild boar; West Nile virus and all food-borne outbreak data. 
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5.2. Statistical analysis of trends over time 
Human data 
Routine surveillance data from TESSy were used to describe two components of the temporal pattern 
(secular trend and seasonality) of human zoonoses cases for the EU and by MS.  
Only confirmed human cases (with the exception of West Nile Fever, for which total numbers of cases were 
used) reported consistently by MSs, throughout the study period 2008–2012, were included in the time series 
analysis. Diseases were analysed either by week or by month, depending on the number of data available. 
Consequently, campylobacteriosis, listeriosis and salmonellosis were analysed by week and brucellosis, 
Q fever and West Nile fever by month. Of the date variables available (date of onset, date of diagnosis, etc.), 
the date chosen by the MS as the official ‘date used for statistics’ was selected.  
For assessing the temporal trends at EU level and by MS, moving averages were applied. Linear regression 
was applied where appropriate to test the significance of trends.  
The level of statistical significance was set at 5 %. All analyses were performed using Stata® 12. 
Data on animals 
In the current report, temporal trends have been statistically analysed for Salmonella in fresh broiler meat 
(single samples). MS-group-weighted prevalence figures were estimated by weighting the MS-specific 
proportion of positive units with the reciprocal of the sampling fraction. The reciprocal is the ratio of ‘the total 
number of units per MS per year’ to the ‘number of tested units in the MS per year’. For broiler meat, the 
‘total number of units per MS per year’ was the number of slaughtered broilers reported by MSs in the 
framework of the 2008 baseline survey in broiler flocks and broiler carcases. These numbers were 
supplemented with EUROSTAT data from 2008 as appropriate. 
In order to obtain yearly estimates of the weighted prevalence for groups of examined MSs, the 
SURVEYLOGISTIC procedure in the Statistical Analysis System (SAS) was used. The weight was applied in 
order to take into account disproportionate sampling at MS level. The statistical significance of trends was 
tested by a weighted logistic regression for binomial data using the GENMOD procedure in the SAS 
software, at a 5 % significance level. As non-independence of observations within each MS could not be 
excluded, for example because of the possibility of sampling animals belonging to the same holdings, the 
REPEATED statement was used. This yielded inflated standard errors for the effect of the year of sampling, 
reducing the probability of detecting significant time trends, and corresponding to a conservative approach to 
statistical analyses.  
Changes in the proportions of positive units (trend watching) for zoonotic agents in food and animals during 
the time period from 2004 to 2012 were visually explored for each MS by trellis graphs using the lattice 
package in the R software (www.r-project.org). Specifically, trellis graphs have been presented for 
Salmonella in fresh broiler meat (single and batches samples); for the target Salmonella serovars in the 
different poultry species; for bovine tuberculosis; and for brucellosis in cattle and small ruminants in the MSs 
with a co-financed control and eradication programme. 
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5.3. Cartographic representation of data 
Human data 
ArcGIS from ESRI was used to map human data. Each map contains three different indicators: notification 
rate of the disease per 100,000 inhabitants, origin of infection and number of cases. Choropleth maps with 
graduated colours were used to map incidence rates across EU countries. Zero incidence, whenever 
reported, was reflected on the map as a category. Countries for which no data were available and countries 
not included within the area of interest were also represented. Pie charts were created to indicate the origin 
of infection of the disease. Each pie chart contains three categories: domestic, travel-associated and missing 
or unknown origin. An exception was made for tuberculosis due to M. bovis because of its often very long 
incubation time. In this case the categories considered have been native origin, foreign origin and missing or 
unknown. Their symbolisation, however, is identical to the other diseases to allow the comparability between 
maps, and to keep their homogeneity. Pie chart sizes are proportional to the number of cases they represent. 
Animal data 
ArcGIS from ESRI was used to map animal data. Choropleth maps with graduated colours over a continuous 
scale of values were used to map the proportion of positive samples across EU and other reporting 
countries.  
For Lyssavirus and West Nile Virus the number of positive samples, rather than the proportion, was 
displayed using proportional circles, while for Trichinella in wild animals a simple absence/presence map was 
produced. 
For disease status data a simple colour code was selected to represent the official status of each country as 
defined in the legislation (free or not free). 
5.4. Data sources 
In the following sections, the types of data submitted by the reporting countries are briefly described. 
Information on human surveillance systems is based on the countries reporting data to ECDC for 2012. 
5.4.1. Salmonella data 
Humans 
The notification of non-typhoidal salmonellosis in humans is mandatory in most MSs, Iceland, Norway and 
Switzerland, except for six MSs, where reporting is based on a voluntary system (Belgium, France, 
Luxembourg, the Netherlands and Spain) or other system (the United Kingdom). In the United Kingdom, 
although the reporting of food poisoning is mandatory, isolation and specification of the organism is 
voluntary. The surveillance systems for salmonellosis have full national coverage in all MSs except three 
(Belgium, the Netherlands and Spain). The coverage in Spain is estimated to be 25 % and in the 
Netherlands 64 %. These proportions of populations were used in the calculation of notification rates for 
Spain and the Netherlands. Studies are being performed in Belgium to assess the coverage of the sentinel 
system. Diagnosis of human Salmonella infections is generally done by culture from human stool samples. 
The majority of countries perform serotyping of strains
66
. 
Foodstuffs 
Salmonella in food is notifiable in 17 MSs (Austria, Belgium, Bulgaria, the Czech Republic, Denmark, 
Estonia, Finland, France, Germany, Hungary, Italy, Latvia, Romania, Slovakia, Slovenia, Spain and Sweden) 
and in 2 non-MSs, Norway and Iceland. Information was not provided from Cyprus, Greece, Lithuania, 
Luxembourg, Malta, the Netherlands, Poland, Portugal or Switzerland. 
Commission Regulation (EC) No 2073/2005 on microbiological criteria for foodstuffs lays down food safety 
criteria for Salmonella in several specific food categories. This Regulation came into force in January 2006 
and was modified by Regulation (EC) No 1441/2007, entering into force in December 2007. Sampling 
schemes for monitoring Salmonella in foodstuffs, e.g. place of sampling, sampling frequency and diagnostic 
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  European Centre for Disease Prevention and Control, 2012. Survey of National Reference Laboratory (NRL) capacity for six food-
and waterborne diseases in EU/EEA countries. Stockholm: ECDC; 2012, 74 pp. Available online: 
http://www.ecdc.europa.eu/en/publications/publications/survey-nrl-capacity-for-food-waterborne-agents.pdf  
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methods, vary between MSs and according to food types. For a full description of monitoring schemes and 
diagnostic methods in individual MSs, refer to the national reports. The monitoring schemes are based on 
various types of samples, such as neck skin samples, carcase swabs and meat cuttings; these samples 
were collected at slaughter, at processing plants, at meat cutting plants and at retail. Several MSs reported 
data collected as part of HACCP programmes based on sampling at critical control points. These targeted 
samples could not be directly compared with those that were randomly collected for monitoring/surveillance 
purposes and were not included in data analysis and tables. Information on serotype distribution was not 
consistently provided by all MSs.  
Animals 
Salmonella in Gallus gallus (fowl) and/or other animal species is notifiable in all MSs, except for Hungary, 
and also in three non-MSs (Iceland, Norway and Switzerland). In Denmark, detection of Salmonella is 
notifiable in broiler and laying hen flocks of Gallus gallus and in other animals. In France, Salmonella 
detection is mandatory only for breeding flocks and laying hens of Gallus gallus, and in Malta for broilers and 
laying hen flocks of Gallus gallus. In Poland and in Romania, the notification of Salmonella is mandatory only 
in poultry (only for findings of Salmonella Enteritidis (S. Enteritidis), S. Typhimurium, S. Pullorum and 
S. Gallinarum in Poland and for findings of S. Enteritidis, S. Typhimurium in Romania). 
The monitoring of Salmonella in animals is mainly conducted through passive, laboratory-based surveillance 
of clinical samples, active routine monitoring of flocks of breeding and production animals in different age 
groups, and tests on organs during meat inspection. Community Regulation (EC) No 2160/2003 prescribes a 
sampling plan for the control of S. Enteritidis, S. Typhimurium, S. Infantis, S. Virchow and S. Hadar in 
breeding flocks of Gallus gallus and for the control of S. Enteritidis and S. Typhimurium in laying hen flocks 
and broiler flocks of Gallus gallus and for turkey flocks to ensure comparability of data among MSs. Non-MSs 
(European Free Trade Association members) must also apply the Regulation in accordance with the 
Decision of the European Economic Area Joint Committee No 101/2006
67
. No specific requirements for the 
monitoring and control of other commercial poultry production systems or in other animals were applicable in 
2012. 
Details of monitoring programmes and control strategies in breeding flocks of Gallus gallus, laying hen 
flocks, broiler flocks and breeding and production turkey flocks are available in the national reports.  
Feedingstuffs 
There is no common sampling scheme for feed materials in the EU. Results from compulsory and voluntary 
monitoring programmes, follow-up investigations and industry quality assurance programmes, as well as 
from surveys, are reported. The MS monitoring programmes often include both random and targeted 
sampling of feedstuffs that are considered at risk. Samples of raw material, materials used during processing 
and final products are collected from batches of feedstuffs of domestic and imported origin. The reported 
epidemiological units were either ‘batch’ (usually based on pooled samples) or ‘single’ (often several 
samples from the same batch). As in previous years, most MSs did not report separately data from the 
different types of monitoring programmes or data from domestic and imported feed. Therefore, it must be 
emphasised that the data related to Salmonella in feedstuffs cannot be considered national prevalence 
estimates. Moreover, owing to the lack of a harmonised surveillance approach, information is not comparable 
among countries. Nevertheless, data at country level are presented in the same tables. Information was 
requested on feed materials of animal and vegetable origin and on compound feedstuffs (mixture of feed 
materials intended for feeding specific animal groups). Data on the detection of Salmonella in fish meal, feed 
material of land animal origin (further categorised as meat and bone meal, dairy products or feed of other 
origin), cereals, oil seeds and products, and compound feed for cattle, pigs and poultry in 2012 are 
presented. Single-sample and batch-based data from the different monitoring systems are summarised.  
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  Decision of the EEA Joint Committee No 101/2006 of 22 September 2006 amending Annex I (Veterinary and phytosanitary matters) 
to the EEA Agreement. OJ L 333, 30.11.2006, p. 6–9. 
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5.4.2. Campylobacter data 
Humans 
The notification of campylobacteriosis is mandatory in most MSs, Iceland, Norway and Switzerland, except 
for seven MSs, where notification is based on a voluntary system (Belgium, France, Italy, Luxembourg, the 
Netherlands and Spain) or other system (the United Kingdom). No surveillance system exists in Greece and 
Portugal. The surveillance systems for campylobacteriosis have full national coverage in all MSs except 
three (Belgium, the Netherlands and Spain). The coverage of the surveillance system is estimated to be 
25 % in Spain and 52 % in the Netherlands. These proportions of populations were used in the calculation of 
notification rates for these two MSs. Studies are being performed in Belgium to assess the coverage of the 
sentinel system. Diagnosis of human infection is generally based on culture from human stool samples and 
both culture and non-culture methods (PCR-based) are used for confirmation. The majority of MSs use 
biochemical tests for speciation of isolates submitted to the National Reference Level Laboratory. 
Foodstuffs 
In food, Campylobacter is notifiable in the following 12 MSs: Austria, Belgium, the Czech Republic, Estonia 
(only C. jejuni), Germany, Italy, Latvia, the Netherlands, Poland, Slovakia, Slovenia and Spain. 
Campylobacter is also notifiable in Iceland and Norway. Information on Campylobacter notification was not 
provided from Cyprus, France, Lithuania, Luxembourg, Malta, Portugal and Romania. Bulgaria did not test 
for Campylobacter. At processing, cutting and retail, sampling was predominantly carried out on fresh meat. 
Food samples were collected in several different contexts, i.e. continuous monitoring or control programmes, 
surveys and as part of HACCP programmes implemented within the food industry. Samples reported as 
HACCP or own controls were not included for analysis and, unless stated differently in the specific chapter, 
data from suspect and selective sampling and outbreak or clinical investigations were also excluded.  
Animals 
Campylobacter is notifiable in Gallus gallus in the Czech Republic, Finland, Slovenia, Iceland and Norway, in 
cattle in Germany and in all animals in Belgium, Estonia (only C. jejuni), Ireland, Latvia, the Netherlands, 
Spain and Switzerland. Information on Campylobacter notification was not provided from Cyprus, France, 
Lithuania, Malta and Poland. Bulgaria did not test for Campylobacter. The most frequently used methods for 
detecting Campylobacter in animals at farm, slaughter and in foodstuffs were bacteriological methods (ISO 
10272
68
 and NMKL 119
69
) as well as PCR methods. In some countries, isolation of the organism is followed 
by biochemical tests for speciation. For poultry sampled prior to slaughter, faecal material was collected 
either as cloacal swabs or as sock samples (faecal material collected from the floor of poultry houses by 
pulling gauze over footwear and walking through the poultry house). At slaughter, several types of samples 
were collected, including cloacal swabs, caecal contents and/or neck skin.  
5.4.3. Listeria data 
Humans 
The notification of listeriosis in humans is mandatory in most MSs, Iceland, Norway and Switzerland, except 
for three MSs, where notification is based on a voluntary system (Belgium, Spain, and the United Kingdom). 
No surveillance system exists in Portugal. The surveillance systems for listeriosis have full national coverage 
in all MSs except Spain, where the estimated coverage is 25 %. This population proportion was used in the 
calculation of notification rates for Spain. Diagnosis of human infections is generally done by culture from 
blood, cerebro-spinal fluid and vaginal swabs.  
Foodstuffs 
Notification of Listeria in food is required in 12 MSs (Austria, Belgium, Estonia, France, Germany, Hungary, 
Italy, Latvia, the Netherlands, Slovakia, Slovenia and Spain); however, several other MSs reported data. 
Commission Regulation (EC) No 2073/2005 on microbiological criteria for foodstuffs lays down food safety 
criteria for L. monocytogenes in RTE foods. This Regulation came into force in January 2006. Surveillance in 
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International Organization for Standardization, 2006. ISO 10272 Microbiology of food and animal feeding stuffs - Horizontal method 
for detection and enumeration of Campylobacter spp. 
69  Nordisk Metodikkomité for Næringsmidler- Nordic Committee on Food Analysis, 2007. NMKL 119. Thermotolerant Campylobacter. 
Detection, semi-quantitative and quantitative determination in foods and drinking water. 
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RTE foods was performed in most MSs. However, owing to differences in sampling and analytical methods, 
comparisons from year to year were difficult. 
Animals 
Listeriosis in animals was notifiable in 13 MSs (Belgium, the Czech Republic, Estonia, Finland, Germany, 
Greece, Latvia, Lithuania, the Netherlands, Slovakia, Slovenia, Spain and Sweden), Switzerland and Norway 
(information is missing from Bulgaria, Cyprus, Ireland, Malta and Poland). The monitoring of Listeria in 
animals is mainly conducted through passive, laboratory-based surveillance of clinical samples, active 
routine monitoring or random national surveys. 
5.4.4. VTEC data 
Humans 
The notification of VTEC infections is mandatory in most MSs, Iceland, Norway and Switzerland, except for 
five MSs, where notification is based on a voluntary system (Belgium, France, Italy and Luxembourg) or 
other system (the United Kingdom). No data were reported from Liechtenstein and no surveillance system 
exists in Portugal. The surveillance systems for VTEC infections have full national coverage in all MSs 
except three (Belgium, France and Italy). In France, the VTEC surveillance is centred on paediatric HUS 
surveillance. Diagnosis of human VTEC infections is generally done by culture from stool samples although 
diagnosis by direct detection of the toxin or the toxin genes, without strain isolation, is increasing. 
Foodstuffs and animals 
VTEC is notifiable in food in 11 MSs (Austria, Belgium, Estonia, Germany, Italy, Latvia, the Netherlands, 
Romania, Slovakia, Slovenia and Spain) and in animals in eight MSs (Belgium, the Czech Republic, Estonia, 
Finland, Latvia, Lithuania, Spain and Sweden) (information is missing from Bulgaria, Cyprus, the Czech 
Republic, Denmark, Greece, Hungary, Lithuania, Malta, Poland, Portugal and Switzerland for food, and from 
Bulgaria, Cyprus, France, Germany, Greece, Ireland, Malta, Poland, Portugal and Romania for animals).  
Samples were collected in a variety of settings, such as slaughterhouses, cutting plants, dairies, wholesalers 
and at retail level, and included different types of samples such as carcase surface swabs, cuts of meats, 
minced meat, milk, cheese, and other products. The majority of investigated products were raw but intended 
to undergo preparation before consumption. The samples were taken as part of official control and 
monitoring programmes as well as random national surveys. The number of samples collected and types of 
food sampled varied among individual MSs. Most of the animal samples were collected at the 
slaughterhouse or at the farm. 
5.4.5. Tuberculosis data  
Humans 
The notification of tuberculosis in humans is mandatory in almost all MSs, Iceland, Norway and Switzerland. 
In France, the notification system for human tuberculosis does not distinguish between tuberculosis cases 
caused by different species of Mycobacterium, and in Greece only cases due to Mycobacterium tuberculosis 
(M. tuberculosis) are reported. Therefore, no reporting of cases due to M. bovis is available from these two 
countries. 
Animals 
Tuberculosis in animals is notifiable in 25 MSs, Norway and Switzerland (information was not provided from 
Bulgaria and Malta). In Cyprus, Greece, Hungary, Poland and Romania only bovine tuberculosis is notifiable, 
and in Ireland only tuberculosis in ruminant animals is notifiable. Rules for intra-EU bovine trade, including 
requirements for cattle herds and country qualification as officially free from tuberculosis, are laid down in 
Council Directive 64/432/EC, as last amended by Commission Decision 2007/729/EC
70
. By the end of 2012, 
15 MSs (Austria, Belgium, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Latvia, 
Luxembourg, the Netherlands, Poland, Slovakia, Slovenia and Sweden), Switzerland and Norway were 
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 Commission Decision 2007/729/EC of 7 November 2007 amending Council Directives 64/432/EEC, 90/539/EEC, 92/35/EEC, 
92/119/EEC, 93/53/EEC, 95/70/EC, 2000/75/EC, 2001/89/EC, 2002/60/EC, and Decisions 2001/618/EC and 2004/233/EC as 
regards lists of national reference laboratories and State institutes. OJ L 294, 13.11.2007, p. 26–35. 
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officially bovine tuberculosis free (OTF). Liechtenstein has the same status (OTF) as Switzerland. In Iceland, 
which has no special agreement concerning animal health (status) with the EU, the last outbreak of bovine 
tuberculosis was in 1959. In the United Kingdom, Scotland is OTF, and in Italy 15 provinces and 6 regions 
have now been declared OTF. In Portugal, all administrative regions within the superior administrative unit of 
Algarve were declared OTF in 2012. Moreover, in 2012, eradication programmes in cattle herds in Ireland, 
Italy, Portugal, Spain and the United Kingdom received co-financing (Decision 2011/807/EU). 
5.4.6. Brucella data 
Humans 
The notification of brucellosis in humans is mandatory in almost all MSs, Iceland, Norway and Switzerland. 
Belgium has a voluntary reporting system and the United Kingdom has a different surveillance system. In 
Denmark, brucellosis is not notifiable and no surveillance is therefore in place. All of the existing surveillance 
systems for brucellosis have full national coverage.  
Foodstuffs 
The notification of Brucella in food is mandatory in 10 MSs (Austria, Belgium, Finland, Germany, Italy, Latvia, 
the Netherlands, Slovenia, Spain and the United Kingdom). Information was not provided from Bulgaria, 
Cyprus, the Czech Republic, Denmark, France, Greece, Lithuania, Luxembourg, Malta, Poland, Portugal, 
Romania, Slovakia and Switzerland.  
Animals 
Brucellosis in animals is notifiable in 24 MSs, Norway and Switzerland (information was not provided from 
Bulgaria, Cyprus and Malta). 
Cattle: Rules for intra-EU bovine trade, including requirements for cattle herds and country qualification as 
officially free from brucellosis, are laid down in Council Directive 64/432/EC, as last amended by Commission 
Decision 2007/729/EC. By the end of 2012, 16 MSs (Austria, Belgium, the Czech Republic, Denmark, 
Estonia, Finland, France, Germany, Ireland, Luxembourg, the Netherlands, Poland, Slovakia, Slovenia and 
Sweden), Norway and Switzerland were officially free from brucellosis in cattle (OBF). Liechtenstein has the 
same status (OBF) as Switzerland. Moreover, in the non-MS Iceland, which has no special agreement 
concerning animal health (status) with the EU, brucellosis (Brucella abortus (B. abortus), B. melitensis, 
B. suis) has never been reported. OBF regions have been declared in Italy (11 regions and 9 provinces), 
Portugal (six Islands of the Azores and all administrative regions within the superior administrative unit of 
Algarve), Spain (two provinces of the Canary Islands) and in the United Kingdom (Great Britain, and Isle of 
Man). In 2012, eradication programmes in cattle herds in Italy, Portugal, Spain and the United Kingdom 
(Northern Ireland) received co-financing (Decision 2011/807/EU). 
Sheep and goats: Rules for intra-EU trade of ovine and caprine animals and country qualification as officially 
free from ovine and caprine brucellosis, caused by B. melitensis (ObmF), are laid down in Council Directive 
91/68/EEC
71
, as last amended by Council Directive 2008/73/EC
72
. By the end of 2012, 19 MSs (Austria, 
Belgium, the Czech Republic, Denmark, Estonia, Finland, Germany, Hungary, Ireland, Latvia, Lithuania, 
Luxembourg, the Netherlands, Poland, Romania, Slovakia, Slovenia, Sweden and the United Kingdom), 
Norway and Switzerland were officially free from ovine and caprine brucellosis caused by B. melitensis 
(ObmF). Liechtenstein has the same status (ObmF) as Switzerland. Moreover, in the non-MS Iceland, which 
has no special agreement concerning animal health (status) with the EU, brucellosis (B. abortus, 
B. melitensis, B. suis) has never been reported. ObmF regions have been declared in France 
(64 departments), Italy (12 regions and 9 provinces ObmF), Portugal (the Azores Islands) and Spain (two 
provinces of the Canary Islands and the Balearic Islands). In 2012, eradication programmes for ovine and 
caprine brucellosis in Cyprus, Greece, Italy, Portugal and Spain received co-financing (Decision 
2011/807/EU). 
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5.4.7. Trichinella data 
Humans 
The notification of Trichinella infections in humans is mandatory in most MSs, Norway and Switzerland, but 
not in Denmark. Three MSs (Belgium, France and the United Kingdom) have a voluntary surveillance system 
for trichinellosis. All surveillance systems have full national coverage except in Belgium. Studies are being 
performed in Belgium to assess the coverage of the sentinel system. No surveillance system for trichinellosis 
exists in Iceland. In humans, diagnosis of Trichinella infections is primarily based on clinical symptoms and 
serology (ELISA and Western blot). Histopathology on muscle biopsies is rarely performed.  
Foodstuffs and animals 
Trichinella in foodstuffs is notifiable in 17 MSs and Norway. Ireland and Switzerland report that Trichinella is 
not notifiable. Information was not provided from Bulgaria, Cyprus, the Czech Republic, Denmark, Latvia, 
Lithuania, Luxembourg, Malta and the Netherlands.  
Trichinella infections in animals are notifiable in most countries except Hungary and Switzerland (information 
was not provided from Malta). 
Rules for testing for Trichinella in slaughtered animals are laid down by Commission Regulation (EC) No 
2075/2005. In accordance with this Regulation, all finisher pigs, sows, boar, horses, wild boar and some 
other wild species must be tested for Trichinella at slaughter. The Regulation allows MSs to apply for status 
as a region with negligible risk of Trichinella infestation in animals. Denmark is the only MS to have been 
assigned this status. Some MSs reported using digestion and compression methods as described in Council 
Directive 77/96/EEC
73
. 
5.4.8. Toxoplasma data 
Humans 
Data on congenital toxoplasmosis in the EU in 2012 are not included in this report but will be published in the 
ECDC Annual Epidemiological Report 2014 (in preparation). 
Animals 
Toxoplasmosis is a notifiable disease in Latvia, Poland and Switzerland in all animals and in Finland in all 
animals except hares, rabbits and rodents; no monitoring programmes are in place in these countries. In 
Germany, toxoplasmosis is notifiable in pigs, dogs and cats. In Austria, Denmark, and Sweden 
toxoplasmosis is not notifiable (information is missing from Belgium, Bulgaria, Cyprus, the Czech Republic, 
Estonia, France, Greece, Hungary, Ireland, Italy, Lithuania, Luxembourg, Malta, the Netherlands, Portugal, 
Romania, Slovakia, Slovenia, Spain and the United Kingdom). 
5.4.9. Rabies data  
Humans 
The notification of rabies in humans is mandatory in most MSs, Iceland, Norway and Switzerland. Belgium 
has a voluntary notification system and the United Kingdom has another system. Most countries examine 
human cases based on blood samples or cerebrospinal fluid, and saliva. However, in the case of post- 
mortem examinations, the central nervous system is sampled. Identification is mostly based on antigen 
detection, viral genome detection by RT-PCR and/or isolation of virus.  
Animals 
Rabies is a notifiable disease in all MSs. In animals, most countries test samples from the central nervous 
system. Identification is mostly carried out using the fluorescent antibody test (FAT), which is recommended 
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by both WHO
74
 and OIE
75
, and the mouse inoculation test. However, ELISA, PCR, and histology are also 
used. 
5.4.10. Q-fever data 
Humans 
The notification of Q fever in humans is mandatory in 22 MSs, Iceland, Norway and Switzerland. The disease 
is not notifiable in Austria, Denmark and Italy. Belgium, France, Spain and the United Kingdom have a 
voluntary system, which for Belgium and Spain is based on sentinel surveillance. The population covered by 
the sentinel surveillance system is estimated to be 25 % for Spain and unknown for Belgium, but both are 
reportedly constant over the study years. Cases are reported in an aggregated format by Bulgaria and 
Poland, and case based for the other countries. 
Animals 
C. burnetii in animals is notifiable in 15 MSs (Bulgaria, the Czech Republic, Denmark, Finland, France, 
Germany, Greece, Italy, Latvia, Lithuania, the Netherlands, Poland, Slovenia, Spain and Sweden) and 
Switzerland. In Austria, C. burnetii in animals is not notifiable (information is missing from the remaining 11 
MSs and Norway).  
Data reported are mostly based on suspect sampling due to an increase in abortions in the herd and 
identification is mostly carried out using serological testing methods as ELISA or immunofluorescence assay 
tests or direct identification methods such as real-time PCR. 
5.4.11. West Nile Virus data 
Humans 
The notification of West Nile fever in humans is mandatory in 21 MSs, Norway and Switzerland. The disease 
is not notifiable in Denmark, Germany and Portugal. Austria, Belgium, France and the United Kingdom have 
a voluntary system, which in Belgium and France is based on sentinel surveillance, and in the United 
Kingdom on another, unspecified, surveillance system. The population covered by the sentinel surveillance 
systems is unknown, but in both cases is reportedly constant over the study years. Cases are reported in an 
aggregated format by Bulgaria and Poland, and case based for the other countries. 
Total case numbers for West Nile were used because case confirmation according to the EU case definition 
is carried out only when cases occur in previously unaffected areas. Subsequent cases are diagnosed with 
laboratory methods for probable cases. Thus, both probable and confirmed cases reflect more accurately the 
epidemiological situation. This approach is also used for the seasonal real-time monitoring of West Nile 
cases in the EU carried out by ECDC.  
Animals 
Reporting of West Nile virus in animals is not mandatory. But where the epidemiological situation in a MS so 
warrants, West Nile virus in animals shall also be monitored. West Nile virus infection is notifiable in horses 
in Great Britain and in animals in Switzerland. 
5.4.12. Other zoonoses and zoonotic agents data 
Foodstuffs and animals 
Cysticercus in foodstuffs and animals: Monitoring is carried out as a visual inspection (macroscopic 
examination) of carcases at the slaughterhouse by meat inspection according to Regulation (EC) No 
854/2004
76
, or by specific serological tests. 
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5.4.13. Food-borne outbreaks data 
Food-borne outbreaks are incidents of two or more human cases of the same disease or infection in which 
the cases are linked or are probably linked to the same food vehicle. Situations in which the observed human 
cases exceed the expected number of cases and where the same food source is suspected are also 
indicative of a food-borne outbreak. 
Information on the total number of food-borne outbreaks (including both ‘weak-evidence’ and ‘strong- 
evidence’ food-borne outbreaks) and the total number of strong-evidence food-borne outbreaks that 
occurred during the reporting year was provided by 25 MSs and 2 non-MSs. Cyprus and Luxembourg did not 
report any outbreaks. For ‘weak-evidence’ food-borne outbreaks, the causative agent, as well as the number 
of human cases, hospitalisations and deaths, should be reported. For the ‘strong-evidence’ food-borne 
outbreaks, more detailed information is collected, including food vehicle and its origin, nature of evidence 
linking the outbreak cases to the food vehicle, type of outbreak, setting, place of origin of the problem and 
contributory factors. All food-borne outbreaks are included in the general tables and figures. In subsequent 
sections, outbreaks are presented in more detail and categorised by the causative agent, but excluding 
strong-evidence waterborne outbreaks. All strong evidence waterborne outbreaks are addressed in a 
separate section (Section 4.13). The denominators used for the calculation of the reporting rates were the 
human populations from the EUROSTAT as extracted on 28 June 2013.  
5.5. Terms used to describe prevalence or proportion-positive values 
In the report a set of standardised terms are used to characterise the proportion of positive sample units or 
the prevalence of zoonotic agents in animals and foodstuffs: 
 Rare: <0.1 % 
 Very low: 0.1 % to 1 % 
 Low: >1 % to 10 % 
 Moderate: >10 % to 20 % 
 High: >20 % to 50 % 
 Very high: >50 % to 70 % 
 Extremely high: >70 % 
 
 Majority of MSs: 60 % (in 2012 this was 16 MSs) 
 Most MSs: 75 % (in 2012 this was 20 MSs) 
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Abbreviations 
List of abbreviations 
Abbreviation Definition 
AHAW Animal Health and Welfare 
BIOHAZ Biological Hazards 
BBLV Bokeloh Bat Lyssavirus 
CFU colony-forming unit 
CI confidence Interval 
CONTAM EFSA Panel on Contaminants in the Food Chain 
DCF Data Collection Framework 
DT definitive phage type 
EAEC enteroaggressive Escherichia  coli 
EBLV European bat Lyssavirus 
EC European Commission 
ECDC European Centre for Disease Prevention and Control 
EEA European Economic Area 
EEC European Economic Community 
EFSA European Food Safety Authority 
EFTA European Free Trade Association 
EHEC enterohaemorragic Escherichia coli 
ELISA enzyme-linked immunosorbent assay  
EPEC enteropathogenic Escherichia coli 
EU European Union 
EURL European Union Reference Laboratory 
EUROSTAT European Committee on Antimicrobial Susceptibility Testing 
FAT fluorescent antibody test 
g  gram 
HACCP Hazard Analysis and Critical Control Point 
HUS Haemolytic–Uraemic Syndrome 
I-ELISA indirect enzyme-linked immunosorbent assay 
IHC ImmunoHistoChemistry 
ISO International Organization for Standardization 
LC-MC Liquid chromatography-mass spectroscopy 
LHT Low heat-treated 
MAC-ELISA IgM-capture ELISA 
MS Member State 
NMKL Nordic Committee on Food Analysis 
NRL National Reference Laboratory 
NT not typeable 
OBF officially brucellosis free specification, e.g. ‘as regards bovine herds’ 
ObmF officially Brucella melitensis free specification, e.g. ‘as regards ovine and caprine’ herds 
OIE World Organisation for Animal Health 
OR odds ratio 
OTF officially tuberculosis free specification, e.g. ‘as regards bovine herd’ 
PCR polymerase chain reaction  
PFGE Pulsed field gel electrophoresis 
RABV rabies virus 
RNA ribonucleic acid 
RTE ready-to-eat  
RT-PCR Real time polymerase chain reaction 
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Abbreviation Definition 
SAS Statistical Analysis System 
SLT-PCR Shiga-like toxin polymerase chain reaction  
spp. subspecies  
STEC Shiga toxin-producing Escherichia coli 
TESSy The European Surveillance System 
UHT ultra-high temperature  
VTEC verotoxigenic Escherichia coli 
WCB West Caucasian Bat virus 
WND West Nile disease 
WNV West Nile Virus 
WHO World Health Organization 
 
Member States of the European Union and other reporting countries in 2012 
Member States of the European Union, 2012 
Member State ISO Country Abbreviations 
Austria AT 
Belgium BE 
Bulgaria BG 
Cyprus CY 
Czech Republic CZ
1
 
Denmark DK 
Estonia EE 
Finland FI 
France FR 
Germany DE 
Greece GR 
Hungary HU 
Ireland IE 
Italy IT 
Latvia LV 
Lithuania LT 
Luxembourg LU 
Malta MT 
Netherlands NL
1
 
Poland PL 
Portugal PT 
Romania RO 
Slovakia SK 
Slovenia SI 
Spain ES 
Sweden SE 
United Kingdom UK
1
 
1. In text, referred to as the Czech Republic, the Netherlands and the United Kingdom. 
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Non Member States reporting in 2012 
Country ISO Country Abbreviations 
Iceland IS 
Norway NO 
Switzerland CH 
 
